term_id,p_values,significant,term_size,query_sizes,intersection_sizes,source,term_name,effective_domain_size,source_order,parents,highlighted
GO:0010604,3.91586554948099e-143,TRUE,3483,553,358,GO:BP,positive regulation of macromolecule metabolic process,21010,4323,GO:0009893|GO:0043170|GO:0060255,TRUE
GO:0051173,4.98716904744705e-142,TRUE,3071,553,339,GO:BP,positive regulation of nitrogen compound metabolic process,21010,14230,GO:0006807|GO:0009893|GO:0051171,FALSE
GO:0009893,2.60042095621597e-139,TRUE,3797,553,367,GO:BP,positive regulation of metabolic process,21010,3811,GO:0008152|GO:0019222|GO:0048518,FALSE
GO:0051171,1.16478601444054e-131,TRUE,5587,553,422,GO:BP,regulation of nitrogen compound metabolic process,21010,14228,GO:0006807|GO:0019222,FALSE
GO:0005654,1.00292519033391e-130,TRUE,4221,548,364,GO:CC,nucleoplasm,22090,252,GO:0031981|GO:0110165,TRUE
GO:0031325,1.61227923534289e-130,TRUE,3407,553,342,GO:BP,positive regulation of cellular metabolic process,21010,7463,GO:0009893|GO:0031323|GO:0044237|GO:0048522,FALSE
GO:0080090,3.02151785210912e-128,TRUE,5766,553,424,GO:BP,regulation of primary metabolic process,21010,18641,GO:0019222|GO:0044238,FALSE
GO:0048522,5.95481966983611e-114,TRUE,5711,553,407,GO:BP,positive regulation of cellular process,21010,13455,GO:0009987|GO:0048518|GO:0050794,FALSE
GO:0060255,4.27198322307289e-112,TRUE,6772,553,436,GO:BP,regulation of macromolecule metabolic process,21010,15204,GO:0019222|GO:0043170,FALSE
GO:0019219,9.03349405399095e-112,TRUE,4038,553,347,GO:BP,regulation of nucleobase-containing compound metabolic process,21010,5852,GO:0006139|GO:0031323|GO:0051171|GO:0080090,FALSE
GO:0010557,4.2868626874464e-111,TRUE,2599,553,285,GO:BP,positive regulation of macromolecule biosynthetic process,21010,4281,GO:0009059|GO:0010556|GO:0010604|GO:0031328,FALSE
GO:0048518,5.89566360088729e-111,TRUE,6253,553,420,GO:BP,positive regulation of biological process,21010,13451,GO:0008150|GO:0050789,FALSE
GO:2001141,7.33952588978364e-111,TRUE,3460,553,323,GO:BP,regulation of RNA biosynthetic process,21010,27454,GO:0010556|GO:0032774|GO:0051252,FALSE
GO:0045935,1.66975501308508e-110,TRUE,2039,553,256,GO:BP,positive regulation of nucleobase-containing compound metabolic process,21010,12346,GO:0006139|GO:0019219|GO:0031325|GO:0051173,FALSE
GO:0006355,6.23331725590769e-110,TRUE,3437,553,321,GO:BP,regulation of DNA-templated transcription,21010,2165,GO:0006351|GO:0010468|GO:2001141,FALSE
GO:0031328,3.1052794924996e-109,TRUE,2684,553,287,GO:BP,positive regulation of cellular biosynthetic process,21010,7466,GO:0009891|GO:0031325|GO:0031326|GO:0044249,FALSE
GO:0009891,2.0019322289007e-108,TRUE,2703,553,287,GO:BP,positive regulation of biosynthetic process,21010,3809,GO:0009058|GO:0009889|GO:0009893,FALSE
GO:0051252,1.85405565119756e-107,TRUE,3753,553,331,GO:BP,regulation of RNA metabolic process,21010,14280,GO:0016070|GO:0019219|GO:0060255,FALSE
GO:0032774,1.07012351272445e-106,TRUE,3600,553,324,GO:BP,RNA biosynthetic process,21010,8184,GO:0009059|GO:0016070|GO:0034654,FALSE
GO:0019222,1.48283681274004e-106,TRUE,7295,553,444,GO:BP,regulation of metabolic process,21010,5855,GO:0008152|GO:0050789,FALSE
GO:0006351,2.90908361792546e-106,TRUE,3563,553,322,GO:BP,DNA-templated transcription,21010,2161,GO:0010467|GO:0032774,FALSE
GO:0045893,9.35990983353585e-104,TRUE,1699,553,230,GO:BP,positive regulation of DNA-templated transcription,21010,12308,GO:0006351|GO:0006355|GO:1902680,FALSE
GO:0034654,1.70564576225085e-103,TRUE,4026,553,337,GO:BP,nucleobase-containing compound biosynthetic process,21010,9112,GO:0006139|GO:0018130|GO:0019438|GO:0044271|GO:1901362,FALSE
GO:1902680,2.29794109827932e-103,TRUE,1706,553,230,GO:BP,positive regulation of RNA biosynthetic process,21010,23342,GO:0010557|GO:0032774|GO:0051254|GO:2001141,FALSE
GO:0005694,3.24537767315397e-102,TRUE,1942,548,235,GO:CC,chromosome,22090,284,GO:0043232,FALSE
GO:0031323,1.16877377706533e-101,TRUE,6726,553,423,GO:BP,regulation of cellular metabolic process,21010,7461,GO:0019222|GO:0044237|GO:0050794,FALSE
GO:0019438,1.20089046692419e-101,TRUE,4110,553,338,GO:BP,aromatic compound biosynthetic process,21010,6052,GO:0006725|GO:0044249,FALSE
GO:0051254,1.3743550789615e-101,TRUE,1845,553,236,GO:BP,positive regulation of RNA metabolic process,21010,14282,GO:0010604|GO:0016070|GO:0045935|GO:0051252,FALSE
GO:0018130,3.73358333676144e-101,TRUE,4099,553,337,GO:BP,heterocycle biosynthetic process,21010,5461,GO:0044249|GO:0046483,FALSE
GO:0031981,5.32961134639077e-100,TRUE,5520,548,373,GO:CC,nuclear lumen,22090,1230,GO:0005634|GO:0070013,FALSE
GO:1901362,8.47579385386517e-99,TRUE,4255,553,340,GO:BP,organic cyclic compound biosynthetic process,21010,22266,GO:1901360|GO:1901576,FALSE
GO:0032993,1.07331948334143e-94,TRUE,1435,548,199,GO:CC,protein-DNA complex,22090,1345,GO:0032991,FALSE
GO:0000785,7.79248123106147e-94,TRUE,1366,548,194,GO:CC,chromatin,22090,92,GO:0005694|GO:0032993,FALSE
GO:0010556,2.65391348877722e-92,TRUE,5631,553,379,GO:BP,regulation of macromolecule biosynthetic process,21010,4280,GO:0009059|GO:0031326|GO:0060255,FALSE
GO:0010468,1.13094157639332e-91,TRUE,5499,553,374,GO:BP,regulation of gene expression,21010,4230,GO:0010467|GO:0010556,FALSE
GO:0031326,6.06177373707336e-90,TRUE,5757,553,380,GO:BP,regulation of cellular biosynthetic process,21010,7464,GO:0009889|GO:0031323|GO:0044249,FALSE
GO:0009889,3.7220525327113e-89,TRUE,5789,553,380,GO:BP,regulation of biosynthetic process,21010,3807,GO:0009058|GO:0019222,FALSE
GO:0044271,6.38151410681308e-88,TRUE,4860,553,348,GO:BP,cellular nitrogen compound biosynthetic process,21010,11501,GO:0034641|GO:0044249,FALSE
GO:0070013,8.31452115536381e-87,TRUE,6656,548,390,GO:CC,intracellular organelle lumen,22090,2404,GO:0043229|GO:0043233,FALSE
GO:0043233,8.31452115536381e-87,TRUE,6656,548,390,GO:CC,organelle lumen,22090,1889,GO:0031974|GO:0043226,FALSE
GO:0031974,8.31452115536381e-87,TRUE,6656,548,390,GO:CC,membrane-enclosed lumen,22090,1224,GO:0110165,FALSE
GO:0051716,2.5507711498153e-86,TRUE,7399,553,423,GO:BP,cellular response to stimulus,21010,14605,GO:0009987|GO:0050896,FALSE
GO:0019899,4.84263615498279e-86,TRUE,2075,555,235,GO:MF,enzyme binding,20139,3750,GO:0005515,TRUE
GO:0006366,8.10842058239255e-84,TRUE,2521,553,250,GO:BP,transcription by RNA polymerase II,21010,2174,GO:0006351,FALSE
GO:0033554,2.82534689727619e-83,TRUE,1925,553,220,GO:BP,cellular response to stress,21010,8667,GO:0006950|GO:0051716,FALSE
GO:0036211,1.34563249472633e-82,TRUE,3409,553,287,GO:BP,protein modification process,21010,9953,GO:0019538|GO:0043412,FALSE
GO:0006357,1.99261068119835e-82,TRUE,2408,553,243,GO:BP,regulation of transcription by RNA polymerase II,21010,2167,GO:0006355|GO:0006366,FALSE
GO:0045934,8.37686637985176e-81,TRUE,1555,553,197,GO:BP,negative regulation of nucleobase-containing compound metabolic process,21010,12345,GO:0006139|GO:0019219|GO:0031324|GO:0051172,FALSE
GO:0043412,1.79943724997025e-80,TRUE,3628,553,293,GO:BP,macromolecule modification,21010,11190,GO:0043170,FALSE
GO:0051172,4.90963334971269e-78,TRUE,2353,553,235,GO:BP,negative regulation of nitrogen compound metabolic process,21010,14229,GO:0006807|GO:0009892|GO:0051171,FALSE
GO:0050794,1.84425976609233e-77,TRUE,11758,553,509,GO:BP,regulation of cellular process,21010,13920,GO:0009987|GO:0050789,FALSE
GO:0050896,1.23828693379847e-76,TRUE,8955,553,450,GO:BP,response to stimulus,21010,14004,GO:0008150,FALSE
GO:0048583,2.41153653772334e-75,TRUE,3909,553,297,GO:BP,regulation of response to stimulus,21010,13506,GO:0050789|GO:0050896,FALSE
GO:0048523,9.24758396111478e-75,TRUE,5511,553,352,GO:BP,negative regulation of cellular process,21010,13456,GO:0009987|GO:0048519|GO:0050794,FALSE
GO:0008134,1.40210999649025e-74,TRUE,594,555,127,GO:MF,transcription factor binding,20139,1574,GO:0005515,TRUE
GO:0051253,2.38182097021032e-74,TRUE,1438,553,183,GO:BP,negative regulation of RNA metabolic process,21010,14281,GO:0010605|GO:0016070|GO:0045934|GO:0051252,FALSE
GO:1902679,3.8826847201939e-74,TRUE,1323,553,176,GO:BP,negative regulation of RNA biosynthetic process,21010,23341,GO:0010558|GO:0032774|GO:0051253|GO:2001141,FALSE
GO:0045892,5.41191049912229e-74,TRUE,1309,553,175,GO:BP,negative regulation of DNA-templated transcription,21010,12307,GO:0006351|GO:0006355|GO:1902679,FALSE
GO:0050789,1.12345433237839e-73,TRUE,12331,553,515,GO:BP,regulation of biological process,21010,13916,GO:0008150|GO:0065007,FALSE
GO:0008219,3.20608739765224e-72,TRUE,1988,553,210,GO:BP,cell death,21010,3199,GO:0009987,FALSE
GO:0006915,3.54117948004514e-72,TRUE,1910,553,206,GO:BP,apoptotic process,21010,2604,GO:0012501,FALSE
GO:0048519,3.88080673611638e-72,TRUE,5913,553,361,GO:BP,negative regulation of biological process,21010,13452,GO:0008150|GO:0050789,FALSE
GO:0065007,8.84468061553519e-72,TRUE,12751,553,520,GO:BP,biological regulation,21010,16682,GO:0008150,FALSE
GO:0012501,1.17732127174988e-71,TRUE,1982,553,209,GO:BP,programmed cell death,21010,4656,GO:0008219,FALSE
GO:0045944,3.50360142803902e-71,TRUE,1245,553,168,GO:BP,positive regulation of transcription by RNA polymerase II,21010,12354,GO:0006357|GO:0006366|GO:0045893,FALSE
GO:0010033,6.77883002672266e-71,TRUE,2775,553,245,GO:BP,response to organic substance,21010,3903,GO:0042221,FALSE
GO:0140297,8.69239319032211e-69,TRUE,486,555,112,GO:MF,DNA-binding transcription factor binding,20139,10537,GO:0008134,FALSE
GO:0071310,1.68418359345848e-68,TRUE,2001,553,206,GO:BP,cellular response to organic substance,21010,17376,GO:0010033|GO:0070887,FALSE
GO:0070887,2.08161025316193e-68,TRUE,2691,553,238,GO:BP,cellular response to chemical stimulus,21010,17162,GO:0042221|GO:0051716,FALSE
GO:0009719,3.46388327002407e-68,TRUE,1696,553,190,GO:BP,response to endogenous stimulus,21010,3674,GO:0050896,FALSE
GO:0050793,1.74844801188559e-65,TRUE,2465,553,224,GO:BP,regulation of developmental process,21010,13919,GO:0032502|GO:0050789,FALSE
GO:0051247,1.98110615147719e-65,TRUE,1374,553,169,GO:BP,positive regulation of protein metabolic process,21010,14275,GO:0010604|GO:0019538|GO:0051173|GO:0051246,FALSE
GO:0006950,2.15661257289963e-65,TRUE,3909,553,283,GO:BP,response to stress,21010,2624,GO:0050896,FALSE
GO:0043067,4.72985690602582e-65,TRUE,1507,553,176,GO:BP,regulation of programmed cell death,21010,11019,GO:0012501|GO:0050794,FALSE
GO:0031399,6.71915882034462e-65,TRUE,1385,553,169,GO:BP,regulation of protein modification process,21010,7503,GO:0036211|GO:0051246,FALSE
GO:0042981,1.40298439024844e-64,TRUE,1463,553,173,GO:BP,regulation of apoptotic process,21010,10971,GO:0006915|GO:0043067,FALSE
GO:0023051,1.55374929021077e-64,TRUE,3396,553,262,GO:BP,regulation of signaling,21010,6954,GO:0023052|GO:0050789,FALSE
GO:0019538,4.69203579081225e-64,TRUE,5373,553,332,GO:BP,protein metabolic process,21010,6144,GO:0043170|GO:0044238|GO:1901564,FALSE
GO:0005634,1.04708156371775e-63,TRUE,10063,548,443,GO:CC,nucleus,22090,243,GO:0043231,FALSE
GO:0010646,1.36339538897717e-63,TRUE,3405,553,261,GO:BP,regulation of cell communication,21010,4364,GO:0007154|GO:0050794,FALSE
GO:0007154,1.62043502570632e-63,TRUE,6495,553,366,GO:BP,cell communication,21010,2765,GO:0009987,FALSE
GO:0065009,9.79413517835349e-63,TRUE,2526,553,223,GO:BP,regulation of molecular function,21010,16684,GO:0065007,FALSE
GO:0051246,4.05368126051472e-62,TRUE,2389,553,216,GO:BP,regulation of protein metabolic process,21010,14274,GO:0019538|GO:0051171|GO:0060255|GO:0080090,FALSE
GO:0009966,7.26331319264829e-62,TRUE,2973,553,241,GO:BP,regulation of signal transduction,21010,3862,GO:0007165|GO:0010646|GO:0023051|GO:0048583,FALSE
GO:0032502,8.11581896814798e-62,TRUE,6414,553,361,GO:BP,developmental process,21010,7976,GO:0008150,FALSE
GO:0003682,1.11665427527235e-61,TRUE,585,555,114,GO:MF,chromatin binding,20139,328,GO:0044877,TRUE
GO:0045595,5.37865280953424e-61,TRUE,1562,553,174,GO:BP,regulation of cell differentiation,21010,12061,GO:0030154|GO:0050793|GO:0050794,FALSE
GO:0031324,9.77805761887549e-61,TRUE,3233,553,250,GO:BP,negative regulation of cellular metabolic process,21010,7462,GO:0009892|GO:0031323|GO:0044237|GO:0048523,FALSE
GO:0051239,1.29439916966498e-60,TRUE,2968,553,239,GO:BP,regulation of multicellular organismal process,21010,14270,GO:0032501|GO:0050789,FALSE
GO:0005667,1.48470347443355e-60,TRUE,520,548,103,GO:CC,transcription regulator complex,22090,262,GO:0032991,FALSE
GO:0023052,3.17608271568768e-60,TRUE,6396,553,358,GO:BP,signaling,21010,6955,GO:0050789,FALSE
GO:0071495,6.96266913545826e-60,TRUE,1458,553,167,GO:BP,cellular response to endogenous stimulus,21010,17539,GO:0009719,FALSE
GO:0007165,8.70661589363662e-60,TRUE,5926,553,343,GO:BP,signal transduction,21010,2776,GO:0007154|GO:0009987|GO:0023052|GO:0050794|GO:0051716,FALSE
GO:0009892,2.14683789605489e-59,TRUE,3563,553,261,GO:BP,negative regulation of metabolic process,21010,3810,GO:0008152|GO:0019222|GO:0048519,FALSE
GO:0042221,4.8153719130475e-59,TRUE,3975,553,276,GO:BP,response to chemical,21010,10548,GO:0050896,FALSE
GO:0007275,1.35645424038959e-58,TRUE,4610,553,298,GO:BP,multicellular organism development,21010,2853,GO:0032501|GO:0048856,FALSE
GO:0010605,6.97804769082756e-58,TRUE,3339,553,250,GO:BP,negative regulation of macromolecule metabolic process,21010,4324,GO:0009892|GO:0043170|GO:0060255,FALSE
GO:0061629,1.41342592079461e-57,TRUE,351,555,89,GO:MF,RNA polymerase II-specific DNA-binding transcription factor binding,20139,8496,GO:0140297,FALSE
GO:0031401,3.48918705201945e-57,TRUE,890,553,130,GO:BP,positive regulation of protein modification process,21010,7505,GO:0031399|GO:0036211|GO:0051247,FALSE
GO:0000122,1.37641375778679e-56,TRUE,978,553,135,GO:BP,negative regulation of transcription by RNA polymerase II,21010,51,GO:0006357|GO:0006366|GO:0045892,FALSE
GO:0030154,2.21791149115155e-56,TRUE,4310,553,284,GO:BP,cell differentiation,21010,7002,GO:0048869,FALSE
GO:1901700,2.26711231400027e-56,TRUE,1774,553,179,GO:BP,response to oxygen-containing compound,21010,22529,GO:0042221,FALSE
GO:0048869,2.33629834831302e-56,TRUE,4311,553,284,GO:BP,cellular developmental process,21010,13764,GO:0009987|GO:0032502,FALSE
GO:0032501,6.26437851114384e-56,TRUE,7648,553,387,GO:BP,multicellular organismal process,21010,7975,GO:0008150,FALSE
GO:0016310,1.38948033444755e-55,TRUE,1735,553,176,GO:BP,phosphorylation,21010,5287,GO:0006796,FALSE
GO:0048856,2.17245236687335e-55,TRUE,5862,553,334,GO:BP,anatomical structure development,21010,13752,GO:0032502,FALSE
GO:0035556,3.20161164428234e-55,TRUE,2609,553,216,GO:BP,intracellular signal transduction,21010,9527,GO:0007165,FALSE
GO:0043687,4.12372003577294e-55,TRUE,1276,553,151,GO:BP,post-translational protein modification,21010,11358,GO:0036211,FALSE
GO:0006468,1.99234110223548e-54,TRUE,1493,553,162,GO:BP,protein phosphorylation,21010,2242,GO:0016310|GO:0036211,FALSE
GO:0009628,3.70426430040666e-54,TRUE,1106,553,140,GO:BP,response to abiotic stimulus,21010,3606,GO:0050896,FALSE
GO:1901564,2.21238571972391e-53,TRUE,6362,553,346,GO:BP,organonitrogen compound metabolic process,21010,22437,GO:0006807|GO:0071704,FALSE
GO:0006807,5.21716107242937e-53,TRUE,12114,553,487,GO:BP,nitrogen compound metabolic process,21010,2527,GO:0008152,FALSE
GO:0007166,6.16952691270351e-53,TRUE,2783,553,220,GO:BP,cell surface receptor signaling pathway,21010,2777,GO:0007165,FALSE
GO:0005829,8.24739935544599e-53,TRUE,5457,548,305,GO:CC,cytosol,22090,380,GO:0005737|GO:0110165,FALSE
GO:0044093,1.33618805393257e-52,TRUE,1500,553,160,GO:BP,positive regulation of molecular function,21010,11466,GO:0065009,FALSE
GO:0080134,2.24434034195972e-52,TRUE,1430,553,156,GO:BP,regulation of response to stress,21010,18659,GO:0006950|GO:0048583,FALSE
GO:0071824,3.88553112126191e-52,TRUE,885,553,124,GO:BP,protein-DNA complex organization,21010,17746,GO:0043933,TRUE
GO:0032991,5.46410819820707e-52,TRUE,8527,548,389,GO:CC,protein-containing complex,22090,1343,GO:0005575,FALSE
GO:0010558,1.88691048831771e-51,TRUE,2741,553,216,GO:BP,negative regulation of macromolecule biosynthetic process,21010,4282,GO:0009059|GO:0010556|GO:0010605|GO:0031327,FALSE
GO:0043170,1.98996578262327e-51,TRUE,12326,553,489,GO:BP,macromolecule metabolic process,21010,11075,GO:0071704,FALSE
GO:0044877,6.86017055542863e-51,TRUE,1761,555,174,GO:MF,protein-containing complex binding,20139,6092,GO:0005488,FALSE
GO:0048513,1.50887087136197e-50,TRUE,3068,553,228,GO:BP,animal organ development,21010,13448,GO:0048856,FALSE
GO:1902494,2.33945385984652e-50,TRUE,1781,548,165,GO:CC,catalytic complex,22090,3631,GO:0032991,FALSE
GO:0044238,2.5995108021577e-50,TRUE,12666,553,494,GO:BP,primary metabolic process,21010,11489,GO:0008152,FALSE
GO:0009890,2.7957383634316e-50,TRUE,2808,553,217,GO:BP,negative regulation of biosynthetic process,21010,3808,GO:0009058|GO:0009889|GO:0009892,FALSE
GO:0090304,3.42307367323013e-50,TRUE,7482,553,373,GO:BP,nucleic acid metabolic process,21010,19056,GO:0006139|GO:0043170,FALSE
GO:0048584,4.41340429302008e-50,TRUE,2212,553,191,GO:BP,positive regulation of response to stimulus,21010,13507,GO:0048518|GO:0048583|GO:0050896,FALSE
GO:0031327,5.24415373497388e-50,TRUE,2794,553,216,GO:BP,negative regulation of cellular biosynthetic process,21010,7465,GO:0009890|GO:0031324|GO:0031326|GO:0044249,FALSE
GO:0005515,1.49825587935007e-49,TRUE,14811,555,539,GO:MF,protein binding,20139,1495,GO:0005488,FALSE
GO:0048731,1.67285500297383e-49,TRUE,3951,553,260,GO:BP,system development,21010,13640,GO:0007275|GO:0048856,FALSE
GO:1901701,1.64407469763469e-47,TRUE,1269,553,141,GO:BP,cellular response to oxygen-containing compound,21010,22530,GO:0070887|GO:1901700,FALSE
REAC:R-HSA-212436,2.54944770385251e-47,TRUE,1236,485,177,REAC,Generic Transcription Pathway,10835,998,REAC:R-HSA-73857,FALSE
GO:0006325,3.85814073330022e-47,TRUE,788,553,112,GO:BP,chromatin organization,21010,2154,GO:0071824,FALSE
REAC:R-HSA-74160,7.33286872613711e-47,TRUE,1493,485,195,REAC,Gene expression (Transcription),10835,996,REAC:0000000,FALSE
GO:0014070,1.83870813246179e-46,TRUE,911,553,119,GO:BP,response to organic cyclic compound,21010,4719,GO:0010033,FALSE
GO:0019900,3.13665191910499e-46,TRUE,766,555,111,GO:MF,kinase binding,20139,3751,GO:0019899,FALSE
GO:0006139,3.52323413203897e-46,TRUE,7990,553,380,GO:BP,nucleobase-containing compound metabolic process,21010,2013,GO:0006725|GO:0034641|GO:0044238|GO:0046483|GO:1901360,FALSE
GO:0006725,1.22940744434493e-45,TRUE,8212,553,385,GO:BP,cellular aromatic compound metabolic process,21010,2468,GO:0044237,FALSE
GO:0003677,1.38142280813624e-45,TRUE,2530,555,202,GO:MF,DNA binding,20139,324,GO:0003676,FALSE
GO:0042325,1.5629424656759e-45,TRUE,1117,553,130,GO:BP,regulation of phosphorylation,21010,10593,GO:0016310|GO:0019220,FALSE
GO:0051338,1.86989769464609e-45,TRUE,834,553,113,GO:BP,regulation of transferase activity,21010,14346,GO:0050790,FALSE
GO:0140110,3.00117695092494e-45,TRUE,1742,555,165,GO:MF,transcription regulator activity,20139,10515,GO:0003674,TRUE
GO:1901360,6.91519950123716e-45,TRUE,8451,553,390,GO:BP,organic cyclic compound metabolic process,21010,22264,GO:0071704,FALSE
GO:0044389,6.97594263648607e-45,TRUE,324,555,75,GO:MF,ubiquitin-like protein ligase binding,20139,6037,GO:0019899,FALSE
GO:0019220,8.60364915522757e-45,TRUE,1261,553,137,GO:BP,regulation of phosphate metabolic process,21010,5853,GO:0006796|GO:0051174,FALSE
GO:0051174,9.44996292458024e-45,TRUE,1262,553,137,GO:BP,regulation of phosphorus metabolic process,21010,14231,GO:0006793|GO:0031323,FALSE
GO:0016570,1.05792875089018e-44,TRUE,291,553,71,GO:BP,histone modification,21010,5344,GO:0043687,FALSE
GO:0006338,2.02821796670898e-44,TRUE,655,553,100,GO:BP,chromatin remodeling,21010,2158,GO:0006325,FALSE
GO:0051726,3.42782216726102e-44,TRUE,1112,553,128,GO:BP,regulation of cell cycle,21010,14607,GO:0007049|GO:0050794,FALSE
GO:0046483,3.63834956584388e-44,TRUE,8160,553,381,GO:BP,heterocycle metabolic process,21010,12812,GO:0044237,FALSE
GO:0001932,6.92085694929776e-44,TRUE,1014,553,122,GO:BP,regulation of protein phosphorylation,21010,557,GO:0006468|GO:0031399|GO:0042325,FALSE
GO:0031625,1.69237897215454e-43,TRUE,306,555,72,GO:MF,ubiquitin protein ligase binding,20139,4172,GO:0044389,FALSE
KEGG:05161,2.98874842442358e-43,TRUE,161,431,68,KEGG,Hepatitis B,8161,435,KEGG:00000,FALSE
GO:0048511,1.03014720733654e-42,TRUE,299,553,70,GO:BP,rhythmic process,21010,13446,GO:0008150,FALSE
GO:0019901,1.55315682353028e-42,TRUE,682,555,101,GO:MF,protein kinase binding,20139,3752,GO:0019900,FALSE
GO:0009725,1.56880288084055e-42,TRUE,858,553,111,GO:BP,response to hormone,21010,3680,GO:0009719|GO:0010033,FALSE
GO:0048585,2.14984481471961e-42,TRUE,1639,553,153,GO:BP,negative regulation of response to stimulus,21010,13508,GO:0048519|GO:0048583|GO:0050896,FALSE
GO:0051094,4.12990586631959e-42,TRUE,1310,553,136,GO:BP,positive regulation of developmental process,21010,14161,GO:0032502|GO:0048518|GO:0050793,FALSE
REAC:R-HSA-73857,5.73887135200794e-42,TRUE,1357,485,178,REAC,RNA Polymerase II Transcription,10835,1807,REAC:R-HSA-74160,FALSE
GO:0006974,9.33107277291647e-42,TRUE,890,553,112,GO:BP,DNA damage response,21010,2643,GO:0033554,FALSE
GO:0050790,1.24359429529024e-41,TRUE,1788,553,159,GO:BP,regulation of catalytic activity,21010,13917,GO:0065009,FALSE
GO:0080135,1.44760429101572e-41,TRUE,658,553,97,GO:BP,regulation of cellular response to stress,21010,18660,GO:0033554|GO:0050794|GO:0080134,FALSE
GO:0051240,2.36726943769594e-41,TRUE,1629,553,151,GO:BP,positive regulation of multicellular organismal process,21010,14271,GO:0032501|GO:0048518|GO:0051239,FALSE
GO:0006796,2.69110744352954e-41,TRUE,2694,553,198,GO:BP,phosphate-containing compound metabolic process,21010,2521,GO:0006793,FALSE
GO:0034641,3.013064154314e-41,TRUE,8625,553,388,GO:BP,cellular nitrogen compound metabolic process,21010,9105,GO:0006807|GO:0044237,FALSE
GO:0043565,3.48938349634643e-41,TRUE,1581,555,151,GO:MF,sequence-specific DNA binding,20139,5815,GO:0003677,FALSE
WP:WP4666,3.66599770519053e-41,TRUE,151,461,65,WP,Hepatitis B infection,8625,104,WP:000000,FALSE
GO:2000026,4.61313740957994e-41,TRUE,1396,553,139,GO:BP,regulation of multicellular organismal development,21010,26446,GO:0007275|GO:0050793|GO:0051239,FALSE
GO:0006793,1.10563095110574e-40,TRUE,2719,553,198,GO:BP,phosphorus metabolic process,21010,2518,GO:0044237,FALSE
GO:0006259,2.0120587488958e-40,TRUE,1039,553,119,GO:BP,DNA metabolic process,21010,2106,GO:0090304,FALSE
GO:0023057,2.7039572031191e-40,TRUE,1378,553,137,GO:BP,negative regulation of signaling,21010,6957,GO:0023051|GO:0023052|GO:0048519,FALSE
GO:0010648,2.7039572031191e-40,TRUE,1378,553,137,GO:BP,negative regulation of cell communication,21010,4366,GO:0007154|GO:0010646|GO:0048523,FALSE
GO:0043231,2.72431138254696e-40,TRUE,14560,548,497,GO:CC,intracellular membrane-bounded organelle,22090,1887,GO:0043227|GO:0043229,FALSE
GO:0043232,5.81871782872517e-40,TRUE,6568,548,315,GO:CC,intracellular non-membrane-bounded organelle,22090,1888,GO:0043228|GO:0043229,FALSE
GO:0043228,6.02063011024911e-40,TRUE,6569,548,315,GO:CC,non-membrane-bounded organelle,22090,1884,GO:0043226,FALSE
GO:0033993,2.399068997874e-39,TRUE,907,553,110,GO:BP,response to lipid,21010,8755,GO:0010033,FALSE
GO:0044237,2.54118199585868e-39,TRUE,12909,553,483,GO:BP,cellular metabolic process,21010,11488,GO:0008152|GO:0009987,FALSE
GO:0016070,6.78156365934289e-39,TRUE,6934,553,337,GO:BP,RNA metabolic process,21010,5184,GO:0090304,FALSE
GO:0071407,9.51809308420833e-39,TRUE,559,553,87,GO:BP,cellular response to organic cyclic compound,21010,17469,GO:0014070|GO:0071310,FALSE
GO:1990234,1.61583367664558e-38,TRUE,892,548,104,GO:CC,transferase complex,22090,3832,GO:1902494,FALSE
GO:0018193,4.563879253888e-38,TRUE,1077,553,118,GO:BP,peptidyl-amino acid modification,21010,5514,GO:0036211,FALSE
GO:1902531,5.07094421323984e-38,TRUE,1691,553,149,GO:BP,regulation of intracellular signal transduction,21010,23244,GO:0009966|GO:0035556,FALSE
GO:0009968,6.31107243901888e-38,TRUE,1268,553,128,GO:BP,negative regulation of signal transduction,21010,3864,GO:0007165|GO:0009966|GO:0010648|GO:0023057|GO:0048585,FALSE
GO:0048468,6.91143769372762e-38,TRUE,2762,553,195,GO:BP,cell development,21010,13419,GO:0030154|GO:0048856|GO:0048869,FALSE
GO:0071704,7.17717001785949e-38,TRUE,13917,553,500,GO:BP,organic substance metabolic process,21010,17686,GO:0008152,FALSE
GO:0043549,1.99155266712462e-37,TRUE,701,553,95,GO:BP,regulation of kinase activity,21010,11276,GO:0042325|GO:0051338,FALSE
GO:0042127,2.79574793107916e-37,TRUE,2184,553,170,GO:BP,regulation of cell population proliferation,21010,10477,GO:0008283|GO:0050794,FALSE
GO:0097190,3.12726699577505e-37,TRUE,613,553,89,GO:BP,apoptotic signaling pathway,21010,19413,GO:0006915|GO:0007165,FALSE
GO:0009967,3.9294429507965e-37,TRUE,1510,553,139,GO:BP,positive regulation of signal transduction,21010,3863,GO:0007165|GO:0009966|GO:0010647|GO:0023056|GO:0048584,FALSE
GO:0023056,5.53504024574797e-37,TRUE,1725,553,149,GO:BP,positive regulation of signaling,21010,6956,GO:0023051|GO:0023052|GO:0048518,FALSE
GO:0045859,8.97612507884152e-37,TRUE,606,553,88,GO:BP,regulation of protein kinase activity,21010,12288,GO:0001932|GO:0043549,FALSE
KEGG:04936,9.79529226389245e-37,TRUE,142,431,59,KEGG,Alcoholic liver disease,8161,386,KEGG:00000,FALSE
GO:0010647,2.44502432194775e-36,TRUE,1725,553,148,GO:BP,positive regulation of cell communication,21010,4365,GO:0007154|GO:0010646|GO:0048522,FALSE
KEGG:04668,3.54498377330448e-36,TRUE,113,431,53,KEGG,TNF signaling pathway,8161,336,KEGG:00000,FALSE
GO:0043085,4.91098707023995e-36,TRUE,1091,553,116,GO:BP,positive regulation of catalytic activity,21010,11024,GO:0044093|GO:0050790,FALSE
GO:0042327,5.09176015032922e-36,TRUE,728,553,95,GO:BP,positive regulation of phosphorylation,21010,10595,GO:0016310|GO:0042325|GO:0045937,FALSE
GO:0010467,8.9252211958132e-36,TRUE,9182,553,392,GO:BP,gene expression,21010,4229,GO:0009059,FALSE
GO:0060070,9.4059975573882e-36,TRUE,304,553,64,GO:BP,canonical Wnt signaling pathway,21010,15062,GO:0016055,TRUE
GO:0016055,1.19845325034551e-35,TRUE,454,553,76,GO:BP,Wnt signaling pathway,21010,5173,GO:0007166|GO:0198738,FALSE
GO:0198738,1.64849888723436e-35,TRUE,456,553,76,GO:BP,cell-cell signaling by wnt,21010,21112,GO:0007267,FALSE
GO:1901698,1.7230701525596e-35,TRUE,1105,553,116,GO:BP,response to nitrogen compound,21010,22527,GO:0042221,FALSE
GO:1901873,2.08559429063894e-35,TRUE,331,553,66,GO:BP,regulation of post-translational protein modification,21010,22696,GO:0031399|GO:0043687,FALSE
GO:0007623,2.75941316945162e-35,TRUE,204,553,54,GO:BP,circadian rhythm,21010,3133,GO:0048511,FALSE
GO:0007049,4.18441589501988e-35,TRUE,1811,553,150,GO:BP,cell cycle,21010,2692,GO:0009987,FALSE
GO:0090575,5.62887138659961e-35,TRUE,258,548,57,GO:CC,RNA polymerase II transcription regulator complex,22090,2864,GO:0005667|GO:0140513,FALSE
GO:0010562,6.6821466148981e-35,TRUE,800,553,98,GO:BP,positive regulation of phosphorus metabolic process,21010,4286,GO:0006793|GO:0031325|GO:0051174,FALSE
GO:0045937,6.6821466148981e-35,TRUE,800,553,98,GO:BP,positive regulation of phosphate metabolic process,21010,12348,GO:0006796|GO:0010562|GO:0019220,FALSE
GO:0003690,1.43279820856054e-34,TRUE,1562,555,140,GO:MF,double-stranded DNA binding,20139,332,GO:0003677,FALSE
GO:0051090,1.75147091030459e-34,TRUE,444,553,74,GO:BP,regulation of DNA-binding transcription factor activity,21010,14157,GO:0006355|GO:0065009,FALSE
GO:0009605,1.78336764116197e-34,TRUE,2686,553,186,GO:BP,response to external stimulus,21010,3590,GO:0050896,FALSE
GO:0008152,2.15673861771621e-34,TRUE,14362,553,503,GO:BP,metabolic process,21010,3178,GO:0008150,FALSE
GO:0043066,2.53142020925241e-34,TRUE,881,553,102,GO:BP,negative regulation of apoptotic process,21010,11018,GO:0006915|GO:0042981|GO:0043069,FALSE
GO:0071496,2.6064380629486e-34,TRUE,332,553,65,GO:BP,cellular response to external stimulus,21010,17540,GO:0009605,FALSE
GO:0001934,2.63467127477495e-34,TRUE,666,553,89,GO:BP,positive regulation of protein phosphorylation,21010,559,GO:0001932|GO:0006468|GO:0031401|GO:0042327,FALSE
GO:0001067,3.56118263887489e-34,TRUE,1393,555,131,GO:MF,transcription regulatory region nucleic acid binding,20139,151,GO:0003676,FALSE
GO:0010243,4.84817048870648e-34,TRUE,1031,553,110,GO:BP,response to organonitrogen compound,21010,4080,GO:0010033|GO:1901698,FALSE
GO:0010628,5.3827913324881e-34,TRUE,1183,553,118,GO:BP,positive regulation of gene expression,21010,4346,GO:0010467|GO:0010468|GO:0010557,FALSE
GO:0043069,6.49765323506749e-34,TRUE,908,553,103,GO:BP,negative regulation of programmed cell death,21010,11021,GO:0012501|GO:0043067|GO:0048523,FALSE
GO:0000118,8.0679292590532e-34,TRUE,81,548,36,GO:CC,histone deacetylase complex,22090,7,GO:0005654|GO:0140513|GO:1902494,FALSE
GO:0140535,9.87455905021365e-34,TRUE,951,548,101,GO:CC,intracellular protein-containing complex,22090,3568,GO:0032991,FALSE
GO:0000976,1.3739033203363e-33,TRUE,1391,555,130,GO:MF,transcription cis-regulatory region binding,20139,115,GO:0001067|GO:1990837,FALSE
GO:0009059,1.86865303297207e-33,TRUE,9681,553,400,GO:BP,macromolecule biosynthetic process,21010,3291,GO:0043170|GO:0044249|GO:1901576,FALSE
GO:1901875,2.22130119933413e-33,TRUE,191,553,51,GO:BP,positive regulation of post-translational protein modification,21010,22698,GO:0031401|GO:0043687|GO:1901873,FALSE
GO:0060284,2.64813927631649e-33,TRUE,835,553,98,GO:BP,regulation of cell development,21010,15232,GO:0045595|GO:0048468,FALSE
GO:1990837,4.1106957519088e-33,TRUE,1466,555,133,GO:MF,sequence-specific double-stranded DNA binding,20139,11191,GO:0003690|GO:0043565,FALSE
GO:0008283,4.3966151891807e-33,TRUE,3218,553,204,GO:BP,cell population proliferation,21010,3204,GO:0009987,FALSE
GO:0003712,6.97588654246577e-33,TRUE,513,555,78,GO:MF,transcription coregulator activity,20139,341,GO:0140110,FALSE
GO:0071396,9.48571000795235e-33,TRUE,602,553,83,GO:BP,cellular response to lipid,21010,17458,GO:0033993|GO:0071310,FALSE
GO:0043227,1.01801001168136e-32,TRUE,15624,548,504,GO:CC,membrane-bounded organelle,22090,1883,GO:0043226,FALSE
GO:0032870,1.07500499923647e-32,TRUE,603,553,83,GO:BP,cellular response to hormone stimulus,21010,8238,GO:0009725|GO:0071310|GO:0071495,FALSE
GO:0051093,1.52324567786058e-32,TRUE,923,553,102,GO:BP,negative regulation of developmental process,21010,14160,GO:0032502|GO:0048519|GO:0050793,FALSE
REAC:R-HSA-162582,1.69795347023227e-32,TRUE,2546,485,236,REAC,Signal Transduction,10835,2105,REAC:0000000,FALSE
GO:0062197,1.7360969772958e-32,TRUE,306,553,61,GO:BP,cellular response to chemical stress,21010,16653,GO:0033554|GO:0070887,FALSE
KEGG:05200,2.20986001938693e-32,TRUE,529,431,104,KEGG,Pathways in cancer,8161,446,KEGG:00000,FALSE
REAC:R-HSA-1643685,5.05261921289367e-32,TRUE,1768,485,189,REAC,Disease,10835,714,REAC:0000000,FALSE
GO:0007267,6.09581972206448e-32,TRUE,1703,553,140,GO:BP,cell-cell signaling,21010,2846,GO:0007154|GO:0023052,FALSE
GO:0030097,2.04507378617337e-31,TRUE,951,553,102,GO:BP,hemopoiesis,21010,6990,GO:0048468,FALSE
GO:0045597,4.1694603106132e-31,TRUE,851,553,96,GO:BP,positive regulation of cell differentiation,21010,12063,GO:0030154|GO:0045595|GO:0048522|GO:0051094,FALSE
GO:0072359,9.1829143260814e-31,TRUE,1119,553,110,GO:BP,circulatory system development,21010,18204,GO:0048731,FALSE
GO:0070848,1.41850575388483e-30,TRUE,709,553,87,GO:BP,response to growth factor,21010,17144,GO:0009719,FALSE
GO:0051347,1.78599441422741e-30,TRUE,522,553,75,GO:BP,positive regulation of transferase activity,21010,14355,GO:0043085|GO:0051338,FALSE
GO:0051128,1.98960368709287e-30,TRUE,2419,553,168,GO:BP,regulation of cellular component organization,21010,14186,GO:0016043|GO:0050794,FALSE
GO:2000628,2.6267858101181e-30,TRUE,82,553,35,GO:BP,regulation of miRNA metabolic process,21010,26997,GO:0010586|GO:0051252,FALSE
GO:1902893,3.07211494487926e-30,TRUE,70,553,33,GO:BP,regulation of miRNA transcription,21010,23508,GO:0061614|GO:0140747|GO:2000628,FALSE
GO:0043229,3.15042679617899e-30,TRUE,15969,548,506,GO:CC,intracellular organelle,22090,1885,GO:0005622|GO:0043226,FALSE
GO:2001233,3.57217878417233e-30,TRUE,386,553,65,GO:BP,regulation of apoptotic signaling pathway,21010,27519,GO:0009966|GO:0042981|GO:0097190,FALSE
GO:0061614,5.60177536536138e-30,TRUE,71,553,33,GO:BP,miRNA transcription,21010,16368,GO:0010586|GO:0098781,FALSE
GO:0005622,7.38369082848265e-30,TRUE,17772,548,532,GO:CC,intracellular anatomical structure,22090,237,GO:0110165,FALSE
GO:0006473,1.35891911471487e-29,TRUE,165,553,45,GO:BP,protein acetylation,21010,2245,GO:0043543,FALSE
GO:0070647,1.53428424619548e-29,TRUE,1019,553,103,GO:BP,protein modification by small protein conjugation or removal,21010,17034,GO:0043687,FALSE
GO:0009888,1.96605849779219e-29,TRUE,2004,553,149,GO:BP,tissue development,21010,3806,GO:0048856,FALSE
GO:0043065,2.09054426560287e-29,TRUE,511,553,73,GO:BP,positive regulation of apoptotic process,21010,11017,GO:0006915|GO:0042981|GO:0043068,FALSE
GO:0043068,3.96508769997159e-29,TRUE,531,553,74,GO:BP,positive regulation of programmed cell death,21010,11020,GO:0012501|GO:0043067|GO:0048522,FALSE
KEGG:05203,5.07390885218535e-29,TRUE,200,431,61,KEGG,Viral carcinogenesis,8161,448,KEGG:00000,FALSE
GO:0044249,5.48819805932374e-29,TRUE,10544,553,412,GO:BP,cellular biosynthetic process,21010,11494,GO:0009058|GO:0044237,FALSE
GO:0008013,5.85944993526136e-29,TRUE,88,555,35,GO:MF,beta-catenin binding,20139,1525,GO:0005515,TRUE
KEGG:04710,8.22387817946231e-29,TRUE,34,431,28,KEGG,Circadian rhythm,8161,339,KEGG:00000,FALSE
GO:0032446,8.65522288994383e-29,TRUE,872,553,94,GO:BP,protein modification by small protein conjugation,21010,7932,GO:0070647,FALSE
GO:0007249,1.70024172254081e-28,TRUE,294,553,56,GO:BP,canonical NF-kappaB signal transduction,21010,2834,GO:0035556,FALSE
GO:0009991,1.87466147671621e-28,TRUE,513,553,72,GO:BP,response to extracellular stimulus,21010,3873,GO:0009605,FALSE
KEGG:05166,2.14045691070488e-28,TRUE,219,431,63,KEGG,Human T-cell leukemia virus 1 infection,8161,440,KEGG:00000,FALSE
GO:0007399,2.14067608347616e-28,TRUE,2513,553,168,GO:BP,nervous system development,21010,2951,GO:0048731,FALSE
WP:WP5087,2.19737546312833e-28,TRUE,436,461,90,WP,Pleural mesothelioma,8625,786,WP:000000,FALSE
GO:0043122,2.2693117610329e-28,TRUE,260,553,53,GO:BP,regulation of canonical NF-kappaB signal transduction,21010,11049,GO:0007249|GO:1902531,FALSE
GO:0051052,2.67748430071689e-28,TRUE,531,553,73,GO:BP,regulation of DNA metabolic process,21010,14134,GO:0006259|GO:0019219|GO:0060255,FALSE
WP:WP382,3.6780583163908e-28,TRUE,245,461,67,WP,MAPK signaling pathway,8625,447,WP:000000,FALSE
GO:1901576,5.48788612407697e-28,TRUE,10632,553,412,GO:BP,organic substance biosynthetic process,21010,22445,GO:0009058|GO:0071704,FALSE
GO:1903320,6.98815510287269e-28,TRUE,254,553,52,GO:BP,regulation of protein modification by small protein conjugation or removal,21010,23846,GO:0070647|GO:1901873,FALSE
GO:0031668,9.21674390110739e-28,TRUE,267,553,53,GO:BP,cellular response to extracellular stimulus,21010,7623,GO:0007154|GO:0009991|GO:0051716|GO:0071496,FALSE
REAC:R-HSA-166166,9.85401118631647e-28,TRUE,107,485,43,REAC,MyD88-independent TLR4 cascade ,10835,1428,REAC:R-HSA-166016,FALSE
REAC:R-HSA-937061,9.85401118631647e-28,TRUE,107,485,43,REAC,TRIF(TICAM1)-mediated TLR4 signaling ,10835,2354,REAC:R-HSA-166166,FALSE
GO:0070482,1.02329937746974e-27,TRUE,329,553,58,GO:BP,response to oxygen levels,21010,16941,GO:0009628,FALSE
GO:0042826,1.02376999588146e-27,TRUE,125,555,39,GO:MF,histone deacetylase binding,20139,5682,GO:0019899,FALSE
GO:0031667,1.46019510989671e-27,TRUE,484,553,69,GO:BP,response to nutrient levels,21010,7622,GO:0009991,FALSE
GO:0009314,1.49157405821694e-27,TRUE,426,553,65,GO:BP,response to radiation,21010,3516,GO:0009628,FALSE
GO:1901699,1.76981265202077e-27,TRUE,676,553,81,GO:BP,cellular response to nitrogen compound,21010,22528,GO:0070887|GO:1901698,FALSE
KEGG:05165,1.82213224401587e-27,TRUE,331,431,76,KEGG,Human papillomavirus infection,8161,439,KEGG:00000,FALSE
GO:0009058,1.99497725666075e-27,TRUE,10682,553,412,GO:BP,biosynthetic process,21010,3290,GO:0008152,FALSE
REAC:R-HSA-168164,2.34696614511123e-27,TRUE,103,485,42,REAC,Toll Like Receptor 3 (TLR3) Cascade,10835,2400,REAC:R-HSA-168898,FALSE
GO:0071363,2.41857352343985e-27,TRUE,679,553,81,GO:BP,cellular response to growth factor stimulus,21010,17425,GO:0070848|GO:0071495,FALSE
GO:0031669,2.84890588139363e-27,TRUE,238,553,50,GO:BP,cellular response to nutrient levels,21010,7624,GO:0031667|GO:0031668,FALSE
GO:0032922,3.36799535263945e-27,TRUE,70,553,31,GO:BP,circadian regulation of gene expression,21010,8285,GO:0007623|GO:0010468,FALSE
KEGG:05417,3.45855611015066e-27,TRUE,214,431,61,KEGG,Lipid and atherosclerosis,8161,487,KEGG:00000,FALSE
GO:0009894,4.9949081297056e-27,TRUE,1013,553,99,GO:BP,regulation of catabolic process,21010,3812,GO:0009056|GO:0019222,FALSE
GO:0016567,5.86634913039976e-27,TRUE,792,553,87,GO:BP,protein ubiquitination,21010,5343,GO:0032446,FALSE
GO:0010586,6.94955263970011e-27,TRUE,99,553,35,GO:BP,miRNA metabolic process,21010,4306,GO:0034660,FALSE
GO:0140747,8.17295191217669e-27,TRUE,92,553,34,GO:BP,regulation of ncRNA transcription,21010,20817,GO:0006355|GO:0098781,FALSE
GO:0051054,9.72211988135156e-27,TRUE,304,553,55,GO:BP,positive regulation of DNA metabolic process,21010,14136,GO:0006259|GO:0010604|GO:0045935|GO:0051052,FALSE
GO:0009653,1.65092293005937e-26,TRUE,2683,553,171,GO:BP,anatomical structure morphogenesis,21010,3628,GO:0032502|GO:0048856,FALSE
GO:0034097,2.06020135240042e-26,TRUE,916,553,93,GO:BP,response to cytokine,21010,8792,GO:0010033,FALSE
GO:0045860,2.52477236748975e-26,TRUE,362,553,59,GO:BP,positive regulation of protein kinase activity,21010,12289,GO:0001934|GO:0033674|GO:0045859,FALSE
GO:0000987,2.54723730876679e-26,TRUE,1181,555,108,GO:MF,cis-regulatory region sequence-specific DNA binding,20139,120,GO:0000976,FALSE
GO:0034612,3.32902451413412e-26,TRUE,250,553,50,GO:BP,response to tumor necrosis factor,21010,9091,GO:0034097,FALSE
GO:0006979,4.24215286952601e-26,TRUE,393,553,61,GO:BP,response to oxidative stress,21010,2646,GO:0006950,FALSE
GO:0036293,4.35299643804836e-26,TRUE,300,553,54,GO:BP,response to decreased oxygen levels,21010,10004,GO:0070482,FALSE
REAC:R-HSA-2262752,4.89373633723302e-26,TRUE,782,485,110,REAC,Cellular responses to stress,10835,330,REAC:R-HSA-8953897,FALSE
WP:WP231,5.00377213992629e-26,TRUE,92,461,41,WP,TNF-alpha signaling pathway,8625,709,WP:000000,FALSE
GO:0030522,6.2546510055386e-26,TRUE,341,553,57,GO:BP,intracellular receptor signaling pathway,21010,7153,GO:0007165,FALSE
GO:0140513,7.54225980776542e-26,TRUE,2711,548,163,GO:CC,nuclear protein-containing complex,22090,3565,GO:0005634|GO:0032991,FALSE
GO:0000978,9.80422083242341e-26,TRUE,1160,555,106,GO:MF,RNA polymerase II cis-regulatory region sequence-specific DNA binding,20139,117,GO:0000977|GO:0000987,FALSE
GO:0033674,1.05072027812414e-25,TRUE,428,553,63,GO:BP,positive regulation of kinase activity,21010,8730,GO:0042327|GO:0043549|GO:0051347,FALSE
GO:0032880,1.13289108702317e-25,TRUE,880,553,90,GO:BP,regulation of protein localization,21010,8248,GO:0008104|GO:0060341,FALSE
GO:0071345,1.17390901998319e-25,TRUE,825,553,87,GO:BP,cellular response to cytokine stimulus,21010,17407,GO:0034097|GO:0071310,FALSE
GO:0043226,1.20434871179143e-25,TRUE,16766,548,512,GO:CC,organelle,22090,1882,GO:0110165,FALSE
GO:0051402,1.3018693953029e-25,TRUE,269,553,51,GO:BP,neuron apoptotic process,21010,14383,GO:0006915,FALSE
GO:0034599,1.52645522304416e-25,TRUE,246,553,49,GO:BP,cellular response to oxidative stress,21010,9085,GO:0006979|GO:0062197,FALSE
KEGG:05169,1.55286694913425e-25,TRUE,198,431,57,KEGG,Epstein-Barr virus infection,8161,443,KEGG:00000,FALSE
GO:0000977,2.24044733194621e-25,TRUE,1293,555,112,GO:MF,RNA polymerase II transcription regulatory region sequence-specific DNA binding,20139,116,GO:0000976,FALSE
GO:0060341,2.33003240045908e-25,TRUE,984,553,95,GO:BP,regulation of cellular localization,21010,15285,GO:0032879|GO:0050794|GO:0051641,FALSE
REAC:R-HSA-8953897,2.36375268165246e-25,TRUE,796,485,110,REAC,Cellular responses to stimuli,10835,329,REAC:0000000,FALSE
GO:0071214,2.40144129795254e-25,TRUE,323,553,55,GO:BP,cellular response to abiotic stimulus,21010,17284,GO:0009628|GO:0104004,FALSE
GO:0104004,2.40144129795254e-25,TRUE,323,553,55,GO:BP,cellular response to environmental stimulus,21010,20105,GO:0051716,FALSE
GO:0031396,2.96090417104007e-25,TRUE,215,553,46,GO:BP,regulation of protein ubiquitination,21010,7500,GO:0016567|GO:1903320,FALSE
GO:1901652,3.35935201772996e-25,TRUE,497,553,67,GO:BP,response to peptide,21010,22494,GO:0010243|GO:1901700,FALSE
GO:0060429,3.9808379245975e-25,TRUE,1233,553,107,GO:BP,epithelium development,21010,15361,GO:0009888,FALSE
GO:0071356,5.25721289667287e-25,TRUE,229,553,47,GO:BP,cellular response to tumor necrosis factor,21010,17418,GO:0034612|GO:0071345,FALSE
GO:0043543,5.74001918713903e-25,TRUE,207,553,45,GO:BP,protein acylation,21010,11273,GO:0036211,FALSE
GO:0005737,8.00117729599102e-25,TRUE,12251,548,424,GO:CC,cytoplasm,22090,309,GO:0005622|GO:0110165,FALSE
REAC:R-HSA-166016,8.05048464728851e-25,TRUE,143,485,46,REAC,Toll Like Receptor 4 (TLR4) Cascade,10835,2401,REAC:R-HSA-168898,FALSE
REAC:R-HSA-168898,9.15415317381764e-25,TRUE,165,485,49,REAC,Toll-like Receptor Cascades,10835,2407,REAC:R-HSA-168249,FALSE
GO:0071417,1.07291681099959e-24,TRUE,637,553,75,GO:BP,cellular response to organonitrogen compound,21010,17479,GO:0010243|GO:0071310|GO:0071495|GO:1901699,FALSE
GO:0040007,1.46545754357677e-24,TRUE,930,553,91,GO:BP,growth,21010,10387,GO:0008150,FALSE
GO:0018205,1.47147782292909e-24,TRUE,308,553,53,GO:BP,peptidyl-lysine modification,21010,5525,GO:0018193,FALSE
GO:0019904,1.60884244227537e-24,TRUE,644,555,76,GO:MF,protein domain specific binding,20139,3755,GO:0005515,FALSE
GO:0018394,1.62842425204399e-24,TRUE,131,553,37,GO:BP,peptidyl-lysine acetylation,21010,5643,GO:0006473|GO:0018205,FALSE
GO:1902533,1.90397776914897e-24,TRUE,972,553,93,GO:BP,positive regulation of intracellular signal transduction,21010,23246,GO:0009967|GO:0035556|GO:1902531,FALSE
GO:0060828,2.69643058170133e-24,TRUE,249,553,48,GO:BP,regulation of canonical Wnt signaling pathway,21010,15723,GO:0030111|GO:0060070,FALSE
GO:0001221,3.86887786038143e-24,TRUE,116,555,35,GO:MF,transcription coregulator binding,20139,181,GO:0008134,FALSE
GO:0006281,5.26519493943522e-24,TRUE,602,553,72,GO:BP,DNA repair,21010,2125,GO:0006259|GO:0006974,FALSE
KEGG:05224,5.55616810668885e-24,TRUE,147,431,48,KEGG,Breast cancer,8161,468,KEGG:00000,FALSE
REAC:R-HSA-3700989,7.01873061238849e-24,TRUE,359,485,70,REAC,Transcriptional Regulation by TP53,10835,2431,REAC:R-HSA-212436,FALSE
REAC:R-HSA-4839726,7.62591188463933e-24,TRUE,273,485,61,REAC,Chromatin organization,10835,345,REAC:0000000,FALSE
REAC:R-HSA-3247509,7.62591188463933e-24,TRUE,273,485,61,REAC,Chromatin modifying enzymes,10835,344,REAC:R-HSA-4839726,FALSE
KEGG:04010,9.60125305585637e-24,TRUE,294,431,67,KEGG,MAPK signaling pathway,8161,238,KEGG:00000,FALSE
GO:0042802,1.00175933380418e-23,TRUE,2143,555,147,GO:MF,identical protein binding,20139,5676,GO:0005515,FALSE
GO:0007417,1.12181944065651e-23,TRUE,1035,553,95,GO:BP,central nervous system development,21010,2965,GO:0007399|GO:0048731,FALSE
KEGG:04310,1.29915719048452e-23,TRUE,170,431,51,KEGG,Wnt signaling pathway,8161,293,KEGG:00000,FALSE
KEGG:05131,1.47694999770052e-23,TRUE,246,431,61,KEGG,Shigellosis,8161,421,KEGG:00000,FALSE
KEGG:01522,1.51487415122555e-23,TRUE,95,431,39,KEGG,Endocrine resistance,8161,196,KEGG:00000,FALSE
GO:0071900,1.79789010765398e-23,TRUE,351,553,55,GO:BP,regulation of protein serine/threonine kinase activity,21010,17794,GO:0045859,FALSE
REAC:R-HSA-5633007,1.92417183896095e-23,TRUE,160,485,47,REAC,Regulation of TP53 Activity,10835,1917,REAC:R-HSA-3700989,FALSE
GO:0031347,2.07769889496174e-23,TRUE,756,553,80,GO:BP,regulation of defense response,21010,7484,GO:0006952|GO:0080134,FALSE
GO:0035295,2.09247166387405e-23,TRUE,1084,553,97,GO:BP,tube development,21010,9376,GO:0007275|GO:0048856,FALSE
WP:WP4262,2.27259349818887e-23,TRUE,154,461,49,WP,Breast cancer pathway,8625,123,WP:000000,FALSE
GO:0042752,2.30894044892755e-23,TRUE,113,553,34,GO:BP,regulation of circadian rhythm,21010,10848,GO:0007623|GO:0050789,FALSE
GO:0045862,2.40633974316828e-23,TRUE,353,553,55,GO:BP,positive regulation of proteolysis,21010,12291,GO:0006508|GO:0030162|GO:0051247,FALSE
GO:0007179,2.92281828251261e-23,TRUE,203,553,43,GO:BP,transforming growth factor beta receptor signaling pathway,21010,2788,GO:0007178|GO:0071560,FALSE
GO:0002521,2.97875233104324e-23,TRUE,619,553,72,GO:BP,leukocyte differentiation,21010,1057,GO:0030097|GO:0030154,FALSE
GO:0030111,2.98702527725255e-23,TRUE,327,553,53,GO:BP,regulation of Wnt signaling pathway,21010,6996,GO:0009966|GO:0016055,FALSE
GO:0097193,3.19347101329748e-23,TRUE,314,553,52,GO:BP,intrinsic apoptotic signaling pathway,21010,19416,GO:0035556|GO:0097190,FALSE
KEGG:05215,3.87292419092114e-23,TRUE,97,431,39,KEGG,Prostate cancer,8161,459,KEGG:00000,FALSE
KEGG:04152,4.76061924214154e-23,TRUE,121,431,43,KEGG,AMPK signaling pathway,8161,280,KEGG:00000,FALSE
GO:0051241,7.38453287404648e-23,TRUE,1102,553,97,GO:BP,negative regulation of multicellular organismal process,21010,14272,GO:0032501|GO:0048519|GO:0051239,FALSE
GO:0043434,8.45068227813547e-23,TRUE,420,553,59,GO:BP,response to peptide hormone,21010,11202,GO:0009725|GO:1901652,FALSE
GO:0002376,1.10239186785552e-22,TRUE,2730,553,165,GO:BP,immune system process,21010,920,GO:0008150,FALSE
GO:0042592,1.16588059530682e-22,TRUE,1704,553,124,GO:BP,homeostatic process,21010,10755,GO:0008150,FALSE
GO:0051091,1.1856370219223e-22,TRUE,270,553,48,GO:BP,positive regulation of DNA-binding transcription factor activity,21010,14158,GO:0044093|GO:0051090,FALSE
GO:0071560,1.30663666497367e-22,TRUE,258,553,47,GO:BP,cellular response to transforming growth factor beta stimulus,21010,17574,GO:0071363|GO:0071559,FALSE
GO:0001666,1.44949772799335e-22,TRUE,284,553,49,GO:BP,response to hypoxia,21010,387,GO:0006950|GO:0036293,FALSE
GO:0062012,1.48489929244265e-22,TRUE,324,553,52,GO:BP,regulation of small molecule metabolic process,21010,16573,GO:0019222|GO:0044281,FALSE
GO:0070603,1.60037288179291e-22,TRUE,96,548,30,GO:CC,SWI/SNF superfamily-type complex,22090,2528,GO:0000785|GO:0140513|GO:1904949,FALSE
GO:0006476,1.60271840314647e-22,TRUE,86,553,30,GO:BP,protein deacetylation,21010,2248,GO:0035601,FALSE
GO:0033043,1.85020769704555e-22,TRUE,1157,553,99,GO:BP,regulation of organelle organization,21010,8371,GO:0006996|GO:0051128,FALSE
KEGG:05167,2.00153659770105e-22,TRUE,194,431,53,KEGG,Kaposi sarcoma-associated herpesvirus infection,8161,441,KEGG:00000,FALSE
GO:0048732,2.53867441574366e-22,TRUE,444,553,60,GO:BP,gland development,21010,13641,GO:0048513,FALSE
GO:0031490,2.93494142931196e-22,TRUE,121,555,34,GO:MF,chromatin DNA binding,20139,4158,GO:0003677|GO:0003682,FALSE
GO:0071559,3.71234726400959e-22,TRUE,264,553,47,GO:BP,response to transforming growth factor beta,21010,17573,GO:0070848,FALSE
KEGG:04931,3.77856381767968e-22,TRUE,108,431,40,KEGG,Insulin resistance,8161,381,KEGG:00000,FALSE
GO:0007507,4.02864152242015e-22,TRUE,594,553,69,GO:BP,heart development,21010,3046,GO:0048513|GO:0072359,FALSE
GO:0003714,5.19840589415552e-22,TRUE,193,555,41,GO:MF,transcription corepressor activity,20139,343,GO:0003712,FALSE
GO:0002682,6.35482029465044e-22,TRUE,1482,553,113,GO:BP,regulation of immune system process,21010,1214,GO:0002376|GO:0050789,FALSE
GO:0061061,6.80591662307998e-22,TRUE,669,553,73,GO:BP,muscle structure development,21010,15930,GO:0048856,FALSE
GO:0018105,8.02187608525212e-22,TRUE,308,553,50,GO:BP,peptidyl-serine phosphorylation,21010,5449,GO:0006468|GO:0018209,FALSE
GO:0098781,8.60303910071985e-22,TRUE,134,553,35,GO:BP,ncRNA transcription,21010,19787,GO:0006351|GO:0034660,FALSE
GO:0004674,9.8837915647507e-22,TRUE,433,555,59,GO:MF,protein serine/threonine kinase activity,20139,978,GO:0004672,TRUE
GO:0048863,1.06330668650303e-21,TRUE,245,553,45,GO:BP,stem cell differentiation,21010,13758,GO:0030154,FALSE
GO:1902532,1.63803595515698e-21,TRUE,524,553,64,GO:BP,negative regulation of intracellular signal transduction,21010,23245,GO:0009968|GO:0035556|GO:1902531,FALSE
GO:0048545,1.76932413393727e-21,TRUE,327,553,51,GO:BP,response to steroid hormone,21010,13476,GO:0009725|GO:0014070|GO:0033993,FALSE
KEGG:04211,2.20883358710517e-21,TRUE,89,431,36,KEGG,Longevity regulating pathway,8161,282,KEGG:00000,FALSE
GO:0046983,2.4258572693058e-21,TRUE,1105,555,96,GO:MF,protein dimerization activity,20139,6317,GO:0005515,FALSE
REAC:R-HSA-5663202,2.88953692802672e-21,TRUE,417,485,72,REAC,Diseases of signal transduction by growth factor receptors and second messengers,10835,739,REAC:R-HSA-1643685,FALSE
GO:0048871,3.21818579530996e-21,TRUE,816,553,80,GO:BP,multicellular organismal-level homeostasis,21010,13766,GO:0032501|GO:0042592,FALSE
REAC:R-HSA-2559583,3.71315947059605e-21,TRUE,195,485,49,REAC,Cellular Senescence,10835,323,REAC:R-HSA-2262752,FALSE
GO:0040029,4.13695716181495e-21,TRUE,228,553,43,GO:BP,epigenetic regulation of gene expression,21010,10408,GO:0006338|GO:0010468,FALSE
GO:1902895,4.21798655591423e-21,TRUE,52,553,24,GO:BP,positive regulation of miRNA transcription,21010,23510,GO:0045893|GO:0061614|GO:1902893|GO:2000630,FALSE
KEGG:04620,4.29869613280347e-21,TRUE,102,431,38,KEGG,Toll-like receptor signaling pathway,8161,319,KEGG:00000,FALSE
GO:0006475,4.4403314937891e-21,TRUE,121,553,33,GO:BP,internal protein amino acid acetylation,21010,2247,GO:0006473,FALSE
GO:0140096,6.0252350023712e-21,TRUE,2332,555,149,GO:MF,"catalytic activity, acting on a protein",20139,10506,GO:0003824,FALSE
GO:0016573,6.16186625819998e-21,TRUE,113,553,32,GO:BP,histone acetylation,21010,5346,GO:0016570|GO:0018393,FALSE
WP:WP4216,6.19821923284699e-21,TRUE,73,461,33,WP,Chromosomal and microsatellite instability in colorectal cancer ,8625,76,WP:000000,FALSE
GO:0045596,6.46287673742348e-21,TRUE,676,553,72,GO:BP,negative regulation of cell differentiation,21010,12062,GO:0030154|GO:0045595|GO:0048523|GO:0051093,FALSE
GO:2000630,6.52034347396963e-21,TRUE,59,553,25,GO:BP,positive regulation of miRNA metabolic process,21010,26999,GO:0010586|GO:0051254|GO:2000628,FALSE
WP:WP2036,6.61234064709654e-21,TRUE,42,461,26,WP,TNF-related weak inducer of apoptosis (TWEAK) signaling pathway,8625,693,WP:000000,FALSE
WP:WP3611,6.68004967973403e-21,TRUE,50,461,28,WP,Photodynamic therapy-induced AP-1 survival signaling,8625,696,WP:000000,FALSE
GO:0098727,6.87830888340876e-21,TRUE,184,553,39,GO:BP,maintenance of cell number,21010,19749,GO:0032502,FALSE
GO:0030099,7.52423521463706e-21,TRUE,426,553,57,GO:BP,myeloid cell differentiation,21010,6992,GO:0030097|GO:0030154,FALSE
REAC:R-HSA-975138,8.59858885284769e-21,TRUE,101,485,36,REAC,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,10835,2351,REAC:R-HSA-975155,FALSE
GO:0035601,9.480243508227e-21,TRUE,97,553,30,GO:BP,protein deacylation,21010,9552,GO:0036211|GO:0098732,FALSE
WP:WP2018,1.10693371289426e-20,TRUE,55,461,29,WP,RANKL/RANK signaling pathway,8625,743,WP:000000,FALSE
GO:0018209,1.13844571172369e-20,TRUE,326,553,50,GO:BP,peptidyl-serine modification,21010,5529,GO:0018193,FALSE
REAC:R-HSA-975155,1.27491526332056e-20,TRUE,102,485,36,REAC,MyD88 dependent cascade initiated on endosome,10835,1427,REAC:R-HSA-168138|REAC:R-HSA-168181,FALSE
WP:WP4659,1.28605684695149e-20,TRUE,114,461,40,WP,Gastrin signaling pathway,8625,586,WP:000000,FALSE
GO:0098732,1.33326804436685e-20,TRUE,98,553,30,GO:BP,macromolecule deacylation,21010,19754,GO:0043412,FALSE
GO:0051403,1.4666542589207e-20,TRUE,235,553,43,GO:BP,stress-activated MAPK cascade,21010,14384,GO:0000165|GO:0031098,FALSE
REAC:R-HSA-400253,1.63234056773762e-20,TRUE,67,485,30,REAC,Circadian Clock,10835,352,REAC:0000000,FALSE
GO:0044092,1.73145970448314e-20,TRUE,956,553,86,GO:BP,negative regulation of molecular function,21010,11465,GO:0065009,FALSE
REAC:R-HSA-168181,1.88035845464356e-20,TRUE,103,485,36,REAC,Toll Like Receptor 7/8 (TLR7/8) Cascade,10835,2403,REAC:R-HSA-168898,FALSE
WP:WP75,1.99621234091625e-20,TRUE,103,461,38,WP,Toll-like receptor signaling pathway,8625,460,WP:000000,FALSE
WP:WP5413,2.21426636524848e-20,TRUE,290,461,63,WP,IL-24 Signaling pathway,8625,143,WP:000000,FALSE
GO:0048589,2.45219686406395e-20,TRUE,655,553,70,GO:BP,developmental growth,21010,13512,GO:0032502|GO:0040007,FALSE
WP:WP3594,2.60397127367453e-20,TRUE,200,461,52,WP,Circadian rhythm genes,8625,490,WP:000000,FALSE
GO:0030162,2.86226452812139e-20,TRUE,693,553,72,GO:BP,regulation of proteolysis,21010,7005,GO:0006508|GO:0051246,FALSE
GO:0019827,3.14992550544885e-20,TRUE,180,553,38,GO:BP,stem cell population maintenance,21010,6336,GO:0032501|GO:0098727,FALSE
REAC:R-HSA-450294,3.32808667227994e-20,TRUE,63,485,29,REAC,MAP kinase activation,10835,1287,REAC:R-HSA-166058|REAC:R-HSA-168164|REAC:R-HSA-448424|REAC:R-HSA-937061|REAC:R-HSA-975138|REAC:R-HSA-975871,FALSE
GO:0018393,3.6571154465916e-20,TRUE,119,553,32,GO:BP,internal peptidyl-lysine acetylation,21010,5642,GO:0006475|GO:0018394,FALSE
GO:0006952,3.67515312072937e-20,TRUE,1769,553,122,GO:BP,defense response,21010,2625,GO:0006950,FALSE
KEGG:05163,3.87545639463363e-20,TRUE,223,431,54,KEGG,Human cytomegalovirus infection,8161,437,KEGG:00000,FALSE
REAC:R-HSA-168188,4.46389272428434e-20,TRUE,112,485,37,REAC,Toll Like Receptor TLR6:TLR2 Cascade,10835,2406,REAC:R-HSA-181438,FALSE
REAC:R-HSA-166058,4.46389272428434e-20,TRUE,112,485,37,REAC,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,10835,1429,REAC:R-HSA-166016|REAC:R-HSA-168179|REAC:R-HSA-168188,FALSE
KEGG:05226,5.17151180941124e-20,TRUE,148,431,44,KEGG,Gastric cancer,8161,470,KEGG:00000,FALSE
GO:0032879,5.41556208759964e-20,TRUE,2123,553,136,GO:BP,regulation of localization,21010,8247,GO:0050789|GO:0051179,FALSE
REAC:R-HSA-168138,5.85191297103945e-20,TRUE,106,485,36,REAC,Toll Like Receptor 9 (TLR9) Cascade,10835,2404,REAC:R-HSA-168898,FALSE
GO:0031098,5.88601965927127e-20,TRUE,243,553,43,GO:BP,stress-activated protein kinase signaling cascade,21010,7358,GO:0033554|GO:0035556,FALSE
GO:0009790,6.25595697052032e-20,TRUE,1120,553,93,GO:BP,embryo development,21010,3735,GO:0007275,FALSE
KEGG:04210,6.68797467923732e-20,TRUE,135,431,42,KEGG,Apoptosis,8161,281,KEGG:00000,FALSE
GO:1903322,7.23819563998846e-20,TRUE,141,553,34,GO:BP,positive regulation of protein modification by small protein conjugation or removal,21010,23848,GO:0070647|GO:1901875|GO:1903320,FALSE
GO:0006109,7.27198435478917e-20,TRUE,184,553,38,GO:BP,regulation of carbohydrate metabolic process,21010,1997,GO:0005975|GO:0080090,FALSE
GO:0035097,7.47825279802074e-20,TRUE,72,548,25,GO:CC,histone methyltransferase complex,22090,1594,GO:0005654|GO:0034708|GO:0140513,FALSE
KEGG:05210,9.47102899577132e-20,TRUE,86,431,34,KEGG,Colorectal cancer,8161,454,KEGG:00000,FALSE
GO:0030163,9.93052775207393e-20,TRUE,1043,553,89,GO:BP,protein catabolic process,21010,7006,GO:0009057|GO:0019538|GO:1901565,FALSE
GO:0000165,1.1720012506794e-19,TRUE,766,553,75,GO:BP,MAPK cascade,21010,59,GO:0035556,FALSE
GO:0000228,1.24791815979755e-19,TRUE,234,548,40,GO:CC,nuclear chromosome,22090,37,GO:0005694|GO:0031981,FALSE
REAC:R-HSA-181438,1.27945905307817e-19,TRUE,115,485,37,REAC,Toll Like Receptor 2 (TLR2) Cascade,10835,2399,REAC:R-HSA-168898,FALSE
REAC:R-HSA-168179,1.27945905307817e-19,TRUE,115,485,37,REAC,Toll Like Receptor TLR1:TLR2 Cascade,10835,2405,REAC:R-HSA-181438,FALSE
GO:0009887,1.57277370329779e-19,TRUE,1050,553,89,GO:BP,animal organ morphogenesis,21010,3805,GO:0009653|GO:0048513,FALSE
GO:0016575,1.90275135601409e-19,TRUE,66,553,25,GO:BP,histone deacetylation,21010,5348,GO:0006476|GO:0016570,FALSE
GO:0022008,2.05616215090394e-19,TRUE,1708,553,118,GO:BP,neurogenesis,21010,6877,GO:0007399|GO:0030154,FALSE
GO:0032868,2.5737177090859e-19,TRUE,265,553,44,GO:BP,response to insulin,21010,8236,GO:0043434,FALSE
WP:WP363,3.09505804012006e-19,TRUE,51,461,27,WP,Wnt signaling pathway,8625,423,WP:000000,FALSE
GO:0032101,3.42451941743341e-19,TRUE,1062,553,89,GO:BP,regulation of response to external stimulus,21010,7724,GO:0009605|GO:0048583,FALSE
GO:0010506,3.84261350144447e-19,TRUE,352,553,50,GO:BP,regulation of autophagy,21010,4250,GO:0006914|GO:0031329,FALSE
GO:0010212,4.29839150957062e-19,TRUE,138,553,33,GO:BP,response to ionizing radiation,21010,4054,GO:0009314,FALSE
KEGG:05170,5.31281520832022e-19,TRUE,210,431,51,KEGG,Human immunodeficiency virus 1 infection,8161,444,KEGG:00000,FALSE
REAC:R-HSA-8939211,5.89378099048446e-19,TRUE,217,485,49,REAC,ESR-mediated signaling,10835,796,REAC:R-HSA-9006931,FALSE
GO:0007178,6.41726889049439e-19,TRUE,371,553,51,GO:BP,transmembrane receptor protein serine/threonine kinase signaling pathway,21010,2787,GO:0007167,FALSE
GO:0035239,6.75057668162602e-19,TRUE,867,553,79,GO:BP,tube morphogenesis,21010,9344,GO:0009653|GO:0035295,FALSE
KEGG:04920,9.41801592111405e-19,TRUE,69,431,30,KEGG,Adipocytokine signaling pathway,8161,370,KEGG:00000,FALSE
GO:0009416,1.05520584630992e-18,TRUE,316,553,47,GO:BP,response to light stimulus,21010,3536,GO:0009314,FALSE
KEGG:04068,1.45435764022541e-18,TRUE,131,431,40,KEGG,FoxO signaling pathway,8161,253,KEGG:00000,FALSE
GO:0031398,1.53405386636574e-18,TRUE,123,553,31,GO:BP,positive regulation of protein ubiquitination,21010,7502,GO:0016567|GO:0031396|GO:1903322,FALSE
REAC:R-HSA-201681,1.98633487061214e-18,TRUE,232,485,50,REAC,TCF dependent signaling in response to WNT,10835,2309,REAC:R-HSA-195721,FALSE
REAC:R-HSA-448424,2.14876935699169e-18,TRUE,71,485,29,REAC,Interleukin-17 signaling,10835,1186,REAC:R-HSA-449147,FALSE
GO:0006954,2.23179781066026e-18,TRUE,824,553,76,GO:BP,inflammatory response,21010,2627,GO:0006952,FALSE
GO:0016043,2.28196005485468e-18,TRUE,8098,553,323,GO:BP,cellular component organization,21010,5163,GO:0071840,FALSE
REAC:R-HSA-168176,2.38214564614085e-18,TRUE,96,485,33,REAC,Toll Like Receptor 5 (TLR5) Cascade,10835,2402,REAC:R-HSA-168898,FALSE
REAC:R-HSA-975871,2.38214564614085e-18,TRUE,96,485,33,REAC,MyD88 cascade initiated on plasma membrane,10835,1424,REAC:R-HSA-168142|REAC:R-HSA-168176,FALSE
REAC:R-HSA-168142,2.38214564614085e-18,TRUE,96,485,33,REAC,Toll Like Receptor 10 (TLR10) Cascade,10835,2398,REAC:R-HSA-168898,FALSE
GO:0051098,2.52374272400729e-18,TRUE,367,553,50,GO:BP,regulation of binding,21010,14165,GO:0065009,FALSE
GO:0010035,2.72165190181085e-18,TRUE,530,553,60,GO:BP,response to inorganic substance,21010,3905,GO:0042221,FALSE
GO:0008284,2.73409690033369e-18,TRUE,1248,553,96,GO:BP,positive regulation of cell population proliferation,21010,3205,GO:0008283|GO:0042127|GO:0048522,FALSE
GO:0045786,2.74440787485317e-18,TRUE,383,553,51,GO:BP,negative regulation of cell cycle,21010,12233,GO:0007049|GO:0048523|GO:0051726,FALSE
GO:0001216,3.17235035220462e-18,TRUE,474,555,57,GO:MF,DNA-binding transcription activator activity,20139,179,GO:0003700,FALSE
GO:0009056,3.21763703267236e-18,TRUE,2616,553,151,GO:BP,catabolic process,21010,3288,GO:0008152,FALSE
GO:0065008,3.30105631001467e-18,TRUE,2918,553,162,GO:BP,regulation of biological quality,21010,16683,GO:0065007,FALSE
GO:0006282,3.88467553681586e-18,TRUE,217,553,39,GO:BP,regulation of DNA repair,21010,2126,GO:0006281|GO:0051052|GO:0080135,FALSE
GO:0031647,4.58998114051573e-18,TRUE,327,553,47,GO:BP,regulation of protein stability,21010,7608,GO:0065008,FALSE
GO:0061919,4.81376929391894e-18,TRUE,571,553,62,GO:BP,process utilizing autophagic mechanism,21010,16513,GO:0009987,FALSE
GO:0006914,4.81376929391894e-18,TRUE,571,553,62,GO:BP,autophagy,21010,2603,GO:0044248|GO:0061919,FALSE
GO:0009267,5.54442976369792e-18,TRUE,171,553,35,GO:BP,cellular response to starvation,21010,3488,GO:0031669|GO:0033554|GO:0042594,FALSE
GO:0007167,6.12366282652235e-18,TRUE,960,553,82,GO:BP,enzyme-linked receptor protein signaling pathway,21010,2778,GO:0007166,FALSE
GO:0010564,6.14717802776928e-18,TRUE,721,553,70,GO:BP,regulation of cell cycle process,21010,4288,GO:0022402|GO:0051726,FALSE
GO:0098687,6.69489022893576e-18,TRUE,399,548,49,GO:CC,chromosomal region,22090,3252,GO:0005694|GO:0110165,FALSE
GO:0031400,6.84513808914044e-18,TRUE,455,553,55,GO:BP,negative regulation of protein modification process,21010,7504,GO:0031399|GO:0036211|GO:0051248,FALSE
KEGG:05145,6.97498991000417e-18,TRUE,109,431,36,KEGG,Toxoplasmosis,8161,430,KEGG:00000,FALSE
GO:0004672,7.35650228135003e-18,TRUE,584,555,63,GO:MF,protein kinase activity,20139,976,GO:0016301|GO:0016773|GO:0140096,FALSE
KEGG:05225,7.96993992729092e-18,TRUE,166,431,44,KEGG,Hepatocellular carcinoma,8161,469,KEGG:00000,FALSE
GO:0000302,8.90362259214653e-18,TRUE,197,553,37,GO:BP,response to reactive oxygen species,21010,93,GO:0006979|GO:1901700,FALSE
GO:0090398,9.09109649744318e-18,TRUE,101,553,28,GO:BP,cellular senescence,21010,19142,GO:0033554|GO:0044237,FALSE
GO:0051276,9.64514894787786e-18,TRUE,633,553,65,GO:BP,chromosome organization,21010,14294,GO:0006996,FALSE
GO:0008285,1.07592479601188e-17,TRUE,866,553,77,GO:BP,negative regulation of cell population proliferation,21010,3206,GO:0008283|GO:0042127|GO:0048523,FALSE
GO:0043523,1.07948902948811e-17,TRUE,223,553,39,GO:BP,regulation of neuron apoptotic process,21010,11264,GO:0042981|GO:0051402,FALSE
GO:0031329,1.09814495445106e-17,TRUE,653,553,66,GO:BP,regulation of cellular catabolic process,21010,7467,GO:0009894|GO:0031323|GO:0044248,FALSE
GO:0001228,1.11484831969837e-17,TRUE,470,555,56,GO:MF,"DNA-binding transcription activator activity, RNA polymerase II-specific",20139,185,GO:0000981|GO:0001216,FALSE
WP:WP138,1.18566240167246e-17,TRUE,89,461,33,WP,Androgen receptor signaling pathway,8625,428,WP:000000,FALSE
GO:0001817,1.26523972089292e-17,TRUE,769,553,72,GO:BP,regulation of cytokine production,21010,484,GO:0001816|GO:0010468|GO:0051239,FALSE
GO:0016604,1.33785292212248e-17,TRUE,888,548,74,GO:CC,nuclear body,22090,768,GO:0005654|GO:0110165,FALSE
GO:0071453,1.66723066303778e-17,TRUE,165,553,34,GO:BP,cellular response to oxygen levels,21010,17498,GO:0070482|GO:0070887,FALSE
GO:1901987,1.72272842134232e-17,TRUE,431,553,53,GO:BP,regulation of cell cycle phase transition,21010,22801,GO:0010564|GO:0044770,FALSE
GO:0010498,1.75555385151622e-17,TRUE,515,553,58,GO:BP,proteasomal protein catabolic process,21010,4246,GO:0030163|GO:0051603,FALSE
TF:M00333_1,1.79345997081438e-17,TRUE,12713,556,453,TF,Factor: ZF5; motif: NRNGNGCGCGCWN; match class: 1,20011,9235,TF:M00333,FALSE
GO:0001816,1.97513697225833e-17,TRUE,775,553,72,GO:BP,cytokine production,21010,483,GO:0010467|GO:0032501,FALSE
GO:0016740,2.17145777232304e-17,TRUE,2354,555,142,GO:MF,transferase activity,20139,2952,GO:0003824,FALSE
TF:M00695,2.19084776637542e-17,TRUE,10683,556,403,TF,Factor: ETF; motif: GVGGMGG,20011,2164,TF:M00000,FALSE
TF:M12351_1,2.99573726567661e-17,TRUE,8430,556,342,TF,Factor: TIEG1; motif: NCCCNSNCCCCGCCCCC; match class: 1,20011,8783,TF:M12351,FALSE
GO:0006508,3.13439059734148e-17,TRUE,1766,553,116,GO:BP,proteolysis,21010,2270,GO:0019538,FALSE
KEGG:05160,3.97665025803712e-17,TRUE,157,431,42,KEGG,Hepatitis C,8161,434,KEGG:00000,FALSE
KEGG:04390,3.97665025803712e-17,TRUE,157,431,42,KEGG,Hippo signaling pathway,8161,304,KEGG:00000,FALSE
GO:0005488,4.55669166977092e-17,TRUE,18282,555,552,GO:MF,binding,20139,1483,GO:0003674,FALSE
GO:0017015,4.87873812441503e-17,TRUE,137,553,31,GO:BP,regulation of transforming growth factor beta receptor signaling pathway,21010,5372,GO:0007179|GO:0090092|GO:1903844,FALSE
GO:0071840,5.01088261776159e-17,TRUE,8309,553,325,GO:BP,cellular component organization or biogenesis,21010,17759,GO:0009987,FALSE
WP:WP3915,5.11367524301022e-17,TRUE,132,461,39,WP,Angiopoietin-like protein 8 regulatory pathway,8625,825,WP:000000,FALSE
GO:0043123,5.65085382906273e-17,TRUE,195,553,36,GO:BP,positive regulation of canonical NF-kappaB signal transduction,21010,11050,GO:0007249|GO:0043122|GO:1902533,FALSE
GO:0003713,6.24515056530974e-17,TRUE,287,555,43,GO:MF,transcription coactivator activity,20139,342,GO:0003712,FALSE
GO:0060322,7.30349572396346e-17,TRUE,793,553,72,GO:BP,head development,21010,15266,GO:0048856,FALSE
GO:1903829,7.76640919106223e-17,TRUE,479,553,55,GO:BP,positive regulation of protein localization,21010,24275,GO:0008104|GO:0032880|GO:0048522,FALSE
GO:0016922,8.22494584330681e-17,TRUE,140,555,31,GO:MF,nuclear receptor binding,20139,3095,GO:0061629,FALSE
GO:0071478,8.22643599213388e-17,TRUE,173,553,34,GO:BP,cellular response to radiation,21010,17522,GO:0009314|GO:0071214,FALSE
GO:0043161,8.27682134006764e-17,TRUE,446,553,53,GO:BP,proteasome-mediated ubiquitin-dependent protein catabolic process,21010,11070,GO:0006511|GO:0010498,FALSE
GO:0042594,8.757592470913e-17,TRUE,210,553,37,GO:BP,response to starvation,21010,10757,GO:0006950|GO:0031667,FALSE
GO:1903844,9.66577541099613e-17,TRUE,140,553,31,GO:BP,regulation of cellular response to transforming growth factor beta stimulus,21010,24287,GO:0071560|GO:0090287,FALSE
GO:0009411,9.79160074568672e-17,TRUE,151,553,32,GO:BP,response to UV,21010,3532,GO:0009416,FALSE
KEGG:04657,1.01114167117375e-16,TRUE,91,431,32,KEGG,IL-17 signaling pathway,8161,329,KEGG:00000,FALSE
GO:0071383,1.03642288432353e-16,TRUE,211,553,37,GO:BP,cellular response to steroid hormone stimulus,21010,17445,GO:0032870|GO:0048545|GO:0071396|GO:0071407,FALSE
GO:0060090,1.05316934575848e-16,TRUE,597,555,62,GO:MF,molecular adaptor activity,20139,8448,GO:0003674,TRUE
GO:0033044,1.11827562164075e-16,TRUE,251,553,40,GO:BP,regulation of chromosome organization,21010,8372,GO:0033043|GO:0051276,FALSE
GO:2001234,1.20207195339109e-16,TRUE,238,553,39,GO:BP,negative regulation of apoptotic signaling pathway,21010,27520,GO:0009968|GO:0043066|GO:0097190|GO:2001233,FALSE
KEGG:05162,1.26986488290097e-16,TRUE,139,431,39,KEGG,Measles,8161,436,KEGG:00000,FALSE
GO:0070201,1.47987039169093e-16,TRUE,538,553,58,GO:BP,regulation of establishment of protein localization,21010,16779,GO:0032880|GO:0045184,FALSE
KEGG:05213,1.52439330551856e-16,TRUE,58,431,26,KEGG,Endometrial cancer,8161,457,KEGG:00000,FALSE
KEGG:05207,1.55222652489567e-16,TRUE,211,431,48,KEGG,Chemical carcinogenesis - receptor activation,8161,452,KEGG:00000,FALSE
REAC:R-HSA-212165,1.80038349351408e-16,TRUE,147,485,38,REAC,Epigenetic regulation of gene expression,10835,814,REAC:R-HSA-74160,FALSE
WP:WP1403,1.8890095014368e-16,TRUE,67,461,28,WP,AMP-activated protein kinase signaling,8625,608,WP:000000,FALSE
GO:0097191,1.99992194005202e-16,TRUE,228,553,38,GO:BP,extrinsic apoptotic signaling pathway,21010,19414,GO:0007166|GO:0097190,FALSE
WP:WP5322,2.13490893505723e-16,TRUE,116,461,36,WP,CKAP4 signaling pathway map,8625,544,WP:000000,FALSE
KEGG:04218,2.19258471314652e-16,TRUE,156,431,41,KEGG,Cellular senescence,8161,289,KEGG:00000,FALSE
GO:0071902,2.48373724206515e-16,TRUE,191,553,35,GO:BP,positive regulation of protein serine/threonine kinase activity,21010,17796,GO:0045860|GO:0071900,FALSE
GO:1904029,2.54535129986933e-16,TRUE,113,553,28,GO:BP,regulation of cyclin-dependent protein kinase activity,21010,24444,GO:0045859|GO:0051726,FALSE
KEGG:05132,2.84472506454708e-16,TRUE,249,431,52,KEGG,Salmonella infection,8161,422,KEGG:00000,FALSE
GO:1903706,3.00742185449873e-16,TRUE,409,553,50,GO:BP,regulation of hemopoiesis,21010,24181,GO:0002682|GO:0030097|GO:0060284|GO:2000026,FALSE
GO:0002573,3.19573735439291e-16,TRUE,231,553,38,GO:BP,myeloid leukocyte differentiation,21010,1108,GO:0002521|GO:0030099,FALSE
TF:M02089_1,3.22875425794662e-16,TRUE,9627,556,372,TF,Factor: E2F-3; motif: GGCGGGN; match class: 1,20011,1497,TF:M02089,FALSE
GO:0051130,3.38385152519783e-16,TRUE,1111,553,86,GO:BP,positive regulation of cellular component organization,21010,14188,GO:0016043|GO:0048522|GO:0051128,FALSE
TF:M00986_1,3.41563411917173e-16,TRUE,10654,556,399,TF,Factor: Churchill; motif: CGGGNN; match class: 1,20011,835,TF:M00986,FALSE
GO:0045321,3.46420943574959e-16,TRUE,939,553,78,GO:BP,leukocyte activation,21010,11966,GO:0001775|GO:0002376,FALSE
GO:0034614,3.59605435751816e-16,TRUE,146,553,31,GO:BP,cellular response to reactive oxygen species,21010,9092,GO:0000302|GO:0034599|GO:1901701,FALSE
WP:WP4155,3.6227898877346e-16,TRUE,63,461,27,WP,Endometrial cancer,8625,772,WP:000000,FALSE
GO:2001242,3.70949978975361e-16,TRUE,181,553,34,GO:BP,regulation of intrinsic apoptotic signaling pathway,21010,27528,GO:0097193|GO:1902531|GO:2001233,FALSE
KEGG:04550,3.79718422333891e-16,TRUE,143,431,39,KEGG,Signaling pathways regulating pluripotency of stem cells,8161,313,KEGG:00000,FALSE
REAC:R-HSA-9006931,3.8525018613059e-16,TRUE,291,485,53,REAC,Signaling by Nuclear Receptors,10835,2180,REAC:R-HSA-162582,FALSE
GO:2000736,4.13650059397395e-16,TRUE,78,553,24,GO:BP,regulation of stem cell differentiation,21010,27089,GO:0045595|GO:0048863,FALSE
GO:0044770,4.68079763472489e-16,TRUE,551,553,58,GO:BP,cell cycle phase transition,21010,11747,GO:0022402,FALSE
GO:1904949,4.74023213971125e-16,TRUE,154,548,30,GO:CC,ATPase complex,22090,3709,GO:1902494,FALSE
GO:0000981,5.18410838475264e-16,TRUE,1181,555,90,GO:MF,"DNA-binding transcription factor activity, RNA polymerase II-specific",20139,119,GO:0003700,FALSE
GO:0016772,5.53258733230165e-16,TRUE,969,555,80,GO:MF,"transferase activity, transferring phosphorus-containing groups",20139,2979,GO:0016740,FALSE
GO:0045444,5.89977896582291e-16,TRUE,235,553,38,GO:BP,fat cell differentiation,21010,11991,GO:0030154,FALSE
WP:WP2637,6.20540853162626e-16,TRUE,49,461,24,WP,Interleukin-1 (IL-1) structural pathway,8625,656,WP:000000,FALSE
GO:0001503,6.26867421040851e-16,TRUE,416,553,50,GO:BP,ossification,21010,329,GO:0032501,FALSE
WP:WP254,6.3569762527267e-16,TRUE,87,461,31,WP,Apoptosis,8625,643,WP:000000,FALSE
GO:0030518,7.0075720140311e-16,TRUE,117,553,28,GO:BP,intracellular steroid hormone receptor signaling pathway,21010,7150,GO:0030522|GO:0043401,FALSE
GO:1901363,7.07700780260386e-16,TRUE,7455,555,306,GO:MF,heterocyclic compound binding,20139,10949,GO:0005488,FALSE
REAC:R-HSA-3108232,7.87122523662928e-16,TRUE,170,485,40,REAC,SUMO E3 ligases SUMOylate target proteins,10835,2056,REAC:R-HSA-2990846,FALSE
GO:0048646,8.5135444230059e-16,TRUE,1172,553,88,GO:BP,anatomical structure formation involved in morphogenesis,21010,13556,GO:0009653|GO:0032502,FALSE
GO:0090545,8.66049346733537e-16,TRUE,17,548,13,GO:CC,CHD-type complex,22090,2856,GO:0070603,FALSE
GO:0016581,8.66049346733537e-16,TRUE,17,548,13,GO:CC,NuRD complex,22090,758,GO:0000118|GO:0005667|GO:0090545,FALSE
GO:0033209,9.03756709882404e-16,TRUE,108,553,27,GO:BP,tumor necrosis factor-mediated signaling pathway,21010,8452,GO:0019221|GO:0071356,FALSE
KEGG:04932,9.23025029517274e-16,TRUE,154,431,40,KEGG,Non-alcoholic fatty liver disease,8161,382,KEGG:00000,FALSE
KEGG:05221,9.50453532387994e-16,TRUE,67,431,27,KEGG,Acute myeloid leukemia,8161,465,KEGG:00000,FALSE
GO:0043933,9.73404120864243e-16,TRUE,4031,553,194,GO:BP,protein-containing complex organization,21010,11384,GO:0016043,FALSE
GO:0043401,1.06421752172139e-15,TRUE,140,553,30,GO:BP,steroid hormone mediated signaling pathway,21010,11181,GO:0009755|GO:0071383,FALSE
GO:0001819,1.14069610706968e-15,TRUE,490,553,54,GO:BP,positive regulation of cytokine production,21010,486,GO:0001816|GO:0001817|GO:0010628|GO:0051240,FALSE
KEGG:04213,1.18572115842422e-15,TRUE,62,431,26,KEGG,Longevity regulating pathway - multiple species,8161,284,KEGG:00000,FALSE
GO:1901653,1.26314401098357e-15,TRUE,358,553,46,GO:BP,cellular response to peptide,21010,22495,GO:0071417|GO:1901652|GO:1901701,FALSE
HPA:0301361,1.34460791453624e-15,TRUE,1091,418,101,HPA,lung; alveolar cells type I[Low],11006,447,HPA:0300000,FALSE
GO:0007346,1.37205802890555e-15,TRUE,492,553,54,GO:BP,regulation of mitotic cell cycle,21010,2908,GO:0000278|GO:0051726,FALSE
WP:WP5124,1.44106779174356e-15,TRUE,260,461,53,WP,Alzheimer's disease,8625,81,WP:000000,FALSE
WP:WP2380,1.49910883069293e-15,TRUE,144,461,39,WP,Brain-derived neurotrophic factor (BDNF) signaling pathway,8625,464,WP:000000,FALSE
GO:0097159,1.58951250152236e-15,TRUE,7526,555,307,GO:MF,organic cyclic compound binding,20139,9139,GO:0005488,FALSE
WP:WP2355,1.97813783017204e-15,TRUE,90,461,31,WP,Corticotropin-releasing hormone signaling pathway,8625,329,WP:000000,FALSE
TF:M04869_1,2.08682520328296e-15,TRUE,10508,556,393,TF,Factor: Egr-1; motif: GCGCATGCG; match class: 1,20011,1609,TF:M04869,FALSE
GO:0034708,2.22928896111733e-15,TRUE,105,548,25,GO:CC,methyltransferase complex,22090,1545,GO:0005622|GO:1990234,FALSE
GO:0051348,2.25087579463633e-15,TRUE,258,553,39,GO:BP,negative regulation of transferase activity,21010,14356,GO:0043086|GO:0051338,FALSE
WP:WP710,2.34039636765719e-15,TRUE,110,461,34,WP,DNA damage response (only ATM dependent),8625,470,WP:000000,FALSE
HPA:0600441,2.3588977799401e-15,TRUE,6107,418,315,HPA,tonsil; non-germinal center cells[Low],11006,846,HPA:0600000,FALSE
KEGG:04914,2.51158832778517e-15,TRUE,100,431,32,KEGG,Progesterone-mediated oocyte maturation,8161,364,KEGG:00000,FALSE
GO:0001775,2.80004951413875e-15,TRUE,1082,553,83,GO:BP,cell activation,21010,450,GO:0009987|GO:0032501,FALSE
KEGG:04919,2.80877040295165e-15,TRUE,121,431,35,KEGG,Thyroid hormone signaling pathway,8161,369,KEGG:00000,FALSE
REAC:R-HSA-2990846,2.95924321983801e-15,TRUE,176,485,40,REAC,SUMOylation,10835,2060,REAC:R-HSA-597592,FALSE
REAC:R-HSA-381340,3.03274362911636e-15,TRUE,82,485,28,REAC,Transcriptional regulation of white adipocyte differentiation,10835,2444,REAC:R-HSA-1266738,FALSE
GO:0032504,3.25207908018631e-15,TRUE,954,553,77,GO:BP,multicellular organism reproduction,21010,7977,GO:0000003|GO:0032501,FALSE
GO:0044419,3.33272503950984e-15,TRUE,1698,553,109,GO:BP,biological process involved in interspecies interaction between organisms,21010,11569,GO:0008150,FALSE
GO:0000003,3.61139398382073e-15,TRUE,1528,553,102,GO:BP,reproduction,21010,3,GO:0008150,FALSE
KEGG:05212,3.87419049064435e-15,TRUE,76,431,28,KEGG,Pancreatic cancer,8161,456,KEGG:00000,FALSE
GO:0003700,4.31796386305465e-15,TRUE,1243,555,91,GO:MF,DNA-binding transcription factor activity,20139,338,GO:0140110,FALSE
GO:0031349,4.64791319320846e-15,TRUE,453,553,51,GO:BP,positive regulation of defense response,21010,7486,GO:0006952|GO:0031347|GO:0048584,FALSE
GO:0010638,5.3119143746246e-15,TRUE,507,553,54,GO:BP,positive regulation of organelle organization,21010,4356,GO:0006996|GO:0033043|GO:0051130,FALSE
GO:0036294,5.63338540886354e-15,TRUE,148,553,30,GO:BP,cellular response to decreased oxygen levels,21010,10005,GO:0036293|GO:0071453,FALSE
GO:0006302,5.66924582379953e-15,TRUE,309,553,42,GO:BP,double-strand break repair,21010,2139,GO:0006281,FALSE
TF:M07354,5.98405620132577e-15,TRUE,8103,556,326,TF,Factor: Egr-1; motif: GCGGGGGCGG,20011,1630,TF:M00000,FALSE
GO:0046649,6.00090021967456e-15,TRUE,776,553,68,GO:BP,lymphocyte activation,21010,12911,GO:0045321,FALSE
REAC:R-HSA-8943724,6.55356990096027e-15,TRUE,59,485,24,REAC,Regulation of PTEN gene transcription,10835,1907,REAC:R-HSA-6807070,FALSE
REAC:R-HSA-201722,6.61922193302411e-15,TRUE,91,485,29,REAC,Formation of the beta-catenin:TCF transactivating complex,10835,925,REAC:R-HSA-201681,FALSE
GO:0009896,6.92138088366958e-15,TRUE,528,553,55,GO:BP,positive regulation of catabolic process,21010,3814,GO:0009056|GO:0009893|GO:0009894,FALSE
GO:0022414,6.93842777434292e-15,TRUE,1518,553,101,GO:BP,reproductive process,21010,6920,GO:0000003|GO:0008150,FALSE
GO:0007254,7.18879368644081e-15,TRUE,173,553,32,GO:BP,JNK cascade,21010,2838,GO:0051403,FALSE
GO:2001235,7.39211328415711e-15,TRUE,138,553,29,GO:BP,positive regulation of apoptotic signaling pathway,21010,27521,GO:0009967|GO:0043065|GO:0097190|GO:2001233,FALSE
GO:0048609,7.58582218978914e-15,TRUE,904,553,74,GO:BP,multicellular organismal reproductive process,21010,13522,GO:0022414|GO:0032504,FALSE
TF:M02036,8.06516626099806e-15,TRUE,10003,556,378,TF,Factor: WT1; motif: CGCCCCCNCN,20011,8986,TF:M00000,FALSE
KEGG:04380,8.76158093667699e-15,TRUE,125,431,35,KEGG,Osteoclast differentiation,8161,303,KEGG:00000,FALSE
GO:0016477,8.87813149258327e-15,TRUE,1475,553,99,GO:BP,cell migration,21010,5318,GO:0048870,FALSE
WP:WP5272,9.01045072492217e-15,TRUE,24,461,17,WP,LDL- influence on CD14 and TLR4,8625,808,WP:000000,FALSE
GO:0016301,9.67652220673085e-15,TRUE,790,555,69,GO:MF,kinase activity,20139,2774,GO:0016772,FALSE
GO:0016773,1.03243949956015e-14,TRUE,693,555,64,GO:MF,"phosphotransferase activity, alcohol group as acceptor",20139,2980,GO:0016772,FALSE
REAC:R-HSA-9614085,1.05517054485489e-14,TRUE,66,485,25,REAC,FOXO-mediated transcription,10835,881,REAC:R-HSA-212436,FALSE
GO:0007420,1.06315621189597e-14,TRUE,744,553,66,GO:BP,brain development,21010,2968,GO:0007417|GO:0048513|GO:0060322,FALSE
REAC:R-HSA-6804758,1.0925772320493e-14,TRUE,30,485,18,REAC,Regulation of TP53 Activity through Acetylation,10835,1918,REAC:R-HSA-5633007,FALSE
GO:0071375,1.19571195719374e-14,TRUE,300,553,41,GO:BP,cellular response to peptide hormone stimulus,21010,17437,GO:0032870|GO:0043434|GO:1901653,FALSE
GO:1901565,1.21913420521732e-14,TRUE,1386,553,95,GO:BP,organonitrogen compound catabolic process,21010,22438,GO:1901564|GO:1901575,FALSE
TF:M10072,1.22049318477273e-14,TRUE,10786,556,398,TF,Factor: sp4; motif: NNGNARGRGGCGGRGCNNRR,20011,7894,TF:M00000,FALSE
GO:1990841,1.45119848385322e-14,TRUE,65,555,21,GO:MF,promoter-specific chromatin binding,20139,11193,GO:0003682,FALSE
HPA:0301362,1.47024880419347e-14,TRUE,887,418,87,HPA,lung; alveolar cells type I[Medium],11006,448,HPA:0301361,FALSE
GO:0000079,1.48054463089185e-14,TRUE,109,553,26,GO:BP,regulation of cyclin-dependent protein serine/threonine kinase activity,21010,30,GO:0071900|GO:1904029,FALSE
GO:0060537,1.49709238725816e-14,TRUE,414,553,48,GO:BP,muscle tissue development,21010,15463,GO:0009888,FALSE
GO:1901575,1.50999829534177e-14,TRUE,2173,553,126,GO:BP,organic substance catabolic process,21010,22444,GO:0009056|GO:0071704,FALSE
GO:0006310,1.55563831512676e-14,TRUE,333,553,43,GO:BP,DNA recombination,21010,2147,GO:0006259,FALSE
GO:0051248,1.61263847767627e-14,TRUE,981,553,77,GO:BP,negative regulation of protein metabolic process,21010,14276,GO:0010605|GO:0019538|GO:0051172|GO:0051246,FALSE
REAC:R-HSA-198725,1.65626000212891e-14,TRUE,61,485,24,REAC,Nuclear Events (kinase and transcription factor activation),10835,1536,REAC:R-HSA-187037,FALSE
GO:0007610,1.72333716653621e-14,TRUE,652,553,61,GO:BP,behavior,21010,3120,GO:0032501,FALSE
GO:0045739,1.76923904050162e-14,TRUE,131,553,28,GO:BP,positive regulation of DNA repair,21010,12194,GO:0006281|GO:0006282|GO:0048584|GO:0051054,FALSE
GO:0032200,1.83672200580965e-14,TRUE,191,553,33,GO:BP,telomere organization,21010,7756,GO:0051276,FALSE
REAC:R-HSA-195721,1.91417317559802e-14,TRUE,328,485,54,REAC,Signaling by WNT,10835,2204,REAC:R-HSA-162582,FALSE
WP:WP2263,1.96428979251762e-14,TRUE,110,461,33,WP,Androgen receptor network in prostate cancer,8625,513,WP:000000,FALSE
TF:M08878,2.07383146932375e-14,TRUE,7674,556,312,TF,Factor: EGR; motif: CGCCCCCGCNN,20011,1670,TF:M00000,FALSE
HPA:0330222,2.17068672038305e-14,TRUE,4353,418,248,HPA,oral mucosa; squamous epithelial cells[Medium],11006,490,HPA:0330221,FALSE
WP:WP4258,2.30150472335463e-14,TRUE,97,461,31,WP,lncRNA in canonical Wnt signaling and colorectal cancer,8625,310,WP:000000,FALSE
KEGG:04922,2.3414194597905e-14,TRUE,107,431,32,KEGG,Glucagon signaling pathway,8161,372,KEGG:00000,FALSE
REAC:R-HSA-73894,2.52310875877767e-14,TRUE,330,485,54,REAC,DNA Repair,10835,427,REAC:0000000,FALSE
GO:0040008,2.61686344535459e-14,TRUE,619,553,59,GO:BP,regulation of growth,21010,10388,GO:0040007|GO:0050789,FALSE
HPA:0010011,2.71899762059876e-14,TRUE,3934,418,231,HPA,adipose tissue; adipocytes[Low],11006,3,HPA:0010000,FALSE
HPA:0010000,2.71899762059876e-14,TRUE,3934,418,231,HPA,adipose tissue,11006,2,HPA:0000000,FALSE
KEGG:05022,2.84509773913112e-14,TRUE,474,431,71,KEGG,Pathways of neurodegeneration - multiple diseases,8161,410,KEGG:00000,FALSE
HPA:0610831,3.30960209733129e-14,TRUE,7297,418,351,HPA,urinary bladder; urothelial cells[Low],11006,853,HPA:0610000,FALSE
HPA:0610000,3.30960209733129e-14,TRUE,7297,418,351,HPA,urinary bladder,11006,852,HPA:0000000,FALSE
GO:0045637,3.41943836075116e-14,TRUE,208,553,34,GO:BP,regulation of myeloid cell differentiation,21010,12103,GO:0030099|GO:1903706,FALSE
GO:0000278,3.53671168562206e-14,TRUE,908,553,73,GO:BP,mitotic cell cycle,21010,80,GO:0007049,FALSE
TF:M00333,3.81342792537653e-14,TRUE,15395,556,504,TF,Factor: ZF5; motif: NRNGNGCGCGCWN,20011,9234,TF:M00000,FALSE
HPA:0160251,4.09197228194786e-14,TRUE,4070,418,236,HPA,endometrium 1; cells in endometrial stroma[Low],11006,307,HPA:0160000,FALSE
HPA:0530711,4.09649713577991e-14,TRUE,5322,418,284,HPA,spleen; cells in red pulp[Low],11006,776,HPA:0530000,FALSE
GO:0009755,4.12927687436476e-14,TRUE,196,553,33,GO:BP,hormone-mediated signaling pathway,21010,3710,GO:0007165|GO:0032870,FALSE
GO:0009057,4.14348805289699e-14,TRUE,1412,553,95,GO:BP,macromolecule catabolic process,21010,3289,GO:0043170|GO:1901575,FALSE
GO:0051223,4.24715643449458e-14,TRUE,513,553,53,GO:BP,regulation of protein transport,21010,14257,GO:0015031|GO:0051049|GO:0070201,FALSE
GO:0051603,4.64175980702842e-14,TRUE,807,553,68,GO:BP,proteolysis involved in protein catabolic process,21010,14516,GO:0006508|GO:0030163,FALSE
GO:0051092,4.67184075042903e-14,TRUE,159,553,30,GO:BP,positive regulation of NF-kappaB transcription factor activity,21010,14159,GO:0051091,FALSE
KEGG:05235,4.80795817696092e-14,TRUE,89,431,29,KEGG,PD-L1 expression and PD-1 checkpoint pathway in cancer,8161,473,KEGG:00000,FALSE
GO:0071339,4.86852276252163e-14,TRUE,31,548,15,GO:CC,MLL1 complex,22090,2736,GO:0044665,FALSE
GO:1990907,5.03280245489938e-14,TRUE,13,548,11,GO:CC,beta-catenin-TCF complex,22090,4042,GO:0090575,FALSE
TF:M10438_1,5.05399749377163e-14,TRUE,15212,556,500,TF,Factor: ZF5; motif: GGSGCGCGS; match class: 1,20011,9227,TF:M10438,FALSE
GO:0009410,5.27427749651224e-14,TRUE,427,553,48,GO:BP,response to xenobiotic stimulus,21010,3531,GO:0042221,FALSE
HPA:0600000,5.5363123395016e-14,TRUE,7779,418,365,HPA,tonsil,11006,842,HPA:0000000,FALSE
HPA:0600431,5.71877754465364e-14,TRUE,5977,418,307,HPA,tonsil; germinal center cells[Low],11006,843,HPA:0600000,FALSE
REAC:R-HSA-9006925,5.84252170869928e-14,TRUE,292,485,50,REAC,Intracellular signaling by second messengers,10835,1214,REAC:R-HSA-162582,FALSE
TF:M11603_1,6.04320919609997e-14,TRUE,13482,556,462,TF,Factor: TCF-1; motif: ACATCGRGRCGCTGW; match class: 1,20011,8411,TF:M11603,FALSE
GO:0051129,6.05574651680896e-14,TRUE,709,553,63,GO:BP,negative regulation of cellular component organization,21010,14187,GO:0016043|GO:0048523|GO:0051128,FALSE
GO:0106310,6.37508889995133e-14,TRUE,360,555,44,GO:MF,protein serine kinase activity,20139,10341,GO:0004672,FALSE
GO:1903131,6.56171939308209e-14,TRUE,482,553,51,GO:BP,mononuclear cell differentiation,21010,23716,GO:0002521,FALSE
GO:0042176,7.16129192405083e-14,TRUE,363,553,44,GO:BP,regulation of protein catabolic process,21010,10503,GO:0009894|GO:0030163|GO:0051246,FALSE
WP:WP707,7.2311756224249e-14,TRUE,69,461,26,WP,DNA damage response,8625,609,WP:000000,FALSE
TF:M12722_1,7.78452793748173e-14,TRUE,6819,556,285,TF,Factor: ZXDL; motif: GSGSCNNGGGMRGCNCCGGGS; match class: 1,20011,11647,TF:M12722,FALSE
REAC:R-HSA-1257604,8.33977948023471e-14,TRUE,252,485,46,REAC,PIP3 activates AKT signaling,10835,1599,REAC:R-HSA-9006925,FALSE
WP:WP4321,8.72423184421717e-14,TRUE,108,461,32,WP,Thermogenesis,8625,101,WP:000000,FALSE
GO:0044665,8.95700258520912e-14,TRUE,32,548,15,GO:CC,MLL1/2 complex,22090,2099,GO:0035097,FALSE
WP:WP4263,9.05815510757103e-14,TRUE,88,461,29,WP,Pancreatic adenocarcinoma pathway,8625,651,WP:000000,FALSE
GO:0140993,9.18157127007605e-14,TRUE,202,555,33,GO:MF,histone modifying activity,20139,10851,GO:0140096,TRUE
GO:0006006,9.23894850960854e-14,TRUE,188,553,32,GO:BP,glucose metabolic process,21010,1903,GO:0019318,FALSE
GO:0019221,9.29587983208939e-14,TRUE,486,553,51,GO:BP,cytokine-mediated signaling pathway,21010,5854,GO:0007166|GO:0071345,FALSE
WP:WP236,9.65363078176834e-14,TRUE,130,461,35,WP,Adipogenesis,8625,303,WP:000000,FALSE
GO:0010821,9.8045468198204e-14,TRUE,151,553,29,GO:BP,regulation of mitochondrion organization,21010,4512,GO:0007005|GO:0033043,FALSE
REAC:R-HSA-9018519,1.00983582104387e-13,TRUE,148,485,35,REAC,Estrogen-dependent gene expression,10835,827,REAC:R-HSA-8939211,FALSE
TF:M08205_1,1.03859811981981e-13,TRUE,10699,556,393,TF,Factor: E2F-1:Elk-1; motif: SGCGCSNNAMCGGAAGT; match class: 1,20011,1429,TF:M08205,FALSE
WP:WP2034,1.10011668358596e-13,TRUE,76,461,27,WP,Leptin signaling pathway,8625,501,WP:000000,FALSE
GO:0045165,1.10119393860886e-13,TRUE,288,553,39,GO:BP,cell fate commitment,21010,11912,GO:0030154|GO:0048869,FALSE
KEGG:05152,1.14352531329109e-13,TRUE,175,431,40,KEGG,Tuberculosis,8161,433,KEGG:00000,FALSE
MIRNA:hsa-miR-34a-5p,1.20719356226619e-13,TRUE,730,514,73,MIRNA,hsa-miR-34a-5p,14846,707,MIRNA:000000,FALSE
KEGG:04935,1.24843992501066e-13,TRUE,120,431,33,KEGG,"Growth hormone synthesis, secretion and action",8161,385,KEGG:00000,FALSE
WP:WP4336,1.27816115070395e-13,TRUE,89,461,29,WP,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,8625,685,WP:000000,FALSE
GO:0000123,1.53959856007344e-13,TRUE,91,548,22,GO:CC,histone acetyltransferase complex,22090,9,GO:0000785|GO:0031248,FALSE
HPA:0610832,1.57807015313445e-13,TRUE,5953,418,305,HPA,urinary bladder; urothelial cells[Medium],11006,854,HPA:0610831,FALSE
GO:0016580,1.61543847234472e-13,TRUE,22,548,13,GO:CC,Sin3 complex,22090,757,GO:0070822,FALSE
GO:0070822,1.61543847234472e-13,TRUE,22,548,13,GO:CC,Sin3-type complex,22090,2574,GO:0000118|GO:0000228|GO:0000785,FALSE
GO:0070727,1.75309010338047e-13,TRUE,2738,553,144,GO:BP,cellular macromolecule localization,21010,17079,GO:0033036|GO:0051641,FALSE
GO:0043009,1.82359276280982e-13,TRUE,665,553,60,GO:BP,chordate embryonic development,21010,10985,GO:0009792,FALSE
GO:0045598,1.85203234478868e-13,TRUE,131,553,27,GO:BP,regulation of fat cell differentiation,21010,12064,GO:0045444|GO:0045595,FALSE
KEGG:04926,1.85546280663398e-13,TRUE,129,431,34,KEGG,Relaxin signaling pathway,8161,376,KEGG:00000,FALSE
GO:0090092,1.93459294607806e-13,TRUE,248,553,36,GO:BP,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,21010,18869,GO:0007178|GO:0009966,FALSE
KEGG:04910,2.00480640015128e-13,TRUE,137,431,35,KEGG,Insulin signaling pathway,8161,360,KEGG:00000,FALSE
WP:WP61,2.04119504648494e-13,TRUE,60,461,24,WP,Notch signaling pathway,8625,182,WP:000000,FALSE
GO:0033036,2.10159835225245e-13,TRUE,3204,553,160,GO:BP,macromolecule localization,21010,8369,GO:0051179,FALSE
GO:0009792,2.10725503877785e-13,TRUE,687,553,61,GO:BP,embryo development ending in birth or egg hatching,21010,3737,GO:0009790,FALSE
GO:0006996,2.2674328654089e-13,TRUE,3562,553,172,GO:BP,organelle organization,21010,2654,GO:0016043,FALSE
TF:M00695_1,2.40437142598386e-13,TRUE,7207,556,295,TF,Factor: ETF; motif: GVGGMGG; match class: 1,20011,2165,TF:M00695,FALSE
GO:1902459,2.58766508871344e-13,TRUE,48,553,18,GO:BP,positive regulation of stem cell population maintenance,21010,23198,GO:0019827|GO:0051094|GO:0051240|GO:2000036,TRUE
TF:M12722,2.6856076156271e-13,TRUE,10824,556,395,TF,Factor: ZXDL; motif: GSGSCNNGGGMRGCNCCGGGS,20011,11646,TF:M00000,FALSE
GO:0050727,2.70888299044521e-13,TRUE,376,553,44,GO:BP,regulation of inflammatory response,21010,13882,GO:0006954|GO:0031347|GO:0032101,FALSE
TF:M01104,2.95451988745271e-13,TRUE,10522,556,387,TF,Factor: MOVO-B; motif: GNGGGGG,20011,5238,TF:M00000,FALSE
HPA:0340461,2.97255059644187e-13,TRUE,3981,418,230,HPA,ovary; ovarian stroma cells[Low],11006,496,HPA:0340000,FALSE
GO:0019216,2.99196714824943e-13,TRUE,344,553,42,GO:BP,regulation of lipid metabolic process,21010,5849,GO:0006629|GO:0080090,FALSE
TF:M00716_1,3.07076209081059e-13,TRUE,14451,556,482,TF,Factor: ZF5; motif: GSGCGCGR; match class: 1,20011,9223,TF:M00716,FALSE
HPA:0340462,3.10859921818984e-13,TRUE,2063,418,146,HPA,ovary; ovarian stroma cells[Medium],11006,497,HPA:0340461,FALSE
GO:0010906,3.11604430168382e-13,TRUE,101,553,24,GO:BP,regulation of glucose metabolic process,21010,4575,GO:0006006|GO:0006109|GO:0062012,FALSE
GO:0008104,3.11860432863439e-13,TRUE,2728,553,143,GO:BP,protein localization,21010,3176,GO:0070727,FALSE
GO:0045787,3.69328088280566e-13,TRUE,346,553,42,GO:BP,positive regulation of cell cycle,21010,12234,GO:0007049|GO:0048522|GO:0051726,FALSE
GO:0001944,3.72268067428404e-13,TRUE,736,553,63,GO:BP,vasculature development,21010,566,GO:0048731|GO:0072359,FALSE
GO:0006511,3.89698658159156e-13,TRUE,696,553,61,GO:BP,ubiquitin-dependent protein catabolic process,21010,2272,GO:0019941,FALSE
HPA:0470000,4.06896012963983e-13,TRUE,7029,418,340,HPA,skin 2,11006,676,HPA:0000000,FALSE
GO:0090090,4.14620798226296e-13,TRUE,135,553,27,GO:BP,negative regulation of canonical Wnt signaling pathway,21010,18867,GO:0030178|GO:0060070|GO:0060828,FALSE
WP:WP3888,4.2979205651164e-13,TRUE,430,461,66,WP,VEGFA-VEGFR2 signaling,8625,802,WP:000000,FALSE
WP:WP4630,4.44114775718184e-13,TRUE,136,461,35,WP,Measles virus infection,8625,99,WP:000000,FALSE
GO:0000151,4.47440581614218e-13,TRUE,320,548,38,GO:CC,ubiquitin ligase complex,22090,23,GO:0140535|GO:1990234,FALSE
KEGG:04917,4.68797656930619e-13,TRUE,70,431,25,KEGG,Prolactin signaling pathway,8161,367,KEGG:00000,FALSE
GO:0022402,4.70115903093229e-13,TRUE,1273,553,87,GO:BP,cell cycle process,21010,6908,GO:0007049|GO:0009987,FALSE
WP:WP481,4.71246403443658e-13,TRUE,160,461,38,WP,Insulin signaling,8625,488,WP:000000,FALSE
KEGG:04621,4.77755112506158e-13,TRUE,182,431,40,KEGG,NOD-like receptor signaling pathway,8161,320,KEGG:00000,FALSE
WP:WP428,4.92652940150681e-13,TRUE,114,461,32,WP,Wnt signaling,8625,79,WP:000000,FALSE
GO:0000723,5.01045281760724e-13,TRUE,160,553,29,GO:BP,telomere maintenance,21010,208,GO:0006259|GO:0032200,FALSE
HPA:0190222,5.01577201772779e-13,TRUE,5052,418,271,HPA,esophagus; squamous epithelial cells[Medium],11006,326,HPA:0190221,FALSE
HPA:0330000,5.05899710509787e-13,TRUE,6252,418,314,HPA,oral mucosa,11006,488,HPA:0000000,FALSE
HPA:0330221,5.05899710509787e-13,TRUE,6252,418,314,HPA,oral mucosa; squamous epithelial cells[Low],11006,489,HPA:0330000,FALSE
GO:0051641,5.12827180772978e-13,TRUE,3652,553,174,GO:BP,cellular localization,21010,14550,GO:0009987|GO:0051179,FALSE
TF:M01199,5.56270388790369e-13,TRUE,8709,556,337,TF,Factor: RNF96; motif: BCCCGCRGCC,20011,7290,TF:M00000,FALSE
GO:1902894,5.85455001270573e-13,TRUE,25,553,14,GO:BP,negative regulation of miRNA transcription,21010,23509,GO:0045892|GO:0061614|GO:1902893|GO:2000629,FALSE
TF:M02089,5.90203345737322e-13,TRUE,13508,556,460,TF,Factor: E2F-3; motif: GGCGGGN,20011,1496,TF:M00000,FALSE
GO:0097300,6.08626084679723e-13,TRUE,50,553,18,GO:BP,programmed necrotic cell death,21010,19468,GO:0012501,FALSE
GO:0043467,6.13495552136129e-13,TRUE,137,553,27,GO:BP,regulation of generation of precursor metabolites and energy,21010,11226,GO:0006091|GO:0031323,FALSE
GO:0000781,6.42286280440735e-13,TRUE,170,548,28,GO:CC,"chromosome, telomeric region",22090,89,GO:0098687,FALSE
WP:WP4879,6.52228793750537e-13,TRUE,57,461,23,WP,Overlap between signal transduction pathways contributing to LMNA laminopathies,8625,506,WP:000000,FALSE
TF:M11882_1,7.13950100972841e-13,TRUE,11697,556,416,TF,Factor: pax-6; motif: NYACGCNYSANYGMNCN; match class: 1,20011,6413,TF:M11882,FALSE
TF:M09723,7.43346880552883e-13,TRUE,10417,556,383,TF,Factor: BTEB1; motif: GGGGGCGGGGCNGSGGGNGS,20011,612,TF:M00000,FALSE
GO:0017053,7.45379554175826e-13,TRUE,77,548,20,GO:CC,transcription repressor complex,22090,782,GO:0005667,FALSE
GO:0019941,7.615374127848e-13,TRUE,706,553,61,GO:BP,modification-dependent protein catabolic process,21010,6376,GO:0043632|GO:0051603,FALSE
WP:WP5158,8.00690050172206e-13,TRUE,69,461,25,WP,Urotensin-II-mediated signaling pathway,8625,457,WP:000000,FALSE
GO:0001568,8.13697510896341e-13,TRUE,707,553,61,GO:BP,blood vessel development,21010,363,GO:0001944|GO:0048856,FALSE
GO:0050673,8.61351149759773e-13,TRUE,440,553,47,GO:BP,epithelial cell proliferation,21010,13863,GO:0008283,FALSE
WP:WP1541,8.81609775586072e-13,TRUE,47,461,21,WP,Energy metabolism,8625,737,WP:000000,FALSE
TF:M07395_1,9.35258553813589e-13,TRUE,6534,556,273,TF,Factor: Sp1; motif: NGGGGCGGGGN; match class: 1,20011,7849,TF:M07395,FALSE
WP:WP5353,9.84381556602248e-13,TRUE,82,461,27,WP,A network map of Macrophage-stimulating protein (MSP) signaling,8625,273,WP:000000,FALSE
TF:M00931_1,9.92502778172021e-13,TRUE,6078,556,259,TF,Factor: Sp1; motif: GGGGCGGGGC; match class: 1,20011,7857,TF:M00931,FALSE
KEGG:05135,1.04080361786063e-12,TRUE,136,431,34,KEGG,Yersinia infection,8161,425,KEGG:00000,FALSE
REAC:R-HSA-9707616,1.22452709926329e-12,TRUE,47,485,20,REAC,Heme signaling,10835,1066,REAC:R-HSA-2262752,FALSE
HPA:0310431,1.23089335348851e-12,TRUE,5055,418,270,HPA,lymph node; germinal center cells[Low],11006,460,HPA:0310000,FALSE
GO:2000629,1.2381150366286e-12,TRUE,26,553,14,GO:BP,negative regulation of miRNA metabolic process,21010,26998,GO:0010586|GO:0051253|GO:2000628,FALSE
GO:0031491,1.24820316458346e-12,TRUE,70,555,20,GO:MF,nucleosome binding,20139,4159,GO:0003682,FALSE
KEGG:04934,1.27340171987155e-12,TRUE,153,431,36,KEGG,Cushing syndrome,8161,384,KEGG:00000,FALSE
KEGG:04915,1.31819178530479e-12,TRUE,137,431,34,KEGG,Estrogen signaling pathway,8161,365,KEGG:00000,FALSE
HPA:0530000,1.32031797319396e-12,TRUE,5882,418,300,HPA,spleen,11006,775,HPA:0000000,FALSE
WP:WP5094,1.32120976677176e-12,TRUE,199,461,42,WP,Orexin receptor pathway,8625,830,WP:000000,FALSE
REAC:R-HSA-449147,1.32833845181747e-12,TRUE,471,485,63,REAC,Signaling by Interleukins,10835,2154,REAC:R-HSA-1280215,FALSE
WP:WP2261,1.38782340689808e-12,TRUE,83,461,27,WP,Glioblastoma signaling pathways,8625,212,WP:000000,FALSE
GO:0043470,1.40870651934576e-12,TRUE,60,553,19,GO:BP,regulation of carbohydrate catabolic process,21010,11229,GO:0006109|GO:0009894|GO:0016052,FALSE
HPA:0310000,1.42635862098606e-12,TRUE,6523,418,322,HPA,lymph node,11006,459,HPA:0000000,FALSE
GO:1903047,1.43254103884781e-12,TRUE,757,553,63,GO:BP,mitotic cell cycle process,21010,23651,GO:0000278|GO:0022402,FALSE
GO:0043632,1.46826823784265e-12,TRUE,716,553,61,GO:BP,modification-dependent macromolecule catabolic process,21010,11331,GO:0009057,FALSE
GO:0031248,1.63039962124308e-12,TRUE,101,548,22,GO:CC,protein acetyltransferase complex,22090,1074,GO:0140535|GO:1902493,FALSE
KEGG:05418,1.66551833782777e-12,TRUE,138,431,34,KEGG,Fluid shear stress and atherosclerosis,8161,488,KEGG:00000,FALSE
GO:0033365,1.69443426693105e-12,TRUE,1182,553,82,GO:BP,protein localization to organelle,21010,8554,GO:0008104,FALSE
GO:0030877,1.74825302531755e-12,TRUE,12,548,10,GO:CC,beta-catenin destruction complex,22090,991,GO:0140535|GO:1902494,TRUE
GO:0042770,1.83449803591064e-12,TRUE,194,553,31,GO:BP,signal transduction in response to DNA damage,21010,10858,GO:0006974|GO:0035556,FALSE
GO:1902493,2.03138218932653e-12,TRUE,102,548,22,GO:CC,acetyltransferase complex,22090,3630,GO:1990234,FALSE
REAC:R-HSA-73887,2.05934108991055e-12,TRUE,153,485,34,REAC,Death Receptor Signaling,10835,438,REAC:R-HSA-162582,FALSE
TF:M07380,2.13383579077375e-12,TRUE,13316,556,454,TF,Factor: E2F-4; motif: NTTTCSCGCC,20011,1516,TF:M00000,FALSE
GO:0044087,2.38543164959448e-12,TRUE,960,553,72,GO:BP,regulation of cellular component biogenesis,21010,11460,GO:0044085|GO:0050794,FALSE
GO:2001236,2.57954105294295e-12,TRUE,157,553,28,GO:BP,regulation of extrinsic apoptotic signaling pathway,21010,27522,GO:0097191|GO:2001233,FALSE
HPA:0040000,2.73450159246431e-12,TRUE,6486,418,320,HPA,bone marrow,11006,50,HPA:0000000,FALSE
HPA:0040081,2.73450159246431e-12,TRUE,6486,418,320,HPA,bone marrow; hematopoietic cells[Low],11006,51,HPA:0040000,FALSE
KEGG:04064,2.75131812900688e-12,TRUE,102,431,29,KEGG,NF-kappa B signaling pathway,8161,251,KEGG:00000,FALSE
GO:0051049,2.83580118195506e-12,TRUE,1762,553,105,GO:BP,regulation of transport,21010,14131,GO:0006810|GO:0032879,FALSE
HP:0034335,2.83991953414517e-12,TRUE,333,241,53,HP,Inheritance qualifier,4962,14315,HP:0000005,FALSE
REAC:R-HSA-5357956,2.8853462738525e-12,TRUE,33,485,17,REAC,TNFR1-induced NF-kappa-B signaling pathway,10835,2330,REAC:R-HSA-75893,FALSE
TF:M09894_1,2.92652750133621e-12,TRUE,14291,556,476,TF,Factor: E2F-4; motif: SNGGGCGGGAANN; match class: 1,20011,1511,TF:M09894,FALSE
HPA:0380000,2.9282193294691e-12,TRUE,7509,418,353,HPA,placenta,11006,517,HPA:0000000,FALSE
TF:M00933_1,2.9444058613103e-12,TRUE,5326,556,234,TF,Factor: Sp1; motif: CCCCGCCCCN; match class: 1,20011,7847,TF:M00933,FALSE
TF:M02036_1,3.04851807343396e-12,TRUE,5454,556,238,TF,Factor: WT1; motif: CGCCCCCNCN; match class: 1,20011,8987,TF:M02036,FALSE
GO:0003676,3.06144309684574e-12,TRUE,5480,555,235,GO:MF,nucleic acid binding,20139,323,GO:0097159|GO:1901363,FALSE
TF:M00932_1,3.18895403898828e-12,TRUE,6229,556,262,TF,Factor: Sp1; motif: NNGGGGCGGGGNN; match class: 1,20011,7853,TF:M00932,FALSE
WP:WP195,3.29131971562404e-12,TRUE,55,461,22,WP,IL-1 signaling pathway,8625,233,WP:000000,FALSE
GO:0034504,3.29619800891686e-12,TRUE,318,553,39,GO:BP,protein localization to nucleus,21010,9071,GO:0033365,FALSE
GO:0043408,3.50372121057438e-12,TRUE,668,553,58,GO:BP,regulation of MAPK cascade,21010,11187,GO:0000165|GO:1902531,FALSE
TF:M09826_1,3.68663442734926e-12,TRUE,7853,556,310,TF,Factor: BTEB3; motif: CCNNSCCNSCCCCKCCCCC; match class: 1,20011,627,TF:M09826,FALSE
GO:0009607,3.75168812293681e-12,TRUE,1565,553,97,GO:BP,response to biotic stimulus,21010,3592,GO:0050896,FALSE
WP:WP399,4.08060455272397e-12,TRUE,100,461,29,WP,Wnt signaling pathway and pluripotency,8625,188,WP:000000,FALSE
HPA:0030071,4.11953556420538e-12,TRUE,4726,418,256,HPA,appendix; lymphoid tissue[Low],11006,44,HPA:0030000,FALSE
HPA:0630000,4.13556316761246e-12,TRUE,6922,418,334,HPA,cervix,11006,201,HPA:0000000,FALSE
GO:2000036,4.17514662750347e-12,TRUE,72,553,20,GO:BP,regulation of stem cell population maintenance,21010,26456,GO:0019827|GO:0050793|GO:0051239,FALSE
GO:0032103,4.24585707680941e-12,TRUE,591,553,54,GO:BP,positive regulation of response to external stimulus,21010,7726,GO:0009605|GO:0032101|GO:0048584,FALSE
TF:M00196,4.3459209947163e-12,TRUE,10509,556,383,TF,Factor: Sp1; motif: NGGGGGCGGGGYN,20011,7854,TF:M00000,FALSE
GO:0002520,4.41261105928414e-12,TRUE,200,553,31,GO:BP,immune system development,21010,1056,GO:0002376|GO:0048731,FALSE
TF:M04869,4.41877006215175e-12,TRUE,11515,556,409,TF,Factor: Egr-1; motif: GCGCATGCG,20011,1608,TF:M00000,FALSE
TF:M11531_1,4.48918290724994e-12,TRUE,12643,556,437,TF,Factor: E2F-2; motif: GCGCGCGCGYW; match class: 1,20011,1473,TF:M11531,FALSE
WP:WP712,4.54124125612487e-12,TRUE,23,461,15,WP,Estrogen signaling pathway,8625,284,WP:000000,FALSE
HPA:0620222,4.59976151748527e-12,TRUE,4042,418,229,HPA,vagina; squamous epithelial cells[Medium],11006,858,HPA:0620221,FALSE
GO:0005975,4.74300752200578e-12,TRUE,573,553,53,GO:BP,carbohydrate metabolic process,21010,1872,GO:0044238|GO:0071704,FALSE
HPA:0050051,4.77669257913969e-12,TRUE,6805,418,330,HPA,breast; glandular cells[Low],11006,58,HPA:0050000,FALSE
TF:M10072_1,4.98999723404278e-12,TRUE,6414,556,267,TF,Factor: sp4; motif: NNGNARGRGGCGGRGCNNRR; match class: 1,20011,7895,TF:M10072,FALSE
GO:0048870,5.4483705424789e-12,TRUE,1676,553,101,GO:BP,cell motility,21010,13765,GO:0009987,FALSE
REAC:R-HSA-5663205,5.51380984937851e-12,TRUE,999,485,99,REAC,Infectious disease,10835,1131,REAC:R-HSA-1643685,FALSE
HPA:0170251,5.5480796200213e-12,TRUE,3511,418,207,HPA,endometrium 2; cells in endometrial stroma[Low],11006,314,HPA:0170000,FALSE
GO:0071456,5.79289708695263e-12,TRUE,137,553,26,GO:BP,cellular response to hypoxia,21010,17501,GO:0001666|GO:0033554|GO:0036294,FALSE
GO:0019902,5.80138443273125e-12,TRUE,190,555,30,GO:MF,phosphatase binding,20139,3753,GO:0019899,FALSE
GO:0032869,5.86863786888218e-12,TRUE,202,553,31,GO:BP,cellular response to insulin stimulus,21010,8237,GO:0032868|GO:0071375,FALSE
TF:M11601_1,5.99478951375633e-12,TRUE,11335,556,404,TF,Factor: TCF-1; motif: ACATCGRGRCGCTGW; match class: 1,20011,8407,TF:M11601,FALSE
WP:WP3931,6.0782221689087e-12,TRUE,116,461,31,WP,Embryonic stem cell pluripotency pathways,8625,839,WP:000000,FALSE
GO:0031072,6.47321466358913e-12,TRUE,128,555,25,GO:MF,heat shock protein binding,20139,4116,GO:0005515,FALSE
REAC:R-HSA-1280215,6.62148562617518e-12,TRUE,719,485,80,REAC,Cytokine Signaling in Immune system,10835,408,REAC:R-HSA-168256,FALSE
TF:M04953_1,6.96102954161784e-12,TRUE,4193,556,196,TF,Factor: Sp1; motif: GGNDGGRGGCGGGG; match class: 1,20011,7831,TF:M04953,FALSE
GO:0032872,7.58127233384347e-12,TRUE,190,553,30,GO:BP,regulation of stress-activated MAPK cascade,21010,8240,GO:0043408|GO:0051403|GO:0070302,FALSE
GO:0033002,7.77727785837157e-12,TRUE,204,553,31,GO:BP,muscle cell proliferation,21010,8344,GO:0008283,FALSE
GO:0009895,7.93415721089191e-12,TRUE,343,553,40,GO:BP,negative regulation of catabolic process,21010,3813,GO:0009056|GO:0009892|GO:0009894,FALSE
REAC:R-HSA-6804756,8.53447841457897e-12,TRUE,92,485,26,REAC,Regulation of TP53 Activity through Phosphorylation,10835,1921,REAC:R-HSA-5633007,FALSE
GO:0010952,9.48367378537927e-12,TRUE,178,553,29,GO:BP,positive regulation of peptidase activity,21010,4614,GO:0045862|GO:0051345|GO:0052547,FALSE
GO:0090287,9.7060369973589e-12,TRUE,312,553,38,GO:BP,regulation of cellular response to growth factor stimulus,21010,19040,GO:0048583|GO:0071363,FALSE
HPA:0160252,9.7881386459369e-12,TRUE,2232,418,150,HPA,endometrium 1; cells in endometrial stroma[Medium],11006,308,HPA:0160251,FALSE
GO:0002684,1.02107823585934e-11,TRUE,1033,553,74,GO:BP,positive regulation of immune system process,21010,1216,GO:0002376|GO:0002682|GO:0048518,FALSE
TF:M08525_1,1.03126464847209e-11,TRUE,15607,556,503,TF,Factor: E2F-1:HES-7; motif: GGCRCGTGSYNNWNGGCGCSM; match class: 1,20011,1433,TF:M08525,FALSE
HP:0001442,1.07566362746362e-11,TRUE,175,241,37,HP,Typified by somatic mosaicism,4962,1078,HP:0034335,FALSE
HPA:0180000,1.1061761650321e-11,TRUE,7330,418,346,HPA,epididymis,11006,320,HPA:0000000,FALSE
HPA:0180051,1.1061761650321e-11,TRUE,7330,418,346,HPA,epididymis; glandular cells[Low],11006,321,HPA:0180000,FALSE
HPA:0040082,1.14145578946144e-11,TRUE,4247,418,236,HPA,bone marrow; hematopoietic cells[Medium],11006,52,HPA:0040081,FALSE
TF:M00196_1,1.15444693446116e-11,TRUE,6093,556,256,TF,Factor: Sp1; motif: NGGGGGCGGGGYN; match class: 1,20011,7855,TF:M00196,FALSE
REAC:R-HSA-5688426,1.15802302630085e-11,TRUE,297,485,47,REAC,Deubiquitination,10835,706,REAC:R-HSA-597592,FALSE
HPA:0460000,1.19325609259919e-11,TRUE,7238,418,343,HPA,skin 1,11006,621,HPA:0000000,FALSE
HPA:0050000,1.21491579984758e-11,TRUE,7176,418,341,HPA,breast,11006,54,HPA:0000000,FALSE
GO:0002831,1.22144473341277e-11,TRUE,490,553,48,GO:BP,regulation of response to biotic stimulus,21010,1355,GO:0009607|GO:0048583,FALSE
HPA:0030000,1.24398971128325e-11,TRUE,7821,418,361,HPA,appendix,11006,22,HPA:0000000,FALSE
REAC:R-HSA-5674400,1.25181942149795e-11,TRUE,26,485,15,REAC,Constitutive Signaling by AKT1 E17K in Cancer,10835,382,REAC:R-HSA-2219528,FALSE
TF:M08526_1,1.25746345955035e-11,TRUE,15329,556,497,TF,Factor: E2F-3:HES-7; motif: NNNSGCGCSNNNNNCRCGYGNN; match class: 1,20011,1483,TF:M08526,FALSE
GO:1901990,1.26526484324304e-11,TRUE,331,553,39,GO:BP,regulation of mitotic cell cycle phase transition,21010,22804,GO:0007346|GO:0044772|GO:1901987,FALSE
WP:WP1772,1.32051229074269e-11,TRUE,90,461,27,WP,Apoptosis modulation and signaling,8625,726,WP:000000,FALSE
GO:0070302,1.3537091951327e-11,TRUE,194,553,30,GO:BP,regulation of stress-activated protein kinase signaling cascade,21010,16841,GO:0031098|GO:0080135|GO:1902531,FALSE
GO:0010948,1.3581965535152e-11,TRUE,299,553,37,GO:BP,negative regulation of cell cycle process,21010,4610,GO:0010564|GO:0022402|GO:0045786,FALSE
HPA:0620000,1.38353822450811e-11,TRUE,5992,418,301,HPA,vagina,11006,856,HPA:0000000,FALSE
HPA:0620221,1.38353822450811e-11,TRUE,5992,418,301,HPA,vagina; squamous epithelial cells[Low],11006,857,HPA:0620000,FALSE
GO:0050767,1.3888943898794e-11,TRUE,383,553,42,GO:BP,regulation of neurogenesis,21010,13899,GO:0022008|GO:0051960|GO:0060284,FALSE
GO:0042110,1.40151023725599e-11,TRUE,549,553,51,GO:BP,T cell activation,21010,10466,GO:0046649,FALSE
REAC:R-HSA-157118,1.48927739203747e-11,TRUE,233,485,41,REAC,Signaling by NOTCH,10835,2165,REAC:R-HSA-162582,FALSE
HP:0000006,1.51321680162187e-11,TRUE,1934,241,152,HP,Autosomal dominant inheritance,4962,5,HP:0034345,FALSE
GO:0065004,1.52196431776256e-11,TRUE,238,553,33,GO:BP,protein-DNA complex assembly,21010,16680,GO:0065003|GO:0071824,FALSE
REAC:R-HSA-1980143,1.53669804635965e-11,TRUE,72,485,23,REAC,Signaling by NOTCH1,10835,2166,REAC:R-HSA-157118,FALSE
TF:M12599_1,1.53726384380838e-11,TRUE,16020,556,511,TF,Factor: E2F4; motif: YCCCGCCNCNNSSNNSNN; match class: 1,20011,1515,TF:M12599,FALSE
GO:1904031,1.54991559369985e-11,TRUE,43,553,16,GO:BP,positive regulation of cyclin-dependent protein kinase activity,21010,24446,GO:0045860|GO:1904029,FALSE
TF:M09826,1.55324209774099e-11,TRUE,11899,556,417,TF,Factor: BTEB3; motif: CCNNSCCNSCCCCKCCCCC,20011,626,TF:M00000,FALSE
KEGG:05142,1.57283861059094e-11,TRUE,101,431,28,KEGG,Chagas disease,8161,427,KEGG:00000,FALSE
GO:0010720,1.60353073483128e-11,TRUE,438,553,45,GO:BP,positive regulation of cell development,21010,4421,GO:0045597|GO:0048468|GO:0060284,FALSE
REAC:R-HSA-2151209,1.60529032253035e-11,TRUE,10,485,10,REAC,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,10835,89,REAC:R-HSA-1592230,FALSE
TF:M07250,1.6783248797586e-11,TRUE,11002,556,394,TF,Factor: E2F-1; motif: NNNSSCGCSAANN,20011,1452,TF:M00000,FALSE
GO:0051707,1.71216680214148e-11,TRUE,1527,553,94,GO:BP,response to other organism,21010,14600,GO:0043207|GO:0044419,FALSE
KEGG:04110,1.71577895131067e-11,TRUE,157,431,35,KEGG,Cell cycle,8161,259,KEGG:00000,FALSE
WP:WP4657,1.78069433436035e-11,TRUE,128,461,32,WP,22q11.2 copy number variation syndrome,8625,444,WP:000000,FALSE
GO:0030178,1.83375508160455e-11,TRUE,169,553,28,GO:BP,negative regulation of Wnt signaling pathway,21010,7013,GO:0009968|GO:0016055|GO:0030111,FALSE
HPA:0190221,1.85300055109301e-11,TRUE,6672,418,324,HPA,esophagus; squamous epithelial cells[Low],11006,325,HPA:0190000,FALSE
HPA:0190000,1.85300055109301e-11,TRUE,6672,418,324,HPA,esophagus,11006,324,HPA:0000000,FALSE
TF:M12351,1.8909424560278e-11,TRUE,12637,556,435,TF,Factor: TIEG1; motif: NCCCNSNCCCCGCCCCC,20011,8782,TF:M00000,FALSE
GO:0043207,1.93061908502571e-11,TRUE,1530,553,94,GO:BP,response to external biotic stimulus,21010,11085,GO:0009605|GO:0009607,FALSE
HPA:0600221,2.00676374142918e-11,TRUE,6645,418,323,HPA,tonsil; squamous epithelial cells[Low],11006,849,HPA:0600000,FALSE
WP:WP4932,2.17531943830781e-11,TRUE,106,461,29,WP,7q11.23 copy number variation syndrome,8625,30,WP:000000,FALSE
TF:M03893,2.23176860530269e-11,TRUE,8506,556,326,TF,Factor: WT1; motif: GNGGGGGCGGGG,20011,8988,TF:M00000,FALSE
GO:0060562,2.29969338241457e-11,TRUE,337,553,39,GO:BP,epithelial tube morphogenesis,21010,15483,GO:0002009|GO:0035239,FALSE
GO:0042692,2.39329518597902e-11,TRUE,389,553,42,GO:BP,muscle cell differentiation,21010,10805,GO:0030154|GO:0061061,FALSE
REAC:R-HSA-187037,2.50508090615857e-11,TRUE,112,485,28,REAC,Signaling by NTRK1 (TRKA),10835,2175,REAC:R-HSA-166520,FALSE
KEGG:04722,2.55763168122263e-11,TRUE,118,431,30,KEGG,Neurotrophin signaling pathway,8161,346,KEGG:00000,FALSE
WP:WP4396,2.58790502275928e-11,TRUE,154,461,35,WP,Nonalcoholic fatty liver disease,8625,648,WP:000000,FALSE
GO:0006110,2.69624849208627e-11,TRUE,52,553,17,GO:BP,regulation of glycolytic process,21010,1998,GO:0006096|GO:0043467|GO:0043470|GO:0062012,FALSE
WP:WP2324,2.72832417359914e-11,TRUE,66,461,23,WP,AGE/RAGE pathway,8625,768,WP:000000,FALSE
WP:WP2059,2.74276221953023e-11,TRUE,325,461,53,WP,Alzheimer's disease and miRNA effects,8625,265,WP:000000,FALSE
WP:WP3865,2.78830985300875e-11,TRUE,60,461,22,WP,Novel intracellular components of RIG-I-like receptor pathway,8625,826,WP:000000,FALSE
TF:M00803,3.03736544324374e-11,TRUE,13497,556,455,TF,Factor: E2F; motif: GGCGSG,20011,1548,TF:M00000,FALSE
GO:0050776,3.27140576012624e-11,TRUE,875,553,66,GO:BP,regulation of immune response,21010,13908,GO:0002682|GO:0006955|GO:0048583,FALSE
GO:2001252,3.31148497650769e-11,TRUE,111,553,23,GO:BP,positive regulation of chromosome organization,21010,27538,GO:0010638|GO:0033044|GO:0051276,FALSE
GO:0032206,3.42519981091057e-11,TRUE,70,553,19,GO:BP,positive regulation of telomere maintenance,21010,7762,GO:0000723|GO:0032204|GO:0051054|GO:2001252,FALSE
TF:M02281,3.42541897986341e-11,TRUE,6639,556,271,TF,Factor: SP1; motif: CCCCKCCCCC,20011,7826,TF:M00000,FALSE
GO:0010563,3.73434645912913e-11,TRUE,394,553,42,GO:BP,negative regulation of phosphorus metabolic process,21010,4287,GO:0006793|GO:0031324|GO:0051174,FALSE
GO:0040011,3.76746158947597e-11,TRUE,1225,553,81,GO:BP,locomotion,21010,10391,GO:0008150,FALSE
TF:M07395,3.80040626424109e-11,TRUE,10931,556,391,TF,Factor: Sp1; motif: NGGGGCGGGGN,20011,7848,TF:M00000,FALSE
REAC:R-HSA-166520,3.83306651717053e-11,TRUE,131,485,30,REAC,Signaling by NTRKs,10835,2178,REAC:R-HSA-9006934,FALSE
WP:WP2795,3.96167993264205e-11,TRUE,55,461,21,WP,Cardiac hypertrophic response,8625,730,WP:000000,FALSE
REAC:R-HSA-5357801,3.97369614043572e-11,TRUE,208,485,38,REAC,Programmed Cell Death,10835,1722,REAC:0000000,FALSE
GO:1902911,4.01222482536395e-11,TRUE,156,548,25,GO:CC,protein kinase complex,22090,3668,GO:0061695,FALSE
GO:0019318,4.06419496290344e-11,TRUE,231,553,32,GO:BP,hexose metabolic process,21010,5938,GO:0005996,FALSE
GO:0071241,4.06419496290344e-11,TRUE,231,553,32,GO:BP,cellular response to inorganic substance,21010,17311,GO:0010035|GO:0070887,FALSE
GO:0003006,4.12524173518975e-11,TRUE,992,553,71,GO:BP,developmental process involved in reproduction,21010,1471,GO:0022414|GO:0032502,FALSE
GO:0030879,4.36700632879007e-11,TRUE,136,553,25,GO:BP,mammary gland development,21010,7266,GO:0048732,FALSE
TF:M07250_1,4.45354191706365e-11,TRUE,5671,556,241,TF,Factor: E2F-1; motif: NNNSSCGCSAANN; match class: 1,20011,1453,TF:M07250,FALSE
GO:0010038,4.47446402016522e-11,TRUE,361,553,40,GO:BP,response to metal ion,21010,3908,GO:0010035,FALSE
REAC:R-HSA-75893,4.53455386061649e-11,TRUE,55,485,20,REAC,TNF signaling,10835,2329,REAC:R-HSA-73887,FALSE
KEGG:04659,4.56304145848718e-11,TRUE,105,431,28,KEGG,Th17 cell differentiation,8161,331,KEGG:00000,FALSE
WP:WP4674,4.92482461559791e-11,TRUE,74,461,24,WP,Head and neck squamous cell carcinoma,8625,662,WP:000000,FALSE
GO:0007005,4.9643988125626e-11,TRUE,547,553,50,GO:BP,mitochondrion organization,21010,2660,GO:0006996,FALSE
GO:0031062,5.06589832695719e-11,TRUE,26,553,13,GO:BP,positive regulation of histone methylation,21010,7348,GO:0016571|GO:0031060|GO:1901875,FALSE
HPA:0270352,5.16931572591371e-11,TRUE,3084,418,186,HPA,kidney; cells in glomeruli[Medium],11006,412,HPA:0270351,FALSE
GO:0031570,5.21247878863266e-11,TRUE,137,553,25,GO:BP,DNA integrity checkpoint signaling,21010,7570,GO:0000075,FALSE
GO:0051147,5.21247878863266e-11,TRUE,137,553,25,GO:BP,regulation of muscle cell differentiation,21010,14204,GO:0042692|GO:0045595,FALSE
GO:1901983,5.51760001632496e-11,TRUE,54,553,17,GO:BP,regulation of protein acetylation,21010,22797,GO:0006473|GO:0031399,FALSE
WP:WP3303,5.67982274495826e-11,TRUE,68,461,23,WP,RAC1/PAK1/p38/MMP2 pathway,8625,573,WP:000000,FALSE
TF:M00716,5.8136503414613e-11,TRUE,16438,556,518,TF,Factor: ZF5; motif: GSGCGCGR,20011,9222,TF:M00000,FALSE
HPA:0040083,5.82030452847044e-11,TRUE,1452,418,110,HPA,bone marrow; hematopoietic cells[High],11006,53,HPA:0040082,FALSE
GO:0009743,5.88259452417688e-11,TRUE,234,553,32,GO:BP,response to carbohydrate,21010,3698,GO:0010033|GO:1901700,FALSE
GO:0033143,6.05021657156229e-11,TRUE,72,553,19,GO:BP,regulation of intracellular steroid hormone receptor signaling pathway,21010,8430,GO:0009966|GO:0030518,FALSE
TF:M07226,6.07398289200852e-11,TRUE,8488,556,324,TF,Factor: SP1; motif: NCCCCKCCCCC,20011,7832,TF:M00000,FALSE
GO:0050678,6.47003646237634e-11,TRUE,365,553,40,GO:BP,regulation of epithelial cell proliferation,21010,13868,GO:0042127|GO:0050673,FALSE
GO:0001046,6.65553532502002e-11,TRUE,41,555,15,GO:MF,core promoter sequence-specific DNA binding,20139,137,GO:0000976,FALSE
HPA:0530721,6.70669547459806e-11,TRUE,4332,418,237,HPA,spleen; cells in white pulp[Low],11006,779,HPA:0530000,FALSE
REAC:R-HSA-9824446,6.78316729758161e-11,TRUE,809,485,84,REAC,Viral Infection Pathways,10835,2527,REAC:R-HSA-5663205,FALSE
WP:WP706,7.1205800614169e-11,TRUE,159,461,35,WP,Sudden infant death syndrome (SIDS) susceptibility pathways,8625,347,WP:000000,FALSE
GO:0019207,7.18118303254079e-11,TRUE,268,555,34,GO:MF,kinase regulator activity,20139,3675,GO:0030234,TRUE
REAC:R-HSA-1640170,7.51149691087079e-11,TRUE,679,485,75,REAC,Cell Cycle,10835,312,REAC:0000000,FALSE
REAC:R-HSA-9634638,7.61841177127227e-11,TRUE,24,485,14,REAC,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,10835,828,REAC:R-HSA-9009391,FALSE
GO:0030512,7.69376307294338e-11,TRUE,93,553,21,GO:BP,negative regulation of transforming growth factor beta receptor signaling pathway,21010,7145,GO:0007179|GO:0017015|GO:0090101,FALSE
KEGG:05202,8.11794749252346e-11,TRUE,192,431,38,KEGG,Transcriptional misregulation in cancer,8161,447,KEGG:00000,FALSE
GO:0040012,8.23309613338973e-11,TRUE,1029,553,72,GO:BP,regulation of locomotion,21010,10392,GO:0040011|GO:0050789,FALSE
GO:0000075,8.36207284289212e-11,TRUE,193,553,29,GO:BP,cell cycle checkpoint signaling,21010,27,GO:0035556|GO:1901988,FALSE
TF:M01219,8.55476810524464e-11,TRUE,6986,556,280,TF,Factor: SP1:SP3; motif: CCSCCCCCYCC,20011,7820,TF:M00000,FALSE
TF:M08911,8.57661527462897e-11,TRUE,9332,556,347,TF,Factor: CTCF; motif: NCCRSTAGGGGGCGC,20011,1140,TF:M00000,FALSE
TF:M11531,8.58233379002156e-11,TRUE,13595,556,456,TF,Factor: E2F-2; motif: GCGCGCGCGYW,20011,1472,TF:M00000,FALSE
KEGG:04933,8.75023470172753e-11,TRUE,100,431,27,KEGG,AGE-RAGE signaling pathway in diabetic complications,8161,383,KEGG:00000,FALSE
GO:0043010,8.78920639443613e-11,TRUE,351,553,39,GO:BP,camera-type eye development,21010,10986,GO:0001654,FALSE
TF:M10438,8.9991007940922e-11,TRUE,16562,556,520,TF,Factor: ZF5; motif: GGSGCGCGS,20011,9226,TF:M00000,FALSE
GO:0000077,9.2736921319061e-11,TRUE,128,553,24,GO:BP,DNA damage checkpoint signaling,21010,29,GO:0031570|GO:0042770,FALSE
HPA:0050011,9.2794672445429e-11,TRUE,2780,418,172,HPA,breast; adipocytes[Low],11006,55,HPA:0050000,FALSE
HPA:0620223,9.30788783589928e-11,TRUE,1137,418,93,HPA,vagina; squamous epithelial cells[High],11006,859,HPA:0620222,FALSE
GO:0042659,9.5368840412448e-11,TRUE,27,553,13,GO:BP,regulation of cell fate specification,21010,10777,GO:0001708|GO:0010453,FALSE
TF:M07436,9.64298158802099e-11,TRUE,6657,556,270,TF,Factor: WT1; motif: NNGGGNGGGSGN,20011,8982,TF:M00000,FALSE
GO:0043620,9.64579202187032e-11,TRUE,40,553,15,GO:BP,regulation of DNA-templated transcription in response to stress,21010,11327,GO:0006355|GO:0033554,FALSE
GO:0045737,9.64579202187032e-11,TRUE,40,553,15,GO:BP,positive regulation of cyclin-dependent protein serine/threonine kinase activity,21010,12192,GO:0000079|GO:0045787|GO:0071902|GO:1904031,FALSE
GO:0042063,9.77154184325656e-11,TRUE,335,553,38,GO:BP,gliogenesis,21010,10443,GO:0022008,FALSE
GO:0032204,9.81675254210764e-11,TRUE,105,553,22,GO:BP,regulation of telomere maintenance,21010,7760,GO:0000723|GO:0033044|GO:0051052,FALSE
GO:0051960,1.03503880219748e-10,TRUE,461,553,45,GO:BP,regulation of nervous system development,21010,14726,GO:0007399|GO:2000026,FALSE
WP:WP4239,1.05413437995209e-10,TRUE,161,461,35,WP,Epithelial to mesenchymal transition in colorectal cancer,8625,264,WP:000000,FALSE
TF:M01240_1,1.07002630588695e-10,TRUE,13522,556,454,TF,Factor: BEN; motif: CAGCGRNV; match class: 1,20011,503,TF:M01240,FALSE
GO:1901522,1.07493112776805e-10,TRUE,17,553,11,GO:BP,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,21010,22400,GO:0045944|GO:0070887,FALSE
GO:0051345,1.07856323818288e-10,TRUE,558,553,50,GO:BP,positive regulation of hydrolase activity,21010,14353,GO:0043085|GO:0051336,FALSE
WP:WP179,1.08937246140652e-10,TRUE,120,461,30,WP,Cell cycle,8625,225,WP:000000,FALSE
GO:0061695,1.14316898140619e-10,TRUE,325,548,35,GO:CC,"transferase complex, transferring phosphorus-containing groups",22090,2324,GO:1990234,FALSE
GO:0030855,1.18761810316632e-10,TRUE,724,553,58,GO:BP,epithelial cell differentiation,21010,7255,GO:0030154|GO:0060429,FALSE
GO:0045732,1.19181486899457e-10,TRUE,210,553,30,GO:BP,positive regulation of protein catabolic process,21010,12188,GO:0009896|GO:0030163|GO:0042176|GO:0051247,FALSE
WP:WP4877,1.22976999143068e-10,TRUE,36,461,17,WP,Host-pathogen interaction of human coronaviruses - MAPK signaling,8625,690,WP:000000,FALSE
REAC:R-HSA-3214815,1.27752310222968e-10,TRUE,94,485,25,REAC,HDACs deacetylate histones,10835,1041,REAC:R-HSA-3247509,FALSE
GO:0016049,1.29968368402277e-10,TRUE,502,553,47,GO:BP,cell growth,21010,5167,GO:0009987|GO:0040007,FALSE
HPA:0250122,1.38342997621752e-10,TRUE,2002,418,136,HPA,hippocampus; glial cells[Medium],11006,383,HPA:0250121,FALSE
GO:1901988,1.44357903350266e-10,TRUE,257,553,33,GO:BP,negative regulation of cell cycle phase transition,21010,22802,GO:0010948|GO:0044770|GO:1901987,FALSE
GO:0043618,1.47010563904997e-10,TRUE,34,553,14,GO:BP,regulation of transcription from RNA polymerase II promoter in response to stress,21010,11325,GO:0006357|GO:0043620,FALSE
GO:0044772,1.49779259220814e-10,TRUE,447,553,44,GO:BP,mitotic cell cycle phase transition,21010,11749,GO:0044770|GO:1903047,FALSE
TF:M00803_1,1.52474957459687e-10,TRUE,10475,556,377,TF,Factor: E2F; motif: GGCGSG; match class: 1,20011,1549,TF:M00803,FALSE
TF:M08205,1.57303821301833e-10,TRUE,14764,556,482,TF,Factor: E2F-1:Elk-1; motif: SGCGCSNNAMCGGAAGT,20011,1428,TF:M00000,FALSE
GO:0045936,1.61365323773356e-10,TRUE,393,553,41,GO:BP,negative regulation of phosphate metabolic process,21010,12347,GO:0006796|GO:0010563|GO:0019220,FALSE
HPA:0310441,1.63562642438754e-10,TRUE,6053,418,300,HPA,lymph node; non-germinal center cells[Low],11006,463,HPA:0310000,FALSE
GO:0030334,1.63621148735615e-10,TRUE,928,553,67,GO:BP,regulation of cell migration,21010,7095,GO:0016477|GO:2000145,FALSE
GO:0051972,1.6910169975621e-10,TRUE,49,553,16,GO:BP,regulation of telomerase activity,21010,14738,GO:0051338|GO:2000278,FALSE
GO:0062013,1.72196277571914e-10,TRUE,144,553,25,GO:BP,positive regulation of small molecule metabolic process,21010,16574,GO:0009893|GO:0044281|GO:0062012,FALSE
GO:0044297,1.75437161319326e-10,TRUE,567,548,47,GO:CC,cell body,22090,2055,GO:0110165,TRUE
TF:M01873,1.75474002985358e-10,TRUE,6888,556,276,TF,Factor: Egr-1; motif: GCGGGGGCGG,20011,1632,TF:M00000,FALSE
GO:0001649,1.77138993495489e-10,TRUE,228,553,31,GO:BP,osteoblast differentiation,21010,377,GO:0001503|GO:0030154,FALSE
GO:0048699,1.78020023805824e-10,TRUE,1485,553,90,GO:BP,generation of neurons,21010,13608,GO:0022008,FALSE
GO:0002039,1.82622431420536e-10,TRUE,69,555,18,GO:MF,p53 binding,20139,289,GO:0005515,FALSE
WP:WP2374,1.86287512402481e-10,TRUE,65,461,22,WP,Oncostatin M signaling pathway,8625,107,WP:000000,FALSE
GO:0005996,2.01899302557682e-10,TRUE,260,553,33,GO:BP,monosaccharide metabolic process,21010,1893,GO:0005975|GO:0044281,FALSE
HPA:0300000,2.02151080946886e-10,TRUE,7370,418,344,HPA,lung,11006,443,HPA:0000000,FALSE
WP:WP4320,2.16436499273518e-10,TRUE,37,461,17,WP,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,8625,165,WP:000000,FALSE
WP:WP4844,2.16436499273518e-10,TRUE,37,461,17,WP,Influence of laminopathies on Wnt signaling,8625,306,WP:000000,FALSE
TF:M11529_1,2.17415032412724e-10,TRUE,14826,556,483,TF,Factor: E2F-2; motif: GCGCGCGCNCS; match class: 1,20011,1469,TF:M11529,FALSE
TF:M03896,2.2067000340188e-10,TRUE,6268,556,257,TF,Factor: EGR1; motif: NACGCCCACGCANW,20011,1604,TF:M00000,FALSE
GO:0043280,2.34161224276125e-10,TRUE,121,553,23,GO:BP,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,21010,11110,GO:0043281|GO:2001056,FALSE
HPA:0270351,2.34653016721793e-10,TRUE,5158,418,267,HPA,kidney; cells in glomeruli[Low],11006,411,HPA:0270000,FALSE
GO:0051050,2.42340986036848e-10,TRUE,913,553,66,GO:BP,positive regulation of transport,21010,14132,GO:0006810|GO:0048518|GO:0051049,FALSE
GO:0071248,2.44919926007063e-10,TRUE,201,553,29,GO:BP,cellular response to metal ion,21010,17318,GO:0010038|GO:0071241,FALSE
TF:M07436_1,2.51014295571406e-10,TRUE,2711,556,140,TF,Factor: WT1; motif: NNGGGNGGGSGN; match class: 1,20011,8983,TF:M07436,FALSE
REAC:R-HSA-5250913,2.62124632439701e-10,TRUE,105,485,26,REAC,Positive epigenetic regulation of rRNA expression,10835,1690,REAC:R-HSA-212165,FALSE
TF:M10426_1,2.62634269131504e-10,TRUE,4496,556,201,TF,Factor: ctcf; motif: CCRSCAGGGGGCGCN; match class: 1,20011,1151,TF:M10426,FALSE
WP:WP1971,2.6537555807824e-10,TRUE,48,461,19,WP,Integrated cancer pathway,8625,37,WP:000000,FALSE
WP:WP2032,2.65789647735729e-10,TRUE,66,461,22,WP,Thyroid stimulating hormone (TSH) signaling pathway,8625,160,WP:000000,FALSE
GO:2000144,2.7668215104128e-10,TRUE,68,553,18,GO:BP,positive regulation of DNA-templated transcription initiation,21010,26559,GO:0006352|GO:0045893|GO:2000142,FALSE
GO:0048729,2.77624857423732e-10,TRUE,633,553,53,GO:BP,tissue morphogenesis,21010,13638,GO:0009653|GO:0009888,FALSE
GO:0043393,2.79054856254393e-10,TRUE,202,553,29,GO:BP,regulation of protein binding,21010,11177,GO:0051098,FALSE
WP:WP2064,2.89608321659518e-10,TRUE,101,461,27,WP,Neural crest differentiation,8625,9,WP:000000,FALSE
HPA:0380512,3.05432287697331e-10,TRUE,3591,418,205,HPA,placenta; decidual cells[Medium],11006,522,HPA:0380511,FALSE
TF:M00933,3.15884799471072e-10,TRUE,9955,556,362,TF,Factor: Sp1; motif: CCCCGCCCCN,20011,7846,TF:M00000,FALSE
GO:2000145,3.29445621913979e-10,TRUE,988,553,69,GO:BP,regulation of cell motility,21010,26560,GO:0040012|GO:0048870|GO:0050794,FALSE
KEGG:05220,3.32301181192971e-10,TRUE,76,431,23,KEGG,Chronic myeloid leukemia,8161,464,KEGG:00000,FALSE
GO:0043967,3.37837896851638e-10,TRUE,43,553,15,GO:BP,histone H4 acetylation,21010,11406,GO:0016573,FALSE
GO:2000278,3.37963152840538e-10,TRUE,123,553,23,GO:BP,regulation of DNA biosynthetic process,21010,26684,GO:0010556|GO:0051052|GO:0071897,FALSE
GO:0045088,3.44726324529536e-10,TRUE,402,553,41,GO:BP,regulation of innate immune response,21010,11876,GO:0002831|GO:0031347|GO:0032101|GO:0045087|GO:0050776,FALSE
GO:0016571,3.50049831378457e-10,TRUE,89,553,20,GO:BP,histone methylation,21010,5345,GO:0006479|GO:0016570,FALSE
HPA:0300411,3.50246432249948e-10,TRUE,6779,418,324,HPA,lung; macrophages[Low],11006,456,HPA:0300000,FALSE
GO:0033673,3.6980438014899e-10,TRUE,219,553,30,GO:BP,negative regulation of kinase activity,21010,8729,GO:0042326|GO:0043549|GO:0051348,FALSE
HPA:0630053,3.75512872784412e-10,TRUE,1183,418,94,HPA,cervix; glandular cells[High],11006,204,HPA:0630052,FALSE
TF:M12227,3.7737447818287e-10,TRUE,11329,556,398,TF,Factor: ZIC4; motif: NNCCNCCCRYNGYGN,20011,9372,TF:M00000,FALSE
GO:0010001,3.83037183359855e-10,TRUE,250,553,32,GO:BP,glial cell differentiation,21010,3881,GO:0030154|GO:0042063,FALSE
REAC:R-HSA-109606,3.83082016795575e-10,TRUE,54,485,19,REAC,Intrinsic Pathway for Apoptosis,10835,1216,REAC:R-HSA-109581,FALSE
REAC:R-HSA-450282,3.95641437153927e-10,TRUE,31,485,15,REAC,MAPK targets/ Nuclear events mediated by MAP kinases,10835,1291,REAC:R-HSA-450294,FALSE
GO:0048514,4.22746506019242e-10,TRUE,619,553,52,GO:BP,blood vessel morphogenesis,21010,13449,GO:0001568|GO:0035239,FALSE
TF:M07206,4.30417034476393e-10,TRUE,14907,556,484,TF,Factor: E2F-1; motif: NGGGCGGGARV,20011,1438,TF:M00000,FALSE
REAC:R-HSA-3769402,4.3279163563668e-10,TRUE,42,485,17,REAC,Deactivation of the beta-catenin transactivating complex,10835,435,REAC:R-HSA-201681,FALSE
GO:0006096,4.39191421180239e-10,TRUE,90,553,20,GO:BP,glycolytic process,21010,1985,GO:0006090|GO:0006091|GO:0016052,FALSE
TF:M07329,4.41403308252788e-10,TRUE,7003,556,278,TF,Factor: Osx; motif: CCNCCCCCNNN,20011,6218,TF:M00000,FALSE
WP:WP3959,4.41421084000943e-10,TRUE,55,461,20,WP,DNA IR-double strand breaks and cellular response via ATM,8625,26,WP:000000,FALSE
TF:M01104_1,4.43370735120453e-10,TRUE,5813,556,242,TF,Factor: MOVO-B; motif: GNGGGGG; match class: 1,20011,5239,TF:M01104,FALSE
TF:M01857,4.63592842683354e-10,TRUE,9389,556,346,TF,Factor: AP-2alpha; motif: NGCCYSNNGSN,20011,134,TF:M00000,FALSE
GO:0061180,4.79905811260551e-10,TRUE,70,553,18,GO:BP,mammary gland epithelium development,21010,16033,GO:0030879|GO:0060429,FALSE
GO:0071479,4.79905811260551e-10,TRUE,70,553,18,GO:BP,cellular response to ionizing radiation,21010,17523,GO:0010212|GO:0071478,FALSE
GO:0007276,4.84778391145388e-10,TRUE,792,553,60,GO:BP,gamete generation,21010,2854,GO:0019953|GO:0048609,FALSE
GO:0043525,4.86565494278168e-10,TRUE,52,553,16,GO:BP,positive regulation of neuron apoptotic process,21010,11266,GO:0043065|GO:0043523|GO:0051402,FALSE
GO:2000142,4.89808942788356e-10,TRUE,80,553,19,GO:BP,regulation of DNA-templated transcription initiation,21010,26557,GO:0006352|GO:0006355,FALSE
GO:0032386,4.90508494867227e-10,TRUE,335,553,37,GO:BP,regulation of intracellular transport,21010,7904,GO:0046907|GO:0051049|GO:0060341,FALSE
TF:M12597_1,5.03724673178898e-10,TRUE,10130,556,366,TF,Factor: E2F1; motif: GSGCGGGAAN; match class: 1,20011,1445,TF:M12597,FALSE
REAC:R-HSA-168643,5.61331824728877e-10,TRUE,55,485,19,REAC,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",10835,1550,REAC:R-HSA-168249,FALSE
HPA:0380511,5.77606439671118e-10,TRUE,4847,418,254,HPA,placenta; decidual cells[Low],11006,521,HPA:0380000,FALSE
KEGG:04622,5.86887455803774e-10,TRUE,71,431,22,KEGG,RIG-I-like receptor signaling pathway,8161,321,KEGG:00000,FALSE
TF:M02090_1,5.88332611288936e-10,TRUE,6549,556,264,TF,Factor: E2F-4; motif: GCGGGAAANA; match class: 1,20011,1519,TF:M02090,FALSE
KEGG:04330,5.89532800462541e-10,TRUE,58,431,20,KEGG,Notch signaling pathway,8161,295,KEGG:00000,FALSE
TF:M07397,6.05402888127249e-10,TRUE,7325,556,287,TF,Factor: ZBP89; motif: CCCCKCCCCCNN,20011,9072,TF:M00000,FALSE
GO:2001056,6.21849787100681e-10,TRUE,139,553,24,GO:BP,positive regulation of cysteine-type endopeptidase activity,21010,27391,GO:0010950|GO:2000116,FALSE
TF:M00931,6.2792910086388e-10,TRUE,10555,556,377,TF,Factor: Sp1; motif: GGGGCGGGGC,20011,7856,TF:M00000,FALSE
GO:0002009,6.29544720448666e-10,TRUE,524,553,47,GO:BP,morphogenesis of an epithelium,21010,624,GO:0048729|GO:0060429,FALSE
WP:WP400,6.41972670798375e-10,TRUE,34,461,16,WP,p38 MAPK signaling pathway,8625,69,WP:000000,FALSE
TF:M01118_1,6.50677475038857e-10,TRUE,2856,556,144,TF,Factor: WT1; motif: SMCNCCNSC; match class: 1,20011,8985,TF:M01118,FALSE
KEGG:05205,6.76294526844335e-10,TRUE,205,431,38,KEGG,Proteoglycans in cancer,8161,450,KEGG:00000,FALSE
GO:0098531,6.77003162527196e-10,TRUE,47,555,15,GO:MF,ligand-activated transcription factor activity,20139,9211,GO:0003700,FALSE
GO:0004879,6.77003162527196e-10,TRUE,47,555,15,GO:MF,nuclear receptor activity,20139,1146,GO:0000981|GO:0038023|GO:0098531,FALSE
GO:0001223,6.77003162527196e-10,TRUE,47,555,15,GO:MF,transcription coactivator binding,20139,183,GO:0001221,FALSE
GO:0000725,6.78610815466438e-10,TRUE,180,553,27,GO:BP,recombinational repair,21010,210,GO:0006281|GO:0006310,FALSE
TF:M12597,6.83149447816646e-10,TRUE,14354,556,471,TF,Factor: E2F1; motif: GSGCGGGAAN,20011,1444,TF:M00000,FALSE
WP:WP4864,6.9951261205928e-10,TRUE,21,461,13,WP,Host-pathogen interaction of human coronaviruses - apoptosis,8625,577,WP:000000,FALSE
TF:M10086,7.03546065119512e-10,TRUE,9231,556,341,TF,Factor: TAFII250; motif: RARRWGGCGGMGGNGR,20011,8172,TF:M00000,FALSE
TF:M07206_1,7.29099880355399e-10,TRUE,11135,556,392,TF,Factor: E2F-1; motif: NGGGCGGGARV; match class: 1,20011,1439,TF:M07206,FALSE
GO:0046328,7.32344337174414e-10,TRUE,140,553,24,GO:BP,regulation of JNK cascade,21010,12679,GO:0007254|GO:0032872,FALSE
GO:0098542,7.32890460650958e-10,TRUE,1196,553,77,GO:BP,defense response to other organism,21010,19686,GO:0006952|GO:0051707,FALSE
GO:1990909,7.42458846704746e-10,TRUE,13,548,9,GO:CC,Wnt signalosome,22090,4043,GO:0032991,TRUE
KEGG:04137,8.04473588712177e-10,TRUE,72,431,22,KEGG,Mitophagy - animal,8161,269,KEGG:00000,FALSE
HP:0001824,8.28143180953824e-10,TRUE,320,241,48,HP,Weight loss,4962,1323,HP:0004325,FALSE
GO:0009408,8.51514728354828e-10,TRUE,93,553,20,GO:BP,response to heat,21010,3529,GO:0006950|GO:0009266,FALSE
GO:0035270,8.61208715367025e-10,TRUE,141,553,24,GO:BP,endocrine system development,21010,9357,GO:0048731,FALSE
REAC:R-HSA-109581,8.72232269439725e-10,TRUE,176,485,33,REAC,Apoptosis,10835,153,REAC:R-HSA-5357801,FALSE
GO:0031060,8.90387853317693e-10,TRUE,31,553,13,GO:BP,regulation of histone methylation,21010,7346,GO:0016571|GO:0031056,FALSE
GO:0001933,9.71193125780279e-10,TRUE,308,553,35,GO:BP,negative regulation of protein phosphorylation,21010,558,GO:0001932|GO:0006468|GO:0031400|GO:0042326,FALSE
GO:1902455,9.84448475094234e-10,TRUE,25,553,12,GO:BP,negative regulation of stem cell population maintenance,21010,23194,GO:0019827|GO:0051093|GO:0051241|GO:2000036,FALSE
HP:0002664,9.87354644491811e-10,TRUE,890,241,89,HP,Neoplasm,4962,1930,HP:0000118,FALSE
HPA:0600222,9.95635069445518e-10,TRUE,4946,418,257,HPA,tonsil; squamous epithelial cells[Medium],11006,850,HPA:0600221,FALSE
GO:0031056,1.00383009508998e-09,TRUE,83,553,19,GO:BP,regulation of histone modification,21010,7345,GO:0016570|GO:1901873,FALSE
GO:2000377,1.01128749769592e-09,TRUE,142,553,24,GO:BP,regulation of reactive oxygen species metabolic process,21010,26775,GO:0031323|GO:0072593,FALSE
GO:0030177,1.01128749769592e-09,TRUE,142,553,24,GO:BP,positive regulation of Wnt signaling pathway,21010,7012,GO:0009967|GO:0016055|GO:0030111,FALSE
GO:0001659,1.02074276144693e-09,TRUE,183,553,27,GO:BP,temperature homeostasis,21010,383,GO:0048871,FALSE
REAC:R-HSA-69473,1.02531191776451e-09,TRUE,94,485,24,REAC,G2/M DNA damage checkpoint,10835,959,REAC:R-HSA-69481,FALSE
GO:0043414,1.02736713777242e-09,TRUE,259,553,32,GO:BP,macromolecule methylation,21010,11192,GO:0032259|GO:0043412,FALSE
REAC:R-HSA-6807070,1.03617107545867e-09,TRUE,138,485,29,REAC,PTEN Regulation,10835,1622,REAC:R-HSA-1257604,FALSE
WP:WP2516,1.03963859706435e-09,TRUE,40,461,17,WP,ATM signaling pathway,8625,56,WP:000000,FALSE
GO:0030182,1.0566064741806e-09,TRUE,1404,553,85,GO:BP,neuron differentiation,21010,7014,GO:0030154|GO:0048699,FALSE
GO:0006469,1.09387499676382e-09,TRUE,198,553,28,GO:BP,negative regulation of protein kinase activity,21010,2243,GO:0001933|GO:0033673|GO:0045859,FALSE
GO:0002218,1.14322227253939e-09,TRUE,260,553,32,GO:BP,activation of innate immune response,21010,767,GO:0002253|GO:0045089,FALSE
GO:0045089,1.15652003701688e-09,TRUE,327,553,36,GO:BP,positive regulation of innate immune response,21010,11877,GO:0002833|GO:0031349|GO:0032103|GO:0045087|GO:0045088|GO:0050778,FALSE
REAC:R-HSA-2894858,1.17228888017179e-09,TRUE,57,485,19,REAC,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,10835,2168,REAC:R-HSA-2644603,FALSE
REAC:R-HSA-2894862,1.17228888017179e-09,TRUE,57,485,19,REAC,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,10835,387,REAC:R-HSA-2894858,FALSE
REAC:R-HSA-2644602,1.17228888017179e-09,TRUE,57,485,19,REAC,Signaling by NOTCH1 PEST Domain Mutants in Cancer,10835,2169,REAC:R-HSA-2644603,FALSE
REAC:R-HSA-2644606,1.17228888017179e-09,TRUE,57,485,19,REAC,Constitutive Signaling by NOTCH1 PEST Domain Mutants,10835,388,REAC:R-HSA-2644602,FALSE
REAC:R-HSA-2644603,1.17228888017179e-09,TRUE,57,485,19,REAC,Signaling by NOTCH1 in Cancer,10835,2170,REAC:R-HSA-5663202,FALSE
HPA:0220051,1.17276885828411e-09,TRUE,7656,418,351,HPA,gallbladder; glandular cells[Low],11006,361,HPA:0220000,FALSE
HPA:0220000,1.17276885828411e-09,TRUE,7656,418,351,HPA,gallbladder,11006,360,HPA:0000000,FALSE
TF:M00932,1.18479904768731e-09,TRUE,10705,556,380,TF,Factor: Sp1; motif: NNGGGGCGGGGNN,20011,7852,TF:M00000,FALSE
HPA:0301363,1.20197750688129e-09,TRUE,507,418,54,HPA,lung; alveolar cells type I[High],11006,449,HPA:0301362,FALSE
TF:M08487_1,1.20633990897051e-09,TRUE,9009,556,334,TF,Factor: GCMa:Erg; motif: ATGCGGGCGGAARKG; match class: 1,20011,3043,TF:M08487,FALSE
HPA:0630052,1.21113015631888e-09,TRUE,4031,418,221,HPA,cervix; glandular cells[Medium],11006,203,HPA:0630051,FALSE
GO:0033157,1.21527070699798e-09,TRUE,229,553,30,GO:BP,regulation of intracellular protein transport,21010,8440,GO:0006886|GO:0032386|GO:0051223,FALSE
GO:0048762,1.26765420523428e-09,TRUE,245,553,31,GO:BP,mesenchymal cell differentiation,21010,13665,GO:0030154|GO:0060485,FALSE
TF:M10026,1.27311999922471e-09,TRUE,8619,556,323,TF,Factor: PATZ; motif: GGGGNGGGGGMKGGRRNGGNRN,20011,6318,TF:M00000,FALSE
HPA:0170253,1.32080581327176e-09,TRUE,359,418,44,HPA,endometrium 2; cells in endometrial stroma[High],11006,316,HPA:0170252,FALSE
WP:WP2586,1.32540351872585e-09,TRUE,46,461,18,WP,Aryl hydrocarbon receptor pathway,8625,333,WP:000000,FALSE
GO:0019953,1.46108761936838e-09,TRUE,1067,553,71,GO:BP,sexual reproduction,21010,6377,GO:0000003,FALSE
GO:1901985,1.46384309536112e-09,TRUE,32,553,13,GO:BP,positive regulation of protein acetylation,21010,22799,GO:0006473|GO:0031401|GO:1901983,FALSE
GO:1904951,1.52154128371732e-09,TRUE,330,553,36,GO:BP,positive regulation of establishment of protein localization,21010,25240,GO:0045184|GO:0070201|GO:1903829,FALSE
REAC:R-HSA-9645723,1.52329457500025e-09,TRUE,104,485,25,REAC,Diseases of programmed cell death,10835,737,REAC:R-HSA-1643685,FALSE
GO:0001701,1.54182237458542e-09,TRUE,402,553,40,GO:BP,in utero embryonic development,21010,403,GO:0043009,FALSE
HPA:0600442,1.54990555397357e-09,TRUE,4190,418,227,HPA,tonsil; non-germinal center cells[Medium],11006,847,HPA:0600441,FALSE
GO:0001217,1.57685886223931e-09,TRUE,315,555,35,GO:MF,DNA-binding transcription repressor activity,20139,180,GO:0003700,FALSE
GO:0009612,1.59591226244324e-09,TRUE,216,553,29,GO:BP,response to mechanical stimulus,21010,3597,GO:0009605|GO:0009628,FALSE
KEGG:04625,1.61125217322949e-09,TRUE,104,431,26,KEGG,C-type lectin receptor signaling pathway,8161,324,KEGG:00000,FALSE
GO:1903008,1.62370654982258e-09,TRUE,145,553,24,GO:BP,organelle disassembly,21010,23614,GO:0006996|GO:0022411,FALSE
GO:0001654,1.6704500819556e-09,TRUE,403,553,40,GO:BP,eye development,21010,378,GO:0007423|GO:0150063,FALSE
GO:0004679,1.69595863955541e-09,TRUE,9,555,8,GO:MF,AMP-activated protein kinase activity,20139,982,GO:0004674,FALSE
KEGG:05010,1.70799403215929e-09,TRUE,382,431,54,KEGG,Alzheimer disease,8161,404,KEGG:00000,FALSE
GO:0051222,1.71457870812432e-09,TRUE,314,553,35,GO:BP,positive regulation of protein transport,21010,14256,GO:0015031|GO:0051050|GO:0051223|GO:1904951,FALSE
HPA:0340000,1.71695454970921e-09,TRUE,5421,418,274,HPA,ovary,11006,492,HPA:0000000,FALSE
GO:0042593,1.76125476085357e-09,TRUE,248,553,31,GO:BP,glucose homeostasis,21010,10756,GO:0033500,FALSE
GO:0009299,1.77415466897789e-09,TRUE,56,553,16,GO:BP,mRNA transcription,21010,3502,GO:0006351|GO:0016071,FALSE
HPA:0050012,1.77549092743439e-09,TRUE,1489,418,108,HPA,breast; adipocytes[Medium],11006,56,HPA:0050011,FALSE
TF:M01199_1,1.80969082921505e-09,TRUE,4459,556,197,TF,Factor: RNF96; motif: BCCCGCRGCC; match class: 1,20011,7291,TF:M01199,FALSE
TF:M07039_1,1.82044768720422e-09,TRUE,13933,556,460,TF,Factor: ETF; motif: CCCCGCCCCYN; match class: 1,20011,2167,TF:M07039,FALSE
REAC:R-HSA-3214847,1.8339702025058e-09,TRUE,141,485,29,REAC,HATs acetylate histones,10835,1036,REAC:R-HSA-3247509,FALSE
GO:1902105,1.88229020561364e-09,TRUE,315,553,35,GO:BP,regulation of leukocyte differentiation,21010,22905,GO:0002521|GO:1903706,FALSE
HP:0000957,1.89462317533405e-09,TRUE,128,241,29,HP,Cafe-au-lait spot,4962,747,HP:0001034,FALSE
GO:0009987,1.89475064772684e-09,TRUE,19660,553,550,GO:BP,cellular process,21010,3869,GO:0008150,FALSE
GO:0033500,1.96303469063315e-09,TRUE,249,553,31,GO:BP,carbohydrate homeostasis,21010,8622,GO:0048878,FALSE
GO:0070888,1.99962506465685e-09,TRUE,59,555,16,GO:MF,E-box binding,20139,8807,GO:0000978,FALSE
GO:0045121,2.03200848030345e-09,TRUE,285,548,31,GO:CC,membrane raft,22090,2135,GO:0098857,TRUE
KEGG:04928,2.03856659050225e-09,TRUE,105,431,26,KEGG,"Parathyroid hormone synthesis, secretion and action",8161,378,KEGG:00000,FALSE
GO:0035265,2.04774617735392e-09,TRUE,160,553,25,GO:BP,organ growth,21010,9353,GO:0032501|GO:0048589,FALSE
REAC:R-HSA-2559580,2.0554676456069e-09,TRUE,123,485,27,REAC,Oxidative Stress Induced Senescence,10835,1574,REAC:R-HSA-2559583,FALSE
GO:0043025,2.09016562841523e-09,TRUE,500,548,42,GO:CC,neuronal cell body,22090,1852,GO:0036477|GO:0044297,FALSE
TF:M07277,2.11921302623109e-09,TRUE,8719,556,325,TF,Factor: BTEB2; motif: RGGGNGKGGN,20011,624,TF:M00000,FALSE
WP:WP5346,2.13170238374766e-09,TRUE,53,461,19,WP,8p23.1 copy number variation syndrome,8625,281,WP:000000,FALSE
GO:2001243,2.14320988806663e-09,TRUE,109,553,21,GO:BP,negative regulation of intrinsic apoptotic signaling pathway,21010,27529,GO:0097193|GO:1902532|GO:2001234|GO:2001242,FALSE
TF:M09834,2.15172277593083e-09,TRUE,7121,556,279,TF,Factor: ZNF148; motif: NNNNNNCCNNCCCCTCCCCCACCCN,20011,9506,TF:M00000,FALSE
GO:0006306,2.15879644722175e-09,TRUE,48,553,15,GO:BP,DNA methylation,21010,2143,GO:0006305|GO:0043414,FALSE
GO:0006305,2.15879644722175e-09,TRUE,48,553,15,GO:BP,DNA alkylation,21010,2142,GO:0006304,FALSE
GO:1900180,2.21122540631598e-09,TRUE,147,553,24,GO:BP,regulation of protein localization to nucleus,21010,21270,GO:0032880|GO:0034504,FALSE
GO:0098857,2.22707832522143e-09,TRUE,286,548,31,GO:CC,membrane microdomain,22090,3296,GO:0016020,FALSE
GO:0038061,2.24219992023812e-09,TRUE,134,553,23,GO:BP,non-canonical NF-kappaB signal transduction,21010,10158,GO:0035556,FALSE
GO:0046332,2.2594135357815e-09,TRUE,79,555,18,GO:MF,SMAD binding,20139,6196,GO:0005515,FALSE
GO:2000116,2.27547617106719e-09,TRUE,219,553,29,GO:BP,regulation of cysteine-type endopeptidase activity,21010,26532,GO:0052548,FALSE
GO:0098772,2.28597175550496e-09,TRUE,2125,555,113,GO:MF,molecular function regulator activity,20139,9253,GO:0003674,FALSE
HPA:0460671,2.28818678368513e-09,TRUE,5297,418,269,HPA,skin 1; melanocytes[Low],11006,667,HPA:0460000,FALSE
GO:0150063,2.29535268891747e-09,TRUE,407,553,40,GO:BP,visual system development,21010,20981,GO:0048880,FALSE
TF:M10071,2.3134224451903e-09,TRUE,8724,556,325,TF,Factor: Sp1; motif: NGGGGGCGGGGCCNGGGGGGGG,20011,7836,TF:M00000,FALSE
HPA:0010012,2.35972256527005e-09,TRUE,2229,418,143,HPA,adipose tissue; adipocytes[Medium],11006,4,HPA:0010011,FALSE
GO:0046890,2.37011848014683e-09,TRUE,175,553,26,GO:BP,regulation of lipid biosynthetic process,21010,13058,GO:0008610|GO:0009889|GO:0019216,FALSE
GO:0043433,2.37011848014683e-09,TRUE,175,553,26,GO:BP,negative regulation of DNA-binding transcription factor activity,21010,11201,GO:0044092|GO:0051090,FALSE
GO:0008631,2.40723644643864e-09,TRUE,57,553,16,GO:BP,intrinsic apoptotic signaling pathway in response to oxidative stress,21010,3274,GO:0097193,FALSE
HPA:0350000,2.44031644604872e-09,TRUE,7400,418,342,HPA,pancreas,11006,499,HPA:0000000,FALSE
HP:0001034,2.44146390935804e-09,TRUE,196,241,36,HP,Hypermelanotic macule,4962,809,HP:0007400|HP:0012733,FALSE
GO:0002694,2.46437569697684e-09,TRUE,585,553,49,GO:BP,regulation of leukocyte activation,21010,1226,GO:0002682|GO:0045321|GO:0050865,FALSE
GO:0007423,2.50753413101701e-09,TRUE,606,553,50,GO:BP,sensory organ development,21010,2971,GO:0048513,FALSE
REAC:R-HSA-2122947,2.51716494279369e-09,TRUE,46,485,17,REAC,NOTCH1 Intracellular Domain Regulates Transcription,10835,1455,REAC:R-HSA-1980143,FALSE
REAC:R-HSA-5357905,2.51716494279369e-09,TRUE,46,485,17,REAC,Regulation of TNFR1 signaling,10835,1916,REAC:R-HSA-75893,FALSE
REAC:R-HSA-9679506,2.58510610069012e-09,TRUE,459,485,56,REAC,SARS-CoV Infections,10835,2006,REAC:R-HSA-9824446,FALSE
WP:WP5205,2.65332826205695e-09,TRUE,80,461,23,WP,Clock-controlled autophagy in bone metabolism,8625,283,WP:000000,FALSE
GO:0097305,2.70876449718399e-09,TRUE,252,553,31,GO:BP,response to alcohol,21010,19472,GO:0010033|GO:1901700,FALSE
GO:0000724,2.7136168645169e-09,TRUE,176,553,26,GO:BP,double-strand break repair via homologous recombination,21010,209,GO:0000725|GO:0006302,FALSE
GO:0009266,2.7294417097599e-09,TRUE,162,553,25,GO:BP,response to temperature stimulus,21010,3487,GO:0009628,FALSE
HPA:0080123,2.77120196859441e-09,TRUE,681,418,64,HPA,caudate; glial cells[High],11006,93,HPA:0080122,FALSE
GO:0042326,2.84887252152736e-09,TRUE,337,553,36,GO:BP,negative regulation of phosphorylation,21010,10594,GO:0016310|GO:0042325|GO:0045936,FALSE
GO:0045913,2.85172338429034e-09,TRUE,77,553,18,GO:BP,positive regulation of carbohydrate metabolic process,21010,12324,GO:0005975|GO:0006109|GO:0009893,FALSE
HPA:0250121,2.94678954526722e-09,TRUE,4138,418,224,HPA,hippocampus; glial cells[Low],11006,382,HPA:0250000,FALSE
GO:0048534,2.9642493186103e-09,TRUE,99,553,20,GO:BP,hematopoietic or lymphoid organ development,21010,13465,GO:0002520|GO:0048513,FALSE
TF:M03567,3.03181683235592e-09,TRUE,7895,556,301,TF,Factor: Sp2; motif: NYSGCCCCGCCCCCY,20011,7878,TF:M00000,FALSE
GO:0002764,3.07388855827538e-09,TRUE,468,553,43,GO:BP,immune response-regulating signaling pathway,21010,1289,GO:0007165|GO:0050776,FALSE
GO:0070266,3.14156048712162e-09,TRUE,41,553,14,GO:BP,necroptotic process,21010,16822,GO:0097300,FALSE
GO:0010453,3.14156048712162e-09,TRUE,41,553,14,GO:BP,regulation of cell fate commitment,21010,4217,GO:0045165|GO:0050793|GO:0050794,FALSE
GO:0010950,3.14586815498802e-09,TRUE,163,553,25,GO:BP,positive regulation of endopeptidase activity,21010,4612,GO:0010952|GO:0052548,FALSE
TF:M03807,3.15420294140777e-09,TRUE,8635,556,322,TF,Factor: SP2; motif: GNNGGGGGCGGGGSN,20011,7880,TF:M00000,FALSE
GO:0010639,3.15924331584206e-09,TRUE,356,553,37,GO:BP,negative regulation of organelle organization,21010,4357,GO:0006996|GO:0033043|GO:0051129,FALSE
HPA:0380513,3.16566462234768e-09,TRUE,1208,418,93,HPA,placenta; decidual cells[High],11006,523,HPA:0380512,FALSE
HPA:0330223,3.20115922138018e-09,TRUE,1151,418,90,HPA,oral mucosa; squamous epithelial cells[High],11006,491,HPA:0330222,FALSE
TF:M10435,3.25594630884019e-09,TRUE,7899,556,301,TF,Factor: Sp2; motif: GGGGCGGGG,20011,7870,TF:M00000,FALSE
GO:0036477,3.31188339417274e-09,TRUE,849,548,57,GO:CC,somatodendritic compartment,22090,1723,GO:0110165,FALSE
GO:1901654,3.33746164539937e-09,TRUE,207,553,28,GO:BP,response to ketone,21010,22496,GO:0010033|GO:1901700,FALSE
WP:WP4149,3.34934767690623e-09,TRUE,32,461,15,WP,White fat cell differentiation,8625,64,WP:000000,FALSE
HPA:0380522,3.37031690640174e-09,TRUE,5045,418,259,HPA,placenta; trophoblastic cells[Medium],11006,537,HPA:0380521,FALSE
GO:0051336,3.43841232583189e-09,TRUE,944,553,65,GO:BP,regulation of hydrolase activity,21010,14344,GO:0050790,FALSE
HPA:0630222,3.46260964074324e-09,TRUE,3723,418,207,HPA,cervix; squamous epithelial cells[Medium],11006,206,HPA:0630221,FALSE
GO:0010508,3.47977178031423e-09,TRUE,150,553,24,GO:BP,positive regulation of autophagy,21010,4252,GO:0006914|GO:0010506|GO:0031331,FALSE
KEGG:04140,3.51761649538141e-09,TRUE,141,431,30,KEGG,Autophagy - animal,8161,272,KEGG:00000,FALSE
GO:0043086,3.62272698086229e-09,TRUE,612,553,50,GO:BP,negative regulation of catalytic activity,21010,11025,GO:0044092|GO:0050790,FALSE
GO:0048880,3.66773250334741e-09,TRUE,413,553,40,GO:BP,sensory system development,21010,13772,GO:0048731,FALSE
GO:0030098,3.69045047133642e-09,TRUE,432,553,41,GO:BP,lymphocyte differentiation,21010,6991,GO:0046649|GO:1903131,FALSE
GO:0061136,3.75021693051004e-09,TRUE,193,553,27,GO:BP,regulation of proteasomal protein catabolic process,21010,15999,GO:0010498|GO:0042176|GO:1903050,FALSE
WP:WP4658,3.75439138531757e-09,TRUE,96,461,25,WP,Small cell lung cancer,8625,545,WP:000000,FALSE
TF:M11601,3.75916841084826e-09,TRUE,15113,556,486,TF,Factor: TCF-1; motif: ACATCGRGRCGCTGW,20011,8406,TF:M00000,FALSE
KEGG:05222,3.77251030945257e-09,TRUE,92,431,24,KEGG,Small cell lung cancer,8161,466,KEGG:00000,FALSE
GO:0007389,3.81015216598266e-09,TRUE,471,553,43,GO:BP,pattern specification process,21010,2942,GO:0007275|GO:0032501,FALSE
GO:0048471,3.81551104117438e-09,TRUE,733,548,52,GO:CC,perinuclear region of cytoplasm,22090,2236,GO:0005737|GO:0110165,FALSE
HPA:0090193,3.91368452008994e-09,TRUE,914,418,77,HPA,cerebellum; cells in molecular layer[High],11006,136,HPA:0090192,FALSE
REAC:R-HSA-9006934,4.10843538247038e-09,TRUE,505,485,59,REAC,Signaling by Receptor Tyrosine Kinases,10835,2193,REAC:R-HSA-162582,FALSE
TF:M00982,4.21666358832385e-09,TRUE,8018,556,304,TF,Factor: KROX; motif: CCCGCCCCCRCCCC,20011,4612,TF:M00000,FALSE
GO:0031648,4.23398948976526e-09,TRUE,50,553,15,GO:BP,protein destabilization,21010,7609,GO:0031647,FALSE
REAC:R-HSA-114452,4.40598405603595e-09,TRUE,30,485,14,REAC,Activation of BH3-only proteins,10835,74,REAC:R-HSA-109606,FALSE
TF:M07063,4.43426432503747e-09,TRUE,6422,556,257,TF,Factor: Sp1; motif: GGGGCGGGGC,20011,7850,TF:M00000,FALSE
HPA:0130000,4.44546361188561e-09,TRUE,8330,418,370,HPA,colon,11006,212,HPA:0000000,FALSE
GO:0052547,4.53189230626948e-09,TRUE,397,553,39,GO:BP,regulation of peptidase activity,21010,14860,GO:0030162|GO:0051336,FALSE
HPA:0400000,4.60163057077441e-09,TRUE,7965,418,359,HPA,rectum,11006,543,HPA:0000000,FALSE
WP:WP3981,4.67686706133016e-09,TRUE,49,461,18,WP,miRNA regulation of prostate cancer signaling pathways,8625,262,WP:000000,FALSE
HPA:0090192,4.77858667307059e-09,TRUE,2787,418,167,HPA,cerebellum; cells in molecular layer[Medium],11006,135,HPA:0090191,FALSE
REAC:R-HSA-1592230,4.80670715376313e-09,TRUE,92,485,23,REAC,Mitochondrial biogenesis,10835,1395,REAC:R-HSA-1852241,FALSE
GO:0019887,4.95183391433487e-09,TRUE,229,555,29,GO:MF,protein kinase regulator activity,20139,3747,GO:0019207,FALSE
GO:0006955,5.01967244783861e-09,TRUE,1951,553,104,GO:BP,immune response,21010,2628,GO:0002376|GO:0050896,FALSE
KEGG:04916,5.08051525294376e-09,TRUE,101,431,25,KEGG,Melanogenesis,8161,366,KEGG:00000,FALSE
HP:0011793,5.1428827624677e-09,TRUE,852,241,85,HP,Neoplasm by anatomical site,4962,8194,HP:0002664,FALSE
GO:1902562,5.26057336623158e-09,TRUE,42,548,13,GO:CC,H4 histone acetyltransferase complex,22090,3646,GO:0000123,FALSE
GO:0019903,5.32227574144786e-09,TRUE,143,555,23,GO:MF,protein phosphatase binding,20139,3754,GO:0019902,FALSE
GO:0014013,5.34064262501519e-09,TRUE,102,553,20,GO:BP,regulation of gliogenesis,21010,4670,GO:0042063|GO:0050767,FALSE
TF:M09723_1,5.39613135351694e-09,TRUE,6300,556,253,TF,Factor: BTEB1; motif: GGGGGCGGGGCNGSGGGNGS; match class: 1,20011,613,TF:M09723,FALSE
GO:0045834,5.41427852127804e-09,TRUE,153,553,24,GO:BP,positive regulation of lipid metabolic process,21010,12267,GO:0006629|GO:0009893|GO:0019216,FALSE
HP:0007400,5.53626188870728e-09,TRUE,233,241,39,HP,Irregular hyperpigmentation,4962,4731,HP:0000953,FALSE
TF:M08523,5.56209720214021e-09,TRUE,12430,556,422,TF,Factor: E2F-1:TBR2; motif: NGGTGNNANGGCGCNNTNNCRNNN,20011,1430,TF:M00000,FALSE
TF:M09834_1,5.57022192074398e-09,TRUE,2964,556,145,TF,Factor: ZNF148; motif: NNNNNNCCNNCCCCTCCCCCACCCN; match class: 1,20011,9507,TF:M09834,FALSE
TF:M09973_1,5.63685371499954e-09,TRUE,6802,556,268,TF,Factor: CPBP; motif: GNNRGGGHGGGGNNGGGRN; match class: 1,20011,945,TF:M09973,FALSE
WP:WP4874,5.84278399003906e-09,TRUE,33,461,15,WP,CAMKK2 pathway,8625,222,WP:000000,FALSE
REAC:R-HSA-168638,5.95599848745744e-09,TRUE,36,485,15,REAC,NOD1/2 Signaling Pathway,10835,1452,REAC:R-HSA-168643,FALSE
HPA:0630051,5.97683558750457e-09,TRUE,5688,418,282,HPA,cervix; glandular cells[Low],11006,202,HPA:0630000,FALSE
HPA:0320000,6.0619265621148e-09,TRUE,7189,418,334,HPA,nasopharynx,11006,466,HPA:0000000,FALSE
HPA:0380523,6.12741023656302e-09,TRUE,1933,418,128,HPA,placenta; trophoblastic cells[High],11006,538,HPA:0380522,FALSE
WP:WP1530,6.14323208612287e-09,TRUE,98,461,25,WP,miRNA regulation of DNA damage response,8625,774,WP:000000,FALSE
TF:M10426,6.161799306232e-09,TRUE,9538,556,346,TF,Factor: ctcf; motif: CCRSCAGGGGGCGCN,20011,1150,TF:M00000,FALSE
WP:WP2037,6.42704358179588e-09,TRUE,76,461,22,WP,Prolactin signaling pathway,8625,583,WP:000000,FALSE
HPA:0490692,6.52828147051116e-09,TRUE,3122,418,181,HPA,smooth muscle; smooth muscle cells[Medium],11006,749,HPA:0490691,FALSE
TF:M00008,6.81785205104192e-09,TRUE,10319,556,367,TF,Factor: Sp1; motif: GGGGCGGGGT,20011,7822,TF:M00000,FALSE
HPA:0600432,6.8707327360053e-09,TRUE,4094,418,221,HPA,tonsil; germinal center cells[Medium],11006,844,HPA:0600431,FALSE
GO:0000209,6.91049038406766e-09,TRUE,261,553,31,GO:BP,protein polyubiquitination,21010,63,GO:0016567,FALSE
GO:0035035,6.94360968518264e-09,TRUE,24,555,11,GO:MF,histone acetyltransferase binding,20139,5297,GO:0019899,FALSE
GO:0060485,7.01373493309436e-09,TRUE,312,553,34,GO:BP,mesenchyme development,21010,15413,GO:0009888|GO:0048513,FALSE
WP:WP673,7.1670374713727e-09,TRUE,91,461,24,WP,ErbB signaling pathway,8625,191,WP:000000,FALSE
TF:M07615,7.35755820263025e-09,TRUE,6985,556,273,TF,Factor: Sp3; motif: GGGGCGGGGSNN,20011,7890,TF:M00000,FALSE
HPA:0630221,7.64055905796507e-09,TRUE,5452,418,273,HPA,cervix; squamous epithelial cells[Low],11006,205,HPA:0630000,FALSE
GO:0034968,8.00931234706435e-09,TRUE,71,553,17,GO:BP,histone lysine methylation,21010,9156,GO:0016571|GO:0018022,FALSE
HPA:0150000,8.57415839871548e-09,TRUE,7891,418,356,HPA,duodenum,11006,256,HPA:0000000,FALSE
HPA:0080122,8.69266558296536e-09,TRUE,2311,418,145,HPA,caudate; glial cells[Medium],11006,92,HPA:0080121,FALSE
GO:0000422,8.8426978227955e-09,TRUE,93,553,19,GO:BP,autophagy of mitochondrion,21010,132,GO:0006914|GO:0061726,FALSE
GO:0061726,8.8426978227955e-09,TRUE,93,553,19,GO:BP,mitochondrion disassembly,21010,16421,GO:0007005|GO:1903008,FALSE
GO:0051059,9.10618219961647e-09,TRUE,31,555,12,GO:MF,NF-kappaB binding,20139,7996,GO:0061629,FALSE
GO:0001558,9.10835058004069e-09,TRUE,425,553,40,GO:BP,regulation of cell growth,21010,358,GO:0016049|GO:0040008|GO:0051128,FALSE
GO:0090263,9.41944585025183e-09,TRUE,105,553,20,GO:BP,positive regulation of canonical Wnt signaling pathway,21010,19020,GO:0030177|GO:0060070|GO:0060828,FALSE
GO:0002833,9.48748953193014e-09,TRUE,351,553,36,GO:BP,positive regulation of response to biotic stimulus,21010,1357,GO:0002831|GO:0009607|GO:0048584,FALSE
GO:0006260,9.58174929357502e-09,TRUE,281,553,32,GO:BP,DNA replication,21010,2107,GO:0006259,FALSE
WP:WP3965,9.78913772357123e-09,TRUE,29,461,14,WP,Lipid metabolism pathway,8625,340,WP:000000,FALSE
GO:0097346,9.88349773314025e-09,TRUE,28,548,11,GO:CC,INO80-type complex,22090,2977,GO:0070603,FALSE
KEGG:04114,9.91694360047111e-09,TRUE,129,431,28,KEGG,Oocyte meiosis,8161,263,KEGG:00000,FALSE
GO:0060261,1.00628334278396e-08,TRUE,62,553,16,GO:BP,positive regulation of transcription initiation by RNA polymerase II,21010,15210,GO:0006367|GO:0045944|GO:0060260|GO:2000144,FALSE
WP:WP3878,1.00721649772882e-08,TRUE,45,461,17,WP,ATM signaling in development and disease ,8625,503,WP:000000,FALSE
GO:0060260,1.02325895903268e-08,TRUE,72,553,17,GO:BP,regulation of transcription initiation by RNA polymerase II,21010,15209,GO:0006357|GO:0006367|GO:2000142,FALSE
TF:M09896,1.0353213579594e-08,TRUE,10195,556,363,TF,Factor: E2F-7; motif: GRGGCGGGAANNN,20011,1530,TF:M00000,FALSE
KEGG:04371,1.04238466598432e-08,TRUE,138,431,29,KEGG,Apelin signaling pathway,8161,302,KEGG:00000,FALSE
HPA:0590000,1.06002909620443e-08,TRUE,7120,418,331,HPA,thyroid gland,11006,838,HPA:0000000,FALSE
HPA:0590051,1.06002909620443e-08,TRUE,7120,418,331,HPA,thyroid gland; glandular cells[Low],11006,839,HPA:0590000,FALSE
GO:0016241,1.10441597843625e-08,TRUE,158,553,24,GO:BP,regulation of macroautophagy,21010,5270,GO:0010506|GO:0016236,FALSE
HPA:0301371,1.10520827457059e-08,TRUE,1533,418,108,HPA,lung; alveolar cells type II[Low],11006,450,HPA:0300000,FALSE
GO:0043281,1.13018923611919e-08,TRUE,187,553,26,GO:BP,regulation of cysteine-type endopeptidase activity involved in apoptotic process,21010,11111,GO:2000116,FALSE
GO:0006839,1.13018923611919e-08,TRUE,187,553,26,GO:BP,mitochondrial transport,21010,2548,GO:0046907,FALSE
TF:M00986,1.17899789493106e-08,TRUE,14512,556,471,TF,Factor: Churchill; motif: CGGGNN,20011,834,TF:M00000,FALSE
KEGG:05034,1.18100584524027e-08,TRUE,185,431,34,KEGG,Alcoholism,8161,415,KEGG:00000,FALSE
GO:0048638,1.20033670176382e-08,TRUE,318,553,34,GO:BP,regulation of developmental growth,21010,13548,GO:0040008|GO:0048589|GO:0050793,FALSE
HPA:0460662,1.21141440316719e-08,TRUE,3285,418,187,HPA,skin 1; keratinocytes[Medium],11006,659,HPA:0460661,FALSE
GO:0007517,1.21738779234528e-08,TRUE,354,553,36,GO:BP,muscle organ development,21010,3052,GO:0048513|GO:0061061,FALSE
TF:M10086_1,1.23006671852803e-08,TRUE,4057,556,181,TF,Factor: TAFII250; motif: RARRWGGCGGMGGNGR; match class: 1,20011,8173,TF:M10086,FALSE
HPA:0030051,1.29458867274594e-08,TRUE,6741,418,318,HPA,appendix; glandular cells[Low],11006,38,HPA:0030000,FALSE
GO:0042803,1.32509691288942e-08,TRUE,716,555,54,GO:MF,protein homodimerization activity,20139,5677,GO:0042802|GO:0046983,FALSE
GO:0050778,1.33735614336954e-08,TRUE,699,553,53,GO:BP,positive regulation of immune response,21010,13910,GO:0002684|GO:0006955|GO:0048584|GO:0050776,FALSE
REAC:R-HSA-400206,1.34180088493519e-08,TRUE,114,485,25,REAC,Regulation of lipid metabolism by PPARalpha,10835,1942,REAC:R-HSA-556833,FALSE
WP:WP127,1.3579680231342e-08,TRUE,40,461,16,WP,IL-5 signaling pathway,8625,363,WP:000000,FALSE
WP:WP3941,1.3579680231342e-08,TRUE,40,461,16,WP,Oxidative damage response,8625,446,WP:000000,FALSE
GO:1990391,1.36943412717408e-08,TRUE,22,548,10,GO:CC,DNA repair complex,22090,3892,GO:1902494,FALSE
TF:M00736,1.38308055934156e-08,TRUE,10624,556,374,TF,Factor: E2F-1:DP-1; motif: TTTCSCGC,20011,1424,TF:M00000,FALSE
REAC:R-HSA-2559586,1.42904964896575e-08,TRUE,80,485,21,REAC,DNA Damage/Telomere Stress Induced Senescence,10835,424,REAC:R-HSA-2559583,FALSE
TF:M08911_1,1.43618704557577e-08,TRUE,4064,556,181,TF,Factor: CTCF; motif: NCCRSTAGGGGGCGC; match class: 1,20011,1141,TF:M08911,FALSE
HPA:0420000,1.44701261282485e-08,TRUE,6893,418,323,HPA,salivary gland,11006,599,HPA:0000000,FALSE
HPA:0420051,1.44701261282485e-08,TRUE,6893,418,323,HPA,salivary gland; glandular cells[Low],11006,600,HPA:0420000,FALSE
GO:0062098,1.45198573502918e-08,TRUE,30,553,12,GO:BP,regulation of programmed necrotic cell death,21010,16611,GO:0043067|GO:0097300,FALSE
HPA:0090000,1.45298456020865e-08,TRUE,7193,418,333,HPA,cerebellum,11006,103,HPA:0000000,FALSE
GO:0044248,1.46137816645122e-08,TRUE,1527,553,87,GO:BP,cellular catabolic process,21010,11493,GO:0009056|GO:0044237,FALSE
WP:WP4566,1.51995768667902e-08,TRUE,46,461,17,WP,Translation inhibitors in chronically activated PDGFRA cells,8625,763,WP:000000,FALSE
GO:0010565,1.52239271487065e-08,TRUE,133,553,22,GO:BP,regulation of cellular ketone metabolic process,21010,4289,GO:0031323|GO:0042180|GO:0062012,FALSE
GO:0048598,1.52900467585886e-08,TRUE,615,553,49,GO:BP,embryonic morphogenesis,21010,13517,GO:0009653|GO:0009790,FALSE
HPA:0090191,1.56839739279634e-08,TRUE,4454,418,234,HPA,cerebellum; cells in molecular layer[Low],11006,134,HPA:0090000,FALSE
KEGG:04613,1.60101990089604e-08,TRUE,187,431,34,KEGG,Neutrophil extracellular trap formation,8161,317,KEGG:00000,FALSE
WP:WP3298,1.65663567597794e-08,TRUE,35,461,15,WP,Melatonin metabolism and effects,8625,514,WP:000000,FALSE
HPA:0160000,1.67769510640518e-08,TRUE,7048,418,328,HPA,endometrium 1,11006,306,HPA:0000000,FALSE
GO:0031492,1.70776426066802e-08,TRUE,40,555,13,GO:MF,nucleosomal DNA binding,20139,4160,GO:0031490|GO:0031491,FALSE
TF:M10432,1.73914276526823e-08,TRUE,9527,556,344,TF,Factor: MAZ; motif: GGGMGGGGS,20011,4996,TF:M00000,FALSE
TF:M11529,1.78605078729407e-08,TRUE,16613,556,516,TF,Factor: E2F-2; motif: GCGCGCGCNCS,20011,1468,TF:M00000,FALSE
TF:M09892,1.8221829864009e-08,TRUE,13853,556,455,TF,Factor: E2F-1; motif: NNNNGGCGGGAARN,20011,1440,TF:M00000,FALSE
TF:M09765,1.86362471905738e-08,TRUE,7652,556,291,TF,Factor: SP1; motif: NRGKGGGCGGGGCN,20011,7834,TF:M00000,FALSE
REAC:R-HSA-1266738,1.86958884261152e-08,TRUE,1140,485,99,REAC,Developmental Biology,10835,707,REAC:0000000,FALSE
TF:M03807_1,1.89066915643162e-08,TRUE,4321,556,189,TF,Factor: SP2; motif: GNNGGGGGCGGGGSN; match class: 1,20011,7881,TF:M03807,FALSE
GO:0010718,1.98267774172988e-08,TRUE,55,553,15,GO:BP,positive regulation of epithelial to mesenchymal transition,21010,4419,GO:0001837|GO:0010717|GO:0045597|GO:0051240,FALSE
HPA:0310433,2.00959879272153e-08,TRUE,945,418,77,HPA,lymph node; germinal center cells[High],11006,462,HPA:0310432,FALSE
GO:0016236,2.02667144715993e-08,TRUE,324,553,34,GO:BP,macroautophagy,21010,5266,GO:0006914,FALSE
TF:M00426_1,2.0383626043903e-08,TRUE,5976,556,241,TF,Factor: E2F; motif: TTTSGCGS; match class: 1,20011,1555,TF:M00426,FALSE
WP:WP3680,2.05034998753428e-08,TRUE,66,461,20,WP,Physico-chemical features and toxicity-associated pathways,8625,635,WP:000000,FALSE
GO:0002758,2.08183490330157e-08,TRUE,239,553,29,GO:BP,innate immune response-activating signaling pathway,21010,1283,GO:0002218|GO:0002757,FALSE
GO:0032813,2.1018543474143e-08,TRUE,49,555,14,GO:MF,tumor necrosis factor receptor superfamily binding,20139,4503,GO:0005126,TRUE
TF:M04950,2.10875567584219e-08,TRUE,11181,556,388,TF,Factor: Egr-1; motif: NGCGTGCGY,20011,1612,TF:M00000,FALSE
GO:0010629,2.110731636635e-08,TRUE,1617,553,90,GO:BP,negative regulation of gene expression,21010,4347,GO:0010467|GO:0010468|GO:0010558,FALSE
GO:0016052,2.19026256765271e-08,TRUE,163,553,24,GO:BP,carbohydrate catabolic process,21010,5170,GO:0005975|GO:1901575,FALSE
HPA:0180052,2.35167211407015e-08,TRUE,5688,418,280,HPA,epididymis; glandular cells[Medium],11006,322,HPA:0180051,FALSE
REAC:R-HSA-9031628,2.37455512440155e-08,TRUE,39,485,15,REAC,NGF-stimulated transcription,10835,1450,REAC:R-HSA-198725,FALSE
GO:0031331,2.4062714077174e-08,TRUE,326,553,34,GO:BP,positive regulation of cellular catabolic process,21010,7469,GO:0009896|GO:0031325|GO:0031329|GO:0044248,FALSE
GO:0044843,2.44111300687035e-08,TRUE,257,553,30,GO:BP,cell cycle G1/S phase transition,21010,11793,GO:0044770,FALSE
HP:0010460,2.47208179548878e-08,TRUE,548,241,63,HP,Abnormality of the female genitalia,4962,6916,HP:0012243,FALSE
TF:M07208,2.48239743127944e-08,TRUE,6349,556,252,TF,Factor: EGR1; motif: NCNCCGCCCCCGCN,20011,1614,TF:M00000,FALSE
WP:WP1544,2.48339077284768e-08,TRUE,104,461,25,WP,MicroRNAs in cardiomyocyte hypertrophy,8625,282,WP:000000,FALSE
WP:WP4016,2.56107851638916e-08,TRUE,81,461,22,WP,DNA IR-damage and cellular response via ATR,8625,439,WP:000000,FALSE
GO:0031519,2.5888136812378e-08,TRUE,47,548,13,GO:CC,PcG protein complex,22090,1157,GO:0140513,FALSE
GO:0000793,2.73327323753192e-08,TRUE,278,548,29,GO:CC,condensed chromosome,22090,96,GO:0005694,FALSE
TF:M12508,2.77094725329996e-08,TRUE,6588,556,259,TF,Factor: EGR1; motif: NNMCGCCCACGCNN,20011,1628,TF:M00000,FALSE
WP:WP3658,2.79239587645171e-08,TRUE,26,461,13,WP,Wnt/beta-catenin signaling pathway in leukemia,8625,667,WP:000000,FALSE
TF:M12313,2.79992440720003e-08,TRUE,5993,556,241,TF,Factor: ZNF460; motif: NNACNCCCCCCNN,20011,10344,TF:M00000,FALSE
TF:M00425,2.80910962613689e-08,TRUE,11352,556,392,TF,Factor: E2F; motif: TTTCGCGC,20011,1550,TF:M00000,FALSE
GO:0045639,2.84791336453331e-08,TRUE,99,553,19,GO:BP,positive regulation of myeloid cell differentiation,21010,12105,GO:0030099|GO:0045597|GO:0045637,FALSE
GO:0090734,2.85117472130299e-08,TRUE,117,548,19,GO:CC,site of DNA damage,22090,2894,GO:0005694|GO:0110165,FALSE
GO:0070059,2.85729114198728e-08,TRUE,66,553,16,GO:BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,21010,16688,GO:0034976|GO:0097193,FALSE
GO:1903146,2.89096212316062e-08,TRUE,39,553,13,GO:BP,regulation of autophagy of mitochondrion,21010,23725,GO:0000422|GO:0010506|GO:0010821,FALSE
TF:M11603,3.05187811587459e-08,TRUE,16640,556,516,TF,Factor: TCF-1; motif: ACATCGRGRCGCTGW,20011,8410,TF:M00000,FALSE
KEGG:04151,3.14317780987968e-08,TRUE,353,431,49,KEGG,PI3K-Akt signaling pathway,8161,279,KEGG:00000,FALSE
KEGG:04912,3.1473250578375e-08,TRUE,93,431,23,KEGG,GnRH signaling pathway,8161,362,KEGG:00000,FALSE
HPA:0320102,3.30775626137307e-08,TRUE,4767,418,245,HPA,nasopharynx; respiratory epithelial cells[Medium],11006,486,HPA:0320101,FALSE
TF:M07277_1,3.3203004045068e-08,TRUE,4286,556,187,TF,Factor: BTEB2; motif: RGGGNGKGGN; match class: 1,20011,625,TF:M07277,FALSE
GO:0001890,3.36465245799854e-08,TRUE,152,553,23,GO:BP,placenta development,21010,527,GO:0048513,FALSE
GO:0051169,3.37767412180116e-08,TRUE,330,553,34,GO:BP,nuclear transport,21010,14226,GO:0046907,FALSE
GO:0006913,3.37767412180116e-08,TRUE,330,553,34,GO:BP,nucleocytoplasmic transport,21010,2602,GO:0051169,FALSE
GO:0045667,3.40271531520052e-08,TRUE,125,553,21,GO:BP,regulation of osteoblast differentiation,21010,12133,GO:0001649|GO:0045595,FALSE
GO:0045087,3.43852988980198e-08,TRUE,947,553,63,GO:BP,innate immune response,21010,11875,GO:0006955|GO:0098542,FALSE
TF:M00940,3.50571105464439e-08,TRUE,8001,556,300,TF,Factor: E2F-1; motif: NTTTCGCGCS,20011,1458,TF:M00000,FALSE
HPA:0320101,3.51878943786724e-08,TRUE,5787,418,283,HPA,nasopharynx; respiratory epithelial cells[Low],11006,485,HPA:0320000,FALSE
HPA:0530712,3.5286012591e-08,TRUE,3133,418,179,HPA,spleen; cells in red pulp[Medium],11006,777,HPA:0530711,FALSE
REAC:R-HSA-8953750,3.57387351213689e-08,TRUE,34,485,14,REAC,Transcriptional Regulation by E2F6,10835,2428,REAC:R-HSA-212436,FALSE
WP:WP2446,3.71019959617587e-08,TRUE,90,461,23,WP,Retinoblastoma gene in cancer,8625,415,WP:000000,FALSE
GO:0032434,3.77393867489546e-08,TRUE,139,553,22,GO:BP,regulation of proteasomal ubiquitin-dependent protein catabolic process,21010,7927,GO:0043161|GO:0061136|GO:2000058,FALSE
REAC:R-HSA-73854,3.79158877169475e-08,TRUE,110,485,24,REAC,RNA Polymerase I Promoter Clearance,10835,1798,REAC:R-HSA-73864,FALSE
WP:WP4482,3.87047416705671e-08,TRUE,22,461,12,WP,Vitamin D in inflammatory diseases,8625,718,WP:000000,FALSE
WP:WP3599,3.87047416705671e-08,TRUE,22,461,12,WP,Transcription factor regulation in adipogenesis,8625,397,WP:000000,FALSE
HP:0010787,3.9222659769623e-08,TRUE,153,241,30,HP,Genital neoplasm,4962,7217,HP:0000078|HP:0007379,FALSE
MIRNA:hsa-miR-19a-3p,4.0547266533432e-08,TRUE,570,514,53,MIRNA,hsa-miR-19a-3p,14846,379,MIRNA:000000,FALSE
REAC:R-HSA-427389,4.07044176324614e-08,TRUE,76,485,20,REAC,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,10835,793,REAC:R-HSA-5250913,FALSE
HPA:0350471,4.08526559926885e-08,TRUE,6935,418,323,HPA,pancreas; exocrine glandular cells[Low],11006,500,HPA:0350000,FALSE
HPA:0390051,4.11030380112228e-08,TRUE,6671,418,314,HPA,prostate; glandular cells[Low],11006,540,HPA:0390000,FALSE
HPA:0390000,4.11030380112228e-08,TRUE,6671,418,314,HPA,prostate,11006,539,HPA:0000000,FALSE
HPA:0550000,4.19622963322697e-08,TRUE,7604,418,345,HPA,stomach 2,11006,786,HPA:0000000,FALSE
HPA:0550051,4.19622963322697e-08,TRUE,7604,418,345,HPA,stomach 2; glandular cells[Low],11006,787,HPA:0550000,FALSE
WP:WP3879,4.23410333452417e-08,TRUE,18,461,11,WP,"4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression",8625,93,WP:000000,FALSE
GO:0071897,4.24173403162503e-08,TRUE,198,553,26,GO:BP,DNA biosynthetic process,21010,17793,GO:0006259|GO:0009059|GO:0034654,FALSE
GO:0003002,4.29124889556228e-08,TRUE,427,553,39,GO:BP,regionalization,21010,1467,GO:0007389,FALSE
WP:WP560,4.32270388585571e-08,TRUE,55,461,18,WP,TGF-beta receptor signaling,8625,498,WP:000000,FALSE
WP:WP4331,4.32457317351942e-08,TRUE,37,461,15,WP,Neovascularisation processes,8625,787,WP:000000,FALSE
HPA:0170000,4.35263271488408e-08,TRUE,6908,418,322,HPA,endometrium 2,11006,313,HPA:0000000,FALSE
GO:1903050,4.43108371807391e-08,TRUE,230,553,28,GO:BP,regulation of proteolysis involved in protein catabolic process,21010,23654,GO:0030162|GO:0051603,FALSE
HPA:0080121,4.46771701302009e-08,TRUE,4572,418,237,HPA,caudate; glial cells[Low],11006,91,HPA:0080000,FALSE
HPA:0170252,4.58360573333869e-08,TRUE,1798,418,119,HPA,endometrium 2; cells in endometrial stroma[Medium],11006,315,HPA:0170251,FALSE
GO:0032182,4.60471389977301e-08,TRUE,118,555,20,GO:MF,ubiquitin-like protein binding,20139,4434,GO:0005515,FALSE
REAC:R-HSA-73864,4.63935618935692e-08,TRUE,111,485,24,REAC,RNA Polymerase I Transcription,10835,1801,REAC:R-HSA-74160,FALSE
HPA:0190223,4.65474849966388e-08,TRUE,1652,418,112,HPA,esophagus; squamous epithelial cells[High],11006,327,HPA:0190222,FALSE
CORUM:685,4.67109824425114e-08,TRUE,9,292,9,CORUM,MeCP1 complex,3383,375,CORUM:0000000,FALSE
CORUM:659,4.67109824425114e-08,TRUE,9,292,9,CORUM,MeCP1 complex,3383,368,CORUM:0000000,FALSE
GO:0001525,4.76525466053733e-08,TRUE,529,553,44,GO:BP,angiogenesis,21010,340,GO:0048514|GO:0048646,FALSE
GO:0018022,4.81317974967578e-08,TRUE,90,553,18,GO:BP,peptidyl-lysine methylation,21010,5418,GO:0006479|GO:0018205,FALSE
KEGG:04660,4.84112187807684e-08,TRUE,103,431,24,KEGG,T cell receptor signaling pathway,8161,332,KEGG:00000,FALSE
WP:WP5180,4.89139375613291e-08,TRUE,62,461,19,WP,DYRK1A involvement regarding cell proliferation in brain development,8625,408,WP:000000,FALSE
GO:0042393,4.90895647181218e-08,TRUE,235,555,28,GO:MF,histone binding,20139,5642,GO:0005515,FALSE
HPA:0490691,4.92146663465253e-08,TRUE,5446,418,270,HPA,smooth muscle; smooth muscle cells[Low],11006,748,HPA:0490000,FALSE
HPA:0490000,4.92146663465253e-08,TRUE,5446,418,270,HPA,smooth muscle,11006,747,HPA:0000000,FALSE
TF:M11882,4.93222815107183e-08,TRUE,15802,556,498,TF,Factor: pax-6; motif: NYACGCNYSANYGMNCN,20011,6412,TF:M00000,FALSE
GO:0042149,4.9601388088088e-08,TRUE,49,553,14,GO:BP,cellular response to glucose starvation,21010,10491,GO:0009267,FALSE
GO:0043124,4.9601388088088e-08,TRUE,49,553,14,GO:BP,negative regulation of canonical NF-kappaB signal transduction,21010,11051,GO:0007249|GO:0043122|GO:1902532,FALSE
GO:0042789,4.9601388088088e-08,TRUE,49,553,14,GO:BP,mRNA transcription by RNA polymerase II,21010,10872,GO:0006366|GO:0009299,FALSE
WP:WP5130,5.0187007725609e-08,TRUE,69,461,20,WP,Th17 cell differentiation pathway,8625,530,WP:000000,FALSE
GO:0000786,5.03605126753356e-08,TRUE,135,548,20,GO:CC,nucleosome,22090,93,GO:0000785|GO:0032993,FALSE
GO:0004707,5.04956544051541e-08,TRUE,16,555,9,GO:MF,MAP kinase activity,20139,999,GO:0004674,FALSE
GO:0006352,5.07915607258653e-08,TRUE,155,553,23,GO:BP,DNA-templated transcription initiation,21010,2162,GO:0006351|GO:0032774,FALSE
GO:0050865,5.08261917510462e-08,TRUE,636,553,49,GO:BP,regulation of cell activation,21010,13978,GO:0001775|GO:0050794|GO:0051239,FALSE
REAC:R-HSA-5357786,5.09151039572077e-08,TRUE,24,485,12,REAC,TNFR1-induced proapoptotic signaling,10835,2331,REAC:R-HSA-75893,FALSE
REAC:R-HSA-3371571,5.09151039572077e-08,TRUE,24,485,12,REAC,HSF1-dependent transactivation,10835,1059,REAC:R-HSA-3371556,FALSE
GO:0140296,5.10319708608681e-08,TRUE,52,555,14,GO:MF,general transcription initiation factor binding,20139,10536,GO:0008134,FALSE
HPA:0050052,5.27821180506672e-08,TRUE,5101,418,257,HPA,breast; glandular cells[Medium],11006,59,HPA:0050051,FALSE
TF:M10432_1,5.32932167428879e-08,TRUE,4494,556,193,TF,Factor: MAZ; motif: GGGMGGGGS; match class: 1,20011,4997,TF:M10432,FALSE
TF:M09892_1,5.46664197852959e-08,TRUE,9415,556,339,TF,Factor: E2F-1; motif: NNNNGGCGGGAARN; match class: 1,20011,1441,TF:M09892,FALSE
REAC:R-HSA-383280,5.51418784167663e-08,TRUE,41,485,15,REAC,Nuclear Receptor transcription pathway,10835,1538,REAC:R-HSA-212436,FALSE
TF:M12703_1,5.55590194057748e-08,TRUE,4465,556,192,TF,Factor: ZNF383; motif: SSNGGGMGGNGSNGGS; match class: 1,20011,10111,TF:M12703,FALSE
HPA:0170051,5.75142346757608e-08,TRUE,6714,418,315,HPA,endometrium 2; glandular cells[Low],11006,317,HPA:0170000,FALSE
TF:M11022,5.78632606258086e-08,TRUE,9710,556,347,TF,Factor: IRX2a; motif: ACRYGNNNNACRYGT,20011,4384,TF:M00000,FALSE
TF:M03893_1,5.81877956298807e-08,TRUE,4098,556,180,TF,Factor: WT1; motif: GNGGGGGCGGGG; match class: 1,20011,8989,TF:M03893,FALSE
GO:0032436,5.85543627983217e-08,TRUE,91,553,18,GO:BP,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,21010,7929,GO:0032434|GO:0043161|GO:1901800|GO:2000060,FALSE
TF:M09984,5.85665985912157e-08,TRUE,9784,556,349,TF,Factor: MAZ; motif: GGGGGAGGGGGNGRGRRRGNRG,20011,4994,TF:M00000,FALSE
GO:0032388,5.9849509094617e-08,TRUE,201,553,26,GO:BP,positive regulation of intracellular transport,21010,7906,GO:0032386|GO:0046907|GO:0048522|GO:0051050,FALSE
HPA:0351181,5.98614083634697e-08,TRUE,5617,418,276,HPA,pancreas; pancreatic endocrine cells[Low],11006,503,HPA:0350000,FALSE
KEGG:04071,6.00588698878003e-08,TRUE,121,431,26,KEGG,Sphingolipid signaling pathway,8161,255,KEGG:00000,FALSE
GO:0002931,6.03253672778168e-08,TRUE,59,553,15,GO:BP,response to ischemia,21010,1453,GO:0006950,FALSE
HPA:0460673,6.16404108530227e-08,TRUE,986,418,78,HPA,skin 1; melanocytes[High],11006,669,HPA:0460672,FALSE
HP:0012733,6.40095256100723e-08,TRUE,229,241,37,HP,Macule,4962,9118,HP:0011355,FALSE
HPA:0160253,6.46642653032519e-08,TRUE,434,418,46,HPA,endometrium 1; cells in endometrial stroma[High],11006,309,HPA:0160252,FALSE
GO:0031264,6.53031833489245e-08,TRUE,9,548,7,GO:CC,death-inducing signaling complex,22090,1088,GO:0098797,TRUE
TF:M04953,6.56064383697085e-08,TRUE,8886,556,324,TF,Factor: Sp1; motif: GGNDGGRGGCGGGG,20011,7830,TF:M00000,FALSE
GO:0009746,6.70280322658813e-08,TRUE,202,553,26,GO:BP,response to hexose,21010,3701,GO:0034284,FALSE
HPA:0310442,6.752732463261e-08,TRUE,3981,418,213,HPA,lymph node; non-germinal center cells[Medium],11006,464,HPA:0310441,FALSE
HPA:0590052,6.79264571806315e-08,TRUE,5595,418,275,HPA,thyroid gland; glandular cells[Medium],11006,840,HPA:0590051,FALSE
REAC:R-HSA-1989781,6.89520603056791e-08,TRUE,113,485,24,REAC,PPARA activates gene expression,10835,1619,REAC:R-HSA-400206,FALSE
TF:M12666,7.00296872752553e-08,TRUE,8890,556,324,TF,Factor: SP1; motif: GGCCCCGCCCCCN,20011,7844,TF:M00000,FALSE
WP:WP4539,7.00812731384121e-08,TRUE,50,461,17,WP,Synaptic signaling pathways associated with autism spectrum disorder,8625,783,WP:000000,FALSE
GO:2000058,7.03781469147631e-08,TRUE,172,553,24,GO:BP,regulation of ubiquitin-dependent protein catabolic process,21010,26477,GO:0006511|GO:0009894|GO:1903050,FALSE
HPA:0530722,7.0401997671117e-08,TRUE,2715,418,160,HPA,spleen; cells in white pulp[Medium],11006,780,HPA:0530721,FALSE
TF:M05327,7.0686155508529e-08,TRUE,5684,556,230,TF,Factor: WT1; motif: NGCGGGGGGGTSMMCYN,20011,8978,TF:M00000,FALSE
HPA:0160051,7.19652064308553e-08,TRUE,6811,418,318,HPA,endometrium 1; glandular cells[Low],11006,310,HPA:0160000,FALSE
HPA:0130051,7.20711773287108e-08,TRUE,6988,418,324,HPA,colon; glandular cells[Low],11006,231,HPA:0130000,FALSE
GO:0046982,7.4054031993556e-08,TRUE,361,555,35,GO:MF,protein heterodimerization activity,20139,6316,GO:0046983,FALSE
GO:0000792,7.58666853635733e-08,TRUE,84,548,16,GO:CC,heterochromatin,22090,95,GO:0000785,FALSE
GO:0051100,7.59066519392798e-08,TRUE,158,553,23,GO:BP,negative regulation of binding,21010,14167,GO:0044092|GO:0051098,FALSE
GO:0043524,7.59066519392798e-08,TRUE,158,553,23,GO:BP,negative regulation of neuron apoptotic process,21010,11265,GO:0043066|GO:0043523|GO:0051402,FALSE
GO:0050821,7.62050763894087e-08,TRUE,219,553,27,GO:BP,protein stabilization,21010,13941,GO:0031647,FALSE
GO:0060419,7.78523798953701e-08,TRUE,81,553,17,GO:BP,heart growth,21010,15352,GO:0007507|GO:0035265,FALSE
GO:0051148,7.8506429498651e-08,TRUE,60,553,15,GO:BP,negative regulation of muscle cell differentiation,21010,14205,GO:0042692|GO:0045596|GO:0051147,FALSE
GO:0051249,7.94128008914489e-08,TRUE,496,553,42,GO:BP,regulation of lymphocyte activation,21010,14277,GO:0002694|GO:0046649,FALSE
REAC:R-HSA-8941326,8.00097387866297e-08,TRUE,30,485,13,REAC,RUNX2 regulates bone development,10835,1842,REAC:R-HSA-8878166,FALSE
REAC:R-HSA-3371556,8.00289985386317e-08,TRUE,87,485,21,REAC,Cellular response to heat stress,10835,326,REAC:R-HSA-2262752,FALSE
HP:0010785,8.30692757629e-08,TRUE,102,241,24,HP,Gonadal neoplasm,4962,7215,HP:0010787,FALSE
TF:M12599,8.35890904963806e-08,TRUE,17521,556,532,TF,Factor: E2F4; motif: YCCCGCCNCNNSSNNSNN,20011,1514,TF:M00000,FALSE
WP:WP3853,8.43125218562378e-08,TRUE,15,461,10,WP,ERK pathway in Huntington's disease,8625,34,WP:000000,FALSE
WP:WP4880,8.47643149948357e-08,TRUE,33,461,14,WP,Host-pathogen interaction of human coronaviruses - interferon induction,8625,775,WP:000000,FALSE
GO:0097718,8.49171178963674e-08,TRUE,29,555,11,GO:MF,disordered domain specific binding,20139,9206,GO:0019904,FALSE
WP:WP1982,8.85092515990642e-08,TRUE,71,461,20,WP,Sterol regulatory element-binding proteins (SREBP) signaling,8625,224,WP:000000,FALSE
GO:0030554,8.86043495837216e-08,TRUE,1658,555,91,GO:MF,adenyl nucleotide binding,20139,3971,GO:0017076,FALSE
HP:0011792,9.00238847515212e-08,TRUE,350,241,47,HP,Neoplasm by histology,4962,8193,HP:0002664,FALSE
WP:WP3851,9.10693773462528e-08,TRUE,28,461,13,WP,TLR4 signaling and tolerance,8625,24,WP:000000,FALSE
TF:M12697,9.38209135834962e-08,TRUE,3193,556,149,TF,Factor: ZNF142; motif: SNSCGCCCGCCCGCSCSS,20011,9502,TF:M00000,FALSE
GO:0032559,9.56141017182958e-08,TRUE,1556,555,87,GO:MF,adenyl ribonucleotide binding,20139,4485,GO:0030554|GO:0032555,FALSE
TF:M07397_1,9.70963423639655e-08,TRUE,3049,556,144,TF,Factor: ZBP89; motif: CCCCKCCCCCNN; match class: 1,20011,9073,TF:M07397,FALSE
HPA:0340463,9.77044408027502e-08,TRUE,378,418,42,HPA,ovary; ovarian stroma cells[High],11006,498,HPA:0340462,FALSE
GO:0048568,9.96584191973906e-08,TRUE,459,553,40,GO:BP,embryonic organ development,21010,13491,GO:0009790|GO:0048513,FALSE
GO:0062014,1.00113630029586e-07,TRUE,106,553,19,GO:BP,negative regulation of small molecule metabolic process,21010,16575,GO:0009892|GO:0044281|GO:0062012,FALSE
GO:0030217,1.01078056814544e-07,TRUE,307,553,32,GO:BP,T cell differentiation,21010,7040,GO:0030098|GO:0042110,FALSE
GO:0006090,1.04097649543044e-07,TRUE,119,553,20,GO:BP,pyruvate metabolic process,21010,1982,GO:0032787,FALSE
HPA:0510651,1.0444354967487e-07,TRUE,4123,418,218,HPA,soft tissue 2; fibroblasts[Low],11006,765,HPA:0510000,FALSE
TF:M09894,1.06009448445653e-07,TRUE,16556,556,513,TF,Factor: E2F-4; motif: SNGGGCGGGAANN,20011,1510,TF:M00000,FALSE
TF:M09984_1,1.0616260678614e-07,TRUE,5706,556,230,TF,Factor: MAZ; motif: GGGGGAGGGGGNGRGRRRGNRG; match class: 1,20011,4995,TF:M09984,FALSE
GO:0002757,1.06225292184749e-07,TRUE,440,553,39,GO:BP,immune response-activating signaling pathway,21010,1282,GO:0002253|GO:0002764,FALSE
WP:WP5347,1.0893327511645e-07,TRUE,45,461,16,WP,IL-26 signaling pathways,8625,668,WP:000000,FALSE
WP:WP268,1.0893327511645e-07,TRUE,45,461,16,WP,Notch signaling,8625,351,WP:000000,FALSE
GO:0052548,1.10067403371283e-07,TRUE,308,553,32,GO:BP,regulation of endopeptidase activity,21010,14861,GO:0052547,FALSE
GO:0016234,1.10610969150532e-07,TRUE,74,548,15,GO:CC,inclusion body,22090,728,GO:0005622,FALSE
GO:0008637,1.18793215378766e-07,TRUE,107,553,19,GO:BP,apoptotic mitochondrial changes,21010,3276,GO:0006915|GO:0007005,FALSE
GO:0071260,1.18834271115559e-07,TRUE,72,553,16,GO:BP,cellular response to mechanical stimulus,21010,17327,GO:0009612|GO:0071214|GO:0071496,FALSE
GO:0046686,1.20846409602919e-07,TRUE,52,553,14,GO:BP,response to cadmium ion,21010,12942,GO:0010038,FALSE
GO:0010332,1.20846409602919e-07,TRUE,52,553,14,GO:BP,response to gamma radiation,21010,4124,GO:0010212,FALSE
WP:WP3651,1.21162316574178e-07,TRUE,65,461,19,WP,Pathways affected in adenoid cystic carcinoma,8625,41,WP:000000,FALSE
GO:0002761,1.21901504149737e-07,TRUE,120,553,20,GO:BP,regulation of myeloid leukocyte differentiation,21010,1286,GO:0002573|GO:0045637|GO:1902105,FALSE
TF:M00189_1,1.22753443417571e-07,TRUE,6239,556,246,TF,Factor: AP-2; motif: MKCCCSCNGGCG; match class: 1,20011,155,TF:M00189,FALSE
GO:1900182,1.24946121304749e-07,TRUE,95,553,18,GO:BP,positive regulation of protein localization to nucleus,21010,21272,GO:0034504|GO:1900180|GO:1903829,FALSE
GO:0034605,1.30829644223677e-07,TRUE,62,553,15,GO:BP,cellular response to heat,21010,9086,GO:0009408|GO:0033554,FALSE
GO:0035051,1.34711804771204e-07,TRUE,148,553,22,GO:BP,cardiocyte differentiation,21010,9201,GO:0007507|GO:0030154,FALSE
GO:0007611,1.34899742808668e-07,TRUE,275,553,30,GO:BP,learning or memory,21010,3121,GO:0007610|GO:0050890,FALSE
TF:M00982_1,1.38290263043793e-07,TRUE,3624,556,163,TF,Factor: KROX; motif: CCCGCCCCCRCCCC; match class: 1,20011,4613,TF:M00982,FALSE
HPA:0060102,1.38954883217396e-07,TRUE,4930,418,249,HPA,bronchus; respiratory epithelial cells[Medium],11006,84,HPA:0060101,FALSE
GO:2000060,1.40676982783576e-07,TRUE,108,553,19,GO:BP,positive regulation of ubiquitin-dependent protein catabolic process,21010,26479,GO:0006511|GO:0009896|GO:1903052|GO:2000058,FALSE
GO:0018107,1.40676982783576e-07,TRUE,108,553,19,GO:BP,peptidyl-threonine phosphorylation,21010,5451,GO:0006468|GO:0018210,FALSE
KEGG:05133,1.43357369276949e-07,TRUE,76,431,20,KEGG,Pertussis,8161,423,KEGG:00000,FALSE
GO:0051571,1.45208085820016e-07,TRUE,16,553,9,GO:BP,positive regulation of histone H3-K4 methylation,21010,14489,GO:0031062|GO:0051568|GO:0051569,FALSE
HPA:0270000,1.46248642581529e-07,TRUE,8228,418,363,HPA,kidney,11006,407,HPA:0000000,FALSE
TF:M10530,1.46840562617255e-07,TRUE,8403,556,309,TF,Factor: sp4; motif: NNNGCYCCGCCCCCY,20011,7896,TF:M00000,FALSE
HPA:0241101,1.49599867054256e-07,TRUE,6323,418,300,HPA,heart muscle; cardiomyocytes[Low],11006,378,HPA:0240000,FALSE
HPA:0240000,1.49599867054256e-07,TRUE,6323,418,300,HPA,heart muscle,11006,377,HPA:0000000,FALSE
REAC:R-HSA-9009391,1.50250673881685e-07,TRUE,73,485,19,REAC,Extra-nuclear estrogen signaling,10835,847,REAC:R-HSA-8939211,FALSE
TF:M04950_1,1.5181729187418e-07,TRUE,5693,556,229,TF,Factor: Egr-1; motif: NGCGTGCGY; match class: 1,20011,1613,TF:M04950,FALSE
TF:M04826_1,1.52667406584176e-07,TRUE,15544,556,491,TF,Factor: p300; motif: ACNTCCG; match class: 1,20011,1941,TF:M04826,FALSE
WP:WP4341,1.52738794509711e-07,TRUE,73,461,20,WP,"Non-genomic actions of 1,25 dihydroxyvitamin D3",8625,788,WP:000000,FALSE
KEGG:04012,1.53758102832493e-07,TRUE,84,431,21,KEGG,ErbB signaling pathway,8161,240,KEGG:00000,FALSE
GO:0002253,1.5873422393298e-07,TRUE,507,553,42,GO:BP,activation of immune response,21010,799,GO:0002376|GO:0050778,FALSE
WP:WP4816,1.59120696771813e-07,TRUE,59,461,18,WP,TGF-beta receptor signaling in skeletal dysplasias,8625,67,WP:000000,FALSE
HPA:0100122,1.59246268324015e-07,TRUE,2674,418,157,HPA,cerebral cortex; glial cells[Medium],11006,187,HPA:0100121,FALSE
WP:WP2526,1.60056363858995e-07,TRUE,40,461,15,WP,PDGF pathway,8625,666,WP:000000,FALSE
GO:2001238,1.60302908719466e-07,TRUE,53,553,14,GO:BP,positive regulation of extrinsic apoptotic signaling pathway,21010,27524,GO:0097191|GO:2001235|GO:2001236,FALSE
GO:0034284,1.61705013339272e-07,TRUE,210,553,26,GO:BP,response to monosaccharide,21010,8933,GO:0009743,FALSE
REAC:R-HSA-5693532,1.62038026595959e-07,TRUE,168,485,29,REAC,DNA Double-Strand Break Repair,10835,426,REAC:R-HSA-73894,FALSE
GO:0001222,1.67299286156177e-07,TRUE,47,555,13,GO:MF,transcription corepressor binding,20139,182,GO:0001221,FALSE
GO:0048738,1.75471447475179e-07,TRUE,227,553,27,GO:BP,cardiac muscle tissue development,21010,13647,GO:0007507|GO:0014706,FALSE
GO:0072593,1.75471447475179e-07,TRUE,227,553,27,GO:BP,reactive oxygen species metabolic process,21010,18293,GO:0044237,FALSE
GO:0006986,1.77922189857916e-07,TRUE,136,553,21,GO:BP,response to unfolded protein,21010,2650,GO:0035966,FALSE
REAC:R-HSA-8878166,1.78303225804989e-07,TRUE,118,485,24,REAC,Transcriptional regulation by RUNX2,10835,2437,REAC:R-HSA-212436,FALSE
REAC:R-HSA-168928,1.80469339079484e-07,TRUE,82,485,20,REAC,DDX58/IFIH1-mediated induction of interferon-alpha/beta,10835,419,REAC:R-HSA-168249,FALSE
GO:0030234,1.80658980630022e-07,TRUE,1319,555,77,GO:MF,enzyme regulator activity,20139,3881,GO:0098772,FALSE
GO:0014706,1.82161094841848e-07,TRUE,244,553,28,GO:BP,striated muscle tissue development,21010,4727,GO:0060537,FALSE
HPA:0300412,1.87063710111759e-07,TRUE,4890,418,247,HPA,lung; macrophages[Medium],11006,457,HPA:0300411,FALSE
TF:M00427_1,1.92222694460975e-07,TRUE,3941,556,173,TF,Factor: E2F; motif: TTTSGCGS; match class: 1,20011,1563,TF:M00427,FALSE
HPA:0130201,1.96036554475826e-07,TRUE,5667,418,276,HPA,colon; endothelial cells[Low],11006,216,HPA:0130000,FALSE
TF:M01857_1,1.99247161844521e-07,TRUE,4716,556,198,TF,Factor: AP-2alpha; motif: NGCCYSNNGSN; match class: 1,20011,135,TF:M01857,FALSE
TF:M07129,2.00561118723071e-07,TRUE,6433,556,251,TF,Factor: Sp2; motif: GYCCCGCCYCYNNNN,20011,7866,TF:M00000,FALSE
WP:WP3927,2.02615363386893e-07,TRUE,20,461,11,WP,BMP signaling in eyelid development,8625,49,WP:000000,FALSE
GO:0008213,2.05055725599578e-07,TRUE,137,553,21,GO:BP,protein alkylation,21010,3193,GO:0036211,FALSE
GO:0006479,2.05055725599578e-07,TRUE,137,553,21,GO:BP,protein methylation,21010,2251,GO:0008213|GO:0043414,FALSE
KEGG:05030,2.06906484980913e-07,TRUE,49,431,16,KEGG,Cocaine addiction,8161,411,KEGG:00000,FALSE
TF:M04823,2.08763038568159e-07,TRUE,13053,556,432,TF,Factor: E2F-4; motif: NNTTCCCGCCNN,20011,1506,TF:M00000,FALSE
GO:0046620,2.13600091895696e-07,TRUE,86,553,17,GO:BP,regulation of organ growth,21010,12885,GO:0035265|GO:0048638|GO:0051239,FALSE
GO:0050863,2.14716297936585e-07,TRUE,372,553,35,GO:BP,regulation of T cell activation,21010,13976,GO:0042110|GO:0051249,FALSE
GO:0000082,2.14853095594613e-07,TRUE,229,553,27,GO:BP,G1/S transition of mitotic cell cycle,21010,32,GO:0044772|GO:0044843,FALSE
HPA:0360051,2.16598533331345e-07,TRUE,5891,418,284,HPA,parathyroid gland; glandular cells[Low],11006,507,HPA:0360000,FALSE
HPA:0360000,2.16598533331345e-07,TRUE,5891,418,284,HPA,parathyroid gland,11006,506,HPA:0000000,FALSE
TF:M00800,2.20192670927794e-07,TRUE,9321,556,334,TF,Factor: AP-2; motif: GSCCSCRGGCNRNRNN,20011,150,TF:M00000,FALSE
GO:0009749,2.2128689185488e-07,TRUE,197,553,25,GO:BP,response to glucose,21010,3704,GO:0009746,FALSE
GO:0051568,2.24848703940491e-07,TRUE,45,553,13,GO:BP,histone H3-K4 methylation,21010,14486,GO:0034968,FALSE
GO:1904019,2.36017691072252e-07,TRUE,138,553,21,GO:BP,epithelial cell apoptotic process,21010,24434,GO:0006915,FALSE
HPA:0300202,2.40933901272083e-07,TRUE,651,418,58,HPA,lung; endothelial cells[Medium],11006,454,HPA:0300201,FALSE
TF:M01303,2.4296536019755e-07,TRUE,8118,556,300,TF,Factor: SP1; motif: GGGGYGGGGNS,20011,7824,TF:M00000,FALSE
HPA:0440342,2.45966310283726e-07,TRUE,3784,418,203,HPA,skeletal muscle; myocytes[Medium],11006,609,HPA:0440341,FALSE
TF:M11883,2.47736466016608e-07,TRUE,13718,556,448,TF,Factor: pax-6; motif: NYACGCNTSRNYGCNYN,20011,6414,TF:M00000,FALSE
GO:0002237,2.49287755388638e-07,TRUE,355,553,34,GO:BP,response to molecule of bacterial origin,21010,784,GO:0009617|GO:0010033|GO:0043207,FALSE
GO:0051179,2.53504542289883e-07,TRUE,5542,553,214,GO:BP,localization,21010,14235,GO:0008150,FALSE
GO:0032496,2.64101744152093e-07,TRUE,337,553,33,GO:BP,response to lipopolysaccharide,21010,7971,GO:0002237|GO:0033993|GO:1901700,FALSE
TF:M09761,2.64746021248408e-07,TRUE,5303,556,216,TF,Factor: EGR1; motif: NGNGKGGGYGGNGS,20011,1620,TF:M00000,FALSE
MIRNA:hsa-miR-21-5p,2.67415380046765e-07,TRUE,636,514,55,MIRNA,hsa-miR-21-5p,14846,413,MIRNA:000000,FALSE
HPA:0220052,2.73259176952583e-07,TRUE,6606,418,309,HPA,gallbladder; glandular cells[Medium],11006,362,HPA:0220051,FALSE
GO:0009952,2.74293095399713e-07,TRUE,215,553,26,GO:BP,anterior/posterior pattern specification,21010,3848,GO:0003002,FALSE
HPA:0170052,2.74753856242085e-07,TRUE,4880,418,246,HPA,endometrium 2; glandular cells[Medium],11006,318,HPA:0170051,FALSE
HPA:0480000,2.75043235106236e-07,TRUE,7868,418,351,HPA,small intestine,11006,725,HPA:0000000,FALSE
MIRNA:hsa-miR-138-5p,2.77316940807844e-07,TRUE,126,514,22,MIRNA,hsa-miR-138-5p,14846,247,MIRNA:000000,FALSE
HPA:0060101,2.88346737133789e-07,TRUE,5931,418,285,HPA,bronchus; respiratory epithelial cells[Low],11006,83,HPA:0060000,FALSE
GO:0005164,2.93782986802344e-07,TRUE,32,555,11,GO:MF,tumor necrosis factor receptor binding,20139,1331,GO:0032813,FALSE
TF:M07226_1,2.98271554785857e-07,TRUE,4023,556,175,TF,Factor: SP1; motif: NCCCCKCCCCC; match class: 1,20011,7833,TF:M07226,FALSE
TF:M02090,3.02732306436867e-07,TRUE,12240,556,411,TF,Factor: E2F-4; motif: GCGGGAAANA,20011,1518,TF:M00000,FALSE
HP:0100587,3.02737700147026e-07,TRUE,34,241,14,HP,Abnormal preputium morphology,4962,16091,HP:0000036,FALSE
GO:0022411,3.07694318134063e-07,TRUE,497,553,41,GO:BP,cellular component disassembly,21010,6917,GO:0016043,FALSE
HPA:0570000,3.07743372229206e-07,TRUE,9008,418,385,HPA,testis,11006,803,HPA:0000000,FALSE
KEGG:05164,3.15689066632407e-07,TRUE,168,431,30,KEGG,Influenza A,8161,438,KEGG:00000,FALSE
GO:0001708,3.18399618543775e-07,TRUE,113,553,19,GO:BP,cell fate specification,21010,410,GO:0045165|GO:0048869,FALSE
GO:0032259,3.22284826398169e-07,TRUE,321,553,32,GO:BP,methylation,21010,7809,GO:0008152,FALSE
TF:M08525,3.23204689183856e-07,TRUE,17424,556,529,TF,Factor: E2F-1:HES-7; motif: GGCRCGTGSYNNWNGGCGCSM,20011,1432,TF:M00000,FALSE
REAC:R-HSA-198693,3.44290790958695e-07,TRUE,10,485,8,REAC,AKT phosphorylates targets in the nucleus,10835,12,REAC:R-HSA-1257604,FALSE
REAC:R-HSA-450341,3.44290790958695e-07,TRUE,10,485,8,REAC,Activation of the AP-1 family of transcription factors,10835,100,REAC:R-HSA-450282,FALSE
GO:0016605,3.44326276736748e-07,TRUE,106,548,17,GO:CC,PML body,22090,769,GO:0016604,FALSE
GO:0001227,3.46799073656023e-07,TRUE,308,555,31,GO:MF,"DNA-binding transcription repressor activity, RNA polymerase II-specific",20139,184,GO:0000981|GO:0001217,FALSE
GO:0010165,3.47725843032776e-07,TRUE,30,553,11,GO:BP,response to X-ray,21010,4025,GO:0010212,FALSE
KEGG:04217,3.52326997582182e-07,TRUE,159,431,29,KEGG,Necroptosis,8161,288,KEGG:00000,FALSE
HP:0007379,3.53416345958957e-07,TRUE,231,241,36,HP,Neoplasm of the genitourinary tract,4962,4717,HP:0000119|HP:0011793,FALSE
GO:0071216,3.54955618364984e-07,TRUE,251,553,28,GO:BP,cellular response to biotic stimulus,21010,17286,GO:0009607|GO:0051716,FALSE
KEGG:01524,3.55294095043102e-07,TRUE,72,431,19,KEGG,Platinum drug resistance,8161,198,KEGG:00000,FALSE
HPA:0400051,3.70763451831134e-07,TRUE,7057,418,324,HPA,rectum; glandular cells[Low],11006,562,HPA:0400000,FALSE
GO:0000979,3.78662137690292e-07,TRUE,19,555,9,GO:MF,RNA polymerase II core promoter sequence-specific DNA binding,20139,118,GO:0000977|GO:0001046,FALSE
GO:0005524,3.81455623527238e-07,TRUE,1495,555,83,GO:MF,ATP binding,20139,1503,GO:0032559|GO:0035639,FALSE
TF:M07329_1,3.81623228886199e-07,TRUE,2589,556,126,TF,Factor: Osx; motif: CCNCCCCCNNN; match class: 1,20011,6219,TF:M07329,FALSE
HP:0100705,3.96792644432313e-07,TRUE,147,241,28,HP,Abnormal glial cell morphology,4962,16196,HP:0002011,FALSE
MIRNA:hsa-miR-92a-3p,3.98214798837215e-07,TRUE,1403,514,93,MIRNA,hsa-miR-92a-3p,14846,2584,MIRNA:000000,FALSE
HPA:0060000,4.1065449757558e-07,TRUE,7421,418,336,HPA,bronchus,11006,64,HPA:0000000,FALSE
TF:M00426,4.22346129748312e-07,TRUE,12183,556,409,TF,Factor: E2F; motif: TTTSGCGS,20011,1554,TF:M00000,FALSE
GO:0008406,4.2863415711768e-07,TRUE,236,553,27,GO:BP,gonad development,21010,3242,GO:0045137|GO:0048513|GO:0048608,FALSE
WP:WP3858,4.32594053810986e-07,TRUE,31,461,13,WP,Toll-like receptor signaling related to MyD88,8625,152,WP:000000,FALSE
WP:WP4787,4.33390410020936e-07,TRUE,118,461,25,WP,Osteoblast differentiation and related diseases,8625,235,WP:000000,FALSE
TF:M08867,4.33453852825557e-07,TRUE,10280,556,359,TF,Factor: AP2; motif: GCCYGSGGSN,20011,152,TF:M00000,FALSE
KEGG:04728,4.34739443956413e-07,TRUE,132,431,26,KEGG,Dopaminergic synapse,8161,352,KEGG:00000,FALSE
GO:0071482,4.35893277393832e-07,TRUE,115,553,19,GO:BP,cellular response to light stimulus,21010,17526,GO:0009416|GO:0071478,FALSE
GO:0006367,4.35893277393832e-07,TRUE,115,553,19,GO:BP,transcription initiation at RNA polymerase II promoter,21010,2175,GO:0006352|GO:0006366,FALSE
GO:1901800,4.35893277393832e-07,TRUE,115,553,19,GO:BP,positive regulation of proteasomal protein catabolic process,21010,22623,GO:0010498|GO:0045732|GO:0061136|GO:1903052,FALSE
GO:0008270,4.35955843165999e-07,TRUE,833,555,56,GO:MF,zinc ion binding,20139,1640,GO:0046914,TRUE
GO:0090316,4.37263513940296e-07,TRUE,157,553,22,GO:BP,positive regulation of intracellular protein transport,21010,19068,GO:0006886|GO:0032388|GO:0033157|GO:0051222,FALSE
HPA:0610833,4.50570551773267e-07,TRUE,2037,418,127,HPA,urinary bladder; urothelial cells[High],11006,855,HPA:0610832,FALSE
GO:0090101,4.67817081233437e-07,TRUE,143,553,21,GO:BP,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,21010,18875,GO:0007178|GO:0009968|GO:0090092,FALSE
TF:M09970,4.71641929185193e-07,TRUE,7915,556,293,TF,Factor: KLF3; motif: NNNNNNGGGCGGGGCNNGN,20011,4570,TF:M00000,FALSE
HPA:0470682,4.7841547612617e-07,TRUE,4009,418,211,HPA,skin 2; epidermal cells[Medium],11006,699,HPA:0470681,FALSE
KEGG:04658,4.78587774231801e-07,TRUE,89,431,21,KEGG,Th1 and Th2 cell differentiation,8161,330,KEGG:00000,FALSE
REAC:R-HSA-350054,4.86001221915693e-07,TRUE,28,485,12,REAC,Notch-HLH transcription pathway,10835,1532,REAC:R-HSA-212436,FALSE
WP:WP3932,4.88173458045152e-07,TRUE,301,461,43,WP,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,8625,412,WP:000000,FALSE
TF:M09603,4.93182983625173e-07,TRUE,4763,556,198,TF,Factor: Egr-1; motif: NNNNNGYGKGGGNGGGNN,20011,1618,TF:M00000,FALSE
TF:M11530_1,4.93422467234272e-07,TRUE,13761,556,448,TF,Factor: E2F-2; motif: NWTTTGGCGCCAWWNN; match class: 1,20011,1471,TF:M11530,FALSE
GO:0035966,4.95718300440457e-07,TRUE,158,553,22,GO:BP,response to topologically incorrect protein,21010,9815,GO:0006950|GO:0010033,FALSE
GO:0070411,5.00817979413383e-07,TRUE,14,555,8,GO:MF,I-SMAD binding,20139,8726,GO:0046332,FALSE
GO:0005901,5.03595530880694e-07,TRUE,82,548,15,GO:CC,caveola,22090,437,GO:0044853,FALSE
TF:M10108,5.06032138382232e-07,TRUE,6688,556,257,TF,Factor: WT1; motif: RGGNGGGGGAGGRGGNGGRG,20011,8980,TF:M00000,FALSE
GO:0002221,5.06416383891974e-07,TRUE,221,553,26,GO:BP,pattern recognition receptor signaling pathway,21010,769,GO:0002758,FALSE
GO:0008585,5.07920544619053e-07,TRUE,103,553,18,GO:BP,female gonad development,21010,3251,GO:0008406|GO:0046545,FALSE
WP:WP3646,5.17211030690361e-07,TRUE,56,461,17,WP,Hepatitis C and hepatocellular carcinoma,8625,639,WP:000000,FALSE
WP:WP722,5.18600126119114e-07,TRUE,37,461,14,WP,Serotonin HTR1 group and FOS pathway,8625,717,WP:000000,FALSE
WP:WP2447,5.18600126119114e-07,TRUE,37,461,14,WP,Amyotrophic lateral sclerosis (ALS),8625,261,WP:000000,FALSE
WP:WP314,5.1952235826451e-07,TRUE,43,461,15,WP,Fas ligand pathway and stress induction of heat shock proteins,8625,472,WP:000000,FALSE
GO:0003300,5.25223997602798e-07,TRUE,79,553,16,GO:BP,cardiac muscle hypertrophy,21010,1741,GO:0014897,FALSE
HPA:0510000,5.27781367376759e-07,TRUE,5198,418,257,HPA,soft tissue 2,11006,761,HPA:0000000,FALSE
GO:0030425,5.30744796875899e-07,TRUE,621,548,43,GO:CC,dendrite,22090,936,GO:0043005|GO:0097447,FALSE
GO:2000758,5.45318778997271e-07,TRUE,24,553,10,GO:BP,positive regulation of peptidyl-lysine acetylation,21010,27109,GO:0018394|GO:1901985|GO:2000756,FALSE
GO:0000775,5.52305851135676e-07,TRUE,258,548,26,GO:CC,"chromosome, centromeric region",22090,86,GO:0098687,FALSE
CORUM:587,5.55104104730549e-07,TRUE,8,292,8,CORUM,NuRD.1 complex,3383,327,CORUM:0000000,FALSE
CORUM:888,5.55104104730549e-07,TRUE,8,292,8,CORUM,MTA2 complex,3383,496,CORUM:0000000,FALSE
CORUM:62,5.55104104730549e-07,TRUE,8,292,8,CORUM,MeCP1 complex,3383,30,CORUM:0000000,FALSE
HPA:0600223,5.61676394089424e-07,TRUE,1471,418,100,HPA,tonsil; squamous epithelial cells[High],11006,851,HPA:0600222,FALSE
TF:M11883_1,5.62288429886568e-07,TRUE,7926,556,293,TF,Factor: pax-6; motif: NYACGCNTSRNYGCNYN; match class: 1,20011,6415,TF:M11883,FALSE
GO:0035631,5.7324304041491e-07,TRUE,11,548,7,GO:CC,CD40 receptor complex,22090,1632,GO:0098802,TRUE
GO:0050679,5.83034630533627e-07,TRUE,206,553,25,GO:BP,positive regulation of epithelial cell proliferation,21010,13869,GO:0008284|GO:0050673|GO:0050678,FALSE
GO:0097447,5.84890609094859e-07,TRUE,623,548,43,GO:CC,dendritic tree,22090,3012,GO:0036477|GO:0043005,FALSE
GO:0051569,5.88737404687669e-07,TRUE,18,553,9,GO:BP,regulation of histone H3-K4 methylation,21010,14487,GO:0031060|GO:0051568,FALSE
GO:0007548,5.93716213849159e-07,TRUE,292,553,30,GO:BP,sex differentiation,21010,3082,GO:0003006,FALSE
REAC:R-HSA-3371568,5.97398521629738e-07,TRUE,14,485,9,REAC,Attenuation phase,10835,183,REAC:R-HSA-3371571,FALSE
REAC:R-HSA-198323,5.97398521629738e-07,TRUE,14,485,9,REAC,AKT phosphorylates targets in the cytosol,10835,11,REAC:R-HSA-1257604,FALSE
GO:0060420,5.99334032303814e-07,TRUE,58,553,14,GO:BP,regulation of heart growth,21010,15353,GO:0046620|GO:0060419|GO:2000026,FALSE
HPA:0630223,6.01962867729507e-07,TRUE,1035,418,78,HPA,cervix; squamous epithelial cells[High],11006,207,HPA:0630222,FALSE
HP:0003220,6.43696093091523e-07,TRUE,55,241,17,HP,Abnormality of chromosome stability,4962,2325,HP:0011017,FALSE
GO:0042921,6.60735399847591e-07,TRUE,13,553,8,GO:BP,glucocorticoid receptor signaling pathway,21010,10951,GO:0031958,FALSE
TF:M07354_1,6.61892967549188e-07,TRUE,3757,556,165,TF,Factor: Egr-1; motif: GCGGGGGCGG; match class: 1,20011,1631,TF:M07354,FALSE
HP:0004377,6.63762395740347e-07,TRUE,283,241,40,HP,Hematological neoplasm,4962,3065,HP:0001871|HP:0011793,FALSE
TF:M07208_1,6.70871897215374e-07,TRUE,2247,556,113,TF,Factor: EGR1; motif: NCNCCGCCCCCGCN; match class: 1,20011,1615,TF:M07208,FALSE
REAC:R-HSA-165159,6.77332078828802e-07,TRUE,41,485,14,REAC,MTOR signalling,10835,1325,REAC:R-HSA-162582,FALSE
TF:M09658,6.77491085043221e-07,TRUE,5419,556,218,TF,Factor: Sp2; motif: GGSNNGGGGGCGGGGCCNGNGS,20011,7868,TF:M00000,FALSE
GO:0140030,6.83740492140816e-07,TRUE,181,555,23,GO:MF,modification-dependent protein binding,20139,10485,GO:0005515,FALSE
HPA:0100121,6.8377943677374e-07,TRUE,4919,418,246,HPA,cerebral cortex; glial cells[Low],11006,186,HPA:0100000,FALSE
GO:0018210,6.89406444098868e-07,TRUE,118,553,19,GO:BP,peptidyl-threonine modification,21010,5530,GO:0018193,FALSE
WP:WP45,6.89703728204611e-07,TRUE,64,461,18,WP,G1 to S cell cycle control,8625,646,WP:000000,FALSE
GO:0045137,6.90538960718285e-07,TRUE,241,553,27,GO:BP,development of primary sexual characteristics,21010,11899,GO:0003006|GO:0007275|GO:0007548,FALSE
GO:0051053,6.95129613712957e-07,TRUE,146,553,21,GO:BP,negative regulation of DNA metabolic process,21010,14135,GO:0006259|GO:0010605|GO:0045934|GO:0051052,FALSE
TF:M11530,7.26868567690934e-07,TRUE,14927,556,475,TF,Factor: E2F-2; motif: NWTTTGGCGCCAWWNN,20011,1470,TF:M00000,FALSE
GO:0048538,7.34439072670002e-07,TRUE,49,553,13,GO:BP,thymus development,21010,13469,GO:0048534|GO:0048732,FALSE
GO:0043966,7.3767663945369e-07,TRUE,40,553,12,GO:BP,histone H3 acetylation,21010,11405,GO:0016573,FALSE
GO:0016051,7.95453834257742e-07,TRUE,209,553,25,GO:BP,carbohydrate biosynthetic process,21010,5169,GO:0005975|GO:1901576,FALSE
WP:WP2035,8.13624329658571e-07,TRUE,27,461,12,WP,Follicle stimulating hormone (FSH) signaling pathway,8625,396,WP:000000,FALSE
HPA:0300201,8.22667330161703e-07,TRUE,798,418,65,HPA,lung; endothelial cells[Low],11006,453,HPA:0300000,FALSE
GO:0008630,8.29979148046881e-07,TRUE,106,553,18,GO:BP,intrinsic apoptotic signaling pathway in response to DNA damage,21010,3273,GO:0006974|GO:0097193,FALSE
GO:0043627,8.35545600380512e-07,TRUE,70,553,15,GO:BP,response to estrogen,21010,11329,GO:0009725,FALSE
TF:M07084,8.41997988154679e-07,TRUE,11111,556,380,TF,Factor: E2F-4; motif: NGGCGGGAARN,20011,1508,TF:M00000,FALSE
TF:M08441,8.60830171291269e-07,TRUE,16667,556,513,TF,Factor: AP-2gamma:Elk-1; motif: NGCCKNRGGSGRCGGAAGTG,20011,8588,TF:M00000,FALSE
GO:0048872,8.70090795649676e-07,TRUE,315,553,31,GO:BP,homeostasis of number of cells,21010,13767,GO:0048871,FALSE
HPA:0600443,8.81194625176781e-07,TRUE,1320,418,92,HPA,tonsil; non-germinal center cells[High],11006,848,HPA:0600442,FALSE
KEGG:04066,8.82675609175906e-07,TRUE,109,431,23,KEGG,HIF-1 signaling pathway,8161,252,KEGG:00000,FALSE
GO:0003007,8.82693910245248e-07,TRUE,261,553,28,GO:BP,heart morphogenesis,21010,1472,GO:0007507|GO:0009887,FALSE
HP:0002733,8.83580613954637e-07,TRUE,250,241,37,HP,Abnormal lymph node morphology,4962,1985,HP:0100763,FALSE
WP:WP5098,8.9907630747032e-07,TRUE,88,461,21,WP,T-cell activation SARS-CoV-2,8625,820,WP:000000,FALSE
TF:M00425_1,9.05275290917954e-07,TRUE,5500,556,220,TF,Factor: E2F; motif: TTTCGCGC; match class: 1,20011,1551,TF:M00425,FALSE
HPA:0090161,9.14713713075224e-07,TRUE,5571,418,270,HPA,cerebellum; Purkinje cells[Low],11006,116,HPA:0090000,FALSE
KEGG:05130,9.22700819251666e-07,TRUE,196,431,32,KEGG,Pathogenic Escherichia coli infection,8161,420,KEGG:00000,FALSE
GO:0031588,9.25886993514418e-07,TRUE,17,548,8,GO:CC,nucleotide-activated protein kinase complex,22090,1170,GO:0140535|GO:1902911,FALSE
GO:0034502,9.28293913157349e-07,TRUE,120,553,19,GO:BP,protein localization to chromosome,21010,9069,GO:0033365,FALSE
GO:0014897,9.45031374007814e-07,TRUE,82,553,16,GO:BP,striated muscle hypertrophy,21010,4856,GO:0014896,FALSE
GO:0030674,9.60178953713255e-07,TRUE,397,555,35,GO:MF,protein-macromolecule adaptor activity,20139,4013,GO:0060090,FALSE
GO:1903747,9.68858869846758e-07,TRUE,50,553,13,GO:BP,regulation of establishment of protein localization to mitochondrion,21010,24211,GO:0070201|GO:0072655,FALSE
GO:0046545,9.73814505215718e-07,TRUE,107,553,18,GO:BP,development of primary female sexual characteristics,21010,12855,GO:0045137|GO:0046660,FALSE
HPA:0150051,9.75634473098417e-07,TRUE,7099,418,324,HPA,duodenum; glandular cells[Low],11006,272,HPA:0150000,FALSE
GO:2001244,9.76574934907245e-07,TRUE,60,553,14,GO:BP,positive regulation of intrinsic apoptotic signaling pathway,21010,27530,GO:0097193|GO:1902533|GO:2001235|GO:2001242,FALSE
GO:0032787,9.77190015209958e-07,TRUE,625,553,46,GO:BP,monocarboxylic acid metabolic process,21010,8193,GO:0019752,FALSE
GO:0051879,9.81434771810341e-07,TRUE,44,555,12,GO:MF,Hsp90 protein binding,20139,8115,GO:0031072,TRUE
HP:0001159,9.93778973256926e-07,TRUE,401,241,49,HP,Syndactyly,4962,905,HP:0011297,FALSE
GO:0043130,9.94260684365761e-07,TRUE,99,555,17,GO:MF,ubiquitin binding,20139,5748,GO:0032182,FALSE
GO:0035861,1.00467236314641e-06,TRUE,86,548,15,GO:CC,site of double-strand break,22090,1654,GO:0090734,FALSE
GO:0045930,1.00774889820695e-06,TRUE,228,553,26,GO:BP,negative regulation of mitotic cell cycle,21010,12341,GO:0000278|GO:0007346|GO:0045786,FALSE
HP:0000008,1.00794827558777e-06,TRUE,455,241,53,HP,Abnormal morphology of female internal genitalia,4962,7,HP:0000812|HP:0010460,FALSE
GO:0050890,1.01815082077419e-06,TRUE,317,553,31,GO:BP,cognition,21010,13999,GO:0050877,FALSE
GO:2000756,1.01819341851929e-06,TRUE,41,553,12,GO:BP,regulation of peptidyl-lysine acetylation,21010,27107,GO:0018394|GO:1901983,FALSE
HP:0000953,1.0263702958346e-06,TRUE,324,241,43,HP,Hyperpigmentation of the skin,4962,744,HP:0001000,FALSE
HPA:0150052,1.02728061531013e-06,TRUE,6098,418,289,HPA,duodenum; glandular cells[Medium],11006,273,HPA:0150051,FALSE
GO:0007004,1.03398623509584e-06,TRUE,71,553,15,GO:BP,telomere maintenance via telomerase,21010,2659,GO:0006278|GO:0010833,FALSE
GO:0032481,1.03398623509584e-06,TRUE,71,553,15,GO:BP,positive regulation of type I interferon production,21010,7956,GO:0001819|GO:0032479|GO:0032606,FALSE
WP:WP23,1.06680507182581e-06,TRUE,97,461,22,WP,B cell receptor signaling pathway,8625,570,WP:000000,FALSE
GO:0042633,1.07466451625922e-06,TRUE,121,553,19,GO:BP,hair cycle,21010,10769,GO:0042303,FALSE
GO:0042303,1.07466451625922e-06,TRUE,121,553,19,GO:BP,molting cycle,21010,10576,GO:0032501,FALSE
WP:WP422,1.08916411192307e-06,TRUE,33,461,13,WP,MAPK cascade,8625,567,WP:000000,FALSE
GO:0036003,1.09257023872834e-06,TRUE,19,553,9,GO:BP,positive regulation of transcription from RNA polymerase II promoter in response to stress,21010,9836,GO:0043618|GO:0045944,FALSE
GO:1904505,1.09257023872834e-06,TRUE,19,553,9,GO:BP,regulation of telomere maintenance in response to DNA damage,21010,24860,GO:0032204|GO:0043247|GO:0080135,FALSE
TF:M10026_1,1.09697767663851e-06,TRUE,5060,556,206,TF,Factor: PATZ; motif: GGGGNGGGGGMKGGRRNGGNRN; match class: 1,20011,6319,TF:M10026,FALSE
TF:M00740,1.104220896017e-06,TRUE,10677,556,368,TF,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC,20011,1422,TF:M00000,FALSE
GO:0046330,1.10551122126216e-06,TRUE,95,553,17,GO:BP,positive regulation of JNK cascade,21010,12681,GO:0007254|GO:0032874|GO:0046328,FALSE
GO:2000146,1.14568740304403e-06,TRUE,300,553,30,GO:BP,negative regulation of cell motility,21010,26561,GO:0040013|GO:0048523|GO:0048870|GO:2000145,FALSE
GO:0070182,1.14685690549939e-06,TRUE,21,555,9,GO:MF,DNA polymerase binding,20139,8689,GO:0019899,FALSE
GO:0120161,1.1600481983074e-06,TRUE,150,553,21,GO:BP,regulation of cold-induced thermogenesis,21010,20448,GO:0019222|GO:0051239|GO:0106106,FALSE
WP:WP5039,1.1870387973293e-06,TRUE,66,461,18,WP,SARS-CoV-2 innate immunity evasion and cell-specific immune response,8625,357,WP:000000,FALSE
HPA:0500652,1.18913979607153e-06,TRUE,2722,418,156,HPA,soft tissue 1; fibroblasts[Medium],11006,756,HPA:0500651,FALSE
WP:WP437,1.19352776749349e-06,TRUE,161,461,29,WP,EGF/EGFR signaling pathway,8625,580,WP:000000,FALSE
TF:M00800_1,1.21263152135441e-06,TRUE,4371,556,184,TF,Factor: AP-2; motif: GSCCSCRGGCNRNRNN; match class: 1,20011,151,TF:M00800,FALSE
GO:0048878,1.22673014698219e-06,TRUE,1008,553,62,GO:BP,chemical homeostasis,21010,13771,GO:0042592,FALSE
TF:M03876_1,1.25035336046591e-06,TRUE,9325,556,331,TF,Factor: Kaiso; motif: GCMGGGRGCRGS; match class: 1,20011,4525,TF:M03876,FALSE
REAC:R-HSA-9615017,1.27284234029074e-06,TRUE,30,485,12,REAC,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",10835,884,REAC:R-HSA-9614085,FALSE
GO:0006513,1.27481569930117e-06,TRUE,72,553,15,GO:BP,protein monoubiquitination,21010,2273,GO:0016567,FALSE
GO:0006278,1.27481569930117e-06,TRUE,72,553,15,GO:BP,RNA-templated DNA biosynthetic process,21010,2123,GO:0071897,FALSE
TF:M12345,1.29652292022763e-06,TRUE,5814,556,229,TF,Factor: Zbtb37; motif: NYACCGCRNTCACCGCR,20011,9130,TF:M00000,FALSE
GO:0106106,1.31489824774646e-06,TRUE,151,553,21,GO:BP,cold-induced thermogenesis,21010,20160,GO:0001659|GO:1990845,FALSE
GO:0043405,1.37522787205163e-06,TRUE,182,553,23,GO:BP,regulation of MAP kinase activity,21010,11184,GO:0071900,FALSE
GO:0030336,1.37524342382747e-06,TRUE,284,553,29,GO:BP,negative regulation of cell migration,21010,7097,GO:0016477|GO:0030334|GO:2000146,FALSE
GO:0010833,1.37759956623985e-06,TRUE,84,553,16,GO:BP,telomere maintenance via telomere lengthening,21010,4524,GO:0000723,FALSE
GO:0014896,1.37759956623985e-06,TRUE,84,553,16,GO:BP,muscle hypertrophy,21010,4855,GO:0003012,FALSE
HPA:0540000,1.38070063535193e-06,TRUE,7656,418,342,HPA,stomach 1,11006,782,HPA:0000000,FALSE
HPA:0540051,1.38070063535193e-06,TRUE,7656,418,342,HPA,stomach 1; glandular cells[Low],11006,783,HPA:0540000,FALSE
WP:WP262,1.40832086108726e-06,TRUE,23,461,11,WP,Ebstein-Barr virus LMP1 signaling,8625,112,WP:000000,FALSE
GO:0048660,1.4175681183033e-06,TRUE,137,553,20,GO:BP,regulation of smooth muscle cell proliferation,21010,13570,GO:0042127|GO:0048659,FALSE
HP:0000812,1.42363147550425e-06,TRUE,515,241,57,HP,Abnormal internal genitalia,4962,631,HP:0012243,FALSE
REAC:R-HSA-111447,1.43449645220262e-06,TRUE,15,485,9,REAC,Activation of BAD and translocation to mitochondria ,10835,73,REAC:R-HSA-114452,FALSE
GO:0071222,1.4552878054412e-06,TRUE,215,553,25,GO:BP,cellular response to lipopolysaccharide,21010,17292,GO:0032496|GO:0071219|GO:0071396|GO:1901701,FALSE
HPA:0100000,1.47856395810294e-06,TRUE,8096,418,356,HPA,cerebral cortex,11006,182,HPA:0000000,FALSE
TF:M01175,1.47994794896755e-06,TRUE,7468,556,278,TF,Factor: CKROX; motif: SCCCTCCCC,20011,852,TF:M00000,FALSE
HPA:0301372,1.48773192106586e-06,TRUE,1233,418,87,HPA,lung; alveolar cells type II[Medium],11006,451,HPA:0301371,FALSE
GO:0030856,1.48883718131209e-06,TRUE,152,553,21,GO:BP,regulation of epithelial cell differentiation,21010,7256,GO:0030855|GO:0045595|GO:2000026,FALSE
GO:0031958,1.5061991090882e-06,TRUE,14,553,8,GO:BP,corticosteroid receptor signaling pathway,21010,7654,GO:0030518,FALSE
GO:0043984,1.5061991090882e-06,TRUE,14,553,8,GO:BP,histone H4-K16 acetylation,21010,11420,GO:0043967,FALSE
GO:0055017,1.56609464520779e-06,TRUE,73,553,15,GO:BP,cardiac muscle tissue growth,21010,14935,GO:0048589|GO:0048738|GO:0060419,FALSE
GO:2000573,1.56609464520779e-06,TRUE,73,553,15,GO:BP,positive regulation of DNA biosynthetic process,21010,26957,GO:0010557|GO:0051054|GO:0071897|GO:2000278,FALSE
GO:0019209,1.75534287186311e-06,TRUE,144,555,20,GO:MF,kinase activator activity,20139,3677,GO:0008047|GO:0019207,FALSE
TF:M09636_1,1.76586052624069e-06,TRUE,14426,556,462,TF,Factor: MAZ; motif: GGGMGGGGSSGGGGGGGGGGGG; match class: 1,20011,4993,TF:M09636,FALSE
TF:M07380_1,1.77288223418918e-06,TRUE,8209,556,299,TF,Factor: E2F-4; motif: NTTTCSCGCC; match class: 1,20011,1517,TF:M07380,FALSE
HPA:0270353,1.81770003139535e-06,TRUE,851,418,67,HPA,kidney; cells in glomeruli[High],11006,413,HPA:0270352,FALSE
MIRNA:hsa-miR-155-5p,1.82504484435344e-06,TRUE,922,514,68,MIRNA,hsa-miR-155-5p,14846,295,MIRNA:000000,FALSE
GO:2001237,1.8320125889774e-06,TRUE,98,553,17,GO:BP,negative regulation of extrinsic apoptotic signaling pathway,21010,27523,GO:0097191|GO:2001234|GO:2001236,FALSE
GO:0033135,1.84413785966149e-06,TRUE,139,553,20,GO:BP,regulation of peptidyl-serine phosphorylation,21010,8424,GO:0001932|GO:0018105,FALSE
TF:M07289_1,1.84648682323722e-06,TRUE,10824,556,371,TF,Factor: GKLF; motif: NNNRGGNGNGGSN; match class: 1,20011,3169,TF:M07289,FALSE
HPA:0570802,1.86280465264983e-06,TRUE,1693,418,109,HPA,testis; sertoli cells[Medium],11006,826,HPA:0570801,FALSE
GO:0071322,1.90283037333421e-06,TRUE,154,553,21,GO:BP,cellular response to carbohydrate stimulus,21010,17388,GO:0009743|GO:0071310|GO:1901701,FALSE
HPA:0050091,1.98134002339281e-06,TRUE,5660,418,272,HPA,breast; myoepithelial cells[Low],11006,61,HPA:0050000,FALSE
REAC:R-HSA-4641262,1.99323084105735e-06,TRUE,31,485,12,REAC,Disassembly of the destruction complex and recruitment of AXIN to the membrane,10835,713,REAC:R-HSA-201681,FALSE
MIRNA:hsa-miR-18a-5p,2.02530383901772e-06,TRUE,263,514,31,MIRNA,hsa-miR-18a-5p,14846,333,MIRNA:000000,FALSE
TF:M04110_1,2.03013461046984e-06,TRUE,3842,556,166,TF,Factor: RUNX3; motif: NRACCGCANWAACCRCAN; match class: 1,20011,7369,TF:M04110,FALSE
TF:M00189,2.09140432490509e-06,TRUE,10870,556,372,TF,Factor: AP-2; motif: MKCCCSCNGGCG,20011,154,TF:M00000,FALSE
GO:0140677,2.10378108175303e-06,TRUE,1188,555,69,GO:MF,molecular function activator activity,20139,10669,GO:0098772,TRUE
WP:WP384,2.13490601179873e-06,TRUE,19,461,10,WP,Apoptosis modulation by HSP70,8625,164,WP:000000,FALSE
WP:WP734,2.13490601179873e-06,TRUE,19,461,10,WP,Serotonin receptor 4/6/7 and NR3C signaling,8625,812,WP:000000,FALSE
GO:0043255,2.15865695438526e-06,TRUE,99,553,17,GO:BP,regulation of carbohydrate biosynthetic process,21010,11098,GO:0006109|GO:0009889|GO:0016051,FALSE
TF:M00430_1,2.17455652089492e-06,TRUE,2574,556,123,TF,Factor: E2F-1; motif: NTTSGCGG; match class: 1,20011,1451,TF:M00430,FALSE
GO:0010614,2.18449860068856e-06,TRUE,27,553,10,GO:BP,negative regulation of cardiac muscle hypertrophy,21010,4333,GO:0003300|GO:0010611|GO:0014741,FALSE
GO:0009648,2.18449860068856e-06,TRUE,27,553,10,GO:BP,photoperiodism,21010,3623,GO:0009416,TRUE
GO:0060544,2.18449860068856e-06,TRUE,27,553,10,GO:BP,regulation of necroptotic process,21010,15470,GO:0062098|GO:0070266,FALSE
GO:2000737,2.18449860068856e-06,TRUE,27,553,10,GO:BP,negative regulation of stem cell differentiation,21010,27090,GO:0045596|GO:0048863|GO:2000736,FALSE
TF:M08878_1,2.18883564442384e-06,TRUE,3303,556,148,TF,Factor: EGR; motif: CGCCCCCGCNN; match class: 1,20011,1671,TF:M08878,FALSE
WP:WP4905,2.20149181814209e-06,TRUE,29,461,12,WP,1q21.1 copy number variation syndrome,8625,834,WP:000000,FALSE
WP:WP395,2.27149902702856e-06,TRUE,54,461,16,WP,IL-4 signaling pathway,8625,327,WP:000000,FALSE
GO:0010822,2.33916791763373e-06,TRUE,75,553,15,GO:BP,positive regulation of mitochondrion organization,21010,4513,GO:0007005|GO:0010638|GO:0010821,FALSE
HPA:0460672,2.33999134807658e-06,TRUE,3703,418,196,HPA,skin 1; melanocytes[Medium],11006,668,HPA:0460671,FALSE
KEGG:05140,2.35219283074642e-06,TRUE,72,431,18,KEGG,Leishmaniasis,8161,426,KEGG:00000,FALSE
GO:0046889,2.37527258826164e-06,TRUE,87,553,16,GO:BP,positive regulation of lipid biosynthetic process,21010,13057,GO:0008610|GO:0009891|GO:0045834|GO:0046890,FALSE
REAC:R-HSA-8878159,2.37984856684564e-06,TRUE,94,485,20,REAC,Transcriptional regulation by RUNX3,10835,2438,REAC:R-HSA-212436,FALSE
GO:0048659,2.38758962921235e-06,TRUE,141,553,20,GO:BP,smooth muscle cell proliferation,21010,13569,GO:0033002,FALSE
GO:1902749,2.44587029463268e-06,TRUE,113,553,18,GO:BP,regulation of cell cycle G2/M phase transition,21010,23386,GO:0044839|GO:1901987,FALSE
CORUM:1257,2.45412621850787e-06,TRUE,28,292,14,CORUM,ALL-1 supercomplex,3383,714,CORUM:0000000,FALSE
GO:0061418,2.48541807386556e-06,TRUE,10,553,7,GO:BP,regulation of transcription from RNA polymerase II promoter in response to hypoxia,21010,16245,GO:0043618|GO:0071456,FALSE
GO:0034660,2.50624645114837e-06,TRUE,621,553,45,GO:BP,ncRNA metabolic process,21010,9116,GO:0016070,FALSE
GO:0042542,2.53828220239467e-06,TRUE,100,553,17,GO:BP,response to hydrogen peroxide,21010,10736,GO:0000302|GO:0010033|GO:0010035,FALSE
WP:WP5182,2.55754795660148e-06,TRUE,15,461,9,WP,Pro-survival signaling of neuroprotectin D1,8625,645,WP:000000,FALSE
WP:WP4946,2.5683287693908e-06,TRUE,119,461,24,WP,"DNA repair pathways, full network",8625,451,WP:000000,FALSE
REAC:R-HSA-5693571,2.58841605303365e-06,TRUE,68,485,17,REAC,Nonhomologous End-Joining (NHEJ),10835,1527,REAC:R-HSA-5693532,FALSE
GO:0002440,2.60471733086132e-06,TRUE,221,553,25,GO:BP,production of molecular mediator of immune response,21010,977,GO:0002376|GO:0010467,FALSE
GO:0048608,2.72247239510423e-06,TRUE,311,553,30,GO:BP,reproductive structure development,21010,13521,GO:0003006|GO:0048856|GO:0061458,FALSE
TF:M11018_1,2.8285072534095e-06,TRUE,16260,556,503,TF,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN; match class: 1,20011,4375,TF:M11018,FALSE
GO:0032355,2.83455848468257e-06,TRUE,114,553,18,GO:BP,response to estradiol,21010,7878,GO:0014070|GO:0033993|GO:1901700,FALSE
GO:0043502,2.84461241619214e-06,TRUE,76,553,15,GO:BP,regulation of muscle adaptation,21010,11252,GO:0043500|GO:0048583|GO:0090257,FALSE
CORUM:6344,2.8593280282765e-06,TRUE,14,292,10,CORUM,TNF-R1-associated signaling complex,3383,2065,CORUM:0000000,FALSE
REAC:R-HSA-5693565,2.90988530310494e-06,TRUE,77,485,18,REAC,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,10835,1865,REAC:R-HSA-5693606,FALSE
GO:0010389,2.97863227429823e-06,TRUE,101,553,17,GO:BP,regulation of G2/M transition of mitotic cell cycle,21010,4161,GO:0000086|GO:1901990|GO:1902749,FALSE
GO:0043254,2.98242763379561e-06,TRUE,410,553,35,GO:BP,regulation of protein-containing complex assembly,21010,11097,GO:0044087|GO:0051128|GO:0065003,FALSE
TF:M08526,2.99024426889369e-06,TRUE,17176,556,522,TF,Factor: E2F-3:HES-7; motif: NNNSGCGCSNNNNNCRCGYGNN,20011,1482,TF:M00000,FALSE
GO:0033558,3.03514797348187e-06,TRUE,23,555,9,GO:MF,protein lysine deacetylase activity,20139,4630,GO:0019213|GO:0140096,FALSE
TF:M04106,3.07903041276923e-06,TRUE,14085,556,453,TF,Factor: RUNX2; motif: NRACCGCAAACCGCAN,20011,7352,TF:M00000,FALSE
TF:M00736_1,3.10145564525668e-06,TRUE,4767,556,195,TF,Factor: E2F-1:DP-1; motif: TTTCSCGC; match class: 1,20011,1425,TF:M00736,FALSE
MIRNA:hsa-miR-27a-3p,3.1884354852442e-06,TRUE,429,514,41,MIRNA,hsa-miR-27a-3p,14846,485,MIRNA:000000,FALSE
TF:M01118,3.24873565277087e-06,TRUE,7005,556,263,TF,Factor: WT1; motif: SMCNCCNSC,20011,8984,TF:M00000,FALSE
HP:0031105,3.27325266861817e-06,TRUE,140,241,26,HP,Abnormal uterus morphology,4962,11180,HP:0000130,FALSE
GO:0043406,3.27967161593201e-06,TRUE,115,553,18,GO:BP,positive regulation of MAP kinase activity,21010,11185,GO:0043405|GO:0043410|GO:0071902,FALSE
TF:M12160_1,3.31219913072452e-06,TRUE,8250,556,299,TF,Factor: KLF15; motif: RCCMCRCCCMCN; match class: 1,20011,4551,TF:M12160,FALSE
GO:0033144,3.31395479233309e-06,TRUE,36,553,11,GO:BP,negative regulation of intracellular steroid hormone receptor signaling pathway,21010,8431,GO:0009968|GO:0030518|GO:0033143,FALSE
KEGG:04150,3.46159455346244e-06,TRUE,155,431,27,KEGG,mTOR signaling pathway,8161,278,KEGG:00000,FALSE
WP:WP4923,3.49322302327598e-06,TRUE,30,461,12,WP,Autophagy,8625,762,WP:000000,FALSE
WP:WP2870,3.49322302327598e-06,TRUE,30,461,12,WP,Extracellular vesicle-mediated signaling in recipient cells,8625,219,WP:000000,FALSE
WP:WP49,3.50480260341963e-06,TRUE,42,461,14,WP,IL-2 signaling pathway,8625,520,WP:000000,FALSE
GO:0044283,3.52211376560685e-06,TRUE,583,553,43,GO:BP,small molecule biosynthetic process,21010,11508,GO:0009058|GO:0044281,FALSE
HPA:0400052,3.56277443856428e-06,TRUE,6099,418,287,HPA,rectum; glandular cells[Medium],11006,563,HPA:0400051,FALSE
TF:M12697_1,3.57611612699719e-06,TRUE,1000,556,63,TF,Factor: ZNF142; motif: SNSCGCCCGCCCGCSCSS; match class: 1,20011,9503,TF:M12697,FALSE
GO:0140678,3.58972675438353e-06,TRUE,521,555,40,GO:MF,molecular function inhibitor activity,20139,10670,GO:0098772,FALSE
HP:0004209,3.62039749503868e-06,TRUE,376,241,46,HP,Clinodactyly of the 5th finger,4962,2923,HP:0009179|HP:0040019,FALSE
REAC:R-HSA-5693606,3.62855915446261e-06,TRUE,78,485,18,REAC,DNA Double Strand Break Response,10835,425,REAC:R-HSA-5693532,FALSE
HPA:0480051,3.67701676950026e-06,TRUE,7070,418,321,HPA,small intestine; glandular cells[Low],11006,738,HPA:0480000,FALSE
GO:0061458,3.69081061986678e-06,TRUE,315,553,30,GO:BP,reproductive system development,21010,16275,GO:0048731,FALSE
TF:M00427,3.70389373845089e-06,TRUE,9761,556,341,TF,Factor: E2F; motif: TTTSGCGS,20011,1562,TF:M00000,FALSE
TF:M12648,3.73252647652906e-06,TRUE,4243,556,178,TF,Factor: PATZ1; motif: SCNCCNCNSCCCCCASCCN,20011,6320,TF:M00000,FALSE
TF:M04863,3.73925555444522e-06,TRUE,13891,556,448,TF,Factor: TF3C-beta; motif: CCNGGAGGGCTTCCTGGAGGAG,20011,3302,TF:M00000,FALSE
GO:0045814,3.7886244879244e-06,TRUE,116,553,18,GO:BP,"negative regulation of gene expression, epigenetic",21010,12251,GO:0010629|GO:0040029,FALSE
GO:0071219,3.79560427696846e-06,TRUE,225,553,25,GO:BP,cellular response to molecule of bacterial origin,21010,17289,GO:0002237|GO:0071216,FALSE
KEGG:04215,3.87345122819103e-06,TRUE,32,431,12,KEGG,Apoptosis - multiple species,8161,286,KEGG:00000,FALSE
GO:1903530,3.93398868512594e-06,TRUE,563,553,42,GO:BP,regulation of secretion by cell,21010,24022,GO:0032940|GO:0050794|GO:0051046,FALSE
GO:0040013,3.94719513472958e-06,TRUE,335,553,31,GO:BP,negative regulation of locomotion,21010,10393,GO:0040011|GO:0040012|GO:0048519,FALSE
HP:0009179,3.95383655356441e-06,TRUE,377,241,46,HP,Deviation of the 5th finger,4962,5721,HP:0004097|HP:0004207,FALSE
GO:0034644,4.00227134509449e-06,TRUE,90,553,16,GO:BP,cellular response to UV,21010,9108,GO:0009411|GO:0071482,FALSE
HPA:0010013,4.01771001300086e-06,TRUE,460,418,44,HPA,adipose tissue; adipocytes[High],11006,5,HPA:0010012,FALSE
TF:M01175_1,4.16347248545327e-06,TRUE,2745,556,128,TF,Factor: CKROX; motif: SCCCTCCCC; match class: 1,20011,853,TF:M01175,FALSE
REAC:R-HSA-5693607,4.23233511485785e-06,TRUE,97,485,20,REAC,Processing of DNA double-strand break ends,10835,1717,REAC:R-HSA-5693567,FALSE
HPA:0270361,4.24427772966373e-06,TRUE,7018,418,319,HPA,kidney; cells in tubules[Low],11006,414,HPA:0270000,FALSE
HPA:0460661,4.29307720258196e-06,TRUE,5159,418,252,HPA,skin 1; keratinocytes[Low],11006,658,HPA:0460000,FALSE
GO:0045912,4.46565237168349e-06,TRUE,56,553,13,GO:BP,negative regulation of carbohydrate metabolic process,21010,12323,GO:0005975|GO:0006109|GO:0009892,FALSE
TF:M09898_1,4.49392535445124e-06,TRUE,2633,556,124,TF,Factor: Egr-2; motif: GNGRRNGWGKGGGNGGRG; match class: 1,20011,1641,TF:M09898,FALSE
TF:M01858,4.53949661137282e-06,TRUE,7609,556,280,TF,Factor: AP-2beta; motif: GCNNNGGSCNGVGGGN,20011,136,TF:M00000,FALSE
KEGG:04664,4.59711152687567e-06,TRUE,67,431,17,KEGG,Fc epsilon RI signaling pathway,8161,334,KEGG:00000,FALSE
CORUM:649,4.62224908303486e-06,TRUE,9,292,8,CORUM,HDAC1-associated core complex cII,3383,361,CORUM:0000000,FALSE
GO:0035019,4.65227529478101e-06,TRUE,67,553,14,GO:BP,somatic stem cell population maintenance,21010,9178,GO:0019827,FALSE
HPA:0100131,4.66837387445754e-06,TRUE,6704,418,308,HPA,cerebral cortex; neuronal cells[Low],11006,189,HPA:0100000,FALSE
WP:WP4172,4.75069570824207e-06,TRUE,336,461,44,WP,PI3K-Akt signaling pathway,8625,801,WP:000000,FALSE
TF:M00649_1,4.77129710359969e-06,TRUE,4256,556,178,TF,Factor: MAZ; motif: GGGGAGGG; match class: 1,20011,5003,TF:M00649,FALSE
GO:0043410,4.78539816334146e-06,TRUE,480,553,38,GO:BP,positive regulation of MAPK cascade,21010,11189,GO:0000165|GO:0043408|GO:1902533,FALSE
REAC:R-HSA-5693538,4.87636186432653e-06,TRUE,138,485,24,REAC,Homology Directed Repair,10835,1078,REAC:R-HSA-5693532,FALSE
GO:0001837,4.87986175938291e-06,TRUE,162,553,21,GO:BP,epithelial to mesenchymal transition,21010,504,GO:0048762,FALSE
GO:0070555,4.89180366169858e-06,TRUE,132,553,19,GO:BP,response to interleukin-1,21010,16977,GO:0034097,FALSE
GO:0014741,4.94629571959292e-06,TRUE,29,553,10,GO:BP,negative regulation of muscle hypertrophy,21010,4761,GO:0014743|GO:0014896|GO:0051241,FALSE
GO:0051099,5.00770754847506e-06,TRUE,178,553,22,GO:BP,positive regulation of binding,21010,14166,GO:0044093|GO:0051098,FALSE
GO:0001501,5.07906032326309e-06,TRUE,524,553,40,GO:BP,skeletal system development,21010,327,GO:0048731,FALSE
REAC:R-HSA-73762,5.12447846843196e-06,TRUE,47,485,14,REAC,RNA Polymerase I Transcription Initiation,10835,1802,REAC:R-HSA-73854,FALSE
HP:0000568,5.19816353737818e-06,TRUE,278,241,38,HP,Microphthalmia,4962,438,HP:0008056|HP:0100887,FALSE
WP:WP3849,5.31022435324484e-06,TRUE,12,461,8,WP,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ,8625,474,WP:000000,FALSE
TF:M11022_1,5.43801987889227e-06,TRUE,6397,556,244,TF,Factor: IRX2a; motif: ACRYGNNNNACRYGT; match class: 1,20011,4385,TF:M11022,FALSE
WP:WP34,5.55748049679552e-06,TRUE,37,461,13,WP,Ovarian infertility,8625,425,WP:000000,FALSE
TF:M12313_1,5.59492315223389e-06,TRUE,2273,556,111,TF,Factor: ZNF460; motif: NNACNCCCCCCNN; match class: 1,20011,10345,TF:M12313,FALSE
GO:0014074,5.68886677562859e-06,TRUE,148,553,20,GO:BP,response to purine-containing compound,21010,4723,GO:0010243|GO:0014070,FALSE
HP:0040019,5.70395274137847e-06,TRUE,408,241,48,HP,Finger clinodactyly,4962,15026,HP:0004097|HP:0030084,FALSE
GO:0045931,5.78629319162188e-06,TRUE,119,553,18,GO:BP,positive regulation of mitotic cell cycle,21010,12342,GO:0000278|GO:0007346|GO:0045787,FALSE
GO:0051101,5.78629319162188e-06,TRUE,119,553,18,GO:BP,regulation of DNA binding,21010,14168,GO:0051098,FALSE
REAC:R-HSA-9679191,5.86100614366834e-06,TRUE,150,485,25,REAC,Potential therapeutics for SARS,10835,1701,REAC:R-HSA-9679506,FALSE
TF:M01253,5.97148078037631e-06,TRUE,3713,556,160,TF,Factor: CNOT3; motif: GGCCGCGSSS,20011,912,TF:M00000,FALSE
GO:0008047,6.00022211643503e-06,TRUE,618,555,44,GO:MF,enzyme activator activity,20139,1535,GO:0030234|GO:0140677,FALSE
GO:0051046,6.0377004240882e-06,TRUE,616,553,44,GO:BP,regulation of secretion,21010,14128,GO:0046903|GO:0051049,FALSE
GO:0060759,6.11767097510023e-06,TRUE,164,553,21,GO:BP,regulation of response to cytokine stimulus,21010,15666,GO:0034097|GO:0048583,FALSE
HPA:0290000,6.17318319498121e-06,TRUE,6292,418,293,HPA,liver,11006,436,HPA:0000000,FALSE
TF:M11541,6.18888529132558e-06,TRUE,5973,556,231,TF,Factor: Foxn2; motif: NNGCGTCNNNNNGACGCNN,20011,2706,TF:M00000,FALSE
GO:0034212,6.19640769917341e-06,TRUE,51,555,12,GO:MF,peptide N-acetyltransferase activity,20139,4966,GO:0008080,FALSE
GO:0043073,6.20559077580101e-06,TRUE,71,548,13,GO:CC,germ cell nucleus,22090,1856,GO:0005634,FALSE
GO:0045926,6.21974330422069e-06,TRUE,248,553,26,GO:BP,negative regulation of growth,21010,12337,GO:0040007|GO:0040008|GO:0048519,FALSE
REAC:R-HSA-9613354,6.24627464049595e-06,TRUE,9,485,7,REAC,Lipophagy,10835,1264,REAC:R-HSA-9663891,FALSE
GO:0003008,6.2895356333682e-06,TRUE,2266,553,106,GO:BP,system process,21010,1473,GO:0032501,FALSE
GO:1903052,6.33339552005593e-06,TRUE,134,553,19,GO:BP,positive regulation of proteolysis involved in protein catabolic process,21010,23656,GO:0045862|GO:0051603|GO:1903050,FALSE
TF:M12598_1,6.34911807461715e-06,TRUE,7116,556,265,TF,Factor: E2F3; motif: NNRGMKGGAR; match class: 1,20011,1495,TF:M12598,FALSE
REAC:R-HSA-450321,6.37364862850401e-06,TRUE,22,485,10,REAC,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,10835,1226,REAC:R-HSA-450294,FALSE
REAC:R-HSA-198753,6.37364862850401e-06,TRUE,22,485,10,REAC,ERK/MAPK targets,10835,794,REAC:R-HSA-198725|REAC:R-HSA-450282,FALSE
REAC:R-HSA-937041,6.37364862850401e-06,TRUE,22,485,10,REAC,IKK complex recruitment mediated by RIP1,10835,1093,REAC:R-HSA-937061,FALSE
CORUM:61,6.575548973931e-06,TRUE,7,292,7,CORUM,Mi2/NuRD complex,3383,29,CORUM:0000000,FALSE
CORUM:1505,6.575548973931e-06,TRUE,7,292,7,CORUM,NCOR2 complex,3383,767,CORUM:0000000,FALSE
GO:0019217,6.60121400858469e-06,TRUE,93,553,16,GO:BP,regulation of fatty acid metabolic process,21010,5850,GO:0006631|GO:0010565|GO:0019216,FALSE
GO:0009617,6.63053064844502e-06,TRUE,710,553,48,GO:BP,response to bacterium,21010,3600,GO:0051707,FALSE
HPA:0320103,6.74210054698742e-06,TRUE,1797,418,112,HPA,nasopharynx; respiratory epithelial cells[High],11006,487,HPA:0320102,FALSE
GO:0044853,6.78687588069291e-06,TRUE,113,548,16,GO:CC,plasma membrane raft,22090,2127,GO:0045121|GO:0098590,FALSE
TF:M12703,6.80482336662674e-06,TRUE,9295,556,327,TF,Factor: ZNF383; motif: SSNGGGMGGNGSNGGS,20011,10110,TF:M00000,FALSE
REAC:R-HSA-4791275,6.84816469212058e-06,TRUE,34,485,12,REAC,Signaling by WNT in cancer,10835,2205,REAC:R-HSA-5663202,FALSE
GO:0051649,6.90966488259896e-06,TRUE,2388,553,110,GO:BP,establishment of localization in cell,21010,14558,GO:0051234|GO:0051641,FALSE
GO:0002224,7.00303634759975e-06,TRUE,69,553,14,GO:BP,toll-like receptor signaling pathway,21010,772,GO:0002221,FALSE
TF:M01219_1,7.15009057642264e-06,TRUE,3032,556,137,TF,Factor: SP1:SP3; motif: CCSCCCCCYCC; match class: 1,20011,7821,TF:M01219,FALSE
GO:0031929,7.19316298544036e-06,TRUE,135,553,19,GO:BP,TOR signaling,21010,7640,GO:0035556,FALSE
GO:0071276,7.245580657873e-06,TRUE,30,553,10,GO:BP,cellular response to cadmium ion,21010,17342,GO:0046686|GO:0071248,FALSE
HPA:0420052,7.28143778727386e-06,TRUE,4868,418,240,HPA,salivary gland; glandular cells[Medium],11006,601,HPA:0420051,FALSE
GO:0005739,7.31273636325088e-06,TRUE,1672,548,79,GO:CC,mitochondrion,22090,310,GO:0005737|GO:0043231,FALSE
TF:M12461,7.34577054281731e-06,TRUE,2945,556,134,TF,Factor: ZBTB14; motif: SSCCGCGCACNS,20011,9094,TF:M00000,FALSE
HPA:0080000,7.3511610510044e-06,TRUE,6956,418,316,HPA,caudate,11006,90,HPA:0000000,FALSE
KEGG:05031,7.37348269796757e-06,TRUE,69,431,17,KEGG,Amphetamine addiction,8161,412,KEGG:00000,FALSE
WP:WP4970,7.39631777312594e-06,TRUE,21,461,10,WP,Galanin receptor pathway,8625,466,WP:000000,FALSE
GO:0033138,7.47197630797649e-06,TRUE,107,553,17,GO:BP,positive regulation of peptidyl-serine phosphorylation,21010,8426,GO:0001934|GO:0018105|GO:0033135,FALSE
GO:1901655,7.47197630797649e-06,TRUE,107,553,17,GO:BP,cellular response to ketone,21010,22497,GO:1901654|GO:1901701,FALSE
REAC:R-HSA-5617472,7.50234161779632e-06,TRUE,120,485,22,REAC,Activation of anterior HOX genes in hindbrain development during early embryogenesis,10835,96,REAC:R-HSA-5619507,FALSE
REAC:R-HSA-5619507,7.50234161779632e-06,TRUE,120,485,22,REAC,Activation of HOX genes during differentiation,10835,81,REAC:R-HSA-1266738,FALSE
TF:M03895,7.58875979535857e-06,TRUE,9447,556,331,TF,Factor: CTCF; motif: WGCGCCMYCTAGYGGYN,20011,1132,TF:M00000,FALSE
GO:0051146,7.67222535923048e-06,TRUE,287,553,28,GO:BP,striated muscle cell differentiation,21010,14203,GO:0042692,FALSE
TF:M01240,7.67757981499586e-06,TRUE,16835,556,514,TF,Factor: BEN; motif: CAGCGRNV,20011,502,TF:M00000,FALSE
GO:0002020,8.17027259112655e-06,TRUE,142,555,19,GO:MF,protease binding,20139,288,GO:0019899,FALSE
HPA:0030072,8.22664933746757e-06,TRUE,2983,418,164,HPA,appendix; lymphoid tissue[Medium],11006,45,HPA:0030071,FALSE
WP:WP3414,8.26590807496458e-06,TRUE,32,461,12,WP,Initiation of transcription and translation elongation at the HIV-1 LTR,8625,126,WP:000000,FALSE
WP:WP2112,8.26590807496458e-06,TRUE,32,461,12,WP,IL-17 signaling pathway,8625,796,WP:000000,FALSE
HPA:0360052,8.3816005413185e-06,TRUE,4410,418,222,HPA,parathyroid gland; glandular cells[Medium],11006,508,HPA:0360051,FALSE
GO:0036297,8.60624992603884e-06,TRUE,39,553,11,GO:BP,interstrand cross-link repair,21010,10008,GO:0006281,TRUE
GO:0051153,8.63104707991847e-06,TRUE,82,553,15,GO:BP,regulation of striated muscle cell differentiation,21010,14210,GO:0051146|GO:0051147,FALSE
GO:0071901,8.65479040765416e-06,TRUE,108,553,17,GO:BP,negative regulation of protein serine/threonine kinase activity,21010,17795,GO:0006469|GO:0071900,FALSE
GO:0046660,8.72008934816884e-06,TRUE,122,553,18,GO:BP,female sex differentiation,21010,12918,GO:0007275|GO:0007548,FALSE
TF:M04797,8.85599557042031e-06,TRUE,5243,556,208,TF,Factor: Egr-1; motif: CCGCCCMCG,20011,1606,TF:M00000,FALSE
WP:WP4754,8.91687926415696e-06,TRUE,273,461,38,WP,IL-18 signaling pathway,8625,395,WP:000000,FALSE
HP:0002716,8.96729400969456e-06,TRUE,235,241,34,HP,Lymphadenopathy,4962,1969,HP:0002733,FALSE
HP:0002027,9.05108554006402e-06,TRUE,334,241,42,HP,Abdominal pain,4962,1484,HP:0011458|HP:0012531,FALSE
GO:0061912,9.1131937266141e-06,TRUE,95,553,16,GO:BP,selective autophagy,21010,16510,GO:0016236,FALSE
WP:WP304,9.21491196266324e-06,TRUE,59,461,16,WP,Kit receptor signaling pathway,8625,771,WP:000000,FALSE
HPA:0510652,9.33294202366502e-06,TRUE,2614,418,148,HPA,soft tissue 2; fibroblasts[Medium],11006,766,HPA:0510651,FALSE
TF:M03811,9.41246613923486e-06,TRUE,9030,556,319,TF,Factor: AP-2gamma; motif: GCCYNCRGSN,20011,144,TF:M00000,FALSE
TF:M12354,9.50446987694597e-06,TRUE,11163,556,377,TF,Factor: ZNF37A; motif: CCYYGGCTCCNTSCCMN,20011,10096,TF:M00000,FALSE
GO:1990845,9.51370222961188e-06,TRUE,168,553,21,GO:BP,adaptive thermogenesis,21010,26371,GO:0008152,FALSE
REAC:R-HSA-5693567,9.61578419820236e-06,TRUE,132,485,23,REAC,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),10835,1047,REAC:R-HSA-5693538,FALSE
GO:0006091,9.64479926643439e-06,TRUE,514,553,39,GO:BP,generation of precursor metabolites and energy,21010,1983,GO:0044237,FALSE
REAC:R-HSA-2219528,9.77635589662492e-06,TRUE,92,485,19,REAC,PI3K/AKT Signaling in Cancer,10835,1594,REAC:R-HSA-5663202,FALSE
GO:0008544,9.86050757534297e-06,TRUE,388,553,33,GO:BP,epidermis development,21010,3247,GO:0009888,FALSE
GO:0048156,9.94878552058938e-06,TRUE,43,555,11,GO:MF,tau protein binding,20139,7310,GO:0008092,TRUE
GO:0004402,9.94878552058938e-06,TRUE,43,555,11,GO:MF,histone acetyltransferase activity,20139,757,GO:0061733|GO:0140993,FALSE
TF:M02281_1,1.0084375321056e-05,TRUE,2639,556,123,TF,Factor: SP1; motif: CCCCKCCCCC; match class: 1,20011,7827,TF:M02281,FALSE
HPA:0020000,1.0274649790451e-05,TRUE,7413,418,331,HPA,adrenal gland,11006,6,HPA:0000000,FALSE
HP:0001000,1.03329527700814e-05,TRUE,499,241,54,HP,Abnormality of skin pigmentation,4962,782,HP:0011121,FALSE
TF:M01973,1.0382601585108e-05,TRUE,6304,556,240,TF,Factor: PLAG1; motif: CCCCCKWNNNGGSCCC,20011,6638,TF:M00000,FALSE
GO:0000086,1.04632968355578e-05,TRUE,138,553,19,GO:BP,G2/M transition of mitotic cell cycle,21010,36,GO:0044772|GO:0044839,FALSE
GO:0043409,1.06013658800972e-05,TRUE,169,553,21,GO:BP,negative regulation of MAPK cascade,21010,11188,GO:0000165|GO:0043408|GO:1902532,FALSE
GO:0007519,1.06013658800972e-05,TRUE,169,553,21,GO:BP,skeletal muscle tissue development,21010,3054,GO:0060537|GO:0060538,FALSE
REAC:R-HSA-2559582,1.06235879697145e-05,TRUE,112,485,21,REAC,Senescence-Associated Secretory Phenotype (SASP),10835,2087,REAC:R-HSA-2559583,FALSE
REAC:R-HSA-8940973,1.08281067782758e-05,TRUE,23,485,10,REAC,RUNX2 regulates osteoblast differentiation,10835,1846,REAC:R-HSA-8941326,FALSE
REAC:R-HSA-450302,1.08281067782758e-05,TRUE,23,485,10,REAC,activated TAK1 mediates p38 MAPK activation,10835,2563,REAC:R-HSA-450294,FALSE
TF:M04515_1,1.09379778425873e-05,TRUE,12480,556,411,TF,Factor: E2F-1; motif: WWTGGCGCCAAA; match class: 1,20011,1435,TF:M04515,FALSE
GO:0022603,1.10949679521797e-05,TRUE,866,553,54,GO:BP,regulation of anatomical structure morphogenesis,21010,6926,GO:0009653|GO:0050793,FALSE
KEGG:05217,1.14050703882288e-05,TRUE,63,431,16,KEGG,Basal cell carcinoma,8161,461,KEGG:00000,FALSE
GO:0000791,1.14511700968689e-05,TRUE,62,548,12,GO:CC,euchromatin,22090,94,GO:0000785,FALSE
GO:0044839,1.14915831291313e-05,TRUE,154,553,20,GO:BP,cell cycle G2/M phase transition,21010,11792,GO:0044770,FALSE
GO:0030324,1.15093442999382e-05,TRUE,186,553,22,GO:BP,lung development,21010,7088,GO:0030323|GO:0048513|GO:0060541,FALSE
GO:1901874,1.15527145191311e-05,TRUE,110,553,17,GO:BP,negative regulation of post-translational protein modification,21010,22697,GO:0031400|GO:0043687|GO:1901873,FALSE
GO:1902175,1.15908811726746e-05,TRUE,40,553,11,GO:BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,21010,22965,GO:0008631|GO:2001242,FALSE
KEGG:04520,1.160834904769e-05,TRUE,71,431,17,KEGG,Adherens junction,8161,310,KEGG:00000,FALSE
GO:0051170,1.18035335298004e-05,TRUE,170,553,21,GO:BP,import into nucleus,21010,14227,GO:0006913,FALSE
GO:0001763,1.18506316071921e-05,TRUE,203,553,23,GO:BP,morphogenesis of a branching structure,21010,439,GO:0009653|GO:0032501,FALSE
GO:0002696,1.21402797167858e-05,TRUE,371,553,32,GO:BP,positive regulation of leukocyte activation,21010,1228,GO:0002684|GO:0002694|GO:0045321|GO:0050867,FALSE
WP:WP4496,1.2366904625274e-05,TRUE,33,461,12,WP,Signal transduction through IL1R,8625,292,WP:000000,FALSE
WP:WP2817,1.2366904625274e-05,TRUE,33,461,12,WP,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),8625,356,WP:000000,FALSE
GO:0006111,1.26111690613764e-05,TRUE,50,553,12,GO:BP,regulation of gluconeogenesis,21010,1999,GO:0006094|GO:0010906|GO:0043255,FALSE
HP:0034930,1.27065283552757e-05,TRUE,312,241,40,HP,Digestive system neoplasm,4962,14908,HP:0025031,FALSE
HP:0007378,1.27065283552757e-05,TRUE,312,241,40,HP,Neoplasm of the gastrointestinal tract,4962,4716,HP:0011024|HP:0034930,FALSE
REAC:R-HSA-69481,1.28364283900521e-05,TRUE,167,485,26,REAC,G2/M Checkpoints,10835,958,REAC:R-HSA-69620,FALSE
GO:0010721,1.28490635340137e-05,TRUE,275,553,27,GO:BP,negative regulation of cell development,21010,4422,GO:0045596|GO:0048468|GO:0060284,FALSE
HPA:0310443,1.29062819949048e-05,TRUE,1209,418,83,HPA,lymph node; non-germinal center cells[High],11006,465,HPA:0310442,FALSE
HPA:0050092,1.31442373043564e-05,TRUE,3777,418,196,HPA,breast; myoepithelial cells[Medium],11006,62,HPA:0050091,FALSE
WP:WP4919,1.31627440629773e-05,TRUE,13,461,8,WP,Neuroinflammation,8625,831,WP:000000,FALSE
GO:0045445,1.33143370223696e-05,TRUE,111,553,17,GO:BP,myoblast differentiation,21010,11992,GO:0030154|GO:0061061,FALSE
TF:M00243,1.34037995756951e-05,TRUE,5495,556,215,TF,Factor: Egr-1; motif: WTGCGTGGGCGK,20011,1600,TF:M00000,FALSE
GO:0043153,1.37475965248783e-05,TRUE,24,553,9,GO:BP,entrainment of circadian clock by photoperiod,21010,11065,GO:0009648|GO:0009649,FALSE
HPA:0210000,1.39366473627805e-05,TRUE,7457,418,332,HPA,fallopian tube,11006,341,HPA:0000000,FALSE
GO:0034399,1.39689047156963e-05,TRUE,151,548,18,GO:CC,nuclear periphery,22090,1481,GO:0031981|GO:0110165,FALSE
GO:1902806,1.40675181503233e-05,TRUE,188,553,22,GO:BP,regulation of cell cycle G1/S phase transition,21010,23439,GO:0044843|GO:1901987,FALSE
GO:0016746,1.41770432501659e-05,TRUE,728,555,48,GO:MF,acyltransferase activity,20139,2957,GO:0016740,TRUE
GO:0003824,1.42411744134576e-05,TRUE,5751,555,218,GO:MF,catalytic activity,20139,368,GO:0003674,FALSE
HP:0008056,1.42713261196903e-05,TRUE,475,241,52,HP,Aplasia/Hypoplasia affecting the eye,4962,5103,HP:0012372,FALSE
HPA:0250123,1.47034504853748e-05,TRUE,549,418,48,HPA,hippocampus; glial cells[High],11006,384,HPA:0250122,FALSE
CORUM:5386,1.48596982732057e-05,TRUE,27,292,13,CORUM,MLL1-WDR5 complex,3383,1664,CORUM:0000000,FALSE
GO:0051881,1.52056450644118e-05,TRUE,73,553,14,GO:BP,regulation of mitochondrial membrane potential,21010,14663,GO:0042391,FALSE
TF:M11541_1,1.54080316255422e-05,TRUE,5667,556,220,TF,Factor: Foxn2; motif: NNGCGTCNNNNNGACGCNN; match class: 1,20011,2707,TF:M11541,FALSE
WP:WP4298,1.54163748275729e-05,TRUE,85,461,19,WP,Acute viral myocarditis,8625,398,WP:000000,FALSE
TF:M09603_1,1.54610446042697e-05,TRUE,1365,556,76,TF,Factor: Egr-1; motif: NNNNNGYGKGGGNGGGNN; match class: 1,20011,1619,TF:M09603,FALSE
TF:M12227_1,1.54695985468375e-05,TRUE,6063,556,232,TF,Factor: ZIC4; motif: NNCCNCCCRYNGYGN; match class: 1,20011,9373,TF:M12227,FALSE
TF:M04515,1.56292978227868e-05,TRUE,13660,556,440,TF,Factor: E2F-1; motif: WWTGGCGCCAAA,20011,1434,TF:M00000,FALSE
GO:0045184,1.5681632145997e-05,TRUE,1925,553,93,GO:BP,establishment of protein localization,21010,11918,GO:0008104|GO:0051234,FALSE
HP:0008062,1.59835232172971e-05,TRUE,140,241,25,HP,Aplasia/Hypoplasia affecting the anterior segment of the eye,4962,5109,HP:0007700|HP:0008056,FALSE
HPA:0310432,1.59865115816735e-05,TRUE,3297,418,176,HPA,lymph node; germinal center cells[Medium],11006,461,HPA:0310431,FALSE
HPA:0130052,1.60857348752646e-05,TRUE,5977,418,280,HPA,colon; glandular cells[Medium],11006,232,HPA:0130051,FALSE
GO:0010611,1.61009566685527e-05,TRUE,51,553,12,GO:BP,regulation of cardiac muscle hypertrophy,21010,4330,GO:0003300|GO:0014743|GO:0043502,FALSE
GO:0006631,1.63635803113152e-05,TRUE,396,553,33,GO:BP,fatty acid metabolic process,21010,2381,GO:0032787|GO:0044255,FALSE
GO:1902554,1.6380208671923e-05,TRUE,136,548,17,GO:CC,serine/threonine protein kinase complex,22090,3642,GO:1902911,FALSE
HP:0011355,1.64539202112908e-05,TRUE,940,241,82,HP,Localized skin lesion,4962,7763,HP:0011121,FALSE
GO:0004712,1.67014518894652e-05,TRUE,45,555,11,GO:MF,protein serine/threonine/tyrosine kinase activity,20139,1003,GO:0004672,FALSE
HPA:0020051,1.67524630525159e-05,TRUE,7406,418,330,HPA,adrenal gland; glandular cells[Low],11006,16,HPA:0020000,FALSE
HPA:0250000,1.68629606042856e-05,TRUE,6822,418,310,HPA,hippocampus,11006,381,HPA:0000000,FALSE
GO:0030323,1.71461871793879e-05,TRUE,190,553,22,GO:BP,respiratory tube development,21010,7087,GO:0035295|GO:0048513,FALSE
WP:WP5144,1.71953192005897e-05,TRUE,54,461,15,WP,NRP1-triggered signaling pathways in pancreatic cancer ,8625,599,WP:000000,FALSE
TF:M07040_1,1.73037526817422e-05,TRUE,8362,556,299,TF,Factor: GKLF; motif: NNRRGRRNGNSNNN; match class: 1,20011,3167,TF:M07040,FALSE
TF:M01972,1.74311763726056e-05,TRUE,5511,556,215,TF,Factor: EGR-1; motif: TGCGTGGGCGK,20011,1602,TF:M00000,FALSE
WP:WP2643,1.7516969665495e-05,TRUE,28,461,11,WP,Nanoparticle-mediated activation of receptor signaling,8625,299,WP:000000,FALSE
GO:1901989,1.75996335548433e-05,TRUE,113,553,17,GO:BP,positive regulation of cell cycle phase transition,21010,22803,GO:0044770|GO:0090068|GO:1901987,FALSE
GO:0035098,1.78355087454021e-05,TRUE,16,548,7,GO:CC,ESC/E(Z) complex,22090,1595,GO:0031519|GO:0035097,FALSE
HPA:0390052,1.79156523946139e-05,TRUE,4806,418,236,HPA,prostate; glandular cells[Medium],11006,541,HPA:0390051,FALSE
GO:0003170,1.83062752822979e-05,TRUE,74,553,14,GO:BP,heart valve development,21010,1617,GO:0007507|GO:0048856,FALSE
HP:0004097,1.88193837917005e-05,TRUE,493,241,53,HP,Deviation of finger,4962,2910,HP:0001167|HP:0009484,FALSE
TF:M12158,1.90766921009038e-05,TRUE,11326,556,380,TF,Factor: KLF15; motif: NCCMCGCCCMCN,20011,4546,TF:M00000,FALSE
TF:M10098,1.94563013664656e-05,TRUE,7224,556,266,TF,Factor: DP-1; motif: NRNNGGCGGGAANN,20011,8666,TF:M00000,FALSE
CORUM:2721,1.95358478830976e-05,TRUE,16,292,10,CORUM,HCF-1 complex,3383,1151,CORUM:0000000,FALSE
TF:M08487,1.99154828213885e-05,TRUE,14250,556,454,TF,Factor: GCMa:Erg; motif: ATGCGGGCGGAARKG,20011,3042,TF:M00000,FALSE
TF:M10071_1,1.99506563344581e-05,TRUE,4745,556,191,TF,Factor: Sp1; motif: NGGGGGCGGGGCCNGGGGGGGG; match class: 1,20011,7837,TF:M10071,FALSE
REAC:R-HSA-9617629,2.00175702894162e-05,TRUE,10,485,7,REAC,Regulation of FOXO transcriptional activity by acetylation,10835,1889,REAC:R-HSA-9614085,FALSE
REAC:R-HSA-9701898,2.00175702894162e-05,TRUE,10,485,7,REAC,STAT3 nuclear events downstream of ALK signaling,10835,2051,REAC:R-HSA-201556,FALSE
GO:0001678,2.01045518054417e-05,TRUE,159,553,20,GO:BP,intracellular glucose homeostasis,21010,392,GO:0042593|GO:0055082,FALSE
GO:0006094,2.01945630221828e-05,TRUE,87,553,15,GO:BP,gluconeogenesis,21010,1984,GO:0006006|GO:0019319,FALSE
GO:0034243,2.01945630221828e-05,TRUE,87,553,15,GO:BP,regulation of transcription elongation by RNA polymerase II,21010,8911,GO:0006368|GO:0032784,FALSE
GO:0055021,2.04355845748573e-05,TRUE,52,553,12,GO:BP,regulation of cardiac muscle tissue growth,21010,14939,GO:0055017|GO:0060420,FALSE
GO:0045599,2.04355845748573e-05,TRUE,52,553,12,GO:BP,negative regulation of fat cell differentiation,21010,12065,GO:0045444|GO:0045596|GO:0045598,FALSE
GO:0009048,2.07895618487396e-05,TRUE,33,553,10,GO:BP,dosage compensation by inactivation of X chromosome,21010,3284,GO:0007549,FALSE
HPA:0301373,2.08085366343096e-05,TRUE,662,418,54,HPA,lung; alveolar cells type II[High],11006,452,HPA:0301372,FALSE
HPA:0130242,2.11074006044481e-05,TRUE,3430,418,181,HPA,colon; peripheral nerve/ganglion[Medium],11006,241,HPA:0130241,FALSE
HP:0001631,2.11612838512998e-05,TRUE,509,241,54,HP,Atrial septal defect,4962,1184,HP:0005120|HP:0011994,FALSE
GO:0061733,2.14093001895106e-05,TRUE,46,555,11,GO:MF,peptide-lysine-N-acetyltransferase activity,20139,8535,GO:0034212|GO:0140096,FALSE
GO:0001889,2.14740942921827e-05,TRUE,144,553,19,GO:BP,liver development,21010,526,GO:0048732|GO:0061008,FALSE
WP:WP5046,2.17696487172679e-05,TRUE,23,461,10,WP,NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence,8625,204,WP:000000,FALSE
TF:M12140,2.18955077328451e-05,TRUE,5525,556,215,TF,Factor: Egr-1; motif: NNCRCCCMCGCNN,20011,1626,TF:M00000,FALSE
GO:0003012,2.25087130457761e-05,TRUE,422,553,34,GO:BP,muscle system process,21010,1477,GO:0003008,FALSE
REAC:R-HSA-168927,2.25376031745727e-05,TRUE,19,485,9,REAC,"TICAM1, RIP1-mediated IKK complex recruitment",10835,2323,REAC:R-HSA-168164,FALSE
GO:0043500,2.28295787855061e-05,TRUE,101,553,16,GO:BP,muscle adaptation,21010,11250,GO:0003012|GO:0050896,FALSE
HPA:0590053,2.36660008495722e-05,TRUE,1882,418,114,HPA,thyroid gland; glandular cells[High],11006,841,HPA:0590052,FALSE
GO:0006470,2.38713364298628e-05,TRUE,246,553,25,GO:BP,protein dephosphorylation,21010,2244,GO:0016311|GO:0036211,TRUE
WP:WP4963,2.43506908647189e-05,TRUE,96,461,20,WP,p53 transcriptional gene network,8625,42,WP:000000,FALSE
GO:0060541,2.49436884408202e-05,TRUE,211,553,23,GO:BP,respiratory system development,21010,15467,GO:0048731,FALSE
GO:0030902,2.49857357884977e-05,TRUE,161,553,20,GO:BP,hindbrain development,21010,7275,GO:0007420|GO:0048856,FALSE
GO:0031663,2.56043563399034e-05,TRUE,64,553,13,GO:BP,lipopolysaccharide-mediated signaling pathway,21010,7618,GO:0007166|GO:0071222,FALSE
HP:0011994,2.61145523906418e-05,TRUE,512,241,54,HP,Abnormal atrial septum morphology,4962,8391,HP:0001671,FALSE
REAC:R-HSA-5675482,2.63299757402156e-05,TRUE,31,485,11,REAC,Regulation of necroptotic cell death,10835,1946,REAC:R-HSA-5213460,FALSE
REAC:R-HSA-5213460,2.63299757402156e-05,TRUE,31,485,11,REAC,RIPK1-mediated regulated necrosis,10835,1794,REAC:R-HSA-5218859,FALSE
REAC:R-HSA-5602358,2.63299757402156e-05,TRUE,31,485,11,REAC,Diseases associated with the TLR signaling cascade,10835,720,REAC:R-HSA-5260271,FALSE
REAC:R-HSA-5260271,2.63299757402156e-05,TRUE,31,485,11,REAC,Diseases of Immune System,10835,726,REAC:R-HSA-1643685,FALSE
GO:0006304,2.64279267302662e-05,TRUE,102,553,16,GO:BP,DNA modification,21010,2141,GO:0006259|GO:0043412,FALSE
GO:0043534,2.64398663171031e-05,TRUE,116,553,17,GO:BP,blood vessel endothelial cell migration,21010,11267,GO:0043542,FALSE
HPA:0210052,2.65133125445464e-05,TRUE,4695,418,231,HPA,fallopian tube; glandular cells[Medium],11006,355,HPA:0210051,FALSE
HPA:0600433,2.67955929721657e-05,TRUE,1229,418,83,HPA,tonsil; germinal center cells[High],11006,845,HPA:0600432,FALSE
WP:WP3972,2.68764283499884e-05,TRUE,29,461,11,WP,PDGFR-beta pathway,8625,115,WP:000000,FALSE
REAC:R-HSA-5689880,2.70135008859967e-05,TRUE,221,485,30,REAC,Ub-specific processing proteases,10835,2497,REAC:R-HSA-5688426,FALSE
GO:2000045,2.78175490320348e-05,TRUE,162,553,20,GO:BP,regulation of G1/S transition of mitotic cell cycle,21010,26465,GO:0000082|GO:1901990|GO:1902806,FALSE
GO:0051591,2.78950766384549e-05,TRUE,89,553,15,GO:BP,response to cAMP,21010,14504,GO:0014074|GO:0046683|GO:1901700,FALSE
GO:1901992,2.78950766384549e-05,TRUE,89,553,15,GO:BP,positive regulation of mitotic cell cycle phase transition,21010,22806,GO:0044772|GO:0045931|GO:1901989|GO:1901990,FALSE
TF:M00431,2.85270715429817e-05,TRUE,7456,556,272,TF,Factor: E2F-1; motif: TTTSGCGS,20011,1456,TF:M00000,FALSE
REAC:R-HSA-9675126,2.86982548633335e-05,TRUE,38,485,12,REAC,Diseases of mitotic cell cycle,10835,735,REAC:R-HSA-1643685,FALSE
GO:0051973,2.87621981335399e-05,TRUE,34,553,10,GO:BP,positive regulation of telomerase activity,21010,14739,GO:0051347|GO:0051972|GO:2000573,FALSE
HPA:0570811,2.90624424469996e-05,TRUE,2822,418,155,HPA,testis; spermatogonia cells[Low],11006,828,HPA:0570000,FALSE
GO:0031011,2.96722439717232e-05,TRUE,17,548,7,GO:CC,Ino80 complex,22090,1030,GO:0000228|GO:0097346,FALSE
GO:0002064,2.9868266359707e-05,TRUE,213,553,23,GO:BP,epithelial cell development,21010,668,GO:0030855|GO:0048468,FALSE
GO:0061008,3.03252762578613e-05,TRUE,147,553,19,GO:BP,hepaticobiliary system development,21010,15885,GO:0048731,FALSE
MIRNA:hsa-miR-22-3p,3.07700056370719e-05,TRUE,161,514,22,MIRNA,hsa-miR-22-3p,14846,446,MIRNA:000000,FALSE
TF:M11058_1,3.08042016249396e-05,TRUE,11134,556,374,TF,Factor: Hey1; motif: NGCRCGYGYN; match class: 1,20011,3379,TF:M11058,FALSE
GO:0050867,3.156924720409e-05,TRUE,386,553,32,GO:BP,positive regulation of cell activation,21010,13980,GO:0001775|GO:0048522|GO:0050865|GO:0051240,FALSE
GO:0005102,3.18072692463584e-05,TRUE,1484,555,77,GO:MF,signaling receptor binding,20139,1280,GO:0005515,FALSE
GO:0090596,3.21171907589887e-05,TRUE,287,553,27,GO:BP,sensory organ morphogenesis,21010,19234,GO:0007423|GO:0009887,FALSE
WP:WP4255,3.22728901011546e-05,TRUE,72,461,17,WP,Non-small cell lung cancer,8625,736,WP:000000,FALSE
GO:0014743,3.23751237728811e-05,TRUE,54,553,12,GO:BP,regulation of muscle hypertrophy,21010,4763,GO:0014896|GO:0090257,FALSE
GO:0019319,3.26736376971267e-05,TRUE,90,553,15,GO:BP,hexose biosynthetic process,21010,5939,GO:0019318|GO:0046364,FALSE
REAC:R-HSA-9616222,3.27398183031315e-05,TRUE,89,485,18,REAC,Transcriptional regulation of granulopoiesis,10835,2441,REAC:R-HSA-1266738,FALSE
HPA:0430052,3.34091326876668e-05,TRUE,5230,418,251,HPA,seminal vesicle; glandular cells[Medium],11006,605,HPA:0430051,FALSE
HPA:0210051,3.35350689898998e-05,TRUE,5767,418,271,HPA,fallopian tube; glandular cells[Low],11006,354,HPA:0210000,FALSE
GO:0036480,3.37423666015245e-05,TRUE,19,553,8,GO:BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,21010,10084,GO:0008631|GO:0051402,FALSE
REAC:R-HSA-5250941,3.38673262701068e-05,TRUE,109,485,20,REAC,Negative epigenetic regulation of rRNA expression,10835,1489,REAC:R-HSA-212165,FALSE
GO:0001667,3.39396990210949e-05,TRUE,429,553,34,GO:BP,ameboidal-type cell migration,21010,388,GO:0016477,FALSE
GO:0032479,3.44265843724074e-05,TRUE,118,553,17,GO:BP,regulation of type I interferon production,21010,7954,GO:0001817|GO:0032606,FALSE
GO:0032606,3.44265843724074e-05,TRUE,118,553,17,GO:BP,type I interferon production,21010,8022,GO:0001816,FALSE
HP:0100887,3.46630117023436e-05,TRUE,310,241,39,HP,Abnormality of globe size,4962,16359,HP:0012372,FALSE
REAC:R-HSA-8878171,3.48067277759711e-05,TRUE,236,485,31,REAC,Transcriptional regulation by RUNX1,10835,2436,REAC:R-HSA-212436,FALSE
WP:WP4540,3.48788906646326e-05,TRUE,98,461,20,WP,Hippo signaling regulation pathways,8625,201,WP:000000,FALSE
GO:2000378,3.49543274867055e-05,TRUE,44,553,11,GO:BP,negative regulation of reactive oxygen species metabolic process,21010,26776,GO:0031324|GO:0072593|GO:2000377,FALSE
GO:0007622,3.49543274867055e-05,TRUE,44,553,11,GO:BP,rhythmic behavior,21010,3132,GO:0007610,FALSE
GO:0048593,3.53754746169221e-05,TRUE,133,553,18,GO:BP,camera-type eye morphogenesis,21010,13514,GO:0043010|GO:0048592,FALSE
KEGG:05211,3.58165049108862e-05,TRUE,68,431,16,KEGG,Renal cell carcinoma,8161,455,KEGG:00000,FALSE
GO:0060538,3.65181078812548e-05,TRUE,181,553,21,GO:BP,skeletal muscle organ development,21010,15464,GO:0007517,FALSE
TF:M11880,3.67875121370926e-05,TRUE,13317,556,430,TF,Factor: pax-6; motif: NYACGCWTSANYGMNCN,20011,6408,TF:M00000,FALSE
TF:M12598,3.69168593844678e-05,TRUE,12723,556,415,TF,Factor: E2F3; motif: NNRGMKGGAR,20011,1494,TF:M00000,FALSE
TF:M11881,3.72325457582609e-05,TRUE,13438,556,433,TF,Factor: pax-6; motif: NYACGCNTSANYGCNYN,20011,6410,TF:M00000,FALSE
HP:0011028,3.72343990819749e-05,TRUE,350,241,42,HP,Abnormality of blood circulation,4962,7446,HP:0011025,FALSE
GO:1903533,3.73152198149089e-05,TRUE,78,553,14,GO:BP,regulation of protein targeting,21010,24025,GO:0006605|GO:0033157,FALSE
WP:WP1471,3.76536895394114e-05,TRUE,36,461,12,WP,Target of rapamycin signaling,8625,843,WP:000000,FALSE
WP:WP4150,3.76536895394114e-05,TRUE,36,461,12,WP,Wnt signaling in kidney disease,8625,547,WP:000000,FALSE
GO:0070301,3.79837184389513e-05,TRUE,66,553,13,GO:BP,cellular response to hydrogen peroxide,21010,16840,GO:0034614|GO:0042542,FALSE
GO:0006606,3.81917905453137e-05,TRUE,165,553,20,GO:BP,protein import into nucleus,21010,2361,GO:0006886|GO:0034504|GO:0051170|GO:0072594,FALSE
GO:0007549,3.93242992491939e-05,TRUE,35,553,10,GO:BP,dosage compensation,21010,3083,GO:0040029,FALSE
TF:M04106_1,3.96487976511812e-05,TRUE,8597,556,304,TF,Factor: RUNX2; motif: NRACCGCAAACCGCAN; match class: 1,20011,7353,TF:M04106,FALSE
TF:M12158_1,3.98974504079806e-05,TRUE,6157,556,233,TF,Factor: KLF15; motif: NCCMCGCCCMCN; match class: 1,20011,4547,TF:M12158,FALSE
MIRNA:hsa-miR-19b-3p,4.02131333412376e-05,TRUE,713,514,54,MIRNA,hsa-miR-19b-3p,14846,383,MIRNA:000000,FALSE
REAC:R-HSA-140534,4.03336024443218e-05,TRUE,15,485,8,REAC,Caspase activation via Death Receptors in the presence of ligand,10835,305,REAC:R-HSA-5357769,FALSE
REAC:R-HSA-9735871,4.03336024443218e-05,TRUE,15,485,8,REAC,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,10835,2012,REAC:R-HSA-9692914,FALSE
GO:0031334,4.04194901264544e-05,TRUE,199,553,22,GO:BP,positive regulation of protein-containing complex assembly,21010,7471,GO:0043254|GO:0044089|GO:0051130|GO:0065003,FALSE
HPA:0500651,4.05309022311287e-05,TRUE,4229,418,212,HPA,soft tissue 1; fibroblasts[Low],11006,755,HPA:0500000,FALSE
GO:0030316,4.05625748697715e-05,TRUE,105,553,16,GO:BP,osteoclast differentiation,21010,7082,GO:0002573,FALSE
WP:WP5373,4.18706283668188e-05,TRUE,50,461,14,WP,"Role of hypoxia, angiogenesis, and FGF pathway in OA chondrocyte hypertrophy",8625,35,WP:000000,FALSE
WP:WP4136,4.2455525399805e-05,TRUE,43,461,13,WP,Fibrin complement receptor 3 signaling pathway,8625,779,WP:000000,FALSE
HPA:0570781,4.27685164894806e-05,TRUE,1706,418,105,HPA,testis; preleptotene spermatocytes[Low],11006,819,HPA:0570000,FALSE
TF:M08874,4.36535435842306e-05,TRUE,7382,556,269,TF,Factor: E2F1; motif: NNNNNGCGSSAAAN,20011,1454,TF:M00000,FALSE
GO:0004407,4.38770695044797e-05,TRUE,22,555,8,GO:MF,histone deacetylase activity,20139,758,GO:0016811|GO:0033558|GO:0140993,FALSE
REAC:R-HSA-69278,4.42341983103538e-05,TRUE,549,485,53,REAC,"Cell Cycle, Mitotic",10835,314,REAC:R-HSA-1640170,FALSE
GO:0006919,4.42709691474968e-05,TRUE,79,553,14,GO:BP,activation of cysteine-type endopeptidase activity involved in apoptotic process,21010,2605,GO:0043280,FALSE
GO:1903708,4.44091376924968e-05,TRUE,183,553,21,GO:BP,positive regulation of hemopoiesis,21010,24183,GO:0002684|GO:0010720|GO:0030097|GO:0051240|GO:1903706,FALSE
GO:1902107,4.44091376924968e-05,TRUE,183,553,21,GO:BP,positive regulation of leukocyte differentiation,21010,22907,GO:0002521|GO:1902105|GO:1903708,FALSE
GO:0002065,4.45733491865209e-05,TRUE,120,553,17,GO:BP,columnar/cuboidal epithelial cell differentiation,21010,669,GO:0030855,FALSE
GO:0008286,4.45733491865209e-05,TRUE,120,553,17,GO:BP,insulin receptor signaling pathway,21010,3207,GO:0007169|GO:0032869,FALSE
GO:0034728,4.49110566160316e-05,TRUE,135,553,18,GO:BP,nucleosome organization,21010,9130,GO:0006338,FALSE
HP:0000130,4.58125875234484e-05,TRUE,238,241,33,HP,Abnormality of the uterus,4962,112,HP:0000008,FALSE
GO:0014015,4.60079547514365e-05,TRUE,67,553,13,GO:BP,positive regulation of gliogenesis,21010,4672,GO:0014013|GO:0042063|GO:0050769,FALSE
GO:0048144,4.6628888966152e-05,TRUE,106,553,16,GO:BP,fibroblast proliferation,21010,13193,GO:0008283,FALSE
GO:0071347,4.6628888966152e-05,TRUE,106,553,16,GO:BP,cellular response to interleukin-1,21010,17409,GO:0070555|GO:0071345,FALSE
HPA:0130241,4.82453282396284e-05,TRUE,5037,418,243,HPA,colon; peripheral nerve/ganglion[Low],11006,240,HPA:0130000,FALSE
CORUM:696,4.87186630583341e-05,TRUE,8,292,7,CORUM,BRMS1-SIN3-HDAC complex,3383,379,CORUM:0000000,FALSE
MIRNA:hsa-miR-125a-5p,4.93796611524194e-05,TRUE,269,514,29,MIRNA,hsa-miR-125a-5p,14846,132,MIRNA:000000,FALSE
HP:0001053,4.96914397095066e-05,TRUE,117,241,22,HP,Hypopigmented skin patches,4962,825,HP:0001010|HP:0011355,FALSE
GO:0043422,4.97045252616408e-05,TRUE,10,555,6,GO:MF,protein kinase B binding,20139,5792,GO:0019901,FALSE
GO:0070878,4.97045252616408e-05,TRUE,10,555,6,GO:MF,primary miRNA binding,20139,8805,GO:0003723,TRUE
HP:0011029,4.97085500487373e-05,TRUE,327,241,40,HP,Internal hemorrhage,4962,7447,HP:0001892|HP:0011028,FALSE
TF:M08266_1,4.9727675805437e-05,TRUE,9184,556,320,TF,Factor: ER71:Pax-5; motif: ACCGGAACYACGCWTSANTG; match class: 1,20011,2237,TF:M08266,FALSE
HPA:0500702,5.00000545809421e-05,TRUE,1350,418,88,HPA,soft tissue 1; peripheral nerve[Medium],11006,759,HPA:0500701,FALSE
TF:M09895,5.10076773721103e-05,TRUE,7982,556,286,TF,Factor: E2F-6; motif: NGGGCGGGARRNN,20011,1524,TF:M00000,FALSE
TF:M00738,5.1298296285153e-05,TRUE,10057,556,344,TF,Factor: E2F-4:DP-1; motif: TTTSGCGC,20011,1498,TF:M00000,FALSE
HPA:0570801,5.17378306009789e-05,TRUE,2290,418,131,HPA,testis; sertoli cells[Low],11006,825,HPA:0570000,FALSE
REAC:R-HSA-9697154,5.29255601460854e-05,TRUE,11,485,7,REAC,Disorders of Nervous System Development,10835,743,REAC:R-HSA-9675151,FALSE
REAC:R-HSA-9005895,5.29255601460854e-05,TRUE,11,485,7,REAC,Pervasive developmental disorders,10835,1648,REAC:R-HSA-9697154,FALSE
REAC:R-HSA-9675151,5.29255601460854e-05,TRUE,11,485,7,REAC,Disorders of Developmental Biology,10835,742,REAC:R-HSA-1643685,FALSE
REAC:R-HSA-9005891,5.29255601460854e-05,TRUE,11,485,7,REAC,Loss of function of MECP2 in Rett syndrome,10835,1278,REAC:R-HSA-9005895,FALSE
GO:0031330,5.31828869797885e-05,TRUE,202,553,22,GO:BP,negative regulation of cellular catabolic process,21010,7468,GO:0009895|GO:0031324|GO:0031329|GO:0044248,FALSE
GO:0003684,5.32678502206116e-05,TRUE,73,555,13,GO:MF,damaged DNA binding,20139,329,GO:0003677,FALSE
HPA:0430051,5.33193649841031e-05,TRUE,6821,418,308,HPA,seminal vesicle; glandular cells[Low],11006,604,HPA:0430000,FALSE
HPA:0430000,5.33193649841031e-05,TRUE,6821,418,308,HPA,seminal vesicle,11006,603,HPA:0000000,FALSE
KEGG:04714,5.34019306625175e-05,TRUE,232,431,32,KEGG,Thermogenesis,8161,343,KEGG:00000,FALSE
GO:0044030,5.49437620069754e-05,TRUE,20,553,8,GO:BP,regulation of DNA methylation,21010,11430,GO:0006306|GO:0051052,FALSE
REAC:R-HSA-9634815,5.54694165054588e-05,TRUE,33,485,11,REAC,Transcriptional Regulation by NPAS4,10835,2430,REAC:R-HSA-212436,FALSE
GO:0045670,5.55308928243914e-05,TRUE,68,553,13,GO:BP,regulation of osteoclast differentiation,21010,12136,GO:0002761|GO:0030316,FALSE
GO:0030235,5.58407837555507e-05,TRUE,6,555,5,GO:MF,nitric-oxide synthase regulator activity,20139,3882,GO:0030234,TRUE
WP:WP205,5.6444762396524e-05,TRUE,25,461,10,WP,IL-7 signaling pathway,8625,694,WP:000000,FALSE
TF:M00976,5.7725928399748e-05,TRUE,3987,556,165,TF,"Factor: AhR,; motif: NRCGTGNGN",20011,14,TF:M00000,FALSE
GO:0060443,5.79724971419994e-05,TRUE,46,553,11,GO:BP,mammary gland morphogenesis,21010,15375,GO:0022612|GO:0030879,FALSE
TF:M12590_1,5.82686143089819e-05,TRUE,6889,556,254,TF,Factor: CP2; motif: NRRRCCGGCYNRARCCGGNN; match class: 1,20011,8663,TF:M12590,FALSE
TF:M03922,5.83957505233309e-05,TRUE,6182,556,233,TF,Factor: SP4; motif: NWRGCCACGCCCMCTYN,20011,7892,TF:M00000,FALSE
HP:0000028,5.87037198892845e-05,TRUE,753,241,69,HP,Cryptorchidism,4962,26,HP:0000035,FALSE
GO:0032635,5.8884992890322e-05,TRUE,153,553,19,GO:BP,interleukin-6 production,21010,8050,GO:0001816,FALSE
GO:0032675,5.8884992890322e-05,TRUE,153,553,19,GO:BP,regulation of interleukin-6 production,21010,8089,GO:0001817|GO:0032635,FALSE
GO:0019218,6.01969124803802e-05,TRUE,94,553,15,GO:BP,regulation of steroid metabolic process,21010,5851,GO:0008202|GO:0019216,FALSE
GO:0032091,6.01969124803802e-05,TRUE,94,553,15,GO:BP,negative regulation of protein binding,21010,7715,GO:0043393|GO:0051100,FALSE
GO:0140662,6.14910577464189e-05,TRUE,31,555,9,GO:MF,ATP-dependent protein folding chaperone,20139,10662,GO:0044183|GO:0140657,TRUE
KEGG:04350,6.16483154256633e-05,TRUE,97,431,19,KEGG,TGF-beta signaling pathway,8161,298,KEGG:00000,FALSE
GO:0001541,6.21290693197949e-05,TRUE,57,553,12,GO:BP,ovarian follicle development,21010,342,GO:0003006|GO:0008585|GO:0048856,FALSE
GO:0046902,6.21290693197949e-05,TRUE,57,553,12,GO:BP,regulation of mitochondrial membrane permeability,21010,13068,GO:0006839|GO:0007006|GO:0090559,FALSE
HP:0005922,6.24775889217413e-05,TRUE,1034,241,86,HP,Abnormal hand morphology,4962,3934,HP:0001155,FALSE
GO:0000152,6.27706923674409e-05,TRUE,47,548,10,GO:CC,nuclear ubiquitin ligase complex,22090,24,GO:0000151|GO:0140513,FALSE
HP:0010786,6.41595486840639e-05,TRUE,139,241,24,HP,Urinary tract neoplasm,4962,7216,HP:0007379,FALSE
TF:M12151,6.44292842199304e-05,TRUE,6998,556,257,TF,Factor: Sp1; motif: NWRGCCMCGCCCMCN,20011,7840,TF:M00000,FALSE
HP:0100026,6.46506204700503e-05,TRUE,56,241,15,HP,Arteriovenous malformation,4962,15546,HP:0033353,FALSE
GO:0044057,6.49160812793152e-05,TRUE,551,553,39,GO:BP,regulation of system process,21010,11436,GO:0003008|GO:0051239,FALSE
GO:0072655,6.50035813277921e-05,TRUE,123,553,17,GO:BP,establishment of protein localization to mitochondrion,21010,18312,GO:0070585|GO:0072594,FALSE
TF:M07289,6.5891716413015e-05,TRUE,14958,556,469,TF,Factor: GKLF; motif: NNNRGGNGNGGSN,20011,3168,TF:M00000,FALSE
WP:WP5083,6.60071361763227e-05,TRUE,140,461,24,WP,Neuroinflammation and glutamatergic signaling,8625,20,WP:000000,FALSE
GO:0033598,6.61041269696617e-05,TRUE,28,553,9,GO:BP,mammary gland epithelial cell proliferation,21010,8685,GO:0050673|GO:0061180,FALSE
REAC:R-HSA-1606322,6.61672628049056e-05,TRUE,21,485,9,REAC,ZBP1(DAI) mediated induction of type I IFNs,10835,2559,REAC:R-HSA-1834949,FALSE
GO:0090559,6.67962880779323e-05,TRUE,69,553,13,GO:BP,regulation of membrane permeability,21010,19228,GO:0065008,FALSE
GO:2000074,6.68930437552271e-05,TRUE,9,553,6,GO:BP,regulation of type B pancreatic cell development,21010,26492,GO:0003323|GO:0060284,FALSE
WP:WP4806,6.72168066672786e-05,TRUE,84,461,18,WP,EGFR tyrosine kinase inhibitor resistance,8625,140,WP:000000,FALSE
WP:WP3657,6.74457081129464e-05,TRUE,20,461,9,WP,Hematopoietic stem cell gene regulation by GABP alpha/beta complex,8625,595,WP:000000,FALSE
WP:WP4206,6.74457081129464e-05,TRUE,20,461,9,WP,Hereditary leiomyomatosis and renal cell carcinoma pathway,8625,348,WP:000000,FALSE
WP:WP5331,6.74457081129464e-05,TRUE,20,461,9,WP,Autophagy in pancreatic ductal adenocarcinoma,8625,208,WP:000000,FALSE
HP:0008053,6.74876878782047e-05,TRUE,129,241,23,HP,Aplasia/Hypoplasia of the iris,4962,5100,HP:0000525|HP:0008055|HP:0008062,FALSE
HP:0008055,6.74876878782047e-05,TRUE,129,241,23,HP,Aplasia/Hypoplasia affecting the uvea,4962,5102,HP:0000553|HP:0008056,FALSE
HPA:0380521,6.77393052385508e-05,TRUE,6353,418,291,HPA,placenta; trophoblastic cells[Low],11006,536,HPA:0380000,FALSE
REAC:R-HSA-1368108,6.78929823444796e-05,TRUE,27,485,10,REAC,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",10835,196,REAC:R-HSA-400253,FALSE
GO:0001822,6.79562840585739e-05,TRUE,317,553,28,GO:BP,kidney development,21010,489,GO:0048513|GO:0072001,FALSE
KEGG:04024,6.81359261560187e-05,TRUE,223,431,31,KEGG,cAMP signaling pathway,8161,247,KEGG:00000,FALSE
GO:0023061,6.86421756369477e-05,TRUE,485,553,36,GO:BP,signal release,21010,6960,GO:0007267|GO:0032940,FALSE
HPA:0300203,6.96761763453856e-05,TRUE,293,418,31,HPA,lung; endothelial cells[High],11006,455,HPA:0300202,FALSE
HPA:0100123,7.06492773206167e-05,TRUE,743,418,57,HPA,cerebral cortex; glial cells[High],11006,188,HPA:0100122,FALSE
TF:M11058,7.10479863998847e-05,TRUE,13404,556,431,TF,Factor: Hey1; motif: NGCRCGYGYN,20011,3378,TF:M00000,FALSE
GO:0022616,7.11631833151019e-05,TRUE,37,553,10,GO:BP,DNA strand elongation,21010,6938,GO:0006259,FALSE
TF:M12464,7.22307911180033e-05,TRUE,7040,556,258,TF,Factor: ZNF148; motif: NNCCCCTCCCCC,20011,9508,TF:M00000,FALSE
TF:M10121,7.24028854967579e-05,TRUE,4062,556,167,TF,Factor: ZFX; motif: SNAGGCCNCR,20011,9340,TF:M00000,FALSE
HP:0030084,7.24239493601758e-05,TRUE,527,241,54,HP,Clinodactyly,4962,10218,HP:0011297,FALSE
TF:M00008_1,7.24815851005891e-05,TRUE,5079,556,199,TF,Factor: Sp1; motif: GGGGCGGGGT; match class: 1,20011,7823,TF:M00008,FALSE
CORUM:2851,7.25515510509821e-05,TRUE,11,292,8,CORUM,ING2 complex,3383,1244,CORUM:0000000,FALSE
GO:0043588,7.27135001958783e-05,TRUE,318,553,28,GO:BP,skin development,21010,11308,GO:0048513,FALSE
KEGG:05231,7.28096779683341e-05,TRUE,98,431,19,KEGG,Choline metabolism in cancer,8161,472,KEGG:00000,FALSE
HP:0005522,7.36317875186817e-05,TRUE,23,241,10,HP,Pyridoxine-responsive sideroblastic anemia,4962,3730,HP:0001924,FALSE
TF:M00050,7.54265716715231e-05,TRUE,7214,556,263,TF,Factor: E2F; motif: TTTSGCGC,20011,1544,TF:M00000,FALSE
REAC:R-HSA-5628897,7.56624236407369e-05,TRUE,84,485,17,REAC,TP53 Regulates Metabolic Genes,10835,2335,REAC:R-HSA-3700989,FALSE
HP:0010936,7.63216129171318e-05,TRUE,822,241,73,HP,Abnormality of the lower urinary tract,4962,7359,HP:0000079,FALSE
TF:M09897,7.70535164591451e-05,TRUE,4348,556,176,TF,Factor: Egr-1; motif: NNNNGCGKGGGYGGNRN,20011,1622,TF:M00000,FALSE
GO:0090257,7.73638900317245e-05,TRUE,224,553,23,GO:BP,regulation of muscle system process,21010,19014,GO:0003012|GO:0044057,FALSE
REAC:R-HSA-2559584,7.7517840270245e-05,TRUE,16,485,8,REAC,Formation of Senescence-Associated Heterochromatin Foci (SAHF),10835,908,REAC:R-HSA-2559586,FALSE
REAC:R-HSA-9614657,7.7517840270245e-05,TRUE,16,485,8,REAC,FOXO-mediated transcription of cell death genes,10835,883,REAC:R-HSA-9614085,FALSE
CORUM:886,7.76420590383391e-05,TRUE,6,292,6,CORUM,MTA1 complex,3383,495,CORUM:0000000,FALSE
TF:M04148,7.80472770738108e-05,TRUE,10235,556,348,TF,Factor: TFAP2A; motif: NGCCCYNNGGGCN,20011,8558,TF:M00000,FALSE
WP:WP4685,7.89528125941082e-05,TRUE,68,461,16,WP,Melanoma,8625,190,WP:000000,FALSE
TF:M12160,7.96591234697807e-05,TRUE,13015,556,421,TF,Factor: KLF15; motif: RCCMCRCCCMCN,20011,4550,TF:M00000,FALSE
GO:0050810,8.008169031593e-05,TRUE,70,553,13,GO:BP,regulation of steroid biosynthetic process,21010,13933,GO:0006694|GO:0019218|GO:0046890,FALSE
GO:1903321,8.07198318825301e-05,TRUE,96,553,15,GO:BP,negative regulation of protein modification by small protein conjugation or removal,21010,23847,GO:0070647|GO:1901874|GO:1903320,FALSE
GO:0048754,8.10281558767431e-05,TRUE,156,553,19,GO:BP,branching morphogenesis of an epithelial tube,21010,13657,GO:0035239|GO:0060562|GO:0061138,FALSE
GO:0016331,8.10281558767431e-05,TRUE,156,553,19,GO:BP,morphogenesis of embryonic epithelium,21010,5296,GO:0002009|GO:0048598,FALSE
HP:0012848,8.3379689928714e-05,TRUE,29,241,11,HP,Small intestinal stenosis,4962,9233,HP:0002244,FALSE
HP:0100867,8.3379689928714e-05,TRUE,29,241,11,HP,Duodenal stenosis,4962,16341,HP:0002246|HP:0012848,FALSE
GO:0031461,8.37807958403947e-05,TRUE,188,548,19,GO:CC,cullin-RING ubiquitin ligase complex,22090,1122,GO:0000151,FALSE
HPA:0090181,8.42223961929789e-05,TRUE,4545,418,223,HPA,cerebellum; cells in granular layer[Low],11006,131,HPA:0090000,FALSE
HP:0012378,8.433714300889e-05,TRUE,387,241,44,HP,Fatigue,4962,8767,HP:0025142,FALSE
HP:0000078,8.43675211724587e-05,TRUE,1711,241,123,HP,Abnormality of the genital system,4962,73,HP:0000119,FALSE
HP:0001892,8.64366313575968e-05,TRUE,515,241,53,HP,Abnormal bleeding,4962,1373,HP:0001871,FALSE
WP:WP3995,8.65767155345398e-05,TRUE,32,461,11,WP,Prion disease pathway,8625,328,WP:000000,FALSE
GO:0098780,8.67143875110208e-05,TRUE,21,553,8,GO:BP,response to mitochondrial depolarisation,21010,19786,GO:0033554,TRUE
KEGG:05219,8.76699358985166e-05,TRUE,41,431,12,KEGG,Bladder cancer,8161,463,KEGG:00000,FALSE
HPA:0440341,8.91169949707326e-05,TRUE,5898,418,274,HPA,skeletal muscle; myocytes[Low],11006,608,HPA:0440000,FALSE
HPA:0440000,8.91169949707326e-05,TRUE,5898,418,274,HPA,skeletal muscle,11006,607,HPA:0000000,FALSE
KEGG:04340,8.92250868758268e-05,TRUE,56,431,14,KEGG,Hedgehog signaling pathway,8161,296,KEGG:00000,FALSE
GO:0007584,8.99649322031882e-05,TRUE,157,553,19,GO:BP,response to nutrient,21010,3099,GO:0031667|GO:0042221,FALSE
TF:M12183_1,9.16242772396154e-05,TRUE,2564,556,117,TF,Factor: KLF14; motif: NRCCACRCCCMCN; match class: 1,20011,4539,TF:M12183,FALSE
MIRNA:hsa-miR-29b-3p,9.28257688802075e-05,TRUE,261,514,28,MIRNA,hsa-miR-29b-3p,14846,503,MIRNA:000000,FALSE
GO:1902176,9.36251510321924e-05,TRUE,29,553,9,GO:BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,21010,22966,GO:0008631|GO:1902175|GO:2001243,FALSE
GO:0010971,9.36251510321924e-05,TRUE,29,553,9,GO:BP,positive regulation of G2/M transition of mitotic cell cycle,21010,4631,GO:0000086|GO:0010389|GO:1901992|GO:1902751,FALSE
GO:0009649,9.36251510321924e-05,TRUE,29,553,9,GO:BP,entrainment of circadian clock,21010,3624,GO:0009605|GO:0042752,FALSE
GO:0042634,9.36251510321924e-05,TRUE,29,553,9,GO:BP,regulation of hair cycle,21010,10770,GO:0042633|GO:0051239,FALSE
GO:0022612,9.37024806102142e-05,TRUE,126,553,17,GO:BP,gland morphogenesis,21010,6934,GO:0009887|GO:0048732,FALSE
GO:0032874,9.37024806102142e-05,TRUE,126,553,17,GO:BP,positive regulation of stress-activated MAPK cascade,21010,8242,GO:0032872|GO:0043410|GO:0051403|GO:0070304,FALSE
GO:0007281,9.41204059747969e-05,TRUE,342,553,29,GO:BP,germ cell development,21010,2859,GO:0003006|GO:0007276|GO:0022412|GO:0048468,FALSE
HP:0100013,9.5634006981004e-05,TRUE,92,241,19,HP,Neoplasm of the breast,4962,15533,HP:0011793|HP:0031093,FALSE
GO:0010657,9.57023094871751e-05,TRUE,71,553,13,GO:BP,muscle cell apoptotic process,21010,4374,GO:0006915,FALSE
GO:0030424,9.58560208486403e-05,TRUE,641,548,39,GO:CC,axon,22090,935,GO:0043005,FALSE
GO:0070412,9.61201188721521e-05,TRUE,24,555,8,GO:MF,R-SMAD binding,20139,8727,GO:0046332,FALSE
HP:0001770,9.64365388970786e-05,TRUE,233,241,32,HP,Toe syndactyly,4962,1285,HP:0001159|HP:0001780,FALSE
TF:M09761_1,9.76649934697473e-05,TRUE,1612,556,83,TF,Factor: EGR1; motif: NGNGKGGGYGGNGS; match class: 1,20011,1621,TF:M09761,FALSE
TF:M08207_1,9.78355062147835e-05,TRUE,15801,556,488,TF,Factor: E2F-3:TBR2; motif: ANGTGYKANGGCGCSTTNNCRNNT; match class: 1,20011,1477,TF:M08207,FALSE
TF:M12183,9.92583985756089e-05,TRUE,7028,556,257,TF,Factor: KLF14; motif: NRCCACRCCCMCN,20011,4538,TF:M00000,FALSE
REAC:R-HSA-438064,9.94538021192109e-05,TRUE,76,485,16,REAC,Post NMDA receptor activation events,10835,1691,REAC:R-HSA-442755,FALSE
GO:0008625,0.000100092392972118,TRUE,84,553,14,GO:BP,extrinsic apoptotic signaling pathway via death domain receptors,21010,3269,GO:0097191,FALSE
HPA:0490693,0.000100124689184901,TRUE,621,418,50,HPA,smooth muscle; smooth muscle cells[High],11006,750,HPA:0490692,FALSE
HP:0031466,0.000101170506844615,TRUE,607,241,59,HP,Impairment in personality functioning,4962,11521,HP:0000708,FALSE
TF:M11535,0.000101471026023512,TRUE,11147,556,372,TF,Factor: E2F-4; motif: TTTTGGCGCCAWWN,20011,1512,TF:M00000,FALSE
HPA:0060103,0.000101745669871111,TRUE,1845,418,110,HPA,bronchus; respiratory epithelial cells[High],11006,85,HPA:0060102,FALSE
WP:WP2203,0.000101904365897271,TRUE,46,461,13,WP,Thymic stromal lymphopoietin (TSLP) signaling pathway,8625,600,WP:000000,FALSE
HP:0010978,0.000102179905000224,TRUE,1716,241,123,HP,Abnormality of immune system physiology,4962,7400,HP:0002715,FALSE
REAC:R-HSA-2173793,0.000104044385019911,TRUE,50,485,13,REAC,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,10835,2435,REAC:R-HSA-170834|REAC:R-HSA-212436,FALSE
HPA:0100201,0.00010455317558972,TRUE,4633,418,226,HPA,cerebral cortex; endothelial cells[Low],11006,183,HPA:0100000,FALSE
HP:0002414,0.000105646604033122,TRUE,132,241,23,HP,Spina bifida,4962,1763,HP:0010301,FALSE
REAC:R-HSA-427413,0.000106636352740403,TRUE,106,485,19,REAC,NoRC negatively regulates rRNA expression,10835,1524,REAC:R-HSA-5250941,FALSE
GO:0032755,0.00010741763364934,TRUE,98,553,15,GO:BP,positive regulation of interleukin-6 production,21010,8167,GO:0001819|GO:0032635|GO:0032675,FALSE
GO:0045202,0.000107449568409877,TRUE,1451,548,68,GO:CC,synapse,22090,2145,GO:0030054,FALSE
GO:0010631,0.00010770019122658,TRUE,304,553,27,GO:BP,epithelial cell migration,21010,4349,GO:0001667|GO:0090132,FALSE
GO:0051251,0.00010844225208213,TRUE,324,553,28,GO:BP,positive regulation of lymphocyte activation,21010,14279,GO:0002696|GO:0046649|GO:0051249,FALSE
KEGG:04120,0.000109012755562582,TRUE,140,431,23,KEGG,Ubiquitin mediated proteolysis,8161,265,KEGG:00000,FALSE
REAC:R-HSA-8951430,0.000109995785214755,TRUE,8,485,6,REAC,RUNX3 regulates WNT signaling,10835,1852,REAC:R-HSA-8878159,FALSE
REAC:R-HSA-4411364,0.000109995785214755,TRUE,8,485,6,REAC,Binding of TCF/LEF:CTNNB1 to target gene promoters,10835,217,REAC:R-HSA-201722,FALSE
GO:0061448,0.000112030694893733,TRUE,285,553,26,GO:BP,connective tissue development,21010,16266,GO:0009888,FALSE
TF:M00144,0.000112073169194217,TRUE,13477,556,432,TF,Factor: Pax-5; motif: RRMSWGANWYCTNRAGCGKRACSRYNSM,20011,6386,TF:M00000,FALSE
GO:0008610,0.000112608487414159,TRUE,728,553,46,GO:BP,lipid biosynthetic process,21010,3261,GO:0006629|GO:1901576,FALSE
HP:0009484,0.000112657296133789,TRUE,519,241,53,HP,Deviation of the hand or of fingers of the hand,4962,6003,HP:0005922,FALSE
GO:0030308,0.000113371376968473,TRUE,193,553,21,GO:BP,negative regulation of cell growth,21010,7078,GO:0001558|GO:0016049|GO:0045926|GO:0048523,FALSE
TF:M04691_1,0.000113588359655888,TRUE,10707,556,360,TF,Factor: Kaiso; motif: TCTCGCGAG; match class: 1,20011,9119,TF:M04691,FALSE
GO:0009615,0.000113954702007836,TRUE,429,553,33,GO:BP,response to virus,21010,3598,GO:0051707,FALSE
GO:0035914,0.000114015226300153,TRUE,72,553,13,GO:BP,skeletal muscle cell differentiation,21010,9783,GO:0007519|GO:0030154,FALSE
HP:0004207,0.00011421282060778,TRUE,490,241,51,HP,Abnormal 5th finger morphology,4962,2922,HP:0001167,FALSE
TF:M04823_1,0.000115979321523215,TRUE,8041,556,286,TF,Factor: E2F-4; motif: NNTTCCCGCCNN; match class: 1,20011,1507,TF:M04823,FALSE
GO:0051087,0.000116315368965094,TRUE,135,555,17,GO:MF,protein-folding chaperone binding,20139,8006,GO:0005515,FALSE
GO:0098978,0.000116736914816929,TRUE,426,548,30,GO:CC,glutamatergic synapse,22090,3323,GO:0045202,FALSE
GO:0099536,0.000117510998851494,TRUE,778,553,48,GO:BP,synaptic signaling,21010,20016,GO:0007267,FALSE
MIRNA:hsa-miR-15a-5p,0.000118458024038041,TRUE,717,514,53,MIRNA,hsa-miR-15a-5p,14846,298,MIRNA:000000,FALSE
GO:1904507,0.00011881901503879,TRUE,15,553,7,GO:BP,positive regulation of telomere maintenance in response to DNA damage,21010,24862,GO:0032206|GO:0043247|GO:0048584|GO:1904505,FALSE
GO:0070304,0.000118836323232318,TRUE,128,553,17,GO:BP,positive regulation of stress-activated protein kinase signaling cascade,21010,16843,GO:0031098|GO:0070302|GO:1902533,FALSE
HPA:0510701,0.000118978770026755,TRUE,3192,418,168,HPA,soft tissue 2; peripheral nerve[Low],11006,768,HPA:0510000,FALSE
WP:WP4191,0.000119214773509823,TRUE,8,461,6,WP,Caloric restriction and aging,8625,392,WP:000000,FALSE
TF:M11881_1,0.000119356227548474,TRUE,7315,556,265,TF,Factor: pax-6; motif: NYACGCNTSANYGCNYN; match class: 1,20011,6411,TF:M11881,FALSE
HPA:0470683,0.000120961182577978,TRUE,1048,418,72,HPA,skin 2; epidermal cells[High],11006,700,HPA:0470682,FALSE
REAC:R-HSA-69620,0.000121262755024085,TRUE,289,485,34,REAC,Cell Cycle Checkpoints,10835,313,REAC:R-HSA-1640170,FALSE
REAC:R-HSA-9614399,0.000122125979466635,TRUE,12,485,7,REAC,Regulation of localization of FOXO transcription factors,10835,1943,REAC:R-HSA-9614085,FALSE
REAC:R-HSA-9755779,0.000122125979466635,TRUE,12,485,7,REAC,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,10835,2021,REAC:R-HSA-9705683,FALSE
GO:0000166,0.000123030406223489,TRUE,2182,555,100,GO:MF,nucleotide binding,20139,31,GO:0036094|GO:1901265,FALSE
TF:M01303_1,0.000123346987417407,TRUE,3627,556,152,TF,Factor: SP1; motif: GGGGYGGGGNS; match class: 1,20011,7825,TF:M01303,FALSE
GO:0046364,0.000123574100437072,TRUE,99,553,15,GO:BP,monosaccharide biosynthetic process,21010,12713,GO:0005996|GO:0016051|GO:0044283,FALSE
GO:0010717,0.000123574100437072,TRUE,99,553,15,GO:BP,regulation of epithelial to mesenchymal transition,21010,4418,GO:0001837|GO:0045595,FALSE
WP:WP4481,0.000123681620989173,TRUE,33,461,11,WP,Resistin as a regulator of inflammation,8625,405,WP:000000,FALSE
GO:0032570,0.000123874577500989,TRUE,39,553,10,GO:BP,response to progesterone,21010,8005,GO:0048545|GO:1901654,FALSE
GO:0000423,0.000123874577500989,TRUE,39,553,10,GO:BP,mitophagy,21010,133,GO:0000422|GO:0061912,FALSE
GO:0021543,0.000124066332225786,TRUE,194,553,21,GO:BP,pallium development,21010,6431,GO:0021537|GO:0048856,FALSE
GO:0034330,0.000125047326174452,TRUE,755,553,47,GO:BP,cell junction organization,21010,8964,GO:0016043,FALSE
REAC:R-HSA-446652,0.0001255550010223,TRUE,151,485,23,REAC,Interleukin-1 family signaling,10835,1179,REAC:R-HSA-449147,FALSE
GO:1901265,0.000125743605401488,TRUE,2183,555,100,GO:MF,nucleoside phosphate binding,20139,10946,GO:0097159|GO:1901363,FALSE
TF:M04148_1,0.000127220302402515,TRUE,9796,556,335,TF,Factor: TFAP2A; motif: NGCCCYNNGGGCN; match class: 1,20011,8559,TF:M04148,FALSE
GO:0002947,0.000127451456679924,TRUE,4,548,4,GO:CC,tumor necrosis factor receptor superfamily complex,22090,196,GO:0043235,TRUE
GO:0043247,0.000130644966906901,TRUE,30,553,9,GO:BP,telomere maintenance in response to DNA damage,21010,11092,GO:0000723|GO:0006974,FALSE
HP:0002143,0.000131888617000177,TRUE,299,241,37,HP,Abnormal spinal cord morphology,4962,1573,HP:0002011,FALSE
GO:0008080,0.000131903387833017,TRUE,66,555,12,GO:MF,N-acetyltransferase activity,20139,1542,GO:0016407|GO:0016410,FALSE
GO:0072001,0.00013190872561368,TRUE,327,553,28,GO:BP,renal system development,21010,17868,GO:0048731,FALSE
GO:0090132,0.000132022234356821,TRUE,307,553,27,GO:BP,epithelium migration,21010,18903,GO:0090130,FALSE
GO:1902074,0.00013204372231026,TRUE,368,553,30,GO:BP,response to salt,21010,22878,GO:0042221,FALSE
MIRNA:hsa-miR-9-5p,0.000132678777524682,TRUE,348,514,33,MIRNA,hsa-miR-9-5p,14846,2577,MIRNA:000000,FALSE
GO:0045821,0.000133132892523505,TRUE,22,553,8,GO:BP,positive regulation of glycolytic process,21010,12256,GO:0006096|GO:0006110|GO:0031331|GO:0045913|GO:0062013,FALSE
GO:0006275,0.000133589356490489,TRUE,129,553,17,GO:BP,regulation of DNA replication,21010,2120,GO:0006260|GO:0051052,FALSE
GO:0006368,0.00013431609011904,TRUE,114,553,16,GO:BP,transcription elongation by RNA polymerase II,21010,2176,GO:0006354|GO:0006366,FALSE
GO:0032006,0.00013431609011904,TRUE,114,553,16,GO:BP,regulation of TOR signaling,21010,7665,GO:0031929|GO:1902531,FALSE
TF:M08441_1,0.000134340933695344,TRUE,13014,556,420,TF,Factor: AP-2gamma:Elk-1; motif: NGCCKNRGGSGRCGGAAGTG; match class: 1,20011,8589,TF:M08441,FALSE
GO:0042391,0.000134453671577618,TRUE,432,553,33,GO:BP,regulation of membrane potential,21010,10641,GO:0065008,FALSE
GO:0042995,0.000134767374625155,TRUE,2329,548,96,GO:CC,cell projection,22090,1849,GO:0110165,FALSE
GO:0014855,0.00013542396890123,TRUE,73,553,13,GO:BP,striated muscle cell proliferation,21010,4816,GO:0033002,FALSE
GO:0046323,0.00013542396890123,TRUE,73,553,13,GO:BP,glucose import,21010,12674,GO:1904659,TRUE
GO:0035050,0.000136388739816848,TRUE,86,553,14,GO:BP,embryonic heart tube development,21010,9200,GO:0007507|GO:0035295|GO:0048568|GO:0060429,FALSE
TF:M00050_1,0.00013903360634701,TRUE,1927,556,94,TF,Factor: E2F; motif: TTTSGCGC; match class: 1,20011,1545,TF:M00050,FALSE
GO:0030225,0.000139049628632144,TRUE,61,553,12,GO:BP,macrophage differentiation,21010,7048,GO:0002573,FALSE
GO:0070231,0.000139049628632144,TRUE,61,553,12,GO:BP,T cell apoptotic process,21010,16796,GO:0070227,FALSE
REAC:R-HSA-9617828,0.000140708628097535,TRUE,17,485,8,REAC,FOXO-mediated transcription of cell cycle genes,10835,882,REAC:R-HSA-9614085,FALSE
TF:M04516_1,0.000141165239001789,TRUE,10501,556,354,TF,Factor: E2F-1; motif: TTTGGCGCCAAA; match class: 1,20011,1437,TF:M04516,FALSE
HPA:0100132,0.000146273307298114,TRUE,4988,418,239,HPA,cerebral cortex; neuronal cells[Medium],11006,190,HPA:0100131,FALSE
REAC:R-HSA-380972,0.000148652763599516,TRUE,29,485,10,REAC,Energy dependent regulation of mTOR by LKB1-AMPK,10835,809,REAC:R-HSA-165159,FALSE
GO:0030218,0.00014999899405796,TRUE,130,553,17,GO:BP,erythrocyte differentiation,21010,7041,GO:0030099|GO:0034101,FALSE
TF:M12173_1,0.000151865398243368,TRUE,5093,556,198,TF,Factor: GKLF; motif: NNCCMCRCCCN; match class: 1,20011,4585,TF:M12173,FALSE
TF:M00430,0.000152087733574253,TRUE,8201,556,290,TF,Factor: E2F-1; motif: NTTSGCGG,20011,1450,TF:M00000,FALSE
GO:0006334,0.000152287128882008,TRUE,115,553,16,GO:BP,nucleosome assembly,21010,2155,GO:0006325|GO:0034728|GO:0065004,FALSE
REAC:R-HSA-9687139,0.000152380488918315,TRUE,36,485,11,REAC,Aberrant regulation of mitotic cell cycle due to RB1 defects,10835,45,REAC:R-HSA-9675126,FALSE
REAC:R-HSA-2173796,0.000152380488918315,TRUE,36,485,11,REAC,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,10835,2047,REAC:R-HSA-2173793,FALSE
WP:WP2513,0.000154283246952201,TRUE,12,461,7,WP,Nanoparticle triggered regulated necrosis,8625,748,WP:000000,FALSE
HP:0012252,0.000159824557850211,TRUE,1409,241,106,HP,Abnormal respiratory system morphology,4962,8646,HP:0002086,FALSE
GO:0046907,0.000160143338240367,TRUE,1816,553,86,GO:BP,intracellular transport,21010,13070,GO:0006810|GO:0051641|GO:0051649,FALSE
GO:0002067,0.000160383477377396,TRUE,74,553,13,GO:BP,glandular epithelial cell differentiation,21010,671,GO:0002065,FALSE
HPA:0540052,0.000161369115169166,TRUE,6342,418,289,HPA,stomach 1; glandular cells[Medium],11006,784,HPA:0540051,FALSE
GO:0061647,0.00016350448227727,TRUE,10,553,6,GO:BP,histone H3-K9 modification,21010,16387,GO:0016570,FALSE
GO:0046015,0.00016350448227727,TRUE,10,553,6,GO:BP,regulation of transcription by glucose,21010,12423,GO:0006355,FALSE
GO:0071144,0.000165218184912382,TRUE,8,548,5,GO:CC,heteromeric SMAD protein complex,22090,2695,GO:0071141|GO:0090575,FALSE
GO:0072331,0.00016746275431774,TRUE,180,553,20,GO:BP,signal transduction by p53 class mediator,21010,18186,GO:0035556,FALSE
GO:0070585,0.000168231373178179,TRUE,131,553,17,GO:BP,protein localization to mitochondrion,21010,16993,GO:0033365,FALSE
GO:1900015,0.000168343573870159,TRUE,62,553,12,GO:BP,regulation of cytokine production involved in inflammatory response,21010,21123,GO:0001817|GO:0002534,FALSE
GO:0002534,0.000168343573870159,TRUE,62,553,12,GO:BP,cytokine production involved in inflammatory response,21010,1070,GO:0001816|GO:0002532,FALSE
KEGG:04725,0.00016889741692455,TRUE,113,431,20,KEGG,Cholinergic synapse,8161,349,KEGG:00000,FALSE
KEGG:04261,0.000169136085236442,TRUE,154,431,24,KEGG,Adrenergic signaling in cardiomyocytes,8161,291,KEGG:00000,FALSE
HP:0200007,0.000171218420832219,TRUE,289,241,36,HP,Abnormal size of the palpebral fissures,4962,16437,HP:0008050,FALSE
GO:0007006,0.000172422690892393,TRUE,116,553,16,GO:BP,mitochondrial membrane organization,21010,2661,GO:0007005|GO:0061024,FALSE
GO:0030900,0.000173145713926255,TRUE,415,553,32,GO:BP,forebrain development,21010,7273,GO:0007420|GO:0048856,FALSE
GO:0004708,0.0001732586326031,TRUE,18,555,7,GO:MF,MAP kinase kinase activity,20139,1000,GO:0004712,FALSE
TF:M12345_1,0.000173827440071622,TRUE,1825,556,90,TF,Factor: Zbtb37; motif: NYACCGCRNTCACCGCR; match class: 1,20011,9131,TF:M12345,FALSE
GO:0030054,0.000174229714905539,TRUE,2214,548,92,GO:CC,cell junction,22090,871,GO:0110165,FALSE
HPA:0351183,0.000175673900633017,TRUE,802,418,59,HPA,pancreas; pancreatic endocrine cells[High],11006,505,HPA:0351182,FALSE
HP:0200005,0.000177614241798633,TRUE,60,241,15,HP,Abnormal shape of the palpebral fissure,4962,16435,HP:0008050,FALSE
GO:0090068,0.000177901357620767,TRUE,253,553,24,GO:BP,positive regulation of cell cycle process,21010,18847,GO:0010564|GO:0022402|GO:0045787,FALSE
CORUM:778,0.000177917389804213,TRUE,19,292,10,CORUM,LARC complex (LCR-associated remodeling complex),3383,434,CORUM:0000000,FALSE
GO:0016574,0.000179817574404227,TRUE,31,553,9,GO:BP,histone ubiquitination,21010,5347,GO:0016567|GO:0016570,FALSE
GO:0002066,0.000183719898159768,TRUE,51,553,11,GO:BP,columnar/cuboidal epithelial cell development,21010,670,GO:0002064|GO:0002065,FALSE
HP:0002715,0.000183940787603446,TRUE,2066,241,140,HP,Abnormality of the immune system,4962,1968,HP:0000118,FALSE
GO:0045685,0.000189405478361279,TRUE,75,553,13,GO:BP,regulation of glial cell differentiation,21010,12148,GO:0010001|GO:0045595,FALSE
GO:2000323,0.000191711812480921,TRUE,6,553,5,GO:BP,negative regulation of glucocorticoid receptor signaling pathway,21010,26727,GO:0033144|GO:0042921|GO:2000322,FALSE
GO:0070932,0.000191711812480921,TRUE,6,553,5,GO:BP,histone H3 deacetylation,21010,17183,GO:0016575,FALSE
HP:0010469,0.000192958390565514,TRUE,25,241,10,HP,Absent testis,4962,6923,HP:0010468,FALSE
GO:0030291,0.000195191719624987,TRUE,35,555,9,GO:MF,protein serine/threonine kinase inhibitor activity,20139,3904,GO:0004860,FALSE
GO:0090130,0.000196727277470472,TRUE,313,553,27,GO:BP,tissue migration,21010,18901,GO:0032501,FALSE
WP:WP69,0.000198702586048572,TRUE,90,461,18,WP,T-cell receptor signaling pathway,8625,280,WP:000000,FALSE
GO:0033522,0.000199445505938617,TRUE,23,553,8,GO:BP,histone H2A ubiquitination,21010,8640,GO:0016574,FALSE
GO:1904356,0.000203036104308999,TRUE,63,553,12,GO:BP,regulation of telomere maintenance via telomere lengthening,21010,24732,GO:0010833|GO:0032204,FALSE
CORUM:646,0.000203056111971882,TRUE,9,292,7,CORUM,HDAC1-associated protein complex,3383,359,CORUM:0000000,FALSE
WP:WP5381,0.000203180252856226,TRUE,159,461,25,WP,Smith-Magenis and Potocki-Lupski syndrome copy number variation,8625,471,WP:000000,FALSE
GO:0043005,0.000203960681026262,TRUE,1299,548,62,GO:CC,neuron projection,22090,1850,GO:0120025,FALSE
GO:0050808,0.00020454386096387,TRUE,484,553,35,GO:BP,synapse organization,21010,13932,GO:0034330,FALSE
WP:WP3874,0.000205450672036997,TRUE,17,461,8,WP,Canonical and non-canonical TGF-B signaling,8625,57,WP:000000,FALSE
WP:WP3664,0.000205450672036997,TRUE,17,461,8,WP,Regulation of Wnt / B-catenin signaling by small molecule compounds,8625,29,WP:000000,FALSE
GO:0060546,0.00020644171257511,TRUE,16,553,7,GO:BP,negative regulation of necroptotic process,21010,15472,GO:0060544|GO:0062099|GO:0070266,FALSE
GO:1900034,0.00020644171257511,TRUE,16,553,7,GO:BP,regulation of cellular response to heat,21010,21139,GO:0034605|GO:0080135,FALSE
MIRNA:hsa-miR-182-5p,0.000207745677190847,TRUE,179,514,22,MIRNA,hsa-miR-182-5p,14846,317,MIRNA:000000,FALSE
GO:0010907,0.000208346006253834,TRUE,41,553,10,GO:BP,positive regulation of glucose metabolic process,21010,4576,GO:0006006|GO:0010906|GO:0045913|GO:0062013,FALSE
GO:0044089,0.000209750169200327,TRUE,507,553,36,GO:BP,positive regulation of cellular component biogenesis,21010,11462,GO:0044085|GO:0044087|GO:0048522,FALSE
GO:0060348,0.000210574468533734,TRUE,218,553,22,GO:BP,bone development,21010,15291,GO:0001501|GO:0048513,FALSE
GO:0042180,0.000210574468533734,TRUE,218,553,22,GO:BP,cellular ketone metabolic process,21010,10507,GO:0044237|GO:0044281|GO:0071704,FALSE
GO:0032784,0.000212695901015857,TRUE,103,553,15,GO:BP,regulation of DNA-templated transcription elongation,21010,8190,GO:0006354|GO:0006355,FALSE
GO:0043535,0.000213372397433405,TRUE,89,553,14,GO:BP,regulation of blood vessel endothelial cell migration,21010,11268,GO:0010594|GO:0043534,FALSE
REAC:R-HSA-9022692,0.00021413196710805,TRUE,30,485,10,REAC,Regulation of MECP2 expression and activity,10835,1899,REAC:R-HSA-8986944,FALSE
REAC:R-HSA-2151201,0.000218080083764804,TRUE,53,485,13,REAC,Transcriptional activation of mitochondrial biogenesis,10835,2433,REAC:R-HSA-1592230,FALSE
HP:0100006,0.000219115890884797,TRUE,170,241,26,HP,Neoplasm of the central nervous system,4962,15526,HP:0002011|HP:0004375,FALSE
HPA:0550052,0.000219787508992386,TRUE,6275,418,286,HPA,stomach 2; glandular cells[Medium],11006,788,HPA:0550051,FALSE
HP:0010301,0.0002236232946419,TRUE,148,241,24,HP,Spinal dysraphism,4962,6761,HP:0002143|HP:0045005,FALSE
HPA:0480052,0.000230314745080426,TRUE,6057,418,278,HPA,small intestine; glandular cells[Medium],11006,739,HPA:0480051,FALSE
GO:0016363,0.000234266710442469,TRUE,128,548,15,GO:CC,nuclear matrix,22090,738,GO:0034399|GO:0110165,FALSE
HPA:0570812,0.000240743498292304,TRUE,2374,418,132,HPA,testis; spermatogonia cells[Medium],11006,829,HPA:0570811,FALSE
HPA:0050013,0.000241856102615291,TRUE,310,418,31,HPA,breast; adipocytes[High],11006,57,HPA:0050012,FALSE
REAC:R-HSA-1368082,0.000243396286885429,TRUE,18,485,8,REAC,RORA activates gene expression,10835,1826,REAC:R-HSA-400253,FALSE
REAC:R-HSA-1362277,0.000243396286885429,TRUE,18,485,8,REAC,Transcription of E2F targets under negative control by DREAM complex,10835,2421,REAC:R-HSA-1538133,FALSE
GO:0032757,0.000243981892301869,TRUE,64,553,12,GO:BP,positive regulation of interleukin-8 production,21010,8169,GO:0001819|GO:0032637|GO:0032677,FALSE
GO:1902751,0.000244375111776888,TRUE,32,553,9,GO:BP,positive regulation of cell cycle G2/M phase transition,21010,23388,GO:0044839|GO:1901989|GO:1902749,FALSE
HP:0004375,0.000246028409961568,TRUE,194,241,28,HP,Neoplasm of the nervous system,4962,3063,HP:0011793|HP:0012639,FALSE
GO:0048145,0.000246659011069034,TRUE,90,553,14,GO:BP,regulation of fibroblast proliferation,21010,13194,GO:0042127|GO:0048144,FALSE
HP:0002896,0.000248189358591964,TRUE,138,241,23,HP,Neoplasm of the liver,4962,2097,HP:0001392|HP:0007378,FALSE
GO:0050769,0.000256808888057656,TRUE,239,553,23,GO:BP,positive regulation of neurogenesis,21010,13901,GO:0010720|GO:0022008|GO:0050767|GO:0051962,FALSE
GO:0046883,0.00025752205626748,TRUE,258,553,24,GO:BP,regulation of hormone secretion,21010,13051,GO:0010646|GO:0010817|GO:0023051|GO:0046879|GO:1903530,FALSE
REAC:R-HSA-4090294,0.000260904345073137,TRUE,24,485,9,REAC,SUMOylation of intracellular receptors,10835,2068,REAC:R-HSA-3108232,FALSE
HPA:0020052,0.000261588767276426,TRUE,6009,418,276,HPA,adrenal gland; glandular cells[Medium],11006,17,HPA:0020051,FALSE
GO:0048512,0.000267059698006394,TRUE,42,553,10,GO:BP,circadian behavior,21010,13447,GO:0007622|GO:0007623,FALSE
HP:0000047,0.00027226129073194,TRUE,361,241,41,HP,Hypospadias,4962,43,HP:0100627,FALSE
HP:0006740,0.000272993089147505,TRUE,32,241,11,HP,Transitional cell carcinoma of the bladder,4962,4406,HP:0002862,FALSE
GO:0015031,0.000279532247836814,TRUE,1810,553,85,GO:BP,protein transport,21010,4880,GO:0045184|GO:0071702|GO:0071705,FALSE
GO:0071887,0.000279575146731667,TRUE,120,553,16,GO:BP,leukocyte apoptotic process,21010,17786,GO:0006915,FALSE
KEGG:03460,0.000279861698645496,TRUE,53,431,13,KEGG,Fanconi anemia pathway,8161,237,KEGG:00000,FALSE
WP:WP3869,0.000284902144638077,TRUE,29,461,10,WP,Cannabinoid receptor signaling,8625,311,WP:000000,FALSE
WP:WP5115,0.000285821479823572,TRUE,217,461,30,WP,Network map of SARS-CoV-2 signaling pathway,8625,25,WP:000000,FALSE
HP:0025031,0.000286540135568633,TRUE,2887,241,178,HP,Abnormality of the digestive system,4962,9486,HP:0000118,FALSE
GO:0017076,0.000288276890183148,TRUE,2019,555,93,GO:MF,purine nucleotide binding,20139,3148,GO:0000166,FALSE
GO:0006303,0.000292148807996716,TRUE,65,553,12,GO:BP,double-strand break repair via nonhomologous end joining,21010,2140,GO:0006302,FALSE
GO:0060760,0.000292148807996716,TRUE,65,553,12,GO:BP,positive regulation of response to cytokine stimulus,21010,15667,GO:0034097|GO:0048584|GO:0060759,FALSE
HPA:0440343,0.000293698379427579,TRUE,873,418,62,HPA,skeletal muscle; myocytes[High],11006,610,HPA:0440342,FALSE
HP:0007874,0.000294383170949909,TRUE,54,241,14,HP,Almond-shaped palpebral fissure,4962,5008,HP:0200005,FALSE
MIRNA:hsa-miR-146a-5p,0.000294518655889864,TRUE,228,514,25,MIRNA,hsa-miR-146a-5p,14846,266,MIRNA:000000,FALSE
GO:0048592,0.000295960915684509,TRUE,169,553,19,GO:BP,eye morphogenesis,21010,13513,GO:0001654|GO:0090596,FALSE
TF:M07348,0.000297219669110344,TRUE,8251,556,290,TF,Factor: AP-2alpha; motif: NSCCNCRGGSN,20011,132,TF:M00000,FALSE
KEGG:05120,0.00029926088086176,TRUE,70,431,15,KEGG,Epithelial cell signaling in Helicobacter pylori infection,8161,419,KEGG:00000,FALSE
MIRNA:hsa-miR-320a,0.000302151256534191,TRUE,581,514,45,MIRNA,hsa-miR-320a,14846,666,MIRNA:000000,FALSE
GO:0003151,0.000306940673573668,TRUE,78,553,13,GO:BP,outflow tract morphogenesis,21010,1600,GO:0003007|GO:0009653,FALSE
GO:0006970,0.000306940673573668,TRUE,78,553,13,GO:BP,response to osmotic stress,21010,2639,GO:0006950|GO:0009628,FALSE
KEGG:01521,0.000307005714137094,TRUE,79,431,16,KEGG,EGFR tyrosine kinase inhibitor resistance,8161,195,KEGG:00000,FALSE
CORUM:282,0.000308786733623814,TRUE,16,292,9,CORUM,SNF2h-cohesin-NuRD complex,3383,164,CORUM:0000000,FALSE
WP:WP2857,0.000310384174119529,TRUE,152,461,24,WP,Mesodermal commitment pathway,8625,239,WP:000000,FALSE
TF:M09862_1,0.000311329698208715,TRUE,4273,556,171,TF,Factor: ZNF614; motif: NCYCWGCCYYNNN; match class: 1,20011,10801,TF:M09862,FALSE
GO:0061138,0.000315966654930462,TRUE,187,553,20,GO:BP,morphogenesis of a branching epithelium,21010,16001,GO:0001763|GO:0002009,FALSE
GO:0001959,0.000318922412071961,TRUE,153,553,18,GO:BP,regulation of cytokine-mediated signaling pathway,21010,579,GO:0009966|GO:0019221|GO:0060759,FALSE
GO:0002244,0.000327193798250725,TRUE,137,553,17,GO:BP,hematopoietic progenitor cell differentiation,21010,791,GO:0030097|GO:0030154,FALSE
GO:0030295,0.000327622751073562,TRUE,129,555,16,GO:MF,protein kinase activator activity,20139,3908,GO:0019209|GO:0019887,FALSE
GO:0043279,0.000327644966043343,TRUE,92,553,14,GO:BP,response to alkaloid,21010,11109,GO:0010243,FALSE
TF:M00918,0.000327677159841569,TRUE,5733,556,216,TF,Factor: E2F; motif: TTTSGCGSG,20011,1552,TF:M00000,FALSE
WP:WP4746,0.000328909758236152,TRUE,93,461,18,WP,Thyroid hormones production and peripheral downstream signaling effects,8625,206,WP:000000,FALSE
GO:0044403,0.000329265449322443,TRUE,321,553,27,GO:BP,biological process involved in symbiotic interaction,21010,11560,GO:0044419,FALSE
GO:0036094,0.000330182058489063,TRUE,2583,555,112,GO:MF,small molecule binding,20139,5425,GO:0005488,FALSE
TF:M03876,0.000330598513044161,TRUE,13918,556,441,TF,Factor: Kaiso; motif: GCMGGGRGCRGS,20011,4524,TF:M00000,FALSE
WP:WP3850,0.000331706318304241,TRUE,36,461,11,WP,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling,8625,100,WP:000000,FALSE
REAC:R-HSA-5621481,0.00033424120651631,TRUE,136,485,21,REAC,C-type lectin receptors (CLRs),10835,251,REAC:R-HSA-168249,FALSE
TF:M06948,0.000335274067889964,TRUE,9076,556,313,TF,Factor: Sp2; motif: TGGGCGCGCCCA,20011,7864,TF:M00000,FALSE
GO:0050804,0.000336134260704615,TRUE,494,553,35,GO:BP,modulation of chemical synaptic transmission,21010,13928,GO:0007268|GO:0099177,FALSE
TF:M05499,0.000336674218016923,TRUE,8085,556,285,TF,Factor: LKLF; motif: NGGGCGG,20011,4764,TF:M00000,FALSE
TF:M05386,0.000336674218016923,TRUE,8085,556,285,TF,Factor: KLF17; motif: NGGGCGG,20011,4562,TF:M00000,FALSE
GO:0071542,0.000339851051743014,TRUE,43,553,10,GO:BP,dopaminergic neuron differentiation,21010,17563,GO:0030182,FALSE
GO:0051770,0.000342991882659722,TRUE,17,553,7,GO:BP,positive regulation of nitric-oxide synthase biosynthetic process,21010,14623,GO:0010557|GO:0051767|GO:0051769,FALSE
GO:0060382,0.000342991882659722,TRUE,17,553,7,GO:BP,regulation of DNA strand elongation,21010,15324,GO:0022616|GO:0051052,FALSE
GO:0062099,0.000342991882659722,TRUE,17,553,7,GO:BP,negative regulation of programmed necrotic cell death,21010,16612,GO:0043069|GO:0062098|GO:0097300,FALSE
GO:0030520,0.000343802600598807,TRUE,54,553,11,GO:BP,intracellular estrogen receptor signaling pathway,21010,7151,GO:0030518,FALSE
GO:0032210,0.000343802600598807,TRUE,54,553,11,GO:BP,regulation of telomere maintenance via telomerase,21010,7766,GO:0007004|GO:1904356|GO:2000278,FALSE
GO:0120025,0.000344985479767447,TRUE,2217,548,91,GO:CC,plasma membrane bounded cell projection,22090,3451,GO:0042995,FALSE
GO:0031099,0.00034506414362152,TRUE,188,553,20,GO:BP,regeneration,21010,7359,GO:0048856,FALSE
HPA:0050093,0.000345207275541679,TRUE,838,418,60,HPA,breast; myoepithelial cells[High],11006,63,HPA:0050092,FALSE
HPA:0350472,0.000347202482390827,TRUE,5297,418,249,HPA,pancreas; exocrine glandular cells[Medium],11006,501,HPA:0350471,FALSE
REAC:R-HSA-1912408,0.000351574115657649,TRUE,93,485,17,REAC,Pre-NOTCH Transcription and Translation,10835,1705,REAC:R-HSA-1912422,FALSE
GO:0071514,0.000351694363428825,TRUE,11,553,6,GO:BP,genomic imprinting,21010,17552,GO:0007281|GO:0022412|GO:0040029,FALSE
GO:0051961,0.000352456310899471,TRUE,154,553,18,GO:BP,negative regulation of nervous system development,21010,14727,GO:0007399|GO:0051093|GO:0051241|GO:0051960,FALSE
WP:WP2011,0.000352612559826663,TRUE,18,461,8,WP,SREBF and miR33 in cholesterol and lipid homeostasis,8625,157,WP:000000,FALSE
HPA:0460641,0.000352797668686901,TRUE,3957,418,197,HPA,skin 1; Langerhans[Low],11006,622,HPA:0460000,FALSE
GO:0099177,0.000352949323884454,TRUE,495,553,35,GO:BP,regulation of trans-synaptic signaling,21010,19986,GO:0010646|GO:0023051|GO:0099537,FALSE
REAC:R-HSA-1834949,0.000355959428051344,TRUE,64,485,14,REAC,Cytosolic sensors of pathogen-associated DNA ,10835,411,REAC:R-HSA-168249,FALSE
TF:M10111,0.000357206461305192,TRUE,2717,556,120,TF,Factor: ZF5; motif: NGAGCGCGC,20011,9224,TF:M00000,FALSE
HP:0012243,0.000358411758209236,TRUE,1177,241,92,HP,Abnormal reproductive system morphology,4962,8637,HP:0000078,FALSE
GO:0071141,0.00036413714165079,TRUE,9,548,5,GO:CC,SMAD protein complex,22090,2693,GO:0032991,FALSE
TF:M12173,0.000366363797564602,TRUE,10243,556,345,TF,Factor: GKLF; motif: NNCCMCRCCCN,20011,4584,TF:M00000,FALSE
GO:0034976,0.000369109489526284,TRUE,263,553,24,GO:BP,response to endoplasmic reticulum stress,21010,9162,GO:0033554,FALSE
HPA:0500000,0.000373286833990646,TRUE,5354,418,251,HPA,soft tissue 1,11006,751,HPA:0000000,FALSE
GO:0032555,0.000373643471690695,TRUE,1916,555,89,GO:MF,purine ribonucleotide binding,20139,4481,GO:0017076|GO:0032553,FALSE
GO:0030901,0.000376523559971925,TRUE,93,553,14,GO:BP,midbrain development,21010,7274,GO:0007420|GO:0048856,FALSE
GO:0140537,0.000378400449241771,TRUE,13,555,6,GO:MF,transcription regulator activator activity,20139,10619,GO:0140677,FALSE
HP:0032101,0.000379656878374654,TRUE,1039,241,84,HP,Unusual infection,4962,12121,HP:0010978,FALSE
TF:M05361_1,0.000381339692907935,TRUE,3413,556,143,TF,Factor: Sp6; motif: WGGGCGG; match class: 1,20011,7907,TF:M05361,FALSE
TF:M05444_1,0.000381339692907935,TRUE,3413,556,143,TF,Factor: CPBP; motif: NGGGCGG; match class: 1,20011,943,TF:M05444,FALSE
TF:M05332_1,0.000381339692907935,TRUE,3413,556,143,TF,Factor: Sp2; motif: WGGGCGG; match class: 1,20011,7863,TF:M05332,FALSE
TF:M01873_1,0.000382364968439109,TRUE,2750,556,121,TF,Factor: Egr-1; motif: GCGGGGGCGG; match class: 1,20011,1633,TF:M01873,FALSE
TF:M01837,0.000385608564247287,TRUE,5579,556,211,TF,Factor: FKLF; motif: BGGGNGGVMD,20011,2418,TF:M00000,FALSE
HPA:0160052,0.000385670447859598,TRUE,5144,418,243,HPA,endometrium 1; glandular cells[Medium],11006,311,HPA:0160051,FALSE
GO:0035264,0.000389184393890296,TRUE,155,553,18,GO:BP,multicellular organism growth,21010,9352,GO:0032501|GO:0048589,FALSE
WP:WP4949,0.000391298099489359,TRUE,76,461,16,WP,16p11.2 proximal deletion syndrome,8625,48,WP:000000,FALSE
REAC:R-HSA-5357769,0.000391616457590483,TRUE,25,485,9,REAC,Caspase activation via extrinsic apoptotic signalling pathway,10835,307,REAC:R-HSA-109581,FALSE
HP:0006716,0.000392105724581841,TRUE,33,241,11,HP,Hereditary nonpolyposis colorectal carcinoma,4962,4391,HP:0002672|HP:0100834,FALSE
MIRNA:hsa-miR-221-3p,0.000398709274379914,TRUE,365,514,33,MIRNA,hsa-miR-221-3p,14846,448,MIRNA:000000,FALSE
HP:0100852,0.000399968113716952,TRUE,422,241,45,HP,Abnormal fear/anxiety-related behavior,4962,16326,HP:0031466,FALSE
GO:1904035,0.000404259029118616,TRUE,108,553,15,GO:BP,regulation of epithelial cell apoptotic process,21010,24450,GO:0042981|GO:1904019,FALSE
HP:0100627,0.000404753313339469,TRUE,380,241,42,HP,Displacement of the urethral meatus,4962,16128,HP:0000795|HP:0032076,FALSE
GO:0071333,0.000405011755181987,TRUE,139,553,17,GO:BP,cellular response to glucose stimulus,21010,17399,GO:0001678|GO:0009749|GO:0071331,FALSE
GO:0034101,0.000405011755181987,TRUE,139,553,17,GO:BP,erythrocyte homeostasis,21010,8793,GO:0002262,FALSE
GO:0050708,0.000425135611313476,TRUE,265,553,24,GO:BP,regulation of protein secretion,21010,13879,GO:0009306|GO:0051223|GO:1903530,FALSE
GO:0010817,0.000428323843855786,TRUE,545,553,37,GO:BP,regulation of hormone levels,21010,4508,GO:0065008,FALSE
TF:M12464_1,0.000428786014713924,TRUE,2608,556,116,TF,Factor: ZNF148; motif: NNCCCCTCCCCC; match class: 1,20011,9509,TF:M12464,FALSE
GO:1903214,0.000429526558877221,TRUE,44,553,10,GO:BP,regulation of protein targeting to mitochondrion,21010,23763,GO:0006626|GO:1903533|GO:1903747,FALSE
GO:0045646,0.000429526558877221,TRUE,44,553,10,GO:BP,regulation of erythrocyte differentiation,21010,12112,GO:0030218|GO:0045637,FALSE
GO:0015630,0.000430287242937614,TRUE,1388,548,64,GO:CC,microtubule cytoskeleton,22090,710,GO:0005856,FALSE
GO:0051051,0.000433346125590336,TRUE,432,553,32,GO:BP,negative regulation of transport,21010,14133,GO:0006810|GO:0048519|GO:0051049,FALSE
KEGG:04662,0.000433715864578507,TRUE,81,431,16,KEGG,B cell receptor signaling pathway,8161,333,KEGG:00000,FALSE
KEGG:05223,0.000434759524548898,TRUE,72,431,15,KEGG,Non-small cell lung cancer,8161,467,KEGG:00000,FALSE
GO:1902235,0.00043602439115185,TRUE,34,553,9,GO:BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,21010,23021,GO:0070059|GO:1905897|GO:2001242,FALSE
HP:0005344,0.000436483419138674,TRUE,91,241,18,HP,Abnormal carotid artery morphology,4962,3632,HP:0011004,FALSE
TF:M10530_1,0.000446899421142547,TRUE,3886,556,158,TF,Factor: sp4; motif: NNNGCYCCGCCCCCY; match class: 1,20011,7897,TF:M10530,FALSE
HPA:0470681,0.000447393280748423,TRUE,5685,418,263,HPA,skin 2; epidermal cells[Low],11006,698,HPA:0470000,FALSE
REAC:R-HSA-597592,0.000462106678605339,TRUE,1419,485,101,REAC,Post-translational protein modification,10835,1695,REAC:R-HSA-392499,FALSE
HP:0032076,0.000469241791536733,TRUE,382,241,42,HP,Abnormal male urethral meatus morphology,4962,12099,HP:0000036,FALSE
GO:0002262,0.000470497426783098,TRUE,174,553,19,GO:BP,myeloid cell homeostasis,21010,808,GO:0002376|GO:0048872,FALSE
WP:WP4018,0.00047246518750948,TRUE,86,461,17,WP,Clear cell renal cell carcinoma pathways,8625,221,WP:000000,FALSE
WP:WP5352,0.000472746307846646,TRUE,60,461,14,WP,10q11.21q11.23 copy number variation syndrome,8625,376,WP:000000,FALSE
GO:0006633,0.000473331545983776,TRUE,157,553,18,GO:BP,fatty acid biosynthetic process,21010,2382,GO:0006631|GO:0008610|GO:0072330,FALSE
HP:0011024,0.000475549847249582,TRUE,1719,241,121,HP,Abnormality of the gastrointestinal tract,4962,7442,HP:0025031,FALSE
HPA:0290401,0.000481796834193657,TRUE,5743,418,265,HPA,liver; hepatocytes[Low],11006,440,HPA:0290000,FALSE
GO:1903039,0.000488934144930405,TRUE,267,553,24,GO:BP,positive regulation of leukocyte cell-cell adhesion,21010,23643,GO:0007159|GO:0022409|GO:1903037,FALSE
TF:M04826,0.000489348624320444,TRUE,18109,556,535,TF,Factor: p300; motif: ACNTCCG,20011,1940,TF:M00000,FALSE
GO:0009611,0.000491003394085603,TRUE,548,553,37,GO:BP,response to wounding,21010,3596,GO:0006950,FALSE
GO:0038034,0.000491612052528003,TRUE,68,553,12,GO:BP,signal transduction in absence of ligand,21010,10151,GO:0007165,FALSE
GO:0097192,0.000491612052528003,TRUE,68,553,12,GO:BP,extrinsic apoptotic signaling pathway in absence of ligand,21010,19415,GO:0038034|GO:0097191,FALSE
GO:2001251,0.000494466878708961,TRUE,95,553,14,GO:BP,negative regulation of chromosome organization,21010,27537,GO:0010639|GO:0033044|GO:0051276,FALSE
GO:0003206,0.000497213803432863,TRUE,125,553,16,GO:BP,cardiac chamber morphogenesis,21010,1653,GO:0003007|GO:0003205|GO:0009653,FALSE
GO:0017162,0.000497743975195618,TRUE,8,555,5,GO:MF,aryl hydrocarbon receptor binding,20139,3182,GO:0005102|GO:0061629,FALSE
GO:0071331,0.00049934930141646,TRUE,141,553,17,GO:BP,cellular response to hexose stimulus,21010,17397,GO:0009746|GO:0071326,FALSE
TF:M12666_1,0.0005007572833895,TRUE,4493,556,177,TF,Factor: SP1; motif: GGCCCCGCCCCCN; match class: 1,20011,7845,TF:M12666,FALSE
TF:M01783,0.000503665909964635,TRUE,9359,556,320,TF,Factor: SP2; motif: GGGCGGGAC,20011,7858,TF:M00000,FALSE
CORUM:283,0.000504041119424787,TRUE,7,292,6,CORUM,Sin3 complex,3383,165,CORUM:0000000,FALSE
CORUM:695,0.000504041119424787,TRUE,7,292,6,CORUM,SIN3-HDAC-SAP30-ARID4 complex,3383,378,CORUM:0000000,FALSE
CORUM:650,0.000504041119424787,TRUE,7,292,6,CORUM,HDAC2-asscociated core complex,3383,362,CORUM:0000000,FALSE
CORUM:732,0.000504041119424787,TRUE,7,292,6,CORUM,SIN3 complex,3383,402,CORUM:0000000,FALSE
CORUM:596,0.000504041119424787,TRUE,7,292,6,CORUM,SIN3-HDAC-SAP30-ARID4 complex,3383,331,CORUM:0000000,FALSE
CORUM:54,0.000504041119424787,TRUE,7,292,6,CORUM,SIN3 complex,3383,23,CORUM:0000000,FALSE
CORUM:698,0.000504041119424787,TRUE,7,292,6,CORUM,SIN3-HDAC-SAP30-ARID4 complex,3383,381,CORUM:0000000,FALSE
GO:0001836,0.000509945438579701,TRUE,56,553,11,GO:BP,release of cytochrome c from mitochondria,21010,503,GO:0008637|GO:0097190,FALSE
GO:0006629,0.000512649382556908,TRUE,1406,553,70,GO:BP,lipid metabolic process,21010,2380,GO:0044238|GO:0071704,FALSE
HP:0025015,0.000518946687160574,TRUE,1133,241,89,HP,Abnormal vascular morphology,4962,9470,HP:0002597|HP:0030680,FALSE
TF:M00976_1,0.000526327337799519,TRUE,866,556,52,TF,"Factor: AhR,; motif: NRCGTGNGN; match class: 1",20011,15,TF:M00976,FALSE
MIRNA:hsa-miR-34a-3p,0.000528780272518719,TRUE,81,514,14,MIRNA,hsa-miR-34a-3p,14846,706,MIRNA:000000,FALSE
GO:0019213,0.000531012103760778,TRUE,39,555,9,GO:MF,deacetylase activity,20139,3681,GO:0016787,FALSE
GO:0007369,0.000531076599466607,TRUE,193,553,20,GO:BP,gastrulation,21010,2924,GO:0048598,FALSE
HPA:0570782,0.000532205458800947,TRUE,1340,418,84,HPA,testis; preleptotene spermatocytes[Medium],11006,820,HPA:0570781,FALSE
GO:0140718,0.000539341751933855,TRUE,45,553,10,GO:BP,facultative heterochromatin formation,21010,20797,GO:0031507,FALSE
GO:0009250,0.000539341751933855,TRUE,45,553,10,GO:BP,glucan biosynthetic process,21010,3471,GO:0000271|GO:0044042,FALSE
GO:0005978,0.000539341751933855,TRUE,45,553,10,GO:BP,glycogen biosynthetic process,21010,1875,GO:0005977|GO:0009250,FALSE
REAC:R-HSA-1852241,0.000540284967789099,TRUE,294,485,33,REAC,Organelle biogenesis and maintenance,10835,1566,REAC:0000000,FALSE
GO:0032553,0.000543783212083363,TRUE,1933,555,89,GO:MF,ribonucleotide binding,20139,4479,GO:0000166|GO:0097367,FALSE
REAC:R-HSA-9678108,0.000546117616706999,TRUE,140,485,21,REAC,SARS-CoV-1 Infection,10835,2008,REAC:R-HSA-9679506,FALSE
HPA:0291163,0.000546617314092843,TRUE,322,418,31,HPA,liver; cholangiocytes[High],11006,439,HPA:0291162,FALSE
GO:0042753,0.000548535300037983,TRUE,18,553,7,GO:BP,positive regulation of circadian rhythm,21010,10849,GO:0007623|GO:0042752|GO:0048518,FALSE
GO:0035066,0.000548535300037983,TRUE,18,553,7,GO:BP,positive regulation of histone acetylation,21010,9207,GO:0016573|GO:0035065|GO:1901875|GO:2000758,FALSE
GO:0007093,0.000553658522119347,TRUE,142,553,17,GO:BP,mitotic cell cycle checkpoint signaling,21010,2723,GO:0000075|GO:0045930|GO:1903047,FALSE
HP:0001924,0.000555031788065007,TRUE,34,241,11,HP,Sideroblastic anemia,4962,1398,HP:0010972,FALSE
HP:0002862,0.000555031788065007,TRUE,34,241,11,HP,Bladder carcinoma,4962,2070,HP:0009725,FALSE
GO:0001942,0.000565106618411032,TRUE,96,553,14,GO:BP,hair follicle development,21010,565,GO:0022405|GO:0048856|GO:0098773,FALSE
KEGG:05208,0.000565881199719235,TRUE,222,431,29,KEGG,Chemical carcinogenesis - reactive oxygen species,8161,453,KEGG:00000,FALSE
HPA:0090182,0.000570007330358658,TRUE,2928,418,154,HPA,cerebellum; cells in granular layer[Medium],11006,132,HPA:0090181,FALSE
WP:WP4838,0.000572617039576707,TRUE,31,461,10,WP,Regucalcin in proximal tubule epithelial kidney cells,8625,739,WP:000000,FALSE
REAC:R-HSA-1538133,0.000575375908365129,TRUE,26,485,9,REAC,G0 and Early G1,10835,952,REAC:R-HSA-453279,FALSE
HP:0002360,0.00057809306370828,TRUE,515,241,51,HP,Sleep disturbance,4962,1730,HP:0000708,FALSE
GO:0001756,0.000581046950306966,TRUE,69,553,12,GO:BP,somitogenesis,21010,435,GO:0009952|GO:0035282|GO:0043009|GO:0048646|GO:0061053,FALSE
KEGG:04921,0.000588414673346597,TRUE,154,431,23,KEGG,Oxytocin signaling pathway,8161,371,KEGG:00000,FALSE
TF:M08207,0.000589964563488851,TRUE,17371,556,520,TF,Factor: E2F-3:TBR2; motif: ANGTGYKANGGCGCSTTNNCRNNT,20011,1476,TF:M00000,FALSE
GO:1904353,0.000592694628273727,TRUE,26,553,8,GO:BP,regulation of telomere capping,21010,24729,GO:0016233|GO:0032204,FALSE
HPA:0100133,0.000596812555522867,TRUE,1844,418,107,HPA,cerebral cortex; neuronal cells[High],11006,191,HPA:0100132,FALSE
WP:WP170,0.000602681546960158,TRUE,38,461,11,WP,Nuclear receptors,8625,394,WP:000000,FALSE
CORUM:632,0.000606843148259223,TRUE,17,292,9,CORUM,Anti-HDAC2 complex,3383,349,CORUM:0000000,FALSE
GO:0071326,0.000613292069305214,TRUE,143,553,17,GO:BP,cellular response to monosaccharide stimulus,21010,17392,GO:0034284|GO:0071322,FALSE
HPA:0130202,0.000616836043275155,TRUE,3711,418,186,HPA,colon; endothelial cells[Medium],11006,217,HPA:0130201,FALSE
GO:0098916,0.000621710716251754,TRUE,747,553,45,GO:BP,anterograde trans-synaptic signaling,21010,19849,GO:0099537,FALSE
GO:0007268,0.000621710716251754,TRUE,747,553,45,GO:BP,chemical synaptic transmission,21010,2847,GO:0098916,FALSE
GO:0046696,0.000624700262221702,TRUE,5,548,4,GO:CC,lipopolysaccharide receptor complex,22090,2204,GO:0043235|GO:0098796,TRUE
TF:M01865,0.000625121807226696,TRUE,10102,556,340,TF,Factor: BTEB3; motif: BNRNGGGAGGNGT,20011,636,TF:M00000,FALSE
CORUM:1401,0.00062695805005186,TRUE,10,292,7,CORUM,MOF complex,3383,750,CORUM:0000000,FALSE
TF:M12152,0.000629612512719062,TRUE,7506,556,267,TF,Factor: Sp1; motif: NWRGCCACGCCCMCN,20011,7842,TF:M00000,FALSE
WP:WP1981,0.000645022822034612,TRUE,25,461,9,WP,Thyroxine (thyroid hormone) production,8625,845,WP:000000,FALSE
REAC:R-HSA-5621575,0.000647126960651814,TRUE,20,485,8,REAC,CD209 (DC-SIGN) signaling,10835,255,REAC:R-HSA-5621481,FALSE
GO:0031397,0.000653017721630153,TRUE,83,553,13,GO:BP,negative regulation of protein ubiquitination,21010,7501,GO:0016567|GO:0031396|GO:1903321,FALSE
GO:0070897,0.000653017721630153,TRUE,83,553,13,GO:BP,transcription preinitiation complex assembly,21010,17164,GO:0006352|GO:0065004,FALSE
GO:2000322,0.000656412088198055,TRUE,7,553,5,GO:BP,regulation of glucocorticoid receptor signaling pathway,21010,26726,GO:0033143|GO:0042921,FALSE
GO:0046016,0.000656412088198055,TRUE,7,553,5,GO:BP,positive regulation of transcription by glucose,21010,12424,GO:0045991|GO:0046015,FALSE
TF:M04918,0.000658432348584675,TRUE,5748,556,215,TF,Factor: Egr-1; motif: ACCGCCC,20011,1610,TF:M00000,FALSE
TF:M09734,0.000663151501274987,TRUE,11974,556,390,TF,Factor: ZNF692; motif: SYNGGSCCCASCCNC,20011,11014,TF:M00000,FALSE
REAC:R-HSA-5218859,0.000666075660131775,TRUE,58,485,13,REAC,Regulated Necrosis,10835,1875,REAC:R-HSA-5357801,FALSE
KEGG:05134,0.000670909874316356,TRUE,57,431,13,KEGG,Legionellosis,8161,424,KEGG:00000,FALSE
GO:1902108,0.000673055433820479,TRUE,46,553,10,GO:BP,regulation of mitochondrial membrane permeability involved in apoptotic process,21010,22908,GO:0008637|GO:0046902,FALSE
GO:0046903,0.000674115736910628,TRUE,954,553,53,GO:BP,secretion,21010,13069,GO:0006810,FALSE
HP:0010293,0.000680533039287596,TRUE,28,241,10,HP,Aplasia/Hypoplasia of the uvula,4962,6753,HP:0000172,FALSE
TF:M04516,0.000681220717634327,TRUE,11672,556,382,TF,Factor: E2F-1; motif: TTTGGCGCCAAA,20011,1436,TF:M00000,FALSE
REAC:R-HSA-9006936,0.000681799184828368,TRUE,119,485,19,REAC,Signaling by TGFB family members,10835,2201,REAC:R-HSA-162582,FALSE
GO:0051123,0.000684694935132699,TRUE,70,553,12,GO:BP,RNA polymerase II preinitiation complex assembly,21010,14181,GO:0006367|GO:0070897,FALSE
GO:1990440,0.000687721903965895,TRUE,12,553,6,GO:BP,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,21010,26222,GO:0034976|GO:0036003,FALSE
GO:0051974,0.000687721903965895,TRUE,12,553,6,GO:BP,negative regulation of telomerase activity,21010,14740,GO:0051348|GO:0051972|GO:2000279,FALSE
GO:0097367,0.00068996795144425,TRUE,2294,555,101,GO:MF,carbohydrate derivative binding,20139,9171,GO:0005488,FALSE
TF:M04110,0.000690247924306098,TRUE,9456,556,322,TF,Factor: RUNX3; motif: NRACCGCANWAACCRCAN,20011,7368,TF:M00000,FALSE
HPA:0270362,0.00069175573596252,TRUE,5817,418,267,HPA,kidney; cells in tubules[Medium],11006,415,HPA:0270361,FALSE
HPA:0050053,0.000698831865357077,TRUE,1349,418,84,HPA,breast; glandular cells[High],11006,60,HPA:0050052,FALSE
TF:M04710_1,0.0006993815099419,TRUE,11712,556,383,TF,Factor: CHD2; motif: TCTCGCGAG; match class: 1,20011,837,TF:M04710,FALSE
WP:WP3863,0.000718110021824895,TRUE,62,461,14,WP,T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection,8625,461,WP:000000,FALSE
TF:M07617,0.000720204585407506,TRUE,3696,556,151,TF,Factor: Sp4; motif: SCCCCKCCCCCSN,20011,7898,TF:M00000,FALSE
GO:1901991,0.000734998539850828,TRUE,179,553,19,GO:BP,negative regulation of mitotic cell cycle phase transition,21010,22805,GO:0044772|GO:0045930|GO:1901988|GO:1901990,FALSE
GO:0043168,0.000741633309145847,TRUE,2446,555,106,GO:MF,anion binding,20139,5754,GO:0043167,FALSE
GO:0000902,0.000743400991607697,TRUE,957,553,53,GO:BP,cell morphogenesis,21010,246,GO:0009653,FALSE
GO:0043276,0.000746733394400514,TRUE,36,553,9,GO:BP,anoikis,21010,11106,GO:0006915,FALSE
GO:0060218,0.000746733394400514,TRUE,36,553,9,GO:BP,hematopoietic stem cell differentiation,21010,15174,GO:0002244|GO:0048863,FALSE
GO:0051154,0.000746733394400514,TRUE,36,553,9,GO:BP,negative regulation of striated muscle cell differentiation,21010,14211,GO:0051146|GO:0051148|GO:0051153,FALSE
HPA:0460663,0.000753707608379535,TRUE,646,418,49,HPA,skin 1; keratinocytes[High],11006,660,HPA:0460662,FALSE
GO:0044773,0.000754257570539371,TRUE,84,553,13,GO:BP,mitotic DNA damage checkpoint signaling,21010,11750,GO:0000077|GO:0044774,FALSE
GO:0070227,0.000754257570539371,TRUE,84,553,13,GO:BP,lymphocyte apoptotic process,21010,16792,GO:0071887,FALSE
GO:0098794,0.000756249549936289,TRUE,644,548,37,GO:CC,postsynapse,22090,3264,GO:0045202|GO:0110165,FALSE
GO:0002768,0.000764947468406559,TRUE,314,553,26,GO:BP,immune response-regulating cell surface receptor signaling pathway,21010,1293,GO:0002764|GO:0007166,FALSE
GO:0046879,0.000764947468406559,TRUE,314,553,26,GO:BP,hormone secretion,21010,13047,GO:0009914|GO:0023061,FALSE
GO:0016607,0.000765778911829804,TRUE,418,548,28,GO:CC,nuclear speck,22090,771,GO:0016604,FALSE
HP:0002315,0.000772070257334173,TRUE,320,241,37,HP,Headache,4962,1699,HP:0012638,FALSE
HP:0009725,0.000775071239264729,TRUE,35,241,11,HP,Bladder neoplasm,4962,6227,HP:0010786,FALSE
GO:0016311,0.000776545597495744,TRUE,335,553,27,GO:BP,dephosphorylation,21010,5288,GO:0006796,FALSE
TF:M09973,0.000776790689255229,TRUE,11118,556,367,TF,Factor: CPBP; motif: GNNRGGGHGGGGNNGGGRN,20011,944,TF:M00000,FALSE
GO:0099537,0.000777890833979976,TRUE,753,553,45,GO:BP,trans-synaptic signaling,21010,20017,GO:0099536,FALSE
TF:M00428,0.000780154949203127,TRUE,9178,556,314,TF,Factor: E2F-1; motif: NKTSSCGC,20011,1446,TF:M00000,FALSE
GO:0000779,0.000785365331244669,TRUE,178,548,17,GO:CC,"condensed chromosome, centromeric region",22090,88,GO:0000775|GO:0000793,FALSE
HP:0002721,0.000785773664206426,TRUE,217,241,29,HP,Immunodeficiency,4962,1974,HP:0010978,FALSE
TF:M12593,0.000802602396962211,TRUE,8823,556,304,TF,Factor: CTCF; motif: NNRSYGCCMCCTGSTGGCCN,20011,1152,TF:M00000,FALSE
HP:0000553,0.000803444976243573,TRUE,581,241,55,HP,Abnormal uvea morphology,4962,426,HP:0012372,FALSE
GO:0031344,0.000804892442291214,TRUE,655,553,41,GO:BP,regulation of cell projection organization,21010,7481,GO:0030030|GO:0042127|GO:0051128,FALSE
REAC:R-HSA-5218920,0.000829117371375454,TRUE,27,485,9,REAC,VEGFR2 mediated vascular permeability,10835,2516,REAC:R-HSA-4420097,FALSE
GO:0022405,0.000834834912153296,TRUE,99,553,14,GO:BP,hair cycle process,21010,6911,GO:0022404|GO:0042633,FALSE
GO:0014020,0.000834834912153296,TRUE,99,553,14,GO:BP,primary neural tube formation,21010,4677,GO:0001838|GO:0001841,FALSE
GO:0022404,0.000834834912153296,TRUE,99,553,14,GO:BP,molting cycle process,21010,6910,GO:0032501|GO:0042303,FALSE
GO:0090311,0.000834988227875557,TRUE,47,553,10,GO:BP,regulation of protein deacetylation,21010,19063,GO:0006476|GO:0031399,FALSE
GO:0050728,0.00083525437092732,TRUE,163,553,18,GO:BP,negative regulation of inflammatory response,21010,13883,GO:0006954|GO:0031348|GO:0032102|GO:0050727,FALSE
GO:0030331,0.000835829921094549,TRUE,41,555,9,GO:MF,nuclear estrogen receptor binding,20139,3913,GO:0016922,FALSE
HP:0012745,0.000837692369488744,TRUE,115,241,20,HP,Short palpebral fissure,4962,9130,HP:0200007,FALSE
GO:0045722,0.000848831177875916,TRUE,19,553,7,GO:BP,positive regulation of gluconeogenesis,21010,12179,GO:0006094|GO:0006111|GO:0010907|GO:0031328,FALSE
GO:0031053,0.000848831177875916,TRUE,19,553,7,GO:BP,primary miRNA processing,21010,7342,GO:0035196,TRUE
GO:0016410,0.000854974883621183,TRUE,92,555,13,GO:MF,N-acyltransferase activity,20139,2792,GO:0016747,FALSE
HP:0006753,0.000856233618664632,TRUE,76,241,16,HP,Neoplasm of the stomach,4962,4414,HP:0002577|HP:0007378,FALSE
HP:5200045,0.000860066726640491,TRUE,772,241,67,HP,Reduced impulse control,4962,17437,HP:0000708,FALSE
HP:0000035,0.000866294957124181,TRUE,972,241,79,HP,Abnormal testis morphology,4962,33,HP:0011961,FALSE
GO:0032677,0.000869322791787604,TRUE,85,553,13,GO:BP,regulation of interleukin-8 production,21010,8091,GO:0001817|GO:0032637,FALSE
GO:0032637,0.000869322791787604,TRUE,85,553,13,GO:BP,interleukin-8 production,21010,8052,GO:0001816,FALSE
GO:0043425,0.000869608378372731,TRUE,31,555,8,GO:MF,bHLH transcription factor binding,20139,5795,GO:0140297,FALSE
TF:M10435_1,0.000870507810834057,TRUE,3614,556,148,TF,Factor: Sp2; motif: GGGGCGGGG; match class: 1,20011,7871,TF:M10435,FALSE
REAC:R-HSA-975163,0.000882035387541579,TRUE,15,485,7,REAC,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,10835,1105,REAC:R-HSA-975138,FALSE
REAC:R-HSA-937072,0.000882035387541579,TRUE,15,485,7,REAC,TRAF6-mediated induction of TAK1 complex within TLR4 complex,10835,2352,REAC:R-HSA-937061,FALSE
GO:0048232,0.00088330226142619,TRUE,633,553,40,GO:BP,male gamete generation,21010,13244,GO:0007276,FALSE
TF:M00649,0.000906329714871089,TRUE,9550,556,324,TF,Factor: MAZ; motif: GGGGAGGG,20011,5002,TF:M00000,FALSE
TF:M11880_1,0.000906423578506738,TRUE,7189,556,257,TF,Factor: pax-6; motif: NYACGCWTSANYGMNCN; match class: 1,20011,6409,TF:M11880,FALSE
GO:0140097,0.000906809813286001,TRUE,247,555,22,GO:MF,"catalytic activity, acting on DNA",20139,10507,GO:0140640,TRUE
CORUM:3048,0.000913849740179476,TRUE,5,292,5,CORUM,mSin3A complex,3383,1357,CORUM:0000000,FALSE
CORUM:1495,0.000913849740179476,TRUE,5,292,5,CORUM,PID complex,3383,766,CORUM:0000000,FALSE
CORUM:889,0.000913849740179476,TRUE,5,292,5,CORUM,MTA1-HDAC core complex,3383,497,CORUM:0000000,FALSE
GO:0050768,0.000914886825725871,TRUE,147,553,17,GO:BP,negative regulation of neurogenesis,21010,13900,GO:0010721|GO:0022008|GO:0050767|GO:0051961,FALSE
GO:0043167,0.000930477512453454,TRUE,6115,555,220,GO:MF,ion binding,20139,5753,GO:0005488,FALSE
GO:0034329,0.000931213583795709,TRUE,447,553,32,GO:BP,cell junction assembly,21010,8963,GO:0022607|GO:0034330,FALSE
MIRNA:hsa-miR-16-5p,0.000942335115735573,TRUE,1556,514,89,MIRNA,hsa-miR-16-5p,14846,303,MIRNA:000000,FALSE
REAC:R-HSA-442755,0.000946079191878092,TRUE,89,485,16,REAC,Activation of NMDA receptors and postsynaptic events,10835,86,REAC:R-HSA-112314,FALSE
HP:0011961,0.000946637650373955,TRUE,974,241,79,HP,Non-obstructive azoospermia,4962,8358,HP:0000027,FALSE
GO:0007219,0.000952938411431211,TRUE,182,553,19,GO:BP,Notch signaling pathway,21010,2822,GO:0007166,FALSE
HP:0005120,0.00095370246057137,TRUE,584,241,55,HP,Abnormal cardiac atrium morphology,4962,3473,HP:0001627,FALSE
GO:0098773,0.00095501898205167,TRUE,131,553,16,GO:BP,skin epidermis development,21010,19780,GO:0008544|GO:0043588|GO:0060429,FALSE
GO:0006354,0.00095501898205167,TRUE,131,553,16,GO:BP,DNA-templated transcription elongation,21010,2164,GO:0006351|GO:0032774,FALSE
GO:0019787,0.000956637609376189,TRUE,480,555,33,GO:MF,ubiquitin-like protein transferase activity,20139,3715,GO:0016755|GO:0140096,FALSE
HP:0011354,0.000960209293506537,TRUE,1043,241,83,HP,Generalized abnormality of skin,4962,7762,HP:0011121,FALSE
GO:1905168,0.000963880962249405,TRUE,37,553,9,GO:BP,positive regulation of double-strand break repair via homologous recombination,21010,25423,GO:0000724|GO:0010569|GO:0045911|GO:2000781,FALSE
GO:0032205,0.000963880962249405,TRUE,37,553,9,GO:BP,negative regulation of telomere maintenance,21010,7761,GO:0000723|GO:0032204|GO:0051053|GO:2001251,FALSE
TF:M12057,0.000968200036802809,TRUE,5346,556,202,TF,Factor: ZBP99; motif: GCCCMTCCCCCR,20011,9270,TF:M00000,FALSE
GO:0016407,0.000969256887575707,TRUE,93,555,13,GO:MF,acetyltransferase activity,20139,2789,GO:0016747,FALSE
TF:M00470,0.000984428262492385,TRUE,9629,556,326,TF,Factor: AP-2gamma; motif: GCCYNNGGS,20011,138,TF:M00000,FALSE
HPA:0250131,0.000988191957963926,TRUE,6219,418,281,HPA,hippocampus; neuronal cells[Low],11006,385,HPA:0250000,FALSE
HP:0100243,0.000994824275792269,TRUE,29,241,10,HP,Leiomyosarcoma,4962,15760,HP:0030448,FALSE
HP:0002891,0.000994824275792269,TRUE,29,241,10,HP,Uterine leiomyosarcoma,4962,2093,HP:0010784|HP:0100243,FALSE
REAC:R-HSA-9768919,0.00100464062086529,TRUE,21,485,8,REAC,NPAS4 regulates expression of target genes,10835,1462,REAC:R-HSA-9634815,FALSE
KEGG:04370,0.0010067711741205,TRUE,59,431,13,KEGG,VEGF signaling pathway,8161,301,KEGG:00000,FALSE
TF:M07039,0.00100695439231769,TRUE,16708,556,505,TF,Factor: ETF; motif: CCCCGCCCCYN,20011,2166,TF:M00000,FALSE
GO:0042113,0.00102816176392392,TRUE,278,553,24,GO:BP,B cell activation,21010,10467,GO:0046649,FALSE
GO:0034198,0.00103008557955836,TRUE,48,553,10,GO:BP,cellular response to amino acid starvation,21010,8883,GO:0009267|GO:1990928,FALSE
TF:M11478,0.00103252866227641,TRUE,10179,556,341,TF,Factor: AP-2beta; motif: NSCCNNNGGSN,20011,8580,TF:M00000,FALSE
TF:M03567_1,0.00104466572412323,TRUE,3718,556,151,TF,Factor: Sp2; motif: NYSGCCCCGCCCCCY; match class: 1,20011,7879,TF:M03567,FALSE
WP:WP2828,0.00105043714365763,TRUE,40,461,11,WP,Bladder cancer,8625,176,WP:000000,FALSE
HP:0001646,0.00106266443447718,TRUE,172,241,25,HP,Abnormal aortic valve morphology,4962,1198,HP:0001654,FALSE
GO:0035639,0.00106470211993784,TRUE,1849,555,85,GO:MF,purine ribonucleoside triphosphate binding,20139,5380,GO:0043168|GO:1901265,FALSE
REAC:R-HSA-1632852,0.00107038190018816,TRUE,134,485,20,REAC,Macroautophagy,10835,1326,REAC:R-HSA-9612973,FALSE
GO:0007169,0.0010921206042131,TRUE,614,553,39,GO:BP,transmembrane receptor protein tyrosine kinase signaling pathway,21010,2780,GO:0007167,FALSE
TF:M10529,0.00109294471788072,TRUE,7066,556,253,TF,Factor: Sp1; motif: RGGGMGGRGSNGGGG,20011,7838,TF:M00000,FALSE
GO:0022407,0.0010959335361313,TRUE,473,553,33,GO:BP,regulation of cell-cell adhesion,21010,6913,GO:0030155|GO:0098609,FALSE
GO:0021915,0.0010981378588859,TRUE,166,553,18,GO:BP,neural tube development,21010,6787,GO:0007399|GO:0035295|GO:0043009|GO:0060429,FALSE
HP:0000080,0.00109838338344145,TRUE,1385,241,102,HP,Abnormality of reproductive system physiology,4962,75,HP:0000078,FALSE
TF:M12354_1,0.00109981533127687,TRUE,5751,556,214,TF,Factor: ZNF37A; motif: CCYYGGCTCCNTSCCMN; match class: 1,20011,10097,TF:M12354,FALSE
GO:0042698,0.0011013707876914,TRUE,73,553,12,GO:BP,ovulation cycle,21010,10811,GO:0048511|GO:0048609,FALSE
GO:0016032,0.00110416763038951,TRUE,428,553,31,GO:BP,viral process,21010,5157,GO:0008150,TRUE
HP:0001654,0.00110859992778081,TRUE,352,241,39,HP,Abnormal heart valve morphology,4962,1205,HP:0001627,FALSE
GO:0033276,0.00111084526932618,TRUE,18,548,6,GO:CC,transcription factor TFTC complex,22090,1415,GO:0016591|GO:0070461|GO:0090575,FALSE
GO:1900017,0.00112563830473117,TRUE,28,553,8,GO:BP,positive regulation of cytokine production involved in inflammatory response,21010,21125,GO:0001819|GO:0002534|GO:1900015,FALSE
GO:0019725,0.00113002085042755,TRUE,814,553,47,GO:BP,cellular homeostasis,21010,6303,GO:0042592,FALSE
GO:0007283,0.00113782915289739,TRUE,615,553,39,GO:BP,spermatogenesis,21010,2861,GO:0003006|GO:0048232,FALSE
HPA:0510702,0.00113896317857368,TRUE,1538,418,92,HPA,soft tissue 2; peripheral nerve[Medium],11006,769,HPA:0510701,FALSE
GO:0010507,0.00114761888359111,TRUE,87,553,13,GO:BP,negative regulation of autophagy,21010,4251,GO:0006914|GO:0010506|GO:0031330,FALSE
TF:M07615_1,0.00115204975354552,TRUE,2987,556,127,TF,Factor: Sp3; motif: GGGGCGGGGSNN; match class: 1,20011,7891,TF:M07615,FALSE
REAC:R-HSA-9711123,0.00115484409447425,TRUE,196,485,25,REAC,Cellular response to chemical stress,10835,325,REAC:R-HSA-2262752,FALSE
GO:0032102,0.00116134727438706,TRUE,429,553,31,GO:BP,negative regulation of response to external stimulus,21010,7725,GO:0009605|GO:0032101|GO:0048585,FALSE
WP:WP286,0.00116435192684559,TRUE,48,461,12,WP,IL-3 signaling pathway,8625,260,WP:000000,FALSE
GO:0021537,0.00117165868162922,TRUE,280,553,24,GO:BP,telencephalon development,21010,6425,GO:0030900|GO:0048856,FALSE
REAC:R-HSA-9619665,0.00117381687996175,TRUE,28,485,9,REAC,EGR2 and SOX10-mediated initiation of Schwann cell myelination,10835,782,REAC:R-HSA-9675108,FALSE
REAC:R-HSA-525793,0.00117381687996175,TRUE,28,485,9,REAC,Myogenesis,10835,1431,REAC:R-HSA-1266738,FALSE
HP:0009726,0.00117868232589245,TRUE,128,241,21,HP,Renal neoplasm,4962,6228,HP:0000077|HP:0010786,FALSE
HP:0002683,0.00118260799775316,TRUE,962,241,78,HP,Abnormal calvaria morphology,4962,1946,HP:0000929,FALSE
GO:0071706,0.00120124876581354,TRUE,167,553,18,GO:BP,tumor necrosis factor superfamily cytokine production,21010,17688,GO:0001816,FALSE
GO:1903555,0.00120124876581354,TRUE,167,553,18,GO:BP,regulation of tumor necrosis factor superfamily cytokine production,21010,24046,GO:0001817|GO:0071706,FALSE
HPA:0471411,0.00121098670746642,TRUE,871,418,60,HPA,skin 2; cells in spinous layer[Low],11006,689,HPA:0470000,FALSE
GO:1903037,0.00121324252147319,TRUE,364,553,28,GO:BP,regulation of leukocyte cell-cell adhesion,21010,23641,GO:0007159|GO:0022407,FALSE
GO:0035282,0.00121519090088106,TRUE,102,553,14,GO:BP,segmentation,21010,9364,GO:0003002,FALSE
GO:1900095,0.00124876302882325,TRUE,13,553,6,GO:BP,regulation of dosage compensation by inactivation of X chromosome,21010,21189,GO:0009048|GO:0010468|GO:1902275,FALSE
GO:0072709,0.00124972576369875,TRUE,4,553,4,GO:BP,cellular response to sorbitol,21010,18356,GO:0071322|GO:0072708,FALSE
GO:0001894,0.00125012506088707,TRUE,281,553,24,GO:BP,tissue homeostasis,21010,530,GO:0048871|GO:0060249,FALSE
GO:0060249,0.00125012506088707,TRUE,281,553,24,GO:BP,anatomical structure homeostasis,21010,15198,GO:0048871,FALSE
TF:M00737,0.00125551274718149,TRUE,8930,556,306,TF,Factor: E2F-1:DP-2; motif: TTTSSCGC,20011,1426,TF:M00000,FALSE
GO:0060038,0.00126398532923061,TRUE,49,553,10,GO:BP,cardiac muscle cell proliferation,21010,15031,GO:0014855|GO:0055017,FALSE
GO:0030857,0.00126398532923061,TRUE,49,553,10,GO:BP,negative regulation of epithelial cell differentiation,21010,7257,GO:0030855|GO:0030856|GO:0045596,FALSE
GO:0030521,0.00126398532923061,TRUE,49,553,10,GO:BP,androgen receptor signaling pathway,21010,7152,GO:0030518,FALSE
GO:0032873,0.00126398532923061,TRUE,49,553,10,GO:BP,negative regulation of stress-activated MAPK cascade,21010,8241,GO:0032872|GO:0043409|GO:0051403|GO:0070303,FALSE
GO:1904705,0.00127129844559003,TRUE,61,553,11,GO:BP,regulation of vascular associated smooth muscle cell proliferation,21010,25035,GO:0048660|GO:1990874,FALSE
GO:0051767,0.00127630901718996,TRUE,20,553,7,GO:BP,nitric-oxide synthase biosynthetic process,21010,14621,GO:0009059,FALSE
GO:0051769,0.00127630901718996,TRUE,20,553,7,GO:BP,regulation of nitric-oxide synthase biosynthetic process,21010,14622,GO:0010556|GO:0051767,FALSE
GO:0044545,0.0012811533270733,TRUE,11,548,5,GO:CC,NSL complex,22090,2086,GO:1902562,FALSE
GO:0010569,0.00128349736388122,TRUE,74,553,12,GO:BP,regulation of double-strand break repair via homologous recombination,21010,4293,GO:0000018|GO:0000724|GO:2000779,FALSE
GO:0046914,0.00129902666062834,TRUE,1109,555,58,GO:MF,transition metal ion binding,20139,6285,GO:0046872,FALSE
GO:0050807,0.00130438291598129,TRUE,242,553,22,GO:BP,regulation of synapse organization,21010,13931,GO:0050803|GO:0050808|GO:0051128,FALSE
HP:0025142,0.00130645117386954,TRUE,1173,241,90,HP,Constitutional symptom,4962,9588,HP:0000118,FALSE
WP:WP2853,0.00131456963305861,TRUE,143,461,22,WP,Endoderm differentiation,8625,142,WP:000000,FALSE
GO:0044774,0.0013146121505378,TRUE,88,553,13,GO:BP,mitotic DNA integrity checkpoint signaling,21010,11751,GO:0007093|GO:0031570,FALSE
GO:0019915,0.0013146121505378,TRUE,88,553,13,GO:BP,lipid storage,21010,6359,GO:0010876|GO:0051235,FALSE
HP:0000027,0.00133623913822568,TRUE,999,241,80,HP,Azoospermia,4962,25,HP:0008669,FALSE
WP:WP4767,0.00134426396049489,TRUE,27,461,9,WP,FGFR3 signaling in chondrocyte proliferation and terminal differentiation,8625,198,WP:000000,FALSE
WP:WP5231,0.00134426396049489,TRUE,27,461,9,WP,Hippocampal synaptogenesis and neurogenesis,8625,652,WP:000000,FALSE
GO:0051082,0.00136565617707239,TRUE,111,555,14,GO:MF,unfolded protein binding,20139,8005,GO:0005515,FALSE
GO:0051235,0.00138874027222591,TRUE,345,553,27,GO:BP,maintenance of location,21010,14266,GO:0051179,FALSE
TF:M08523_1,0.00139145081385726,TRUE,7567,556,267,TF,Factor: E2F-1:TBR2; motif: NGGTGNNANGGCGCNNTNNCRNNN; match class: 1,20011,1431,TF:M08523,FALSE
REAC:R-HSA-445989,0.00140466247949071,TRUE,44,485,11,REAC,TAK1-dependent IKK and NF-kappa-B activation  ,10835,2305,REAC:R-HSA-166058|REAC:R-HSA-168164|REAC:R-HSA-9020702|REAC:R-HSA-937061|REAC:R-HSA-975138|REAC:R-HSA-975871,FALSE
GO:0035267,0.00142502171339528,TRUE,28,548,7,GO:CC,NuA4 histone acetyltransferase complex,22090,1604,GO:0043189,FALSE
GO:0043189,0.00142502171339528,TRUE,28,548,7,GO:CC,H4/H2A histone acetyltransferase complex,22090,1866,GO:1902562,FALSE
HP:0100760,0.00142920623836378,TRUE,30,241,10,HP,Clubbing of toes,4962,16244,HP:0001217|HP:0010161,FALSE
HP:0002245,0.00142920623836378,TRUE,30,241,10,HP,Meckel diverticulum,4962,1654,HP:0001549,FALSE
HP:0000739,0.00143251969778279,TRUE,412,241,43,HP,Anxiety,4962,576,HP:0100852,FALSE
GO:0032940,0.00144068708909627,TRUE,821,553,47,GO:BP,secretion by cell,21010,8298,GO:0046903|GO:0140352,FALSE
GO:2000779,0.00144460396563851,TRUE,135,553,16,GO:BP,regulation of double-strand break repair,21010,27127,GO:0006282|GO:0006302,FALSE
WP:WP313,0.00146423015264792,TRUE,34,461,10,WP,Hepatocyte growth factor receptor signaling,8625,516,WP:000000,FALSE
WP:WP5358,0.00146423015264792,TRUE,34,461,10,WP,JAK-STAT signaling in the regulation of Beta-cells,8625,388,WP:000000,FALSE
WP:WP5300,0.0014683993177446,TRUE,49,461,12,WP,TROP2 regulatory signaling,8625,518,WP:000000,FALSE
GO:0072073,0.00147881715145065,TRUE,152,553,17,GO:BP,kidney epithelium development,21010,17938,GO:0001822|GO:0060429,FALSE
GO:0009914,0.00148438098325798,TRUE,325,553,26,GO:BP,hormone transport,21010,3828,GO:0006810|GO:0010817,FALSE
GO:0000776,0.00148924311359991,TRUE,167,548,16,GO:CC,kinetochore,22090,87,GO:0000779|GO:0043232|GO:0099080,FALSE
GO:0050870,0.0015012304256782,TRUE,244,553,22,GO:BP,positive regulation of T cell activation,21010,13983,GO:0042110|GO:0050863|GO:0051251|GO:1903039,FALSE
GO:0001892,0.00150298210830567,TRUE,89,553,13,GO:BP,embryonic placenta development,21010,528,GO:0001701|GO:0001890|GO:0048568,FALSE
REAC:R-HSA-936964,0.00150777125764151,TRUE,16,485,7,REAC,"Activation of IRF3, IRF7 mediated by TBK1, IKBKE",10835,82,REAC:R-HSA-937061,FALSE
REAC:R-HSA-5676594,0.00150777125764151,TRUE,16,485,7,REAC,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,10835,2328,REAC:R-HSA-5668541,FALSE
GO:0032655,0.00150919067282373,TRUE,62,553,11,GO:BP,regulation of interleukin-12 production,21010,8070,GO:0001817|GO:0032615,FALSE
GO:0032615,0.00150919067282373,TRUE,62,553,11,GO:BP,interleukin-12 production,21010,8031,GO:0001816,FALSE
REAC:R-HSA-9612973,0.0015349445173629,TRUE,149,485,21,REAC,Autophagy,10835,187,REAC:0000000,FALSE
GO:1902275,0.00154308996325519,TRUE,50,553,10,GO:BP,regulation of chromatin organization,21010,23057,GO:0006325|GO:0051128,FALSE
GO:0070303,0.00154308996325519,TRUE,50,553,10,GO:BP,negative regulation of stress-activated protein kinase signaling cascade,21010,16842,GO:0031098|GO:0070302|GO:1902532,FALSE
TF:M12725,0.0015586894407779,TRUE,9957,556,334,TF,Factor: PHB; motif: NCCCAGCCCCY,20011,6540,TF:M00000,FALSE
GO:0048666,0.00155952944908336,TRUE,1142,553,59,GO:BP,neuron development,21010,13576,GO:0030182|GO:0048468,FALSE
GO:0016233,0.00156670631506293,TRUE,39,553,9,GO:BP,telomere capping,21010,5265,GO:0000723,FALSE
REAC:R-HSA-1445148,0.00159889274965229,TRUE,72,485,14,REAC,Translocation of SLC2A4 (GLUT4) to the plasma membrane,10835,2459,REAC:R-HSA-199991,FALSE
WP:WP4538,0.0016029045212266,TRUE,75,461,15,WP,Regulatory circuits of the STAT3 signaling pathway,8625,427,WP:000000,FALSE
REAC:R-HSA-9014325,0.00161665278086763,TRUE,11,485,6,REAC,"TICAM1,TRAF6-dependent induction of TAK1 complex",10835,2324,REAC:R-HSA-168164,FALSE
KEGG:05216,0.00162658488385601,TRUE,37,431,10,KEGG,Thyroid cancer,8161,460,KEGG:00000,FALSE
GO:0072594,0.00162947218507893,TRUE,673,553,41,GO:BP,establishment of protein localization to organelle,21010,18294,GO:0033365|GO:0045184,FALSE
REAC:R-HSA-2173795,0.00163514073232475,TRUE,29,485,9,REAC,Downregulation of SMAD2/3:SMAD4 transcriptional activity,10835,753,REAC:R-HSA-2173793,FALSE
MIRNA:hsa-miR-15b-5p,0.00164082095614449,TRUE,760,514,52,MIRNA,hsa-miR-15b-5p,14846,300,MIRNA:000000,FALSE
GO:0043621,0.00165018649650525,TRUE,69,555,11,GO:MF,protein self-association,20139,5816,GO:0005515,FALSE
GO:0043426,0.00170199238318606,TRUE,5,555,4,GO:MF,MRF binding,20139,5796,GO:0043425,FALSE
GO:0160009,0.00170199238318606,TRUE,5,555,4,GO:MF,histone decrotonylase activity,20139,10888,GO:0140993|GO:0160008,FALSE
GO:0160008,0.00170199238318606,TRUE,5,555,4,GO:MF,protein decrotonylase activity,20139,10887,GO:0016811,FALSE
HP:0008669,0.00171008848302742,TRUE,1022,241,81,HP,Abnormal spermatogenesis,4962,5449,HP:0000025,FALSE
GO:0045991,0.00171242168966067,TRUE,8,553,5,GO:BP,carbon catabolite activation of transcription,21010,12400,GO:0045893|GO:0045990,FALSE
GO:0045990,0.00171242168966067,TRUE,8,553,5,GO:BP,carbon catabolite regulation of transcription,21010,12399,GO:0006355|GO:0031670,FALSE
GO:0097527,0.00171242168966067,TRUE,8,553,5,GO:BP,necroptotic signaling pathway,21010,19576,GO:0007165|GO:0070266,FALSE
WP:WP5336,0.00171257926154821,TRUE,11,461,6,WP,Induction of autophagy and toll-like receptor signaling pathways by graphene oxide ,8625,197,WP:000000,FALSE
WP:WP3630,0.00171257926154821,TRUE,11,461,6,WP,"NAD metabolism, sirtuins and aging",8625,507,WP:000000,FALSE
GO:0034620,0.00171508860524171,TRUE,90,553,13,GO:BP,cellular response to unfolded protein,21010,9094,GO:0006986|GO:0035967,FALSE
GO:0048709,0.00174446617743205,TRUE,105,553,14,GO:BP,oligodendrocyte differentiation,21010,13618,GO:0007417|GO:0010001,FALSE
GO:0070828,0.00174446617743205,TRUE,105,553,14,GO:BP,heterochromatin organization,21010,17130,GO:0006338,FALSE
GO:1903557,0.00174446617743205,TRUE,105,553,14,GO:BP,positive regulation of tumor necrosis factor superfamily cytokine production,21010,24048,GO:0001819|GO:0071706|GO:1903555,FALSE
WP:WP4205,0.00175205394454144,TRUE,58,461,13,WP,MET in type 1 papillary renal cell carcinoma,8625,15,WP:000000,FALSE
TF:M00237,0.00177690888136913,TRUE,6490,556,235,TF,Factor: AhR:Arnt; motif: GRGKATYGCGTGMCWNSCC,20011,12,TF:M00000,FALSE
GO:0046824,0.00178549260077877,TRUE,63,553,11,GO:BP,positive regulation of nucleocytoplasmic transport,21010,13013,GO:0006913|GO:0032388|GO:0046822,FALSE
GO:1990874,0.00178549260077877,TRUE,63,553,11,GO:BP,vascular associated smooth muscle cell proliferation,21010,26382,GO:0048659,FALSE
HP:0001881,0.00178837849842628,TRUE,658,241,59,HP,Abnormal leukocyte morphology,4962,1363,HP:0001871|HP:0010987,FALSE
HP:0010987,0.00178837849842628,TRUE,658,241,59,HP,Abnormal cellular immune system morphology,4962,7407,HP:0032251,FALSE
HP:0000864,0.00179345711761545,TRUE,401,241,42,HP,Abnormality of the hypothalamus-pituitary axis,4962,674,HP:0000818,FALSE
HPA:0351182,0.00181254809728857,TRUE,3618,418,180,HPA,pancreas; pancreatic endocrine cells[Medium],11006,504,HPA:0351181,FALSE
GO:0097342,0.00183720156629408,TRUE,6,548,4,GO:CC,ripoptosome,22090,2975,GO:0005829|GO:1902494,TRUE
GO:0031265,0.00183720156629408,TRUE,6,548,4,GO:CC,CD95 death-inducing signaling complex,22090,1089,GO:0031264,FALSE
GO:0005856,0.00184311368985893,TRUE,2407,548,94,GO:CC,cytoskeleton,22090,401,GO:0043232,FALSE
GO:0048771,0.00186173071832722,TRUE,172,553,18,GO:BP,tissue remodeling,21010,13672,GO:0032501,FALSE
CORUM:5212,0.00187000848852415,TRUE,8,292,6,CORUM,Kinase maturation complex 2,3383,1590,CORUM:0000000,FALSE
CORUM:591,0.00187000848852415,TRUE,8,292,6,CORUM,SAP complex (Sin3-associated protein complex),3383,328,CORUM:0000000,FALSE
CORUM:5268,0.00187000848852415,TRUE,8,292,6,CORUM,TNF-alpha/NF-kappa B signaling complex 7,3383,1620,CORUM:0000000,FALSE
GO:0097049,0.00187110633202944,TRUE,21,553,7,GO:BP,motor neuron apoptotic process,21010,19340,GO:0051402,FALSE
GO:0043968,0.00187110633202944,TRUE,21,553,7,GO:BP,histone H2A acetylation,21010,11407,GO:0016573,FALSE
GO:1990928,0.00187464363766871,TRUE,51,553,10,GO:BP,response to amino acid starvation,21010,26398,GO:0042594,FALSE
REAC:R-HSA-212300,0.00189854492222878,TRUE,73,485,14,REAC,PRC2 methylates histones and DNA,10835,1620,REAC:R-HSA-212165,FALSE
TF:M09970_1,0.00191231732744626,TRUE,3880,556,155,TF,Factor: KLF3; motif: NNNNNNGGGCGGGGCNNGN; match class: 1,20011,4571,TF:M09970,FALSE
HP:0000002,0.00191931834924972,TRUE,1474,241,106,HP,Abnormality of body height,4962,2,HP:0001507,FALSE
GO:0048285,0.00192141362013469,TRUE,485,553,33,GO:BP,organelle fission,21010,13277,GO:0006996,FALSE
TF:M09765_1,0.00192264997921373,TRUE,3413,556,140,TF,Factor: SP1; motif: NRGKGGGCGGGGCN; match class: 1,20011,7835,TF:M09765,FALSE
TF:M03811_1,0.00192929234689018,TRUE,3912,556,156,TF,Factor: AP-2gamma; motif: GCCYNCRGSN; match class: 1,20011,145,TF:M03811,FALSE
GO:0090100,0.00195350953520697,TRUE,91,553,13,GO:BP,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,21010,18874,GO:0007178|GO:0009967|GO:0090092,FALSE
MIRNA:hsa-miR-214-3p,0.00195714503251501,TRUE,204,514,22,MIRNA,hsa-miR-214-3p,14846,429,MIRNA:000000,FALSE
GO:0001841,0.00196212522783988,TRUE,106,553,14,GO:BP,neural tube formation,21010,508,GO:0001838|GO:0021915,FALSE
GO:0002377,0.00196212522783988,TRUE,106,553,14,GO:BP,immunoglobulin production,21010,921,GO:0002440,FALSE
HP:0040012,0.00196279027108397,TRUE,38,241,11,HP,Chromosome breakage,4962,15019,HP:0003220,FALSE
GO:0014037,0.00197472678438786,TRUE,40,553,9,GO:BP,Schwann cell differentiation,21010,4691,GO:0007422|GO:0010001,FALSE
REAC:R-HSA-4420097,0.00200026191587796,TRUE,94,485,16,REAC,VEGFA-VEGFR2 Pathway,10835,2514,REAC:R-HSA-194138,FALSE
HPA:0510703,0.002014946910589,TRUE,293,418,28,HPA,soft tissue 2; peripheral nerve[High],11006,770,HPA:0510702,FALSE
TF:M09918,0.00201540256136516,TRUE,13856,556,436,TF,Factor: Pet-1; motif: GCNGGAAGYG,20011,6538,TF:M00000,FALSE
GO:0045648,0.00202356479313427,TRUE,30,553,8,GO:BP,positive regulation of erythrocyte differentiation,21010,12114,GO:0030218|GO:0045639|GO:0045646,FALSE
GO:0016755,0.00202749178705616,TRUE,497,555,33,GO:MF,aminoacyltransferase activity,20139,2966,GO:0016746,FALSE
TF:M00024_1,0.00203513444888589,TRUE,2717,556,117,TF,Factor: E2F-1; motif: TWSGCGCGAAAAYKR; match class: 1,20011,1543,TF:M00024,FALSE
WP:WP2882,0.00206051917049899,TRUE,313,461,36,WP,Nuclear receptors meta-pathway,8625,399,WP:000000,FALSE
HP:0003022,0.0020947451457266,TRUE,54,241,13,HP,Hypoplasia of the ulna,4962,2182,HP:0006495|HP:0009821,FALSE
GO:0031175,0.00210374936749582,TRUE,990,553,53,GO:BP,neuron projection development,21010,7422,GO:0048666|GO:0120036,FALSE
GO:0000271,0.00210542878555699,TRUE,64,553,11,GO:BP,polysaccharide biosynthetic process,21010,78,GO:0005976|GO:0009059|GO:0016051,FALSE
MIRNA:hsa-miR-17-5p,0.00210611177544493,TRUE,1176,514,71,MIRNA,hsa-miR-17-5p,14846,305,MIRNA:000000,FALSE
KEGG:05218,0.00211108237216625,TRUE,72,431,14,KEGG,Melanoma,8161,462,KEGG:00000,FALSE
GO:0030335,0.00211390097689075,TRUE,534,553,35,GO:BP,positive regulation of cell migration,21010,7096,GO:0016477|GO:0030334|GO:2000147,FALSE
GO:0050803,0.0021184164350592,TRUE,249,553,22,GO:BP,regulation of synapse structure or activity,21010,13927,GO:0065008,FALSE
WP:WP5294,0.00213043573146305,TRUE,22,461,8,WP,Sildenafil treatment,8625,450,WP:000000,FALSE
TF:M03814,0.00213705070707914,TRUE,5270,556,198,TF,Factor: BTEB2; motif: GNAGGGGGNGGGSSNN,20011,622,TF:M00000,FALSE
REAC:R-HSA-211163,0.00215619634156101,TRUE,4,485,4,REAC,AKT-mediated inactivation of FOXO1A,10835,13,REAC:R-HSA-210745,FALSE
HPA:0080131,0.00216018850828119,TRUE,6154,418,277,HPA,caudate; neuronal cells[Low],11006,94,HPA:0080000,FALSE
TF:M10529_1,0.00218053430473968,TRUE,2901,556,123,TF,Factor: Sp1; motif: RGGGMGGRGSNGGGG; match class: 1,20011,7839,TF:M10529,FALSE
HP:0002597,0.00218317312680636,TRUE,1919,241,129,HP,Abnormality of the vasculature,4962,1880,HP:0001626,FALSE
HPA:0300413,0.00220024655300162,TRUE,1367,418,83,HPA,lung; macrophages[High],11006,458,HPA:0300412,FALSE
GO:0001091,0.00221257931922225,TRUE,25,555,7,GO:MF,RNA polymerase II general transcription initiation factor binding,20139,157,GO:0001099|GO:0140296,FALSE
TF:M09636,0.0022224535507162,TRUE,16581,556,501,TF,Factor: MAZ; motif: GGGMGGGGSSGGGGGGGGGGGG,20011,4992,TF:M00000,FALSE
GO:0030527,0.00222735168921911,TRUE,100,555,13,GO:MF,structural constituent of chromatin,20139,3959,GO:0005198,TRUE
TF:M09632,0.00223911652918502,TRUE,3054,556,128,TF,Factor: Kaiso; motif: GNTCTCGCGAGRNNNNGGN,20011,9122,TF:M00000,FALSE
WP:WP4249,0.00225871902664236,TRUE,43,461,11,WP,Hedgehog signaling pathway,8625,814,WP:000000,FALSE
GO:0010823,0.00226681405503475,TRUE,52,553,10,GO:BP,negative regulation of mitochondrion organization,21010,4514,GO:0007005|GO:0010639|GO:0010821,FALSE
GO:0140352,0.00230457957290229,TRUE,887,553,49,GO:BP,export from cell,21010,20673,GO:0006810|GO:0009987,FALSE
REAC:R-HSA-9692914,0.00230793767906049,TRUE,95,485,16,REAC,SARS-CoV-1-host interactions,10835,2013,REAC:R-HSA-9678108,FALSE
TF:M07084_1,0.00233366501345576,TRUE,5573,556,207,TF,Factor: E2F-4; motif: NGGCGGGAARN; match class: 1,20011,1509,TF:M07084,FALSE
REAC:R-HSA-8864260,0.00243817972075505,TRUE,38,485,10,REAC,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,10835,2440,REAC:R-HSA-212436,FALSE
REAC:R-HSA-1810476,0.00246471509832228,TRUE,17,485,7,REAC,RIP-mediated NFkB activation via ZBP1,10835,1793,REAC:R-HSA-1606322,FALSE
REAC:R-HSA-9661069,0.00246471509832228,TRUE,17,485,7,REAC,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",10835,670,REAC:R-HSA-9659787,FALSE
REAC:R-HSA-9659787,0.00246471509832228,TRUE,17,485,7,REAC,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,10835,44,REAC:R-HSA-9687139,FALSE
GO:0010660,0.00247480063283778,TRUE,65,553,11,GO:BP,regulation of muscle cell apoptotic process,21010,4377,GO:0010657|GO:0042981,FALSE
GO:0045471,0.00250223006565468,TRUE,124,553,15,GO:BP,response to ethanol,21010,12014,GO:0097305,FALSE
TF:M00245,0.00250911443394012,TRUE,7475,556,263,TF,Factor: Egr-3; motif: NTGCGTGGGCGK,20011,1650,TF:M00000,FALSE
GO:0045995,0.00252079353215082,TRUE,93,553,13,GO:BP,regulation of embryonic development,21010,12404,GO:0009790|GO:2000026,FALSE
GO:0001843,0.00252079353215082,TRUE,93,553,13,GO:BP,neural tube closure,21010,510,GO:0014020|GO:0060606,FALSE
GO:0043491,0.0025477437262233,TRUE,194,553,19,GO:BP,phosphatidylinositol 3-kinase/protein kinase B signal transduction,21010,11247,GO:0035556,FALSE
HP:0030448,0.00255564224004282,TRUE,123,241,20,HP,Soft tissue sarcoma,4962,10560,HP:0100242,FALSE
GO:0001673,0.00260922459131443,TRUE,55,548,9,GO:CC,male germ cell nucleus,22090,152,GO:0043073,FALSE
HP:0001549,0.00261795023177235,TRUE,39,241,11,HP,Abnormal ileum morphology,4962,1138,HP:0002244,FALSE
GO:0007422,0.00265801735264936,TRUE,79,553,12,GO:BP,peripheral nervous system development,21010,2970,GO:0007399|GO:0048731,FALSE
GO:0022409,0.00267197836461047,TRUE,314,553,25,GO:BP,positive regulation of cell-cell adhesion,21010,6915,GO:0022407|GO:0045785|GO:0098609,FALSE
GO:0042026,0.00268216060379886,TRUE,22,553,7,GO:BP,protein refolding,21010,10424,GO:0006457,TRUE
GO:0060444,0.00268216060379886,TRUE,22,553,7,GO:BP,branching involved in mammary gland duct morphogenesis,21010,15376,GO:0048754|GO:0060603,FALSE
GO:0035902,0.00268216060379886,TRUE,22,553,7,GO:BP,response to immobilization stress,21010,9771,GO:0006950,FALSE
MIRNA:hsa-miR-126-3p,0.00274890560481521,TRUE,57,514,11,MIRNA,hsa-miR-126-3p,14846,136,MIRNA:000000,FALSE
HP:0011972,0.0027715271046193,TRUE,6,241,5,HP,Hypoglycorrhachia,4962,8369,HP:0031884,FALSE
HP:0031884,0.0027715271046193,TRUE,6,241,5,HP,Abnormal CSF glucose concentration,4962,11923,HP:0025454,FALSE
HP:0007565,0.00280448883758861,TRUE,64,241,14,HP,Multiple cafe-au-lait spots,4962,4845,HP:0000957,FALSE
HP:0000271,0.00281649676343874,TRUE,3003,241,180,HP,Abnormality of the face,4962,224,HP:0000234,FALSE
GO:0007159,0.00283140867982753,TRUE,402,553,29,GO:BP,leukocyte cell-cell adhesion,21010,2770,GO:0098609,FALSE
GO:0003013,0.00283320707742681,TRUE,589,553,37,GO:BP,circulatory system process,21010,1478,GO:0003008,FALSE
WP:WP3286,0.00283669687788803,TRUE,52,461,12,WP,Copper homeostasis,8625,102,WP:000000,FALSE
HP:0032251,0.00284188847359646,TRUE,683,241,60,HP,Abnormal immune system morphology,4962,12263,HP:0002715,FALSE
GO:0060606,0.00285605114345061,TRUE,94,553,13,GO:BP,tube closure,21010,15522,GO:0035148,FALSE
WP:WP2332,0.00286873120557462,TRUE,44,461,11,WP,Interleukin-11 signaling pathway,8625,23,WP:000000,FALSE
GO:0050729,0.00287103815466064,TRUE,142,553,16,GO:BP,positive regulation of inflammatory response,21010,13884,GO:0006954|GO:0031349|GO:0032103|GO:0050727,FALSE
TF:M00244,0.0029205465347915,TRUE,6325,556,229,TF,Factor: NGFI-C; motif: WTGCGTGGGYGG,20011,5764,TF:M00000,FALSE
TF:M08208,0.00292337007938973,TRUE,12825,556,409,TF,Factor: E2F-3:FOXI1; motif: NGACACCGCGCCCAC,20011,1478,TF:M00000,FALSE
GO:0004709,0.0029560908528464,TRUE,26,555,7,GO:MF,MAP kinase kinase kinase activity,20139,1001,GO:0004674,FALSE
GO:0045927,0.00296056761203352,TRUE,254,553,22,GO:BP,positive regulation of growth,21010,12338,GO:0040007|GO:0040008|GO:0048518,FALSE
GO:0019752,0.00297988639650353,TRUE,948,553,51,GO:BP,carboxylic acid metabolic process,21010,6321,GO:0043436,FALSE
WP:WP3678,0.00299569192774944,TRUE,17,461,7,WP,Amplification and expansion of oncogenic pathways as metastatic traits,8625,307,WP:000000,FALSE
WP:WP4872,0.00299569192774944,TRUE,17,461,7,WP,MAP3K1 role in promoting and blocking gonadal determination,8625,735,WP:000000,FALSE
GO:0072330,0.00299723378158614,TRUE,215,553,20,GO:BP,monocarboxylic acid biosynthetic process,21010,18185,GO:0032787|GO:0046394,FALSE
TF:M03978,0.00303250475249863,TRUE,12289,556,395,TF,Factor: ETS1; motif: GCCGGAWGTACTTCCGGN,20011,2170,TF:M00000,FALSE
GO:0031016,0.00305329525091646,TRUE,80,553,12,GO:BP,pancreas development,21010,7316,GO:0048513,FALSE
GO:0120035,0.00306262730043218,TRUE,640,553,39,GO:BP,regulation of plasma membrane bounded cell projection organization,21010,20387,GO:0031344|GO:0120036,FALSE
GO:0014014,0.00307273820011941,TRUE,42,553,9,GO:BP,negative regulation of gliogenesis,21010,4671,GO:0014013|GO:0042063|GO:0050768,FALSE
HP:0004348,0.00307372695224354,TRUE,621,241,56,HP,Abnormality of bone mineral density,4962,3040,HP:0011849,FALSE
GO:0035967,0.00309701240959627,TRUE,110,553,14,GO:BP,cellular response to topologically incorrect protein,21010,9816,GO:0033554|GO:0035966|GO:0071310,FALSE
GO:0044183,0.00310324160952178,TRUE,60,555,10,GO:MF,protein folding chaperone,20139,6026,GO:0003674,FALSE
REAC:R-HSA-9013973,0.00311117958226863,TRUE,12,485,6,REAC,TICAM1-dependent activation of IRF3/IRF7,10835,2325,REAC:R-HSA-168164,FALSE
REAC:R-HSA-4641265,0.00311117958226863,TRUE,12,485,6,REAC,Repression of WNT target genes,10835,1962,REAC:R-HSA-195253,FALSE
GO:0031348,0.00311138976997759,TRUE,275,553,23,GO:BP,negative regulation of defense response,21010,7485,GO:0006952|GO:0031347|GO:0048585,FALSE
WP:WP3612,0.00311517969590117,TRUE,23,461,8,WP,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,8625,331,WP:000000,FALSE
TF:M00737_1,0.00312623955107288,TRUE,3012,556,126,TF,Factor: E2F-1:DP-2; motif: TTTSSCGC; match class: 1,20011,1427,TF:M00737,FALSE
REAC:R-HSA-8853884,0.00314920364748456,TRUE,39,485,10,REAC,Transcriptional Regulation by VENTX,10835,2432,REAC:R-HSA-212436,FALSE
TF:M02052,0.00316785333821987,TRUE,10272,556,341,TF,Factor: EHF; motif: CSCGGAARTN,20011,1674,TF:M00000,FALSE
HP:0000769,0.00322242507314731,TRUE,439,241,44,HP,Abnormality of the breast,4962,601,HP:0000118,FALSE
REAC:R-HSA-9734009,0.00322343819921368,TRUE,24,485,8,REAC,Defective Intrinsic Pathway for Apoptosis,10835,555,REAC:R-HSA-9645723,FALSE
GO:0031507,0.00323044864883648,TRUE,95,553,13,GO:BP,heterochromatin formation,21010,7540,GO:0045814|GO:0070828,FALSE
GO:0021766,0.00323044864883648,TRUE,95,553,13,GO:BP,hippocampus development,21010,6650,GO:0021543|GO:0021761|GO:0048856,FALSE
WP:WP5382,0.00327087527614421,TRUE,12,461,6,WP,TGF/Smad signaling pathway,8625,453,WP:000000,FALSE
TF:M00740_1,0.0032732789433283,TRUE,4713,556,180,TF,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC; match class: 1,20011,1423,TF:M00740,FALSE
TF:M11393_1,0.00328513906336569,TRUE,13895,556,436,TF,Factor: Erg; motif: NACCGGATATCCGGTN; match class: 1,20011,2035,TF:M11393,FALSE
MIRNA:hsa-miR-34c-3p,0.0032877378045273,TRUE,58,514,11,MIRNA,hsa-miR-34c-3p,14846,710,MIRNA:000000,FALSE
TF:M03895_1,0.00331814798653276,TRUE,3601,556,145,TF,Factor: CTCF; motif: WGCGCCMYCTAGYGGYN; match class: 1,20011,1133,TF:M03895,FALSE
TF:M11533,0.00332127102289808,TRUE,13421,556,424,TF,Factor: E2F-1; motif: NTTTTGGCGCCAWWWN,20011,1442,TF:M00000,FALSE
GO:1905952,0.00333595258292934,TRUE,161,553,17,GO:BP,regulation of lipid localization,21010,26082,GO:0010876|GO:0032879,FALSE
GO:0055088,0.00333595258292934,TRUE,161,553,17,GO:BP,lipid homeostasis,21010,14968,GO:0048878,FALSE
GO:0008202,0.00336728888287833,TRUE,318,553,25,GO:BP,steroid metabolic process,21010,3182,GO:0006629|GO:1901360,FALSE
GO:0016538,0.00337017210549645,TRUE,48,555,9,GO:MF,cyclin-dependent protein serine/threonine kinase regulator activity,20139,2850,GO:0019887,FALSE
GO:0045600,0.00338823406439474,TRUE,67,553,11,GO:BP,positive regulation of fat cell differentiation,21010,12066,GO:0045444|GO:0045597|GO:0045598,FALSE
GO:0045669,0.00338823406439474,TRUE,67,553,11,GO:BP,positive regulation of osteoblast differentiation,21010,12135,GO:0001649|GO:0045597|GO:0045667,FALSE
KEGG:05171,0.00338982731903249,TRUE,231,431,28,KEGG,Coronavirus disease - COVID-19,8161,445,KEGG:00000,FALSE
TF:M06948_1,0.00341600309427312,TRUE,6337,556,229,TF,Factor: Sp2; motif: TGGGCGCGCCCA; match class: 1,20011,7865,TF:M06948,FALSE
GO:0005815,0.00341797851597692,TRUE,855,548,43,GO:CC,microtubule organizing center,22090,368,GO:0015630|GO:0110165,FALSE
KEGG:05214,0.00342457644156729,TRUE,75,431,14,KEGG,Glioma,8161,458,KEGG:00000,FALSE
GO:0043240,0.00342470499924072,TRUE,13,548,5,GO:CC,Fanconi anaemia nuclear complex,22090,1891,GO:0140513,FALSE
GO:0005677,0.00342470499924072,TRUE,13,548,5,GO:CC,chromatin silencing complex,22090,269,GO:0140513,FALSE
REAC:R-HSA-5696398,0.00342674546278722,TRUE,109,485,17,REAC,Nucleotide Excision Repair,10835,1544,REAC:R-HSA-73894,FALSE
REAC:R-HSA-1912422,0.00342674546278722,TRUE,109,485,17,REAC,Pre-NOTCH Expression and Processing,10835,1702,REAC:R-HSA-157118,FALSE
REAC:R-HSA-2454202,0.00345413461122443,TRUE,182,485,23,REAC,Fc epsilon receptor (FCERI) signaling,10835,896,REAC:R-HSA-168249,FALSE
MIRNA:hsa-miR-206,0.00345547106758581,TRUE,121,514,16,MIRNA,hsa-miR-206,14846,403,MIRNA:000000,FALSE
HP:0012539,0.0034578639522043,TRUE,40,241,11,HP,Non-Hodgkin lymphoma,4962,8926,HP:0002665,FALSE
GO:0071354,0.00347169919415719,TRUE,32,553,8,GO:BP,cellular response to interleukin-6,21010,17416,GO:0070741|GO:0071345,FALSE
GO:0060603,0.00347169919415719,TRUE,32,553,8,GO:BP,mammary gland duct morphogenesis,21010,15519,GO:0060443|GO:0060562|GO:0061180,FALSE
GO:0035518,0.00348196076051421,TRUE,15,553,6,GO:BP,histone H2A monoubiquitination,21010,9506,GO:0010390|GO:0033522,FALSE
GO:0061307,0.00348196076051421,TRUE,15,553,6,GO:BP,cardiac neural crest cell differentiation involved in heart development,21010,16155,GO:0014033|GO:0035051,FALSE
GO:0061308,0.00348196076051421,TRUE,15,553,6,GO:BP,cardiac neural crest cell development involved in heart development,21010,16156,GO:0014032|GO:0061307,FALSE
WP:WP2864,0.00349216864699972,TRUE,53,461,12,WP,Apoptosis-related network due to altered Notch3 in ovarian cancer,8625,141,WP:000000,FALSE
REAC:R-HSA-9012852,0.0035176714030056,TRUE,48,485,11,REAC,Signaling by NOTCH3,10835,2173,REAC:R-HSA-157118,FALSE
TF:M00144_1,0.00352875037191448,TRUE,7295,556,257,TF,Factor: Pax-5; motif: RRMSWGANWYCTNRAGCGKRACSRYNSM; match class: 1,20011,6387,TF:M00144,FALSE
HP:0002894,0.00355769474403864,TRUE,84,241,16,HP,Neoplasm of the pancreas,4962,2095,HP:0001732|HP:0011793,FALSE
HP:0000951,0.00356517734942126,TRUE,2175,241,141,HP,Abnormality of the skin,4962,742,HP:0001574,FALSE
TF:M07040,0.00361480427302136,TRUE,12959,556,412,TF,Factor: GKLF; motif: NNRRGRRNGNSNNN,20011,3166,TF:M00000,FALSE
WP:WP2873,0.0036167600147204,TRUE,45,461,11,WP,Aryl hydrocarbon receptor pathway,8625,562,WP:000000,FALSE
GO:0032680,0.00363780844803633,TRUE,162,553,17,GO:BP,regulation of tumor necrosis factor production,21010,8094,GO:0032640|GO:1903555,FALSE
GO:0032640,0.00363780844803633,TRUE,162,553,17,GO:BP,tumor necrosis factor production,21010,8055,GO:0071706,FALSE
TF:M12648_1,0.00369666511663416,TRUE,1289,556,66,TF,Factor: PATZ1; motif: SCNCCNCNSCCCCCASCCN; match class: 1,20011,6321,TF:M12648,FALSE
TF:M09760_1,0.00372583873569859,TRUE,3083,556,128,TF,Factor: DPF2; motif: NYCACYTCCYCNYYCY; match class: 1,20011,1357,TF:M09760,FALSE
MIRNA:hsa-miR-145-5p,0.00376252878609617,TRUE,245,514,24,MIRNA,hsa-miR-145-5p,14846,261,MIRNA:000000,FALSE
GO:0001838,0.00376435103557832,TRUE,128,553,15,GO:BP,embryonic epithelial tube formation,21010,505,GO:0016331|GO:0072175,FALSE
GO:0035666,0.00376933249704247,TRUE,9,553,5,GO:BP,TRIF-dependent toll-like receptor signaling pathway,21010,9591,GO:0002756,TRUE
GO:0045687,0.00379614950410137,TRUE,43,553,9,GO:BP,positive regulation of glial cell differentiation,21010,12150,GO:0010001|GO:0014015|GO:0045685,FALSE
GO:0003176,0.00379614950410137,TRUE,43,553,9,GO:BP,aortic valve development,21010,1623,GO:1905314,FALSE
GO:0032735,0.00379614950410137,TRUE,43,553,9,GO:BP,positive regulation of interleukin-12 production,21010,8148,GO:0001819|GO:0032615|GO:0032655,FALSE
GO:0042552,0.00380177519691737,TRUE,145,553,16,GO:BP,myelination,21010,10746,GO:0008366,FALSE
WP:WP4906,0.00381641234860424,TRUE,71,461,14,WP,3q29 copy number variation syndrome,8625,837,WP:000000,FALSE
GO:0031996,0.00383296109007256,TRUE,11,555,5,GO:MF,thioesterase binding,20139,4395,GO:0019899,FALSE
GO:0046822,0.00386002532479956,TRUE,112,553,14,GO:BP,regulation of nucleocytoplasmic transport,21010,13011,GO:0006913|GO:0032386,FALSE
GO:0022412,0.00387733048643392,TRUE,454,553,31,GO:BP,cellular process involved in reproduction in multicellular organism,21010,6918,GO:0009987|GO:0022414|GO:0032504,FALSE
REAC:R-HSA-6785807,0.00388869802151974,TRUE,110,485,17,REAC,Interleukin-4 and Interleukin-13 signaling,10835,1200,REAC:R-HSA-449147,FALSE
GO:1901224,0.00394723129475498,TRUE,68,553,11,GO:BP,positive regulation of non-canonical NF-kappaB signal transduction,21010,22155,GO:0038061|GO:1901222|GO:1902533,FALSE
GO:0048645,0.00394723129475498,TRUE,68,553,11,GO:BP,animal organ formation,21010,13555,GO:0009887|GO:0048646,FALSE
HP:0000072,0.00394994761070997,TRUE,75,241,15,HP,Hydroureter,4962,67,HP:0025633,FALSE
HP:0001780,0.0039933783936084,TRUE,706,241,61,HP,Abnormal toe morphology,4962,1291,HP:0001760|HP:0011297,FALSE
TF:M02102,0.00403482724070578,TRUE,2075,556,94,TF,Factor: NRF-1; motif: YGCGCMTGCGC,20011,6048,TF:M00000,FALSE
KEGG:05206,0.00406531083335613,TRUE,310,431,34,KEGG,MicroRNAs in cancer,8161,451,KEGG:00000,FALSE
HP:0012302,0.004074372824401,TRUE,10,241,6,HP,Herpes simplex encephalitis,4962,8694,HP:0033993,FALSE
HP:0030063,0.0041949680264872,TRUE,85,241,16,HP,Neuroepithelial neoplasm,4962,10198,HP:0030061,FALSE
GO:0016589,0.00420246855503881,TRUE,7,548,4,GO:CC,NURF complex,22090,761,GO:0031010,TRUE
GO:0008015,0.00428451353355253,TRUE,503,553,33,GO:BP,blood circulation,21010,3149,GO:0003013,FALSE
GO:0040017,0.00428660981493251,TRUE,575,553,36,GO:BP,positive regulation of locomotion,21010,10397,GO:0040011|GO:0040012|GO:0048518,FALSE
GO:0043542,0.00429342619533348,TRUE,220,553,20,GO:BP,endothelial cell migration,21010,11272,GO:0010631,FALSE
WP:WP4925,0.00445620218356927,TRUE,24,461,8,WP,Unfolded protein response,8625,494,WP:000000,FALSE
WP:WP1528,0.00445620218356927,TRUE,24,461,8,WP,Physiological and pathological hypertrophy of the heart,8625,213,WP:000000,FALSE
HP:0001626,0.0044716366879654,TRUE,2708,241,166,HP,Abnormality of the cardiovascular system,4962,1181,HP:0000118,FALSE
GO:0010464,0.0044776126345275,TRUE,33,553,8,GO:BP,regulation of mesenchymal cell proliferation,21010,4227,GO:0010463|GO:0042127,FALSE
GO:0110165,0.00447986926119874,TRUE,21541,548,547,GO:CC,cellular anatomical entity,22090,3447,GO:0005575,FALSE
TF:M09897_1,0.00448327233652364,TRUE,1032,556,56,TF,Factor: Egr-1; motif: NNNNGCGKGGGYGGNRN; match class: 1,20011,1623,TF:M09897,FALSE
TF:M04710,0.00449923957986363,TRUE,14361,556,447,TF,Factor: CHD2; motif: TCTCGCGAG,20011,836,TF:M00000,FALSE
TF:M01593,0.0045533772099363,TRUE,4253,556,165,TF,Factor: Zfx; motif: SNSCAGGCCKCGSCSS,20011,9336,TF:M00000,FALSE
TF:M01865_1,0.00455487601741628,TRUE,4317,556,167,TF,Factor: BTEB3; motif: BNRNGGGAGGNGT; match class: 1,20011,637,TF:M01865,FALSE
REAC:R-HSA-201556,0.00455606019527166,TRUE,25,485,8,REAC,Signaling by ALK,10835,2110,REAC:R-HSA-9006934,FALSE
REAC:R-HSA-453279,0.00455937867520049,TRUE,147,485,20,REAC,Mitotic G1 phase and G1/S transition,10835,1408,REAC:R-HSA-69278,FALSE
GO:0008366,0.0045649461486326,TRUE,147,553,16,GO:BP,axon ensheathment,21010,3239,GO:0007272,FALSE
GO:0007272,0.0045649461486326,TRUE,147,553,16,GO:BP,ensheathment of neurons,21010,2851,GO:0007399|GO:0009987,FALSE
TF:M08209_1,0.00456608627415597,TRUE,7976,556,276,TF,Factor: E2F-3:FOXO6; motif: NAATGACACGCGCCCMC; match class: 1,20011,1481,TF:M08209,FALSE
GO:0048661,0.00456918466825343,TRUE,83,553,12,GO:BP,positive regulation of smooth muscle cell proliferation,21010,13571,GO:0008284|GO:0048659|GO:0048660,FALSE
GO:0021987,0.00458845546769647,TRUE,130,553,15,GO:BP,cerebral cortex development,21010,6856,GO:0021543|GO:0048856,FALSE
HPA:0500113,0.0046051471284331,TRUE,323,418,29,HPA,soft tissue 1; chondrocytes[High],11006,754,HPA:0500112,FALSE
GO:0044281,0.00464004880828289,TRUE,1846,553,82,GO:BP,small molecule metabolic process,21010,11506,GO:0008152,FALSE
HPA:0250132,0.00464156331883409,TRUE,4222,418,202,HPA,hippocampus; neuronal cells[Medium],11006,386,HPA:0250131,FALSE
GO:0046324,0.00464234139566964,TRUE,56,553,10,GO:BP,regulation of glucose import,21010,12675,GO:0010827|GO:0046323,FALSE
GO:0032007,0.00464234139566964,TRUE,56,553,10,GO:BP,negative regulation of TOR signaling,21010,7666,GO:0031929|GO:0032006|GO:1902532,FALSE
GO:0048713,0.00466185254715901,TRUE,44,553,9,GO:BP,regulation of oligodendrocyte differentiation,21010,13622,GO:0045685|GO:0048709,FALSE
GO:0031670,0.00466185254715901,TRUE,44,553,9,GO:BP,cellular response to nutrient,21010,7625,GO:0007584|GO:0031669|GO:0070887,FALSE
MIRNA:hsa-miR-16-2-3p,0.00477674436755269,TRUE,84,514,13,MIRNA,hsa-miR-16-2-3p,14846,302,MIRNA:000000,FALSE
GO:0045765,0.00478918953907524,TRUE,282,553,23,GO:BP,regulation of angiogenesis,21010,12216,GO:0001525|GO:0022603|GO:1901342,FALSE
REAC:R-HSA-163680,0.00479039558099603,TRUE,8,485,5,REAC,AMPK inhibits chREBP transcriptional activation activity,10835,17,REAC:R-HSA-163685,FALSE
REAC:R-HSA-168256,0.00479723942961109,TRUE,2051,485,130,REAC,Immune System,10835,1118,REAC:0000000,FALSE
HP:0001010,0.00481878737775517,TRUE,211,241,27,HP,Hypopigmentation of the skin,4962,790,HP:0001000,FALSE
TF:M10112_1,0.00483126437119736,TRUE,4034,556,158,TF,Factor: Miz-1; motif: NNRGGWGGGGGAGGGGMRR; match class: 1,20011,5201,TF:M10112,FALSE
HP:0030061,0.00493309920005939,TRUE,86,241,16,HP,Neuroectodermal neoplasm,4962,10196,HP:0030060,FALSE
HP:0030060,0.00493309920005939,TRUE,86,241,16,HP,Nervous tissue neoplasm,4962,10195,HP:0011792,FALSE
TF:M08993,0.00495918751139034,TRUE,10826,556,355,TF,Factor: ZNF777; motif: GTCCGYCCCGTCSAACAAT,20011,11304,TF:M00000,FALSE
GO:0004691,0.00499429558204707,TRUE,6,555,4,GO:MF,cAMP-dependent protein kinase activity,20139,988,GO:0004690,FALSE
GO:0055131,0.00499429558204707,TRUE,6,555,4,GO:MF,C3HC4-type RING finger domain binding,20139,8443,GO:0019904,FALSE
REAC:R-HSA-8986944,0.00502816978972415,TRUE,59,485,12,REAC,Transcriptional Regulation by MECP2,10835,2429,REAC:R-HSA-212436,FALSE
TF:M08867_1,0.00504582346766517,TRUE,5299,556,197,TF,Factor: AP2; motif: GCCYGSGGSN; match class: 1,20011,153,TF:M08867,FALSE
HPA:0130053,0.00505161695631732,TRUE,2416,418,128,HPA,colon; glandular cells[High],11006,233,HPA:0130052,FALSE
GO:0046683,0.00505829639256433,TRUE,131,553,15,GO:BP,response to organophosphorus,21010,12939,GO:0010033,FALSE
HP:0100568,0.00506412897960805,TRUE,151,241,22,HP,Neoplasm of the endocrine system,4962,16072,HP:0000818|HP:0011793,FALSE
CORUM:2727,0.00509488814588515,TRUE,6,292,5,CORUM,SRC-3 complex,3383,1157,CORUM:0000000,FALSE
GO:0098609,0.00511311611297247,TRUE,939,553,50,GO:BP,cell-cell adhesion,21010,19697,GO:0007155,FALSE
GO:0070369,0.00516517490585227,TRUE,3,548,3,GO:CC,beta-catenin-TCF7L2 complex,22090,2474,GO:0071664|GO:1990907,FALSE
CORUM:592,0.00520391324162866,TRUE,9,292,6,CORUM,SAP complex (Sin3-associated protein complex),3383,329,CORUM:0000000,FALSE
CORUM:738,0.00520391324162866,TRUE,9,292,6,CORUM,SIN3-ING1b complex I,3383,404,CORUM:0000000,FALSE
HP:0030858,0.00521617747545866,TRUE,27,241,9,HP,Addictive behavior,4962,10948,HP:5200045,FALSE
HP:0030955,0.00521617747545866,TRUE,27,241,9,HP,Alcoholism,4962,11037,HP:0030858,FALSE
GO:0004842,0.00523000168321889,TRUE,450,555,30,GO:MF,ubiquitin-protein transferase activity,20139,1115,GO:0019787,FALSE
REAC:R-HSA-170834,0.00524719294330326,TRUE,90,485,15,REAC,Signaling by TGF-beta Receptor Complex,10835,2199,REAC:R-HSA-9006936,FALSE
REAC:R-HSA-5250924,0.00524719294330326,TRUE,90,485,15,REAC,B-WICH complex positively regulates rRNA expression,10835,192,REAC:R-HSA-5250913,FALSE
WP:WP3584,0.00531264862048997,TRUE,73,461,14,WP,MECP2 and associated Rett syndrome,8625,96,WP:000000,FALSE
GO:0045911,0.0053129414474914,TRUE,70,553,11,GO:BP,positive regulation of DNA recombination,21010,12322,GO:0000018|GO:0006310|GO:0051054,FALSE
GO:0003208,0.0053129414474914,TRUE,70,553,11,GO:BP,cardiac ventricle morphogenesis,21010,1655,GO:0003206|GO:0003231,FALSE
GO:0055007,0.00532082417380567,TRUE,115,553,14,GO:BP,cardiac muscle cell differentiation,21010,14925,GO:0035051|GO:0048738|GO:0051146,FALSE
HPA:0460651,0.00534270440347013,TRUE,4078,418,196,HPA,skin 1; fibroblasts[Low],11006,649,HPA:0460000,FALSE
GO:0070661,0.00536292419604784,TRUE,348,553,26,GO:BP,leukocyte proliferation,21010,17045,GO:0008283,FALSE
HPA:0500653,0.00541244861302877,TRUE,541,418,41,HPA,soft tissue 1; fibroblasts[High],11006,757,HPA:0500652,FALSE
GO:0030073,0.00543615459966738,TRUE,204,553,19,GO:BP,insulin secretion,21010,6988,GO:0009306|GO:0030072,FALSE
GO:0043982,0.00544727218927769,TRUE,16,553,6,GO:BP,histone H4-K8 acetylation,21010,11418,GO:0043967,FALSE
GO:0043981,0.00544727218927769,TRUE,16,553,6,GO:BP,histone H4-K5 acetylation,21010,11417,GO:0043967,FALSE
GO:0010803,0.00549879021141559,TRUE,57,553,10,GO:BP,regulation of tumor necrosis factor-mediated signaling pathway,21010,4496,GO:0001959|GO:0033209,FALSE
HP:0002665,0.00552182965974596,TRUE,118,241,19,HP,Lymphoma,4962,1931,HP:0004377,FALSE
HP:0031093,0.00553796262731288,TRUE,433,241,43,HP,Abnormal breast morphology,4962,11168,HP:0000769,FALSE
MIRNA:hsa-miR-218-5p,0.00554218314835688,TRUE,814,514,53,MIRNA,hsa-miR-218-5p,14846,440,MIRNA:000000,FALSE
REAC:R-HSA-202670,0.00555983552403686,TRUE,13,485,6,REAC,ERKs are inactivated,10835,795,REAC:R-HSA-198753,FALSE
GO:0003158,0.00557080230764298,TRUE,132,553,15,GO:BP,endothelium development,21010,1605,GO:0060429,FALSE
REAC:R-HSA-9020702,0.00562796918514346,TRUE,113,485,17,REAC,Interleukin-1 signaling,10835,1181,REAC:R-HSA-446652,FALSE
GO:0090199,0.00569248024596532,TRUE,45,553,9,GO:BP,regulation of release of cytochrome c from mitochondria,21010,18961,GO:0001836|GO:0010821,FALSE
GO:0006984,0.00569248024596532,TRUE,45,553,9,GO:BP,ER-nucleus signaling pathway,21010,2649,GO:0007165,FALSE
GO:0031641,0.00569248024596532,TRUE,45,553,9,GO:BP,regulation of myelination,21010,7602,GO:0042552|GO:0050794|GO:0051960,FALSE
GO:1905953,0.00569248024596532,TRUE,45,553,9,GO:BP,negative regulation of lipid localization,21010,26083,GO:0010876|GO:0048519|GO:1905952,FALSE
GO:0032212,0.00572117824787385,TRUE,34,553,8,GO:BP,positive regulation of telomere maintenance via telomerase,21010,7768,GO:0007004|GO:0032210|GO:1904358|GO:2000573,FALSE
GO:1901342,0.00573425586258045,TRUE,285,553,23,GO:BP,regulation of vasculature development,21010,22248,GO:0001944|GO:2000026,FALSE
KEGG:05017,0.00575593934166688,TRUE,142,431,20,KEGG,Spinocerebellar ataxia,8161,408,KEGG:00000,FALSE
TF:M09898,0.00575606010990651,TRUE,6649,556,237,TF,Factor: Egr-2; motif: GNGRRNGWGKGGGNGGRG,20011,1640,TF:M00000,FALSE
HP:0033353,0.00577889951621393,TRUE,965,241,76,HP,Abnormal blood vessel morphology,4962,13338,HP:0025015,FALSE
GO:0043436,0.00578462457682437,TRUE,970,553,51,GO:BP,oxoacid metabolic process,21010,11204,GO:0006082,FALSE
WP:WP4211,0.00580111936970525,TRUE,13,461,6,WP,Transcriptional cascade regulating adipogenesis,8625,499,WP:000000,FALSE
REAC:R-HSA-9663891,0.00580741245802252,TRUE,80,485,14,REAC,Selective autophagy,10835,2079,REAC:R-HSA-1632852,FALSE
TF:M08875,0.00586175667245683,TRUE,6379,556,229,TF,Factor: E2F; motif: NNTTTCGCGCN,20011,1560,TF:M00000,FALSE
GO:0022037,0.0059073628883236,TRUE,116,553,14,GO:BP,metencephalon development,21010,6904,GO:0030902|GO:0048856,FALSE
GO:0048708,0.0059177208746718,TRUE,85,553,12,GO:BP,astrocyte differentiation,21010,13617,GO:0007417|GO:0010001,FALSE
GO:0072332,0.0059177208746718,TRUE,85,553,12,GO:BP,intrinsic apoptotic signaling pathway by p53 class mediator,21010,18187,GO:0072331|GO:0097193,FALSE
HP:0000795,0.00595552517745425,TRUE,449,241,44,HP,Abnormality of the urethra,4962,618,HP:0010936,FALSE
HP:0012191,0.00599717399497313,TRUE,21,241,8,HP,B-cell lymphoma,4962,8586,HP:0012539,FALSE
GO:0003205,0.00602775548446813,TRUE,168,553,17,GO:BP,cardiac chamber development,21010,1652,GO:0007507|GO:0048856,FALSE
HPA:0291161,0.0060486769839199,TRUE,3959,418,191,HPA,liver; cholangiocytes[Low],11006,437,HPA:0290000,FALSE
HP:0100526,0.00606457392700597,TRUE,68,241,14,HP,Neoplasm of the lung,4962,16032,HP:0002088|HP:0100606,FALSE
HP:0001643,0.00608436941720019,TRUE,362,241,38,HP,Patent ductus arteriosus,4962,1195,HP:0011603,FALSE
GO:0055082,0.00608993997039382,TRUE,709,553,41,GO:BP,intracellular chemical homeostasis,21010,14965,GO:0019725|GO:0048878,FALSE
TF:M05439,0.00610987953404475,TRUE,8812,556,299,TF,Factor: RREB-1; motif: GGGWCSA,20011,7342,TF:M00000,FALSE
GO:0061419,0.00611798053814134,TRUE,5,553,4,GO:BP,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,21010,16246,GO:0036003|GO:0061418|GO:1901522,FALSE
HPA:0471441,0.00612876387272722,TRUE,1021,418,65,HPA,skin 2; fibrohistiocytic cells[Low],11006,704,HPA:0470000,FALSE
GO:0042476,0.00612934048231572,TRUE,133,553,15,GO:BP,odontogenesis,21010,10711,GO:0009887,FALSE
HP:0006495,0.00615263250314176,TRUE,59,241,13,HP,Aplasia/Hypoplasia of the ulna,4962,4246,HP:0006503|HP:0040071,FALSE
TF:M00024,0.00620758211455341,TRUE,9063,556,306,TF,Factor: E2F-1; motif: TWSGCGCGAAAAYKR,20011,1542,TF:M00000,FALSE
GO:2000147,0.0062268406322756,TRUE,560,553,35,GO:BP,positive regulation of cell motility,21010,26562,GO:0040017|GO:0048522|GO:0048870|GO:2000145,FALSE
MIRNA:hsa-miR-223-3p,0.00622766005230046,TRUE,99,514,14,MIRNA,hsa-miR-223-3p,14846,452,MIRNA:000000,FALSE
TF:M01007_1,0.00622826826781463,TRUE,9,556,5,TF,Factor: SRF; motif: CNKNKCCTTATWTGGNNNN; match class: 1,20011,8055,TF:M01007,FALSE
TF:M04934_1,0.00623176418564136,TRUE,15746,556,480,TF,Factor: TR4; motif: ACCCCGS; match class: 1,20011,5945,TF:M04934,FALSE
WP:WP3668,0.00624969835370323,TRUE,25,461,8,WP,Hypothesized pathways in pathogenesis of cardiovascular disease,8625,38,WP:000000,FALSE
WP:WP4483,0.00624969835370323,TRUE,25,461,8,WP,"Relationship between inflammation, COX-2 and EGFR",8625,255,WP:000000,FALSE
WP:WP26,0.00624969835370323,TRUE,25,461,8,WP,S1P receptor signal transduction,8625,455,WP:000000,FALSE
WP:WP3844,0.00633041572945673,TRUE,32,461,9,WP,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer,8625,334,WP:000000,FALSE
GO:0019210,0.00637795377394135,TRUE,79,555,11,GO:MF,kinase inhibitor activity,20139,3678,GO:0004857|GO:0019207,FALSE
GO:0035497,0.00642177856648541,TRUE,12,555,5,GO:MF,cAMP response element binding,20139,5356,GO:0000978,TRUE
REAC:R-HSA-5675221,0.00645805725708479,TRUE,42,485,10,REAC,Negative regulation of MAPK pathway,10835,1496,REAC:R-HSA-5673001,FALSE
GO:0097306,0.0065427565581168,TRUE,101,553,13,GO:BP,cellular response to alcohol,21010,19473,GO:0071310|GO:0097305|GO:1901701,FALSE
GO:1901222,0.0065427565581168,TRUE,101,553,13,GO:BP,regulation of non-canonical NF-kappaB signal transduction,21010,22153,GO:0038061|GO:1902531,FALSE
GO:0032760,0.0065427565581168,TRUE,101,553,13,GO:BP,positive regulation of tumor necrosis factor production,21010,8172,GO:0032640|GO:0032680|GO:1903557,FALSE
GO:0120162,0.0065427565581168,TRUE,101,553,13,GO:BP,positive regulation of cold-induced thermogenesis,21010,20449,GO:0009893|GO:0051240|GO:0106106|GO:0120161,FALSE
TF:M11018,0.00657548829543796,TRUE,17285,556,515,TF,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN,20011,4374,TF:M00000,FALSE
TF:M11435,0.00663451594818369,TRUE,11937,556,384,TF,Factor: Elk-1; motif: NNCCGGAAGTN,20011,1854,TF:M00000,FALSE
TF:M11066,0.00668499442985167,TRUE,11711,556,378,TF,Factor: HES-7; motif: GNCACGYGNN,20011,3362,TF:M00000,FALSE
HP:0000009,0.00671365684457809,TRUE,451,241,44,HP,Functional abnormality of the bladder,4962,8,HP:0000014,FALSE
GO:2000781,0.00671521421204669,TRUE,86,553,12,GO:BP,positive regulation of double-strand break repair,21010,27129,GO:0006302|GO:0045739|GO:2000779,FALSE
GO:0071868,0.00671521421204669,TRUE,86,553,12,GO:BP,cellular response to monoamine stimulus,21010,17771,GO:0071417|GO:0071867,FALSE
GO:0071870,0.00671521421204669,TRUE,86,553,12,GO:BP,cellular response to catecholamine stimulus,21010,17773,GO:0071407|GO:0071868|GO:0071869|GO:1901701,FALSE
GO:0006289,0.00671521421204669,TRUE,86,553,12,GO:BP,nucleotide-excision repair,21010,2132,GO:0006281,FALSE
GO:0032368,0.00673750215406459,TRUE,134,553,15,GO:BP,regulation of lipid transport,21010,7886,GO:0006869|GO:0051049|GO:1905952,FALSE
GO:0000018,0.00673750215406459,TRUE,134,553,15,GO:BP,regulation of DNA recombination,21010,7,GO:0006310|GO:0051052,FALSE
REAC:R-HSA-168249,0.00677464961793948,TRUE,1100,485,79,REAC,Innate Immune System,10835,1152,REAC:R-HSA-168256,FALSE
GO:0051962,0.00684692364135749,TRUE,288,553,23,GO:BP,positive regulation of nervous system development,21010,14728,GO:0007399|GO:0051094|GO:0051240|GO:0051960,FALSE
GO:0006082,0.00689786068246879,TRUE,976,553,51,GO:BP,organic acid metabolic process,21010,1976,GO:0044237|GO:0044281|GO:0071704,FALSE
GO:0035794,0.00691342141648705,TRUE,46,553,9,GO:BP,positive regulation of mitochondrial membrane permeability,21010,9695,GO:0046902|GO:1905710,FALSE
HPA:0461411,0.00692701696941554,TRUE,760,418,52,HPA,skin 1; cells in spinous layer[Low],11006,637,HPA:0460000,FALSE
WP:WP410,0.00695949519738086,TRUE,48,461,11,WP,Exercise-induced circadian regulation,8625,759,WP:000000,FALSE
GO:0003015,0.00696006423791486,TRUE,247,553,21,GO:BP,heart process,21010,1480,GO:0003013,FALSE
TF:M08568,0.00696594270214795,TRUE,18512,556,540,TF,Factor: ER71:E2A; motif: CASSTGNACCGGAWRYN,20011,2250,TF:M00000,FALSE
GO:0010632,0.00696848826237634,TRUE,227,553,20,GO:BP,regulation of epithelial cell migration,21010,4350,GO:0010631|GO:0030334|GO:0051239,FALSE
GO:0071705,0.006973684398011,TRUE,2292,553,96,GO:BP,nitrogen compound transport,21010,17687,GO:0006810,FALSE
WP:WP4478,0.00706751151168283,TRUE,19,461,7,WP,LTF danger signal response pathway,8625,650,WP:000000,FALSE
REAC:R-HSA-3214841,0.00719812249520922,TRUE,71,485,13,REAC,PKMTs methylate histone lysines,10835,1611,REAC:R-HSA-3247509,FALSE
MIRNA:hsa-miR-505-3p,0.00723852842307495,TRUE,221,514,22,MIRNA,hsa-miR-505-3p,14846,1545,MIRNA:000000,FALSE
GO:0140035,0.00724866500704739,TRUE,20,555,6,GO:MF,ubiquitination-like modification-dependent protein binding,20139,10490,GO:0140030,FALSE
GO:0002367,0.00725618135026846,TRUE,118,553,14,GO:BP,cytokine production involved in immune response,21010,913,GO:0001816|GO:0002440|GO:0006955,FALSE
GO:0002718,0.00725618135026846,TRUE,118,553,14,GO:BP,regulation of cytokine production involved in immune response,21010,1250,GO:0001817|GO:0002367|GO:0002700,FALSE
GO:0002700,0.00732185221970276,TRUE,189,553,18,GO:BP,regulation of production of molecular mediator of immune response,21010,1232,GO:0002440|GO:0002697|GO:0010468,FALSE
GO:0070391,0.00737516051180767,TRUE,10,553,5,GO:BP,response to lipoteichoic acid,21010,16888,GO:0002237|GO:1901700,FALSE
GO:0098779,0.00737516051180767,TRUE,10,553,5,GO:BP,positive regulation of mitophagy in response to mitochondrial depolarization,21010,19785,GO:0000423|GO:1904925,FALSE
GO:0071223,0.00737516051180767,TRUE,10,553,5,GO:BP,cellular response to lipoteichoic acid,21010,17293,GO:0070391|GO:0071219|GO:1901701,FALSE
HPA:0091012,0.00738597552503385,TRUE,170,418,19,HPA,cerebellum; molecular layer cells - nucleus[Medium],11006,153,HPA:0091011,FALSE
KEGG:05016,0.00741719034476588,TRUE,306,431,33,KEGG,Huntington disease,8161,407,KEGG:00000,FALSE
HP:0000153,0.00746461619393273,TRUE,2281,241,145,HP,Abnormality of the mouth,4962,134,HP:0000271,FALSE
HP:0012719,0.00755704468442929,TRUE,1147,241,86,HP,Functional abnormality of the gastrointestinal tract,4962,9104,HP:0011024|HP:0025032,FALSE
GO:0006112,0.00760602946459955,TRUE,87,553,12,GO:BP,energy reserve metabolic process,21010,2000,GO:0015980,FALSE
GO:0002532,0.00760602946459955,TRUE,87,553,12,GO:BP,production of molecular mediator involved in inflammatory response,21010,1068,GO:0006954|GO:0032501,FALSE
GO:0061053,0.00760602946459955,TRUE,87,553,12,GO:BP,somite development,21010,15922,GO:0009790|GO:0060429,FALSE
HPA:0090162,0.00762551548273038,TRUE,4124,418,197,HPA,cerebellum; Purkinje cells[Medium],11006,117,HPA:0090161,FALSE
REAC:R-HSA-194138,0.00765120590768027,TRUE,104,485,16,REAC,Signaling by VEGF,10835,2203,REAC:R-HSA-9006934,FALSE
TF:M01783_1,0.00765695228578076,TRUE,4449,556,170,TF,Factor: SP2; motif: GGGCGGGAC; match class: 1,20011,7859,TF:M01783,FALSE
GO:0090571,0.00766842936259915,TRUE,15,548,5,GO:CC,RNA polymerase II transcription repressor complex,22090,2860,GO:0017053|GO:0140513,FALSE
GO:0050796,0.00768896817916973,TRUE,171,553,17,GO:BP,regulation of insulin secretion,21010,13922,GO:0030073|GO:0050708|GO:0090276,FALSE
TF:M01597,0.00786475104973699,TRUE,1025,556,55,TF,Factor: Zfp281; motif: TGGGGGAGGGG,20011,9266,TF:M00000,FALSE
HPA:0470671,0.00790934877302421,TRUE,724,418,50,HPA,skin 2; melanocytes[Low],11006,716,HPA:0470000,FALSE
WP:WP2868,0.00797457933620581,TRUE,5,461,4,WP,TCA cycle nutrient use and invasiveness of ovarian cancer,8625,352,WP:000000,FALSE
HP:0011276,0.00804442551523846,TRUE,561,241,51,HP,Vascular skin abnormality,4962,7686,HP:0002597|HP:0011354,FALSE
HP:0006101,0.00807702305707196,TRUE,204,241,26,HP,Finger syndactyly,4962,4017,HP:0001159,FALSE
GO:1903376,0.00823142508379656,TRUE,17,553,6,GO:BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,21010,23897,GO:0036480|GO:0043523|GO:1902175,FALSE
GO:1904948,0.00823142508379656,TRUE,17,553,6,GO:BP,midbrain dopaminergic neuron differentiation,21010,25238,GO:0030901|GO:0071542,FALSE
GO:0097413,0.00823971892516521,TRUE,8,548,4,GO:CC,Lewy body,22090,2991,GO:0016234,FALSE
WP:WP4553,0.00829752568849041,TRUE,33,461,9,WP,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,8625,568,WP:000000,FALSE
GO:0070849,0.0083530503295792,TRUE,47,553,9,GO:BP,response to epidermal growth factor,21010,17145,GO:0070848,FALSE
GO:1905314,0.0083530503295792,TRUE,47,553,9,GO:BP,semi-lunar valve development,21010,25549,GO:0003170,FALSE
GO:0120163,0.0083530503295792,TRUE,47,553,9,GO:BP,negative regulation of cold-induced thermogenesis,21010,20450,GO:0009892|GO:0051241|GO:0106106|GO:0120161,FALSE
HPA:0530723,0.00842061902917634,TRUE,846,418,56,HPA,spleen; cells in white pulp[High],11006,781,HPA:0530722,FALSE
GO:0016235,0.0084593889207769,TRUE,36,548,7,GO:CC,aggresome,22090,729,GO:0016234,FALSE
HP:0003221,0.00850374474177754,TRUE,16,241,7,HP,Chromosomal breakage induced by crosslinking agents,4962,2326,HP:0040012,FALSE
MIRNA:hsa-miR-193b-3p,0.00855114063237035,TRUE,848,514,54,MIRNA,hsa-miR-193b-3p,14846,359,MIRNA:000000,FALSE
GO:0051851,0.00859941114576721,TRUE,88,553,12,GO:BP,modulation by host of symbiont process,21010,14651,GO:0051702,FALSE
HPA:0100202,0.00860070484919261,TRUE,2489,418,130,HPA,cerebral cortex; endothelial cells[Medium],11006,184,HPA:0100201,FALSE
GO:0005635,0.00860105365496706,TRUE,502,548,29,GO:CC,nuclear envelope,22090,244,GO:0005634|GO:0012505|GO:0031967,FALSE
WP:WP5385,0.00860945502329007,TRUE,26,461,8,WP,Growth factors and hormones in Beta-cell proliferation,8625,777,WP:000000,FALSE
HPA:0091011,0.00864312659426653,TRUE,187,418,20,HPA,cerebellum; molecular layer cells - nucleus[Low],11006,152,HPA:0090000,FALSE
KEGG:05321,0.00871583433365079,TRUE,62,431,12,KEGG,Inflammatory bowel disease,8161,476,KEGG:00000,FALSE
REAC:R-HSA-9013695,0.00873606050711374,TRUE,20,485,7,REAC,NOTCH4 Intracellular Domain Regulates Transcription,10835,1461,REAC:R-HSA-9013694,FALSE
REAC:R-HSA-6803204,0.00873606050711374,TRUE,20,485,7,REAC,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,10835,2341,REAC:R-HSA-5633008,FALSE
WP:WP2636,0.00892838069116126,TRUE,41,461,10,WP,Common pathways underlying drug addiction,8625,196,WP:000000,FALSE
GO:1903828,0.00896667402073358,TRUE,211,553,19,GO:BP,negative regulation of protein localization,21010,24274,GO:0008104|GO:0032880|GO:0048523,FALSE
GO:0030155,0.00897769651393604,TRUE,772,553,43,GO:BP,regulation of cell adhesion,21010,7003,GO:0007155|GO:0050794,FALSE
REAC:R-HSA-195253,0.00900338270636038,TRUE,83,485,14,REAC,Degradation of beta-catenin by the destruction complex,10835,694,REAC:R-HSA-195721,FALSE
REAC:R-HSA-1500620,0.00901703038893895,TRUE,117,485,17,REAC,Meiosis,10835,1342,REAC:R-HSA-1474165|REAC:R-HSA-1640170,FALSE
TF:M07063_1,0.00903063039086938,TRUE,2618,556,111,TF,Factor: Sp1; motif: GGGGCGGGGC; match class: 1,20011,7851,TF:M07063,FALSE
GO:0051607,0.0090576420112815,TRUE,336,553,25,GO:BP,defense response to virus,21010,14519,GO:0009615|GO:0140546,FALSE
REAC:R-HSA-6802948,0.00906614856971151,TRUE,35,485,9,REAC,Signaling by high-kinase activity BRAF mutants,10835,2211,REAC:R-HSA-6802957,FALSE
GO:0010573,0.00910352805139589,TRUE,36,553,8,GO:BP,vascular endothelial growth factor production,21010,4297,GO:0001816,FALSE
GO:1903749,0.00910352805139589,TRUE,36,553,8,GO:BP,positive regulation of establishment of protein localization to mitochondrion,21010,24213,GO:0072655|GO:1903747|GO:1904951,FALSE
GO:0070741,0.00910352805139589,TRUE,36,553,8,GO:BP,response to interleukin-6,21010,17084,GO:0034097,FALSE
GO:0046320,0.00910352805139589,TRUE,36,553,8,GO:BP,regulation of fatty acid oxidation,21010,12671,GO:0019217|GO:0019395,FALSE
GO:0002068,0.00910352805139589,TRUE,36,553,8,GO:BP,glandular epithelial cell development,21010,672,GO:0002066|GO:0002067,FALSE
GO:0033045,0.0091274458121299,TRUE,104,553,13,GO:BP,regulation of sister chromatid segregation,21010,8373,GO:0000819|GO:0033044|GO:0051983,FALSE
TF:M09738_1,0.00917673233208952,TRUE,4851,556,182,TF,Factor: ZNF511; motif: GGRRGRGGCWGNG; match class: 1,20011,10449,TF:M09738,FALSE
TF:M00431_1,0.00921117777747286,TRUE,2321,556,101,TF,Factor: E2F-1; motif: TTTSGCGS; match class: 1,20011,1457,TF:M00431,FALSE
WP:WP4480,0.00929209604567672,TRUE,9,461,5,WP,Altered glycosylation of MUC1 in tumor microenvironment,8625,150,WP:000000,FALSE
WP:WP288,0.00929209604567672,TRUE,9,461,5,WP,Nod-like receptor (NLR) signaling pathway,8625,521,WP:000000,FALSE
GO:0005977,0.00933336828823381,TRUE,74,553,11,GO:BP,glycogen metabolic process,21010,1874,GO:0006112|GO:0044042,FALSE
GO:0150076,0.00933336828823381,TRUE,74,553,11,GO:BP,neuroinflammatory response,21010,20994,GO:0006954,FALSE
HPA:0381192,0.00935265928769599,TRUE,424,418,34,HPA,placenta; cytotrophoblasts[Medium],11006,519,HPA:0381191,FALSE
REAC:R-HSA-8941856,0.00936278125119238,TRUE,14,485,6,REAC,RUNX3 regulates NOTCH signaling,10835,1850,REAC:R-HSA-8878159,FALSE
REAC:R-HSA-6804759,0.00936278125119238,TRUE,14,485,6,REAC,Regulation of TP53 Activity through Association with Co-factors,10835,1919,REAC:R-HSA-5633007,FALSE
TF:M00469,0.00936282717135301,TRUE,5279,556,195,TF,Factor: AP-2alpha; motif: GCCNNNRGS,20011,126,TF:M00000,FALSE
GO:0032727,0.00944054925286446,TRUE,26,553,7,GO:BP,positive regulation of interferon-alpha production,21010,8140,GO:0032481|GO:0032607|GO:0032647,FALSE
GO:0090594,0.00944054925286446,TRUE,26,553,7,GO:BP,inflammatory response to wounding,21010,19233,GO:0006954|GO:0009611,FALSE
GO:0002053,0.00944054925286446,TRUE,26,553,7,GO:BP,positive regulation of mesenchymal cell proliferation,21010,665,GO:0008284|GO:0010463|GO:0010464,FALSE
GO:0140546,0.00954710490186446,TRUE,337,553,25,GO:BP,defense response to symbiont,21010,20747,GO:0098542,FALSE
HP:0000316,0.00958819434275774,TRUE,774,241,64,HP,Hypertelorism,4962,256,HP:0100886,FALSE
GO:0031594,0.00959331748480543,TRUE,80,548,10,GO:CC,neuromuscular junction,22090,1172,GO:0045202,FALSE
GO:0002285,0.00961291282992447,TRUE,212,553,19,GO:BP,lymphocyte activation involved in immune response,21010,831,GO:0002366|GO:0046649,FALSE
HP:0100707,0.00964696004302066,TRUE,44,241,11,HP,Abnormal astrocyte morphology,4962,16198,HP:0100705,FALSE
HP:0011298,0.00964696004302066,TRUE,44,241,11,HP,Prominent digit pad,4962,7708,HP:0011356,FALSE
HP:0005927,0.00967762967606552,TRUE,518,241,48,HP,Aplasia/hypoplasia involving bones of the hand,4962,3939,HP:0005922|HP:0006496,FALSE
WP:WP5192,0.00969553434191426,TRUE,14,461,6,WP,Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids,8625,727,WP:000000,FALSE
GO:0071867,0.00970534813861835,TRUE,89,553,12,GO:BP,response to monoamine,21010,17770,GO:0010243,FALSE
GO:0032092,0.00970534813861835,TRUE,89,553,12,GO:BP,positive regulation of protein binding,21010,7716,GO:0043393|GO:0051099,FALSE
GO:0071869,0.00970534813861835,TRUE,89,553,12,GO:BP,response to catecholamine,21010,17772,GO:0014070|GO:0071867|GO:1901700,FALSE
GO:0048588,0.00972381246809942,TRUE,232,553,20,GO:BP,developmental cell growth,21010,13511,GO:0016049|GO:0048468|GO:0048589,FALSE
GO:0021782,0.00979550668003765,TRUE,121,553,14,GO:BP,glial cell development,21010,6665,GO:0010001|GO:0048468,FALSE
REAC:R-HSA-9710421,0.0098474007514266,TRUE,73,485,13,REAC,Defective pyroptosis,10835,682,REAC:R-HSA-9645723,FALSE
TF:M05327_1,0.00990153854114637,TRUE,1830,556,84,TF,Factor: WT1; motif: NGCGGGGGGGTSMMCYN; match class: 1,20011,8979,TF:M05327,FALSE
GO:0071702,0.00993906771357362,TRUE,3039,553,119,GO:BP,organic substance transport,21010,17684,GO:0006810,FALSE
GO:0051234,0.00996782311390058,TRUE,4905,553,175,GO:BP,establishment of localization,21010,14265,GO:0051179,FALSE
HP:0030012,0.0100373253339384,TRUE,341,241,36,HP,Abnormal female reproductive system physiology,4962,10149,HP:0000080,FALSE
GO:0031018,0.0100429652718917,TRUE,48,553,9,GO:BP,endocrine pancreas development,21010,7318,GO:0031016|GO:0035270|GO:0048856,FALSE
GO:0035094,0.0100429652718917,TRUE,48,553,9,GO:BP,response to nicotine,21010,9227,GO:0042221,FALSE
HP:0410266,0.0100625397904049,TRUE,4,241,4,HP,Visceral hemangioma,4962,16717,HP:0001028,FALSE
HP:0031207,0.0100625397904049,TRUE,4,241,4,HP,Hepatic hemangioma,4962,11270,HP:0002896|HP:0410266,FALSE
TF:M00778,0.0101554796687641,TRUE,3609,556,143,TF,Factor: AhR; motif: NTNGCGTGNNN,20011,18,TF:M00000,FALSE
GO:0006626,0.0101706929344242,TRUE,105,553,13,GO:BP,protein targeting to mitochondrion,21010,2378,GO:0006605|GO:0006839|GO:0007005|GO:0072655,FALSE
GO:0042116,0.0101706929344242,TRUE,105,553,13,GO:BP,macrophage activation,21010,10468,GO:0002274,FALSE
GO:0035259,0.0101988898897627,TRUE,13,555,5,GO:MF,nuclear glucocorticoid receptor binding,20139,5321,GO:0016922,FALSE
WP:WP2840,0.0102380443906271,TRUE,87,461,15,WP,Hair follicle development: cytodifferentiation - part 3 of 3,8625,73,WP:000000,FALSE
GO:1902115,0.0103009798934314,TRUE,213,553,19,GO:BP,regulation of organelle assembly,21010,22914,GO:0033043|GO:0044087|GO:0070925,FALSE
REAC:R-HSA-5696399,0.0103693919716939,TRUE,84,485,14,REAC,Global Genome Nucleotide Excision Repair (GG-NER),10835,1000,REAC:R-HSA-5696398,FALSE
REAC:R-HSA-162592,0.010381521549287,TRUE,9,485,5,REAC,Integration of provirus,10835,1162,REAC:R-HSA-162594,FALSE
REAC:R-HSA-111453,0.010381521549287,TRUE,9,485,5,REAC,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,10835,195,REAC:R-HSA-109606,FALSE
REAC:R-HSA-2562578,0.010381521549287,TRUE,9,485,5,REAC,TRIF-mediated programmed cell death,10835,2355,REAC:R-HSA-937061,FALSE
REAC:R-HSA-8874211,0.010381521549287,TRUE,9,485,5,REAC,CREB3 factors activate genes,10835,277,REAC:R-HSA-381119,FALSE
HPA:0020053,0.0103972619916423,TRUE,2287,418,121,HPA,adrenal gland; glandular cells[High],11006,18,HPA:0020052,FALSE
REAC:R-HSA-3304349,0.0103979587402893,TRUE,5,485,4,REAC,Loss of Function of SMAD2/3 in Cancer,10835,1269,REAC:R-HSA-3304351,FALSE
REAC:R-HSA-3134973,0.0103979587402893,TRUE,5,485,4,REAC,LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,10835,1245,REAC:R-HSA-1834949,FALSE
TF:M12593_1,0.0104276489792949,TRUE,3423,556,137,TF,Factor: CTCF; motif: NNRSYGCCMCCTGSTGGCCN; match class: 1,20011,1153,TF:M12593,FALSE
GO:1904036,0.0104492068587,TRUE,61,553,10,GO:BP,negative regulation of epithelial cell apoptotic process,21010,24451,GO:0043066|GO:1904019|GO:1904035,FALSE
GO:0046661,0.0105424773217689,TRUE,175,553,17,GO:BP,male sex differentiation,21010,12919,GO:0007275|GO:0007548,FALSE
TF:M11052,0.0105723070628988,TRUE,12741,556,404,TF,Factor: Hey2; motif: NNCACGYGNN,20011,3386,TF:M00000,FALSE
HP:0000014,0.010574332548668,TRUE,489,241,46,HP,Abnormality of the bladder,4962,13,HP:0010936,FALSE
TF:M12516,0.0105858439133899,TRUE,3864,556,151,TF,Factor: E2F6; motif: NNNGGCGGGAANN,20011,1526,TF:M00000,FALSE
KEGG:05020,0.0105984562984505,TRUE,272,431,30,KEGG,Prion disease,8161,409,KEGG:00000,FALSE
HP:0002019,0.0106647719567119,TRUE,429,241,42,HP,Constipation,4962,1478,HP:0011458,FALSE
HP:0100836,0.0106795621676719,TRUE,91,241,16,HP,Malignant neoplasm of the central nervous system,4962,16312,HP:0100006,FALSE
GO:0016239,0.0106811213690096,TRUE,75,553,11,GO:BP,positive regulation of macroautophagy,21010,5268,GO:0010508|GO:0016236|GO:0016241,FALSE
CORUM:2692,0.0107218690002307,TRUE,4,292,4,CORUM,SMAD3-SMAD4-cJun-cFos complex,3383,1130,CORUM:0000000,FALSE
CORUM:7383,0.0107218690002307,TRUE,4,292,4,CORUM,OGT-HIRA complex,3383,2811,CORUM:0000000,FALSE
CORUM:4,0.0107218690002307,TRUE,4,292,4,CORUM,Multisubunit ACTR coactivator complex,3383,5,CORUM:0000000,FALSE
CORUM:6347,0.0107218690002307,TRUE,4,292,4,CORUM,TNF-R1 signaling complex,3383,2067,CORUM:0000000,FALSE
CORUM:749,0.0107218690002307,TRUE,4,292,4,CORUM,MeCP2-SIN3A-HDAC complex,3383,415,CORUM:0000000,FALSE
GO:0030374,0.0107656301433827,TRUE,55,555,9,GO:MF,nuclear receptor coactivator activity,20139,3938,GO:0003713,FALSE
GO:0051702,0.0108025582204895,TRUE,122,553,14,GO:BP,biological process involved in interaction with symbiont,21010,14598,GO:0044403,FALSE
HP:0000582,0.0108223230012715,TRUE,314,241,34,HP,Upslanted palpebral fissure,4962,450,HP:0200006,FALSE
KEGG:04115,0.0109118904173388,TRUE,73,431,13,KEGG,p53 signaling pathway,8161,264,KEGG:00000,FALSE
GO:0002088,0.0109346188360609,TRUE,90,553,12,GO:BP,lens development in camera-type eye,21010,687,GO:0043010|GO:0048856,FALSE
GO:0032088,0.0109346188360609,TRUE,90,553,12,GO:BP,negative regulation of NF-kappaB transcription factor activity,21010,7714,GO:0043433,FALSE
WP:WP5366,0.0109850261413801,TRUE,108,461,17,WP,NF1 copy number variation syndrome ,8625,432,WP:000000,FALSE
HP:0100886,0.0111015341851523,TRUE,1051,241,80,HP,Abnormality of globe location,4962,16358,HP:0012372,FALSE
HPA:0400053,0.0111248306398437,TRUE,2573,418,133,HPA,rectum; glandular cells[High],11006,564,HPA:0400052,FALSE
GO:0034248,0.0112185621107716,TRUE,478,553,31,GO:BP,regulation of amide metabolic process,21010,8914,GO:0043603|GO:0051171,FALSE
HPA:0030052,0.0113093919410169,TRUE,5499,418,249,HPA,appendix; glandular cells[Medium],11006,39,HPA:0030051,FALSE
GO:0021549,0.0113181271299682,TRUE,106,553,13,GO:BP,cerebellum development,21010,6437,GO:0022037|GO:0048856,FALSE
GO:0045833,0.0113181271299682,TRUE,106,553,13,GO:BP,negative regulation of lipid metabolic process,21010,12266,GO:0006629|GO:0009892|GO:0019216,FALSE
GO:0060043,0.011348947938057,TRUE,37,553,8,GO:BP,regulation of cardiac muscle cell proliferation,21010,15036,GO:0042127|GO:0055021|GO:0060038,FALSE
GO:1904358,0.011348947938057,TRUE,37,553,8,GO:BP,positive regulation of telomere maintenance via telomere lengthening,21010,24734,GO:0010833|GO:0032206|GO:1904356,FALSE
HP:0001871,0.0114503945136025,TRUE,1432,241,101,HP,Abnormality of blood and blood-forming tissues,4962,1353,HP:0000118,FALSE
HP:0001671,0.0115076110867671,TRUE,745,241,62,HP,Abnormal cardiac septum morphology,4962,1217,HP:0001627,FALSE
HPA:0510653,0.0115357243996237,TRUE,521,418,39,HPA,soft tissue 2; fibroblasts[High],11006,767,HPA:0510652,FALSE
REAC:R-HSA-9619483,0.0116256551870623,TRUE,28,485,8,REAC,Activation of AMPK downstream of NMDARs,10835,70,REAC:R-HSA-438064,FALSE
WP:WP3845,0.0116684828392038,TRUE,27,461,8,WP,Canonical and non-canonical Notch signaling,8625,619,WP:000000,FALSE
HPA:0090981,0.0116692668320958,TRUE,146,418,17,HPA,cerebellum; granular cells - nucleus[Low],11006,143,HPA:0090000,FALSE
GO:0006886,0.0117753852543362,TRUE,1105,553,55,GO:BP,intracellular protein transport,21010,2582,GO:0008104|GO:0015031|GO:0046907,FALSE
GO:0043200,0.0119006312983956,TRUE,123,553,14,GO:BP,response to amino acid,21010,11083,GO:0001101|GO:0010243|GO:1901700,FALSE
MIRNA:hsa-miR-141-3p,0.011903315083796,TRUE,148,514,17,MIRNA,hsa-miR-141-3p,14846,252,MIRNA:000000,FALSE
GO:0000794,0.0119249963062985,TRUE,82,548,10,GO:CC,condensed nuclear chromosome,22090,97,GO:0000228|GO:0000793,FALSE
HP:0011893,0.0119616636073113,TRUE,476,241,45,HP,Abnormal leukocyte count,4962,8291,HP:0001881,FALSE
GO:0043392,0.0120182357589905,TRUE,49,553,9,GO:BP,negative regulation of DNA binding,21010,11176,GO:0051100|GO:0051101,FALSE
GO:1905710,0.0120182357589905,TRUE,49,553,9,GO:BP,positive regulation of membrane permeability,21010,25888,GO:0090559,FALSE
GO:0010883,0.0120182357589905,TRUE,49,553,9,GO:BP,regulation of lipid storage,21010,4552,GO:0019915|GO:0032879,FALSE
HP:0100242,0.0120200546594666,TRUE,171,241,23,HP,Sarcoma,4962,15759,HP:0011792,FALSE
CORUM:2829,0.0120693460289939,TRUE,10,292,6,CORUM,RSmad complex,3383,1229,CORUM:0000000,FALSE
CORUM:5286,0.0120693460289939,TRUE,10,292,6,CORUM,TNF-alpha/NF-kappa B signaling complex 10,3383,1633,CORUM:0000000,FALSE
CORUM:743,0.0120693460289939,TRUE,10,292,6,CORUM,SIN3-SAP25 complex,3383,409,CORUM:0000000,FALSE
GO:0070102,0.0120728699756759,TRUE,18,553,6,GO:BP,interleukin-6-mediated signaling pathway,21010,16709,GO:0019221|GO:0071354,FALSE
GO:0044042,0.01219596007726,TRUE,76,553,11,GO:BP,glucan metabolic process,21010,11434,GO:0005976,FALSE
HP:0100615,0.012349782833722,TRUE,72,241,14,HP,Ovarian neoplasm,4962,16116,HP:0000137|HP:0010785,FALSE
GO:0005813,0.0123563092983367,TRUE,647,548,34,GO:CC,centrosome,22090,366,GO:0005815,FALSE
GO:0031967,0.0123827947223202,TRUE,1293,548,56,GO:CC,organelle envelope,22090,1218,GO:0031975|GO:0043227|GO:0043229,FALSE
GO:0031975,0.0123827947223202,TRUE,1293,548,56,GO:CC,envelope,22090,1225,GO:0110165,FALSE
GO:0071480,0.0124567215024873,TRUE,27,553,7,GO:BP,cellular response to gamma radiation,21010,17524,GO:0010332|GO:0071479,FALSE
GO:0002252,0.0125573397283323,TRUE,628,553,37,GO:BP,immune effector process,21010,798,GO:0002376,FALSE
REAC:R-HSA-8863678,0.012601770450238,TRUE,21,485,7,REAC,Neurodegenerative Diseases,10835,1510,REAC:R-HSA-9734009,FALSE
REAC:R-HSA-8862803,0.012601770450238,TRUE,21,485,7,REAC,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,10835,703,REAC:R-HSA-8863678,FALSE
HP:0011004,0.0126742437187947,TRUE,523,241,48,HP,Abnormal systemic arterial morphology,4962,7424,HP:0033353,FALSE
GO:0072175,0.0127384962015107,TRUE,141,553,15,GO:BP,epithelial tube formation,21010,18037,GO:0035148|GO:0060562,FALSE
GO:0009306,0.0127987045683906,TRUE,365,553,26,GO:BP,protein secretion,21010,3508,GO:0015031|GO:0032940|GO:0035592,FALSE
REAC:R-HSA-9705683,0.0128132764392713,TRUE,197,485,23,REAC,SARS-CoV-2-host interactions,10835,2022,REAC:R-HSA-9694516,FALSE
HP:0031816,0.0129851854813337,TRUE,2197,241,140,HP,Abnormal oral morphology,4962,11858,HP:0000153,FALSE
HP:0000163,0.0129851854813337,TRUE,2197,241,140,HP,Abnormal oral cavity morphology,4962,143,HP:0031816,FALSE
TF:M01073,0.0130559895092524,TRUE,4197,556,161,TF,Factor: HIC1; motif: NNNGGKTGCCCSNNNNNN,20011,3404,TF:M00000,FALSE
GO:0007613,0.0130967914552898,TRUE,124,553,14,GO:BP,memory,21010,3123,GO:0007611,FALSE
GO:0021761,0.0130967914552898,TRUE,124,553,14,GO:BP,limbic system development,21010,6645,GO:0030900|GO:0048731,FALSE
GO:1902947,0.0132280489687901,TRUE,11,553,5,GO:BP,regulation of tau-protein kinase activity,21010,23554,GO:0045859,FALSE
GO:0009950,0.0132280489687901,TRUE,11,553,5,GO:BP,dorsal/ventral axis specification,21010,3846,GO:0009798|GO:0009953,TRUE
HPA:0471391,0.0132844847003844,TRUE,963,418,61,HPA,skin 2; cells in basal layer[Low],11006,680,HPA:0470000,FALSE
REAC:R-HSA-8936459,0.0132890494258306,TRUE,97,485,15,REAC,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,10835,1835,REAC:R-HSA-8878171,FALSE
REAC:R-HSA-5607764,0.0132890494258306,TRUE,97,485,15,REAC,CLEC7A (Dectin-1) signaling,10835,266,REAC:R-HSA-5621481,FALSE
GO:0010485,0.0133133734584431,TRUE,22,555,6,GO:MF,histone H4 acetyltransferase activity,20139,2252,GO:0004402,FALSE
MIRNA:hsa-miR-29a-3p,0.0133641488474708,TRUE,264,514,24,MIRNA,hsa-miR-29a-3p,14846,499,MIRNA:000000,FALSE
GO:0002274,0.0134323304885399,TRUE,237,553,20,GO:BP,myeloid leukocyte activation,21010,820,GO:0045321,FALSE
GO:0035592,0.0134445029679152,TRUE,366,553,26,GO:BP,establishment of protein localization to extracellular region,21010,9549,GO:0045184|GO:0071692,FALSE
WP:WP3617,0.0138051656838335,TRUE,35,461,9,WP,Photodynamic therapy-induced NF-kB survival signaling,8625,795,WP:000000,FALSE
WP:WP364,0.0138665339259696,TRUE,43,461,10,WP,IL6 signaling pathway,8625,147,WP:000000,FALSE
WP:WP5198,0.0138665339259696,TRUE,43,461,10,WP,Inflammatory bowel disease signaling,8625,161,WP:000000,FALSE
GO:0097009,0.0138951567670996,TRUE,77,553,11,GO:BP,energy homeostasis,21010,19318,GO:0048871,FALSE
HPA:0220053,0.0139352657691061,TRUE,2872,418,145,HPA,gallbladder; glandular cells[High],11006,363,HPA:0220052,FALSE
GO:0032147,0.0139616512178035,TRUE,108,553,13,GO:BP,activation of protein kinase activity,21010,7745,GO:0045860,FALSE
GO:1904707,0.0140463353495771,TRUE,38,553,8,GO:BP,positive regulation of vascular associated smooth muscle cell proliferation,21010,25037,GO:0048661|GO:1904705|GO:1990874,FALSE
GO:0016578,0.0140463353495771,TRUE,38,553,8,GO:BP,histone deubiquitination,21010,5350,GO:0016570|GO:0016579,FALSE
GO:0035883,0.0140463353495771,TRUE,38,553,8,GO:BP,enteroendocrine cell differentiation,21010,9756,GO:0002067,FALSE
GO:0099173,0.0141404632337036,TRUE,198,553,18,GO:BP,postsynapse organization,21010,19982,GO:0016043|GO:0050808,FALSE
TF:M01660,0.0141418365456442,TRUE,11290,556,365,TF,Factor: GABP-alpha; motif: CTTCCK,20011,2886,TF:M00000,FALSE
MIRNA:hsa-miR-196b-5p,0.0142174826142797,TRUE,150,514,17,MIRNA,hsa-miR-196b-5p,14846,368,MIRNA:000000,FALSE
HP:0011603,0.0144397327619688,TRUE,510,241,47,HP,Congenital malformation of the great arteries,4962,8007,HP:0030962,FALSE
GO:0070461,0.0146151922915735,TRUE,39,548,7,GO:CC,SAGA-type complex,22090,2498,GO:0000123,FALSE
WP:WP4961,0.0148533316957116,TRUE,21,461,7,WP,STING pathway in Kawasaki-like disease and COVID-19,8625,138,WP:000000,FALSE
REAC:R-HSA-392517,0.0150166118269595,TRUE,15,485,6,REAC,Rap1 signalling,10835,1856,REAC:R-HSA-1280218,FALSE
WP:WP4747,0.0153241623814314,TRUE,52,461,11,WP,Netrin-UNC5B signaling pathway,8625,829,WP:000000,FALSE
HP:0009733,0.0153894958734952,TRUE,46,241,11,HP,Glioma,4962,6235,HP:0030063|HP:0100705|HP:0100836,FALSE
HPA:0471412,0.0153935499185187,TRUE,683,418,47,HPA,skin 2; cells in spinous layer[Medium],11006,690,HPA:0471411,FALSE
HPA:0461441,0.0154013759669248,TRUE,885,418,57,HPA,skin 1; fibrohistiocytic cells[Low],11006,652,HPA:0460000,FALSE
WP:WP3969,0.0154334132717935,TRUE,15,461,6,WP,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity,8625,681,WP:000000,FALSE
GO:1901796,0.0154773675038519,TRUE,109,553,13,GO:BP,regulation of signal transduction by p53 class mediator,21010,22619,GO:0072331|GO:1902531,FALSE
GO:0010484,0.0155056214058679,TRUE,14,555,5,GO:MF,histone H3 acetyltransferase activity,20139,2251,GO:0004402,FALSE
MIRNA:hsa-miR-429,0.0155184506295451,TRUE,151,514,17,MIRNA,hsa-miR-429,14846,982,MIRNA:000000,FALSE
WP:WP5036,0.0155805909000125,TRUE,28,461,8,WP,Angiotensin II receptor type 1 pathway,8625,254,WP:000000,FALSE
HP:0000483,0.0155887977656908,TRUE,186,241,24,HP,Astigmatism,4962,368,HP:0000539|HP:0100691,FALSE
REAC:R-HSA-912446,0.0156241254797107,TRUE,87,485,14,REAC,Meiotic recombination,10835,1343,REAC:R-HSA-1500620,FALSE
MIRNA:hsa-miR-494-3p,0.015663403784438,TRUE,136,514,16,MIRNA,hsa-miR-494-3p,14846,1496,MIRNA:000000,FALSE
HP:0001167,0.0158014874705228,TRUE,1203,241,88,HP,Abnormal finger morphology,4962,909,HP:0001155|HP:0011297,FALSE
HPA:0030073,0.0160188824251894,TRUE,764,418,51,HPA,appendix; lymphoid tissue[High],11006,46,HPA:0030072,FALSE
HP:0000069,0.0160281809075234,TRUE,348,241,36,HP,Abnormality of the ureter,4962,64,HP:0010935,FALSE
HP:0033019,0.0160619793875859,TRUE,64,241,13,HP,Male reproductive system neoplasm,4962,13007,HP:0010787,FALSE
HP:0000818,0.0161288294659823,TRUE,1405,241,99,HP,Abnormality of the endocrine system,4962,636,HP:0000118,FALSE
GO:1904030,0.0162337492350727,TRUE,28,553,7,GO:BP,negative regulation of cyclin-dependent protein kinase activity,21010,24445,GO:0006469|GO:1904029,FALSE
GO:0030325,0.0162337492350727,TRUE,28,553,7,GO:BP,adrenal gland development,21010,7089,GO:0035270|GO:0048732,FALSE
GO:0035522,0.0162337492350727,TRUE,28,553,7,GO:BP,monoubiquitinated histone H2A deubiquitination,21010,9510,GO:0035521,FALSE
GO:0035521,0.0162337492350727,TRUE,28,553,7,GO:BP,monoubiquitinated histone deubiquitination,21010,9509,GO:0016578|GO:0035520,FALSE
GO:0060765,0.0162337492350727,TRUE,28,553,7,GO:BP,regulation of androgen receptor signaling pathway,21010,15672,GO:0030521|GO:0033143,FALSE
GO:0030307,0.0163067455388334,TRUE,162,553,16,GO:BP,positive regulation of cell growth,21010,7077,GO:0001558|GO:0016049|GO:0045927|GO:0048522,FALSE
GO:0016811,0.016417456196258,TRUE,72,555,10,GO:MF,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",20139,3009,GO:0016810,FALSE
GO:0004860,0.016417456196258,TRUE,72,555,10,GO:MF,protein kinase inhibitor activity,20139,1133,GO:0019210|GO:0019887,FALSE
TF:M07461,0.0164650663971626,TRUE,8970,556,301,TF,Factor: KLF; motif: GGGNGGGG,20011,4604,TF:M00000,FALSE
HP:0002171,0.0165021745719114,TRUE,94,241,16,HP,Gliosis,4962,1597,HP:0100705,FALSE
HP:0025269,0.0165130666546854,TRUE,55,241,12,HP,Panic attack,4962,9707,HP:0100852,FALSE
CORUM:614,0.0165720057120361,TRUE,7,292,5,CORUM,NRD complex (Nucleosome remodeling and deacetylation complex),3383,336,CORUM:0000000,FALSE
TF:M11533_1,0.0165883793417171,TRUE,8935,556,300,TF,Factor: E2F-1; motif: NTTTTGGCGCCAWWWN; match class: 1,20011,1443,TF:M11533,FALSE
MIRNA:hsa-miR-195-3p,0.0167718496542304,TRUE,94,514,13,MIRNA,hsa-miR-195-3p,14846,363,MIRNA:000000,FALSE
REAC:R-HSA-9609690,0.0169254343305246,TRUE,135,485,18,REAC,HCMV Early Events,10835,1037,REAC:R-HSA-9609646,FALSE
KEGG:04510,0.0171113104405695,TRUE,202,431,24,KEGG,Focal adhesion,8161,307,KEGG:00000,FALSE
GO:0034244,0.0172531955746604,TRUE,19,553,6,GO:BP,negative regulation of transcription elongation by RNA polymerase II,21010,8912,GO:0006368|GO:0032785|GO:0034243,FALSE
GO:0007252,0.0172531955746604,TRUE,19,553,6,GO:BP,I-kappaB phosphorylation,21010,2836,GO:0006468|GO:0007249,FALSE
GO:0071391,0.0172531955746604,TRUE,19,553,6,GO:BP,cellular response to estrogen stimulus,21010,17453,GO:0032870|GO:0043627,FALSE
GO:1902004,0.0172531955746604,TRUE,19,553,6,GO:BP,positive regulation of amyloid-beta formation,21010,22817,GO:0034205|GO:0034250|GO:1902003|GO:1902993,TRUE
GO:0060438,0.0172531955746604,TRUE,19,553,6,GO:BP,trachea development,21010,15370,GO:0048513|GO:0060541,FALSE
GO:0045923,0.017266884777839,TRUE,39,553,8,GO:BP,positive regulation of fatty acid metabolic process,21010,12334,GO:0006631|GO:0019217|GO:0031325|GO:0045834|GO:0062013,FALSE
GO:0097345,0.017266884777839,TRUE,39,553,8,GO:BP,mitochondrial outer membrane permeabilization,21010,19505,GO:0097190|GO:1902110,FALSE
GO:0051384,0.0173513942363222,TRUE,127,553,14,GO:BP,response to glucocorticoid,21010,14374,GO:0031960,FALSE
MIRNA:hsa-miR-744-5p,0.017392265305811,TRUE,435,514,33,MIRNA,hsa-miR-744-5p,14846,2463,MIRNA:000000,FALSE
KEGG:04062,0.0176786066223979,TRUE,190,431,23,KEGG,Chemokine signaling pathway,8161,250,KEGG:00000,FALSE
WP:WP3934,0.0177689929813209,TRUE,10,461,5,WP,Leptin and adiponectin,8625,217,WP:000000,FALSE
REAC:R-HSA-112409,0.0177745436295412,TRUE,22,485,7,REAC,RAF-independent MAPK1/3 activation,10835,1757,REAC:R-HSA-5684996,FALSE
HP:0009826,0.0177839665854012,TRUE,239,241,28,HP,Limb undergrowth,4962,6321,HP:0009815,FALSE
HP:0002023,0.0178248796319256,TRUE,139,241,20,HP,Anal atresia,4962,1481,HP:0034915,FALSE
GO:1905323,0.0179705179894621,TRUE,6,553,4,GO:BP,telomerase holoenzyme complex assembly,21010,25558,GO:0022618,TRUE
GO:0071455,0.0179705179894621,TRUE,6,553,4,GO:BP,cellular response to hyperoxia,21010,17500,GO:0036295|GO:0055093|GO:0062197,FALSE
GO:1902949,0.0179705179894621,TRUE,6,553,4,GO:BP,positive regulation of tau-protein kinase activity,21010,23556,GO:0045860|GO:1902947,FALSE
GO:0060789,0.0179705179894621,TRUE,6,553,4,GO:BP,hair follicle placode formation,21010,15696,GO:0001942|GO:0060788,FALSE
GO:0072708,0.0179705179894621,TRUE,6,553,4,GO:BP,response to sorbitol,21010,18355,GO:0009743,FALSE
GO:0000430,0.0179705179894621,TRUE,6,553,4,GO:BP,regulation of transcription from RNA polymerase II promoter by glucose,21010,138,GO:0000429|GO:0046015,FALSE
GO:0000432,0.0179705179894621,TRUE,6,553,4,GO:BP,positive regulation of transcription from RNA polymerase II promoter by glucose,21010,140,GO:0000430|GO:0000436|GO:0046016,FALSE
GO:0003062,0.0179705179894621,TRUE,6,553,4,GO:BP,regulation of heart rate by chemical signal,21010,1527,GO:0002027,TRUE
GO:0031960,0.0179917430300214,TRUE,145,553,15,GO:BP,response to corticosteroid,21010,7656,GO:0048545,FALSE
HP:0010935,0.0180586001654319,TRUE,1427,241,100,HP,Abnormality of the upper urinary tract,4962,7358,HP:0000079,FALSE
TF:M01100,0.0181183162622321,TRUE,7744,556,266,TF,Factor: LRF; motif: GGGGKYNNB,20011,4798,TF:M00000,FALSE
HP:0000079,0.0184370504659163,TRUE,1987,241,129,HP,Abnormality of the urinary system,4962,74,HP:0000119,FALSE
KEGG:05415,0.0184744460763985,TRUE,203,431,24,KEGG,Diabetic cardiomyopathy,8161,485,KEGG:00000,FALSE
REAC:R-HSA-5696394,0.0185661741260043,TRUE,38,485,9,REAC,DNA Damage Recognition in GG-NER,10835,422,REAC:R-HSA-5696399,FALSE
REAC:R-HSA-9758941,0.0185801581491438,TRUE,47,485,10,REAC,Gastrulation,10835,993,REAC:R-HSA-1266738,FALSE
GO:0090276,0.0186958348456963,TRUE,202,553,18,GO:BP,regulation of peptide hormone secretion,21010,19033,GO:0002791|GO:0030072|GO:0046883,FALSE
GO:0071692,0.0188667630095023,TRUE,373,553,26,GO:BP,protein localization to extracellular region,21010,17674,GO:0008104,FALSE
TF:M10137,0.018909548525746,TRUE,624,556,38,TF,Factor: ZBP99; motif: NGGNGGGGGAGGGGN,20011,9268,TF:M00000,FALSE
HP:0011361,0.0189409700469779,TRUE,308,241,33,HP,Congenital abnormal hair pattern,4962,7768,HP:0010720,FALSE
MIRNA:hsa-miR-200b-3p,0.0190096162944257,TRUE,185,514,19,MIRNA,hsa-miR-200b-3p,14846,386,MIRNA:000000,FALSE
KEGG:04720,0.019033618048912,TRUE,67,431,12,KEGG,Long-term potentiation,8161,344,KEGG:00000,FALSE
GO:0007565,0.0192567205549777,TRUE,183,553,17,GO:BP,female pregnancy,21010,3096,GO:0044703|GO:0044706,TRUE
HP:0004298,0.0193141118915854,TRUE,531,241,48,HP,Abnormality of the abdominal wall,4962,3000,HP:0025031,FALSE
GO:0014033,0.0193695300323192,TRUE,95,553,12,GO:BP,neural crest cell differentiation,21010,4687,GO:0048762|GO:0048863,FALSE
TF:M10151,0.0193885389688916,TRUE,2183,556,95,TF,Factor: EZI; motif: GGGGAGGGGRRGGRGRRGGRRR,20011,2374,TF:M00000,FALSE
REAC:R-HSA-3371453,0.019442639842784,TRUE,67,485,12,REAC,Regulation of HSF1-mediated heat shock response,10835,1893,REAC:R-HSA-3371556,FALSE
REAC:R-HSA-69242,0.0194467423219879,TRUE,162,485,20,REAC,S Phase,10835,2005,REAC:R-HSA-69278,FALSE
TF:M00938,0.0194519758447388,TRUE,7472,556,258,TF,Factor: E2F-1; motif: TTGGCGCGRAANNGNM,20011,1448,TF:M00000,FALSE
HPA:0461451,0.0194675599753441,TRUE,367,418,30,HPA,skin 1; hair follicles[Low],11006,655,HPA:0460000,FALSE
HP:0002031,0.0195798263787955,TRUE,227,241,27,HP,Abnormal esophagus morphology,4962,1486,HP:0012718,FALSE
MIRNA:hsa-miR-195-5p,0.0196431462693555,TRUE,639,514,43,MIRNA,hsa-miR-195-5p,14846,364,MIRNA:000000,FALSE
REAC:R-HSA-69416,0.0199993324380999,TRUE,10,485,5,REAC,Dimerization of procaspase-8,10835,712,REAC:R-HSA-140534,FALSE
REAC:R-HSA-5218900,0.0199993324380999,TRUE,10,485,5,REAC,CASP8 activity is inhibited,10835,253,REAC:R-HSA-5675482,FALSE
REAC:R-HSA-3371378,0.0199993324380999,TRUE,10,485,5,REAC,Regulation by c-FLIP,10835,1878,REAC:R-HSA-140534,FALSE
GO:0043536,0.0200643632884241,TRUE,52,553,9,GO:BP,positive regulation of blood vessel endothelial cell migration,21010,11269,GO:0010595|GO:0043534|GO:0043535,FALSE
GO:2000677,0.0200643632884241,TRUE,52,553,9,GO:BP,regulation of transcription regulatory region DNA binding,21010,27039,GO:0051101,FALSE
GO:0051656,0.0201121864250479,TRUE,468,553,30,GO:BP,establishment of organelle localization,21010,14565,GO:0051234|GO:0051640,FALSE
GO:0000307,0.0202365609453002,TRUE,55,548,8,GO:CC,cyclin-dependent protein kinase holoenzyme complex,22090,45,GO:1902554,FALSE
GO:1990589,0.0202783452533694,TRUE,4,548,3,GO:CC,ATF4-CREB1 transcription factor complex,22090,3952,GO:0090575,FALSE
GO:0071664,0.0202783452533694,TRUE,4,548,3,GO:CC,catenin-TCF7L2 complex,22090,2753,GO:0140513,FALSE
HP:0000152,0.0205463914104954,TRUE,3322,241,191,HP,Abnormality of head or neck,4962,133,HP:0000118,FALSE
WP:WP4141,0.0207906831456942,TRUE,22,461,7,WP,PI3K/AKT/mTOR - vitamin D3 signaling,8625,753,WP:000000,FALSE
GO:0010575,0.0209157829367027,TRUE,29,553,7,GO:BP,positive regulation of vascular endothelial growth factor production,21010,4299,GO:0001819|GO:0010573|GO:0010574,FALSE
GO:0045446,0.0209324893926461,TRUE,112,553,13,GO:BP,endothelial cell differentiation,21010,11993,GO:0003158|GO:0030855,FALSE
HP:0012874,0.0209333770849905,TRUE,1139,241,84,HP,Abnormal male reproductive system physiology,4962,9259,HP:0000080,FALSE
GO:0006458,0.0210899242762017,TRUE,40,553,8,GO:BP,'de novo' protein folding,21010,2239,GO:0006457,TRUE
GO:2000279,0.0210899242762017,TRUE,40,553,8,GO:BP,negative regulation of DNA biosynthetic process,21010,26685,GO:0010558|GO:0051053|GO:0071897|GO:2000278,FALSE
GO:0071459,0.0210899242762017,TRUE,40,553,8,GO:BP,"protein localization to chromosome, centromeric region",21010,17503,GO:0034502,FALSE
MIRNA:hsa-miR-29c-3p,0.0212948818510317,TRUE,254,514,23,MIRNA,hsa-miR-29c-3p,14846,504,MIRNA:000000,FALSE
HPA:0301173,0.0216075333376331,TRUE,442,418,34,HPA,lung; alveolar cells[High],11006,446,HPA:0301172,FALSE
GO:0031100,0.0217303220427289,TRUE,66,553,10,GO:BP,animal organ regeneration,21010,7360,GO:0031099|GO:0048513,FALSE
GO:0014910,0.0217303220427289,TRUE,66,553,10,GO:BP,regulation of smooth muscle cell migration,21010,4867,GO:0014909|GO:0030334,FALSE
TF:M00738_1,0.0218461696710559,TRUE,4105,556,157,TF,Factor: E2F-4:DP-1; motif: TTTSGCGC; match class: 1,20011,1499,TF:M00738,FALSE
HP:0003330,0.0220225414633931,TRUE,810,241,65,HP,Abnormal bone structure,4962,2406,HP:0011842,FALSE
WP:WP585,0.022042026045278,TRUE,54,461,11,WP,Interferon type I signaling pathways,8625,791,WP:000000,FALSE
GO:0001098,0.0221512869770405,TRUE,60,555,9,GO:MF,basal transcription machinery binding,20139,164,GO:0005515,FALSE
GO:0001099,0.0221512869770405,TRUE,60,555,9,GO:MF,basal RNA polymerase II transcription machinery binding,20139,165,GO:0001098,FALSE
GO:1904953,0.0221854254436646,TRUE,12,553,5,GO:BP,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,21010,25242,GO:0016055|GO:1904948,FALSE
GO:1903377,0.0221854254436646,TRUE,12,553,5,GO:BP,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,21010,23898,GO:0036480|GO:0043524|GO:1902176|GO:1903376,FALSE
GO:0004690,0.0222996449319267,TRUE,8,555,4,GO:MF,cyclic nucleotide-dependent protein kinase activity,20139,987,GO:0004674,FALSE
GO:0017151,0.0222996449319267,TRUE,8,555,4,GO:MF,DEAD/H-box RNA helicase binding,20139,3177,GO:0019899,FALSE
TF:M12153,0.0223587569693529,TRUE,6352,556,225,TF,Factor: Sp3; motif: NGCCACGCCCMCN,20011,7884,TF:M00000,FALSE
WP:WP4186,0.0229109535003963,TRUE,6,461,4,WP,Somatroph axis (GH) and its relationship to dietary restriction and aging,8625,58,WP:000000,FALSE
HP:0003002,0.022917207513543,TRUE,66,241,13,HP,Breast carcinoma,4962,2169,HP:0100013,FALSE
GO:0002720,0.0229324109995081,TRUE,81,553,11,GO:BP,positive regulation of cytokine production involved in immune response,21010,1252,GO:0001819|GO:0002367|GO:0002702|GO:0002718,FALSE
GO:0002791,0.0229354994973569,TRUE,205,553,18,GO:BP,regulation of peptide secretion,21010,1316,GO:0002790|GO:0051046|GO:0090087,FALSE
GO:1904659,0.0230945603589643,TRUE,113,553,13,GO:BP,glucose transmembrane transport,21010,24993,GO:0008645,FALSE
REAC:R-HSA-5684264,0.0231219161685504,TRUE,16,485,6,REAC,MAP3K8 (TPL2)-dependent MAPK1/3 activation,10835,1289,REAC:R-HSA-450294|REAC:R-HSA-9020702,FALSE
REAC:R-HSA-5674135,0.0231912652695603,TRUE,39,485,9,REAC,MAP2K and MAPK activation,10835,1288,REAC:R-HSA-5673001,FALSE
REAC:R-HSA-6783310,0.0231912652695603,TRUE,39,485,9,REAC,Fanconi Anemia Pathway,10835,890,REAC:R-HSA-73894,FALSE
REAC:R-HSA-186712,0.0231912652695603,TRUE,39,485,9,REAC,Regulation of beta-cell development,10835,1927,REAC:R-HSA-1266738,FALSE
HPA:0471392,0.023346300682451,TRUE,755,418,50,HPA,skin 2; cells in basal layer[Medium],11006,681,HPA:0471391,FALSE
KEGG:04530,0.0235202826741384,TRUE,169,431,21,KEGG,Tight junction,8161,311,KEGG:00000,FALSE
WP:WP4928,0.0235853998002194,TRUE,16,461,6,WP,MAPK pathway in congenital thyroid cancer,8625,581,WP:000000,FALSE
GO:0033047,0.0236102782031602,TRUE,53,553,9,GO:BP,regulation of mitotic sister chromatid segregation,21010,8375,GO:0000070|GO:0033045,FALSE
GO:0061900,0.0236102782031602,TRUE,53,553,9,GO:BP,glial cell activation,21010,16503,GO:0001775|GO:0150076,FALSE
HP:0010720,0.0236270318932442,TRUE,354,241,36,HP,Abnormal hair pattern,4962,7154,HP:0001595,FALSE
HP:0000581,0.0238478837388638,TRUE,130,241,19,HP,Blepharophimosis,4962,449,HP:0200007,FALSE
HP:0002672,0.023854294158585,TRUE,76,241,14,HP,Gastrointestinal carcinoma,4962,1937,HP:0006749,FALSE
HP:0006749,0.023854294158585,TRUE,76,241,14,HP,Malignant gastrointestinal tract tumors,4962,4412,HP:0007378,FALSE
HP:0011121,0.0240616578186298,TRUE,2036,241,131,HP,Abnormality of skin morphology,4962,7537,HP:0000951,FALSE
GO:0010390,0.0241004326707193,TRUE,20,553,6,GO:BP,histone monoubiquitination,21010,4162,GO:0006513|GO:0016574,FALSE
GO:1902236,0.0241004326707193,TRUE,20,553,6,GO:BP,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,21010,23022,GO:0070059|GO:1902235|GO:1903573|GO:2001243,FALSE
GO:0046777,0.0243128079895326,TRUE,226,553,19,GO:BP,protein autophosphorylation,21010,12991,GO:0006468,FALSE
HP:0004299,0.0244146055260641,TRUE,489,241,45,HP,Hernia of the abdominal wall,4962,3001,HP:0010866|HP:0100790,FALSE
CORUM:691,0.0246359579558225,TRUE,11,292,6,CORUM,SIN3-SAP25 complex,3383,377,CORUM:0000000,FALSE
GO:0045785,0.024727107004378,TRUE,473,553,30,GO:BP,positive regulation of cell adhesion,21010,12232,GO:0007155|GO:0030155|GO:0048522,FALSE
GO:0030072,0.0249107347878069,TRUE,247,553,20,GO:BP,peptide hormone secretion,21010,6987,GO:0002790|GO:0046879,FALSE
HP:0000010,0.0249248824930225,TRUE,154,241,21,HP,Recurrent urinary tract infections,4962,9,HP:0002719|HP:0011277,FALSE
HP:0000137,0.0250198309876451,TRUE,230,241,27,HP,Abnormality of the ovary,4962,119,HP:0000008,FALSE
TF:M05444,0.02516122659546,TRUE,8759,556,294,TF,Factor: CPBP; motif: NGGGCGG,20011,942,TF:M00000,FALSE
TF:M05332,0.02516122659546,TRUE,8759,556,294,TF,Factor: Sp2; motif: WGGGCGG,20011,7862,TF:M00000,FALSE
TF:M05361,0.02516122659546,TRUE,8759,556,294,TF,Factor: Sp6; motif: WGGGCGG,20011,7906,TF:M00000,FALSE
TF:M03976,0.0255979273378827,TRUE,13012,556,409,TF,Factor: ERG; motif: ACCGGAWATCCGGT,20011,2022,TF:M00000,FALSE
GO:0090087,0.0262222145514776,TRUE,207,553,18,GO:BP,regulation of peptide transport,21010,18864,GO:0015833|GO:0051049,FALSE
TF:M00939,0.0263820721234484,TRUE,6604,556,232,TF,Factor: E2F; motif: TTTSGCGSG,20011,1558,TF:M00000,FALSE
GO:0097421,0.0266655884586584,TRUE,30,553,7,GO:BP,liver regeneration,21010,19542,GO:0001889|GO:0031100,FALSE
WP:WP5102,0.026692145976077,TRUE,30,461,8,WP,Familial partial lipodystrophy,8625,371,WP:000000,FALSE
TF:M01837_1,0.0268227715638471,TRUE,1479,556,70,TF,Factor: FKLF; motif: BGGGNGGVMD; match class: 1,20011,2419,TF:M01837,FALSE
HP:0002246,0.0269884410152791,TRUE,87,241,15,HP,Abnormal duodenum morphology,4962,1655,HP:0002244,FALSE
HPA:0470181,0.0270095286029546,TRUE,719,418,48,HPA,skin 2; cells in granular layer[Low],11006,686,HPA:0470000,FALSE
HP:0000539,0.0276177902811703,TRUE,666,241,56,HP,Abnormality of refraction,4962,413,HP:0012373,FALSE
HPA:0470672,0.0277432723161347,TRUE,640,418,44,HPA,skin 2; melanocytes[Medium],11006,717,HPA:0470671,FALSE
HP:0100606,0.0279107829647315,TRUE,77,241,14,HP,Neoplasm of the respiratory system,4962,16108,HP:0002086|HP:0011793,FALSE
TF:M03896_1,0.0279973576897146,TRUE,2173,556,94,TF,Factor: EGR1; motif: NACGCCCACGCANW; match class: 1,20011,1605,TF:M03896,FALSE
GO:0061351,0.0279982628433139,TRUE,169,553,16,GO:BP,neural precursor cell proliferation,21010,16197,GO:0008283,FALSE
HP:0001679,0.0281200806884909,TRUE,386,241,38,HP,Abnormal aortic morphology,4962,1221,HP:0011004|HP:0030962,FALSE
WP:WP306,0.0282622246652159,TRUE,198,461,24,WP,Focal adhesion,8625,17,WP:000000,FALSE
TF:M08313,0.0283556373022557,TRUE,15654,556,475,TF,Factor: GCMa:PEA3; motif: ATRCGGGCGGAAGTR,20011,3046,TF:M00000,FALSE
HPA:0460652,0.0284849632815505,TRUE,2839,418,142,HPA,skin 1; fibroblasts[Medium],11006,650,HPA:0460651,FALSE
WP:WP5181,0.0285237159049787,TRUE,23,461,7,WP,Roles of ceramides in development of insulin resistance,8625,440,WP:000000,FALSE
TF:M09738,0.0285840941175425,TRUE,11057,556,357,TF,Factor: ZNF511; motif: GGRRGRGGCWGNG,20011,10448,TF:M00000,FALSE
HPA:0471471,0.0286972839937988,TRUE,802,418,52,HPA,skin 2; lymphocytes[Low],11006,713,HPA:0470000,FALSE
REAC:R-HSA-2426168,0.0287533811173007,TRUE,40,485,9,REAC,Activation of gene expression by SREBF (SREBP),10835,98,REAC:R-HSA-1655829,FALSE
REAC:R-HSA-5693616,0.0287533811173007,TRUE,40,485,9,REAC,Presynaptic phase of homologous DNA pairing and strand exchange,10835,1712,REAC:R-HSA-5693579,FALSE
REAC:R-HSA-9656223,0.0287533811173007,TRUE,40,485,9,REAC,Signaling by RAF1 mutants,10835,2187,REAC:R-HSA-6802957,FALSE
TF:M00915_1,0.0288210944314783,TRUE,4675,556,174,TF,Factor: AP-2; motif: SNNNCCNCAGGCN; match class: 1,20011,157,TF:M00915,FALSE
TF:M00244_1,0.0289641744734675,TRUE,1824,556,82,TF,Factor: NGFI-C; motif: WTGCGTGGGYGG; match class: 1,20011,5765,TF:M00244,FALSE
TF:M08208_1,0.0289646960939822,TRUE,7299,556,252,TF,Factor: E2F-3:FOXI1; motif: NGACACCGCGCCCAC; match class: 1,20011,1479,TF:M08208,FALSE
GO:1905897,0.0291186863207327,TRUE,83,553,11,GO:BP,regulation of response to endoplasmic reticulum stress,21010,26035,GO:0034976|GO:0080135,FALSE
KEGG:05230,0.0292433603488364,TRUE,70,431,12,KEGG,Central carbon metabolism in cancer,8161,471,KEGG:00000,FALSE
WP:WP4329,0.0293765317492176,TRUE,65,461,12,WP,miRNA role in immune response in sepsis,8625,409,WP:000000,FALSE
GO:0048667,0.0293785265139719,TRUE,576,553,34,GO:BP,cell morphogenesis involved in neuron differentiation,21010,13577,GO:0000902|GO:0048666,FALSE
HP:0033993,0.029410240235503,TRUE,13,241,6,HP,Viral encephalitis,4962,13975,HP:0002383|HP:0032169,FALSE
GO:0070530,0.0294530000611463,TRUE,25,555,6,GO:MF,K63-linked polyubiquitin modification-dependent protein binding,20139,8739,GO:0031593,TRUE
TF:M09641,0.0296433537798199,TRUE,3303,556,131,TF,Factor: NRF-1; motif: SYGCGCMTGCGCRNNGSN,20011,6040,TF:M00000,FALSE
TF:M07486_1,0.0297373584303513,TRUE,7544,556,259,TF,Factor: ZNF300; motif: SWGGGGGSN; match class: 1,20011,9901,TF:M07486,FALSE
GO:0005976,0.0297804848692798,TRUE,99,553,12,GO:BP,polysaccharide metabolic process,21010,1873,GO:0005975|GO:0043170,FALSE
TF:M11397,0.0298693478445288,TRUE,12223,556,388,TF,Factor: Erg; motif: NACCGGATATCCGGTN,20011,2042,TF:M00000,FALSE
GO:0005657,0.0298850105384658,TRUE,74,548,9,GO:CC,replication fork,22090,255,GO:0005694|GO:0110165,FALSE
TF:M12057_1,0.0298910105090083,TRUE,1400,556,67,TF,Factor: ZBP99; motif: GCCCMTCCCCCR; match class: 1,20011,9271,TF:M12057,FALSE
GO:0120039,0.0300746615459468,TRUE,653,553,37,GO:BP,plasma membrane bounded cell projection morphogenesis,21010,20389,GO:0048858,FALSE
REAC:R-HSA-9013957,0.0300872475363278,TRUE,6,485,4,REAC,TLR3-mediated TICAM1-dependent programmed cell death,10835,2327,REAC:R-HSA-168164,FALSE
REAC:R-HSA-5339717,0.0300872475363278,TRUE,6,485,4,REAC,Signaling by LRP5 mutants ,10835,2156,REAC:R-HSA-4791275,FALSE
REAC:R-HSA-3304351,0.0300872475363278,TRUE,6,485,4,REAC,Signaling by TGF-beta Receptor Complex in Cancer,10835,2200,REAC:R-HSA-5663202,FALSE
WP:WP4217,0.0301384990979625,TRUE,128,461,18,WP,Ebola virus infection in host,8625,813,WP:000000,FALSE
TF:M11393,0.0302050569264224,TRUE,14359,556,443,TF,Factor: Erg; motif: NACCGGATATCCGGTN,20011,2034,TF:M00000,FALSE
GO:0051219,0.0304091737600314,TRUE,93,555,11,GO:MF,phosphoprotein binding,20139,8018,GO:0005515,FALSE
HP:0002239,0.0305189864233791,TRUE,156,241,21,HP,Gastrointestinal hemorrhage,4962,1649,HP:0011029|HP:0012719,FALSE
GO:0008645,0.0308071018661286,TRUE,116,553,13,GO:BP,hexose transmembrane transport,21010,3278,GO:0015749,FALSE
WP:WP1591,0.0308909633679299,TRUE,47,461,10,WP,Heart development,8625,556,WP:000000,FALSE
GO:0140467,0.0309048266806594,TRUE,42,553,8,GO:BP,integrated stress response signaling,21010,20713,GO:0033554,FALSE
GO:1902110,0.0309048266806594,TRUE,42,553,8,GO:BP,positive regulation of mitochondrial membrane permeability involved in apoptotic process,21010,22910,GO:1902108|GO:1902686,FALSE
GO:1902116,0.0309048266806594,TRUE,42,553,8,GO:BP,negative regulation of organelle assembly,21010,22915,GO:0010639|GO:0070925|GO:1902115,FALSE
WP:WP4147,0.0311493377477981,TRUE,11,461,5,WP,PTF1A related regulatory pathway,8625,424,WP:000000,FALSE
TF:M02023_1,0.0313004811408357,TRUE,3213,556,128,TF,Factor: MAZ; motif: NKGGGAGGGGRGGR; match class: 1,20011,5005,TF:M02023,FALSE
TF:M04863_1,0.031498969726991,TRUE,8744,556,293,TF,Factor: TF3C-beta; motif: CCNGGAGGGCTTCCTGGAGGAG; match class: 1,20011,3303,TF:M04863,FALSE
HP:0010866,0.0318133625456074,TRUE,494,241,45,HP,Abdominal wall defect,4962,7293,HP:0004298,FALSE
HP:0009815,0.0318793188031134,TRUE,702,241,58,HP,Aplasia/hypoplasia of the extremities,4962,6310,HP:0009115|HP:0040064,FALSE
HP:0004325,0.031889842066317,TRUE,1482,241,102,HP,Decreased body weight,4962,3019,HP:0004323,FALSE
HPA:0570813,0.03194675008322,TRUE,1338,418,77,HPA,testis; spermatogonia cells[High],11006,830,HPA:0570812,FALSE
GO:0035148,0.0319525047949708,TRUE,152,553,15,GO:BP,tube formation,21010,9266,GO:0035239|GO:0048646,FALSE
HPA:0460642,0.0319893248339294,TRUE,2629,418,133,HPA,skin 1; Langerhans[Medium],11006,623,HPA:0460641,FALSE
TF:M07062,0.0320493422793809,TRUE,1515,556,71,TF,Factor: RREB-1; motif: GRSDSGGGKTGGGKGG,20011,7344,TF:M00000,FALSE
TF:M00919,0.0322567425375124,TRUE,6315,556,223,TF,Factor: E2F; motif: NCSCGCSAAAN,20011,1556,TF:M00000,FALSE
GO:0060612,0.0323295570863743,TRUE,55,553,9,GO:BP,adipose tissue development,21010,15528,GO:0048513|GO:0061448,FALSE
HP:0011025,0.0323928098698134,TRUE,1389,241,97,HP,Abnormal cardiovascular system physiology,4962,7443,HP:0001626,FALSE
GO:0070534,0.0326340857766159,TRUE,69,553,10,GO:BP,protein K63-linked ubiquitination,21010,16967,GO:0000209,FALSE
GO:0071300,0.0326340857766159,TRUE,69,553,10,GO:BP,cellular response to retinoic acid,21010,17366,GO:0032526|GO:0071396|GO:1901701,FALSE
GO:0061515,0.0327221176243599,TRUE,84,553,11,GO:BP,myeloid cell development,21010,16299,GO:0030097|GO:0030099,FALSE
TF:M09724_1,0.0327369466993061,TRUE,2968,556,120,TF,Factor: DATF1; motif: SNGGRRGCWGNGGG; match class: 1,20011,1193,TF:M09724,FALSE
HPA:0241102,0.0328914269869551,TRUE,4367,418,203,HPA,heart muscle; cardiomyocytes[Medium],11006,379,HPA:0241101,FALSE
GO:0043539,0.0329599622547244,TRUE,63,555,9,GO:MF,protein serine/threonine kinase activator activity,20139,5809,GO:0030295,FALSE
GO:0043011,0.0329921632061952,TRUE,21,553,6,GO:BP,myeloid dendritic cell differentiation,21010,10987,GO:0001773|GO:0002573|GO:0097028,FALSE
GO:0061117,0.0329921632061952,TRUE,21,553,6,GO:BP,negative regulation of heart growth,21010,15983,GO:0046621|GO:0060419|GO:0060420,FALSE
GO:0055022,0.0329921632061952,TRUE,21,553,6,GO:BP,negative regulation of cardiac muscle tissue growth,21010,14940,GO:0055017|GO:0055021|GO:0061117,FALSE
GO:0090043,0.0329921632061952,TRUE,21,553,6,GO:BP,regulation of tubulin deacetylation,21010,18827,GO:0090042|GO:0090311,FALSE
GO:0001657,0.0330452531129539,TRUE,100,553,12,GO:BP,ureteric bud development,21010,381,GO:0072164,FALSE
HP:0000290,0.0331726869093566,TRUE,1170,241,85,HP,Abnormality of the forehead,4962,239,HP:0000271,FALSE
HP:0004323,0.0333137858709326,TRUE,1790,241,118,HP,Abnormality of body weight,4962,3017,HP:0001507,FALSE
REAC:R-HSA-9709603,0.0333635561895543,TRUE,24,485,7,REAC,Impaired BRCA2 binding to PALB2,10835,1120,REAC:R-HSA-9701190,FALSE
MIRNA:hsa-miR-222-3p,0.0333763586951201,TRUE,391,514,30,MIRNA,hsa-miR-222-3p,14846,450,MIRNA:000000,FALSE
GO:0002790,0.0334699380787439,TRUE,252,553,20,GO:BP,peptide secretion,21010,1315,GO:0015833|GO:0046903,FALSE
HP:0030680,0.0334862514104359,TRUE,1908,241,124,HP,Abnormality of cardiovascular system morphology,4962,10785,HP:0001626,FALSE
GO:0016342,0.03349023125591,TRUE,31,548,6,GO:CC,catenin complex,22090,737,GO:0019897|GO:0098797,TRUE
GO:0051085,0.0336657985418113,TRUE,31,553,7,GO:BP,chaperone cofactor-dependent protein refolding,21010,14154,GO:0051084|GO:0061077,TRUE
GO:0035065,0.0336657985418113,TRUE,31,553,7,GO:BP,regulation of histone acetylation,21010,9206,GO:0016573|GO:0031056|GO:2000756,FALSE
GO:0003309,0.0336657985418113,TRUE,31,553,7,GO:BP,type B pancreatic cell differentiation,21010,1748,GO:0031018|GO:0035883,FALSE
WP:WP4868,0.0343161373817357,TRUE,31,461,8,WP,Type I interferon induction and signaling during SARS-CoV-2 infection,8625,353,WP:000000,FALSE
REAC:R-HSA-196299,0.0343894803886748,TRUE,17,485,6,REAC,Beta-catenin phosphorylation cascade,10835,210,REAC:R-HSA-195253,FALSE
GO:0007612,0.0345830901499669,TRUE,153,553,15,GO:BP,learning,21010,3122,GO:0007611,FALSE
HP:0000036,0.0345867287853227,TRUE,737,241,60,HP,Abnormal penis morphology,4962,34,HP:0000032,FALSE
TF:M04934,0.0348013599913541,TRUE,18392,556,536,TF,Factor: TR4; motif: ACCCCGS,20011,5944,TF:M00000,FALSE
WP:WP5372,0.0348161495488394,TRUE,17,461,6,WP,Involvement of -secretase in neurodegenerative diseases,8625,660,WP:000000,FALSE
WP:WP3859,0.0348161495488394,TRUE,17,461,6,WP,TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition,8625,293,WP:000000,FALSE
HP:0025033,0.0350092563569125,TRUE,1082,241,80,HP,Abnormality of digestive system morphology,4962,9488,HP:0025031,FALSE
TF:M00051,0.0350311332140186,TRUE,6526,556,229,TF,Factor: NF-kappaB; motif: GGGGATYCCC,20011,5698,TF:M00000,FALSE
GO:0001650,0.0352285815635799,TRUE,151,548,13,GO:CC,fibrillar center,22090,148,GO:0005730|GO:0110165,FALSE
REAC:R-HSA-6802957,0.035246828016259,TRUE,82,485,13,REAC,Oncogenic MAPK signaling,10835,1561,REAC:R-HSA-5663202,FALSE
REAC:R-HSA-69202,0.035246828016259,TRUE,82,485,13,REAC,Cyclin E associated events during G1/S transition ,10835,404,REAC:R-HSA-69206,FALSE
GO:0002702,0.0352507096526151,TRUE,135,553,14,GO:BP,positive regulation of production of molecular mediator of immune response,21010,1234,GO:0002440|GO:0002699|GO:0002700|GO:0010628,FALSE
GO:0061029,0.0352708394529402,TRUE,13,553,5,GO:BP,eyelid development in camera-type eye,21010,15899,GO:0043010|GO:0048856,FALSE
REAC:R-HSA-376172,0.0353182321524601,TRUE,11,485,5,REAC,DSCAM interactions,10835,433,REAC:R-HSA-373752,FALSE
REAC:R-HSA-3899300,0.0353994526125338,TRUE,41,485,9,REAC,SUMOylation of transcription cofactors,10835,2070,REAC:R-HSA-3108232,FALSE
TF:M10107,0.0354707914495249,TRUE,5985,556,213,TF,Factor: DB1; motif: GGRRRRGRRGGAGGGGGNGRRR,20011,1196,TF:M00000,FALSE
GO:0048858,0.0355634406684134,TRUE,658,553,37,GO:BP,cell projection morphogenesis,21010,13754,GO:0000902|GO:0030030|GO:0032990,FALSE
GO:0005109,0.0355736004323531,TRUE,37,555,7,GO:MF,frizzled binding,20139,1283,GO:0001664,TRUE
REAC:R-HSA-69206,0.0358934318289326,TRUE,130,485,17,REAC,G1/S Transition,10835,955,REAC:R-HSA-453279,FALSE
HP:0001511,0.0360333363101247,TRUE,607,241,52,HP,Intrauterine growth retardation,4962,1117,HP:0001510,FALSE
HP:0000554,0.0362448368552975,TRUE,50,241,11,HP,Uveitis,4962,427,HP:0000553|HP:0100533,FALSE
HPA:0471461,0.0363971183473386,TRUE,789,418,51,HPA,skin 2; langerhans cells[Low],11006,710,HPA:0470000,FALSE
TF:M04109,0.0364158366072084,TRUE,9979,556,327,TF,Factor: RUNX3; motif: NRACCGCAAACCGCAN,20011,7366,TF:M00000,FALSE
GO:0072163,0.0366186234349545,TRUE,101,553,12,GO:BP,mesonephric epithelium development,21010,18025,GO:0001823|GO:0072073,FALSE
GO:0072164,0.0366186234349545,TRUE,101,553,12,GO:BP,mesonephric tubule development,21010,18026,GO:0035295|GO:0072163,FALSE
GO:0035304,0.0367065549790435,TRUE,85,553,11,GO:BP,regulation of protein dephosphorylation,21010,9381,GO:0006470|GO:0031399|GO:0035303,FALSE
HPA:0241103,0.0367091261068173,TRUE,1169,418,69,HPA,heart muscle; cardiomyocytes[High],11006,380,HPA:0241102,FALSE
WP:WP5265,0.0367450657838569,TRUE,57,461,11,WP,Neurogenesis regulation in the olfactory epithelium,8625,463,WP:000000,FALSE
HPA:0090982,0.0367699169281678,TRUE,130,418,15,HPA,cerebellum; granular cells - nucleus[Medium],11006,144,HPA:0090981,FALSE
HP:0000119,0.0367704610518079,TRUE,2673,241,161,HP,Abnormality of the genitourinary system,4962,103,HP:0000118,FALSE
GO:0046622,0.0371010957495869,TRUE,43,553,8,GO:BP,positive regulation of organ growth,21010,12887,GO:0035265|GO:0046620|GO:0048639|GO:0051240,FALSE
GO:0043507,0.0371010957495869,TRUE,43,553,8,GO:BP,positive regulation of JUN kinase activity,21010,11256,GO:0043406|GO:0043506,FALSE
HP:0002236,0.037238216520529,TRUE,26,241,8,HP,Frontal upsweep of hair,4962,1648,HP:0010721,FALSE
GO:0042974,0.0374020728236363,TRUE,26,555,6,GO:MF,nuclear retinoic acid receptor binding,20139,5727,GO:0016922,FALSE
HP:0001155,0.0376001764804675,TRUE,1601,241,108,HP,Abnormality of the hand,4962,903,HP:0002817,FALSE
HP:0000722,0.037659118102955,TRUE,146,241,20,HP,Compulsive behaviors,4962,562,HP:0031432,FALSE
REAC:R-HSA-5625740,0.0377813298914398,TRUE,94,485,14,REAC,RHO GTPases activate PKNs,10835,1774,REAC:R-HSA-195258,FALSE
CORUM:739,0.0378205580185263,TRUE,16,292,7,CORUM,SIN3-ING1b complex II,3383,405,CORUM:0000000,FALSE
HP:0000025,0.0378308050593585,TRUE,1102,241,81,HP,Functional abnormality of male internal genitalia,4962,23,HP:0012874,FALSE
TF:M08993_1,0.0383980120724789,TRUE,4210,556,159,TF,Factor: ZNF777; motif: GTCCGYCCCGTCSAACAAT; match class: 1,20011,11305,TF:M08993,FALSE
HP:0045060,0.0384095757837033,TRUE,657,241,55,HP,Aplasia/hypoplasia involving bones of the extremities,4962,15496,HP:0002813|HP:0009815,FALSE
WP:WP1539,0.0384338686137945,TRUE,24,461,7,WP,Angiogenesis,8625,40,WP:000000,FALSE
REAC:R-HSA-9755511,0.0384509284907122,TRUE,106,485,15,REAC,KEAP1-NFE2L2 pathway,10835,1228,REAC:R-HSA-9711123,FALSE
KEGG:05014,0.0392413085288832,TRUE,362,431,35,KEGG,Amyotrophic lateral sclerosis,8161,406,KEGG:00000,FALSE
HP:0000520,0.0398248501504486,TRUE,263,241,29,HP,Proptosis,4962,398,HP:0100886,FALSE
TF:M01858_1,0.0399949375563371,TRUE,3229,556,128,TF,Factor: AP-2beta; motif: GCNNNGGSCNGVGGGN; match class: 1,20011,137,TF:M01858,FALSE
GO:0007059,0.0403315075417042,TRUE,413,553,27,GO:BP,chromosome segregation,21010,2701,GO:0022402,FALSE
GO:0006694,0.0404354755282507,TRUE,174,553,16,GO:BP,steroid biosynthetic process,21010,2440,GO:0008202|GO:0008610|GO:1901362,FALSE
GO:0060840,0.0405249811855079,TRUE,102,553,12,GO:BP,artery development,21010,15734,GO:0001568,FALSE
GO:0140888,0.0405249811855079,TRUE,102,553,12,GO:BP,interferon-mediated signaling pathway,21010,20852,GO:0019221,FALSE
GO:0015749,0.0406994641479602,TRUE,119,553,13,GO:BP,monosaccharide transmembrane transport,21010,4953,GO:0034219,FALSE
GO:0070371,0.0407934228817765,TRUE,321,553,23,GO:BP,ERK1 and ERK2 cascade,21010,16878,GO:0000165,FALSE
GO:0000436,0.041055992524481,TRUE,7,553,4,GO:BP,carbon catabolite activation of transcription from RNA polymerase II promoter,21010,144,GO:0000429|GO:0045944|GO:0045991,FALSE
GO:1905691,0.041055992524481,TRUE,7,553,4,GO:BP,lipid droplet disassembly,21010,25870,GO:0034389|GO:1903008,FALSE
GO:0060440,0.041055992524481,TRUE,7,553,4,GO:BP,trachea formation,21010,15372,GO:0048645|GO:0060439,FALSE
GO:0000429,0.041055992524481,TRUE,7,553,4,GO:BP,carbon catabolite regulation of transcription from RNA polymerase II promoter,21010,137,GO:0006357|GO:0045990,FALSE
GO:1903944,0.041055992524481,TRUE,7,553,4,GO:BP,negative regulation of hepatocyte apoptotic process,21010,24377,GO:0097284|GO:1903943|GO:1904036,FALSE
CORUM:1152,0.0410753344178893,TRUE,8,292,5,CORUM,FA complex (Fanconi anemia complex),3383,635,CORUM:0000000,FALSE
HPA:0570731,0.0415021555645468,TRUE,7171,418,307,HPA,testis; Leydig cells[Low],11006,804,HPA:0570000,FALSE
HPA:0381191,0.0415668694078341,TRUE,476,418,35,HPA,placenta; cytotrophoblasts[Low],11006,518,HPA:0380000,FALSE
GO:0001101,0.0417180120923309,TRUE,137,553,14,GO:BP,response to acid chemical,21010,296,GO:0042221,FALSE
HP:0003003,0.0417374574023038,TRUE,42,241,10,HP,Colon cancer,4962,2170,HP:0100273,FALSE
HP:0001212,0.0417374574023038,TRUE,42,241,10,HP,Prominent fingertip pads,4962,930,HP:0001211|HP:0011298,FALSE
GO:0048812,0.0417736626550093,TRUE,637,553,36,GO:BP,neuron projection morphogenesis,21010,13710,GO:0031175|GO:0120039,FALSE
HP:0000525,0.0417753497845091,TRUE,453,241,42,HP,Abnormality iris morphology,4962,402,HP:0000553|HP:0004328,FALSE
HP:0002088,0.0420761608717896,TRUE,1195,241,86,HP,Abnormal lung morphology,4962,1536,HP:0012252,FALSE
GO:0032607,0.0421201463591546,TRUE,32,553,7,GO:BP,interferon-alpha production,21010,8023,GO:0032606,FALSE
GO:0030511,0.0421201463591546,TRUE,32,553,7,GO:BP,positive regulation of transforming growth factor beta receptor signaling pathway,21010,7144,GO:0007179|GO:0017015|GO:0090100|GO:1903846,FALSE
GO:0060421,0.0421201463591546,TRUE,32,553,7,GO:BP,positive regulation of heart growth,21010,15354,GO:0046622|GO:0060419|GO:0060420,FALSE
GO:0006346,0.0421201463591546,TRUE,32,553,7,GO:BP,DNA methylation-dependent heterochromatin formation,21010,2159,GO:0140718,FALSE
GO:0010574,0.0421201463591546,TRUE,32,553,7,GO:BP,regulation of vascular endothelial growth factor production,21010,4298,GO:0001817|GO:0010573,FALSE
GO:1903846,0.0421201463591546,TRUE,32,553,7,GO:BP,positive regulation of cellular response to transforming growth factor beta stimulus,21010,24289,GO:0048584|GO:0071560|GO:1903844,FALSE
GO:0032647,0.0421201463591546,TRUE,32,553,7,GO:BP,regulation of interferon-alpha production,21010,8062,GO:0032479|GO:0032607,FALSE
GO:0016242,0.0421201463591546,TRUE,32,553,7,GO:BP,negative regulation of macroautophagy,21010,5271,GO:0010507|GO:0016236|GO:0016241,FALSE
GO:0016444,0.042277465398727,TRUE,71,553,10,GO:BP,somatic cell DNA recombination,21010,5312,GO:0006310,FALSE
GO:0002562,0.042277465398727,TRUE,71,553,10,GO:BP,somatic diversification of immune receptors via germline recombination within a single locus,21010,1097,GO:0002200|GO:0016444,FALSE
HP:0011750,0.0423947641430448,TRUE,60,241,12,HP,Neoplasm of the anterior pituitary,4962,8152,HP:0011747|HP:0040277,FALSE
HP:0040277,0.0423947641430448,TRUE,60,241,12,HP,Neoplasm of the pituitary gland,4962,15250,HP:0012503|HP:0100568,FALSE
GO:0001530,0.0425792403024787,TRUE,38,555,7,GO:MF,lipopolysaccharide binding,20139,191,GO:0008289|GO:0097367,TRUE
REAC:R-HSA-1980145,0.042618681955014,TRUE,33,485,8,REAC,Signaling by NOTCH2,10835,2172,REAC:R-HSA-157118,FALSE
TF:M09972,0.042819717831299,TRUE,9416,556,311,TF,Factor: BTEB2; motif: WGGGTGKGGCNGGN,20011,616,TF:M00000,FALSE
HPA:0460202,0.0431036098824684,TRUE,593,418,41,HPA,skin 1; endothelial cells[Medium],11006,644,HPA:0460201,FALSE
HP:0100787,0.0432639305092024,TRUE,34,241,9,HP,Prostate neoplasm,4962,16269,HP:0008775|HP:0033019,FALSE
HP:0012125,0.0432639305092024,TRUE,34,241,9,HP,Prostate cancer,4962,8522,HP:0100787,FALSE
GO:0002366,0.0434922742241029,TRUE,300,553,22,GO:BP,leukocyte activation involved in immune response,21010,912,GO:0002263|GO:0045321,FALSE
TF:M12489,0.0440569431702829,TRUE,6206,556,219,TF,Factor: KLF4; motif: NNCCCCACCCNN,20011,4588,TF:M00000,FALSE
GO:0005741,0.0441898919666612,TRUE,220,548,16,GO:CC,mitochondrial outer membrane,22090,312,GO:0031966|GO:0031968,TRUE
GO:1902686,0.0443098164612374,TRUE,44,553,8,GO:BP,mitochondrial outer membrane permeabilization involved in programmed cell death,21010,23348,GO:0012501|GO:0035794,FALSE
GO:0035196,0.0443098164612374,TRUE,44,553,8,GO:BP,miRNA processing,21010,9307,GO:0070918,FALSE
GO:0009409,0.0443098164612374,TRUE,44,553,8,GO:BP,response to cold,21010,3530,GO:0006950|GO:0009266,FALSE
GO:0032785,0.0443584141820937,TRUE,22,553,6,GO:BP,"negative regulation of DNA-templated transcription, elongation",21010,8191,GO:0006354|GO:0032784|GO:0045892,FALSE
KEGG:04962,0.0444149126845827,TRUE,44,431,9,KEGG,Vasopressin-regulated water reabsorption,8161,391,KEGG:00000,FALSE
HPA:0530713,0.0444907754191759,TRUE,816,418,52,HPA,spleen; cells in red pulp[High],11006,778,HPA:0530712,FALSE
GO:0030278,0.0445662498676395,TRUE,120,553,13,GO:BP,regulation of ossification,21010,7070,GO:0001503|GO:0051239,FALSE
REAC:R-HSA-9704646,0.0445664712984419,TRUE,25,485,7,REAC,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,10835,546,REAC:R-HSA-9701193,FALSE
REAC:R-HSA-933542,0.0445664712984419,TRUE,25,485,7,REAC,TRAF6 mediated NF-kB activation,10835,2350,REAC:R-HSA-168928,FALSE
REAC:R-HSA-9704331,0.0445664712984419,TRUE,25,485,7,REAC,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,10835,545,REAC:R-HSA-9701193,FALSE
REAC:R-HSA-9701193,0.0445664712984419,TRUE,25,485,7,REAC,Defective homologous recombination repair (HRR) due to PALB2 loss of function,10835,679,REAC:R-HSA-9675136,FALSE
REAC:R-HSA-9701192,0.0445664712984419,TRUE,25,485,7,REAC,Defective homologous recombination repair (HRR) due to BRCA1 loss of function,10835,677,REAC:R-HSA-9675136,FALSE
GO:0046965,0.0447473368248614,TRUE,17,555,5,GO:MF,nuclear retinoid X receptor binding,20139,6303,GO:0042974,FALSE
GO:2000177,0.0447902397684592,TRUE,103,553,12,GO:BP,regulation of neural precursor cell proliferation,21010,26590,GO:0042127|GO:0061351,FALSE
REAC:R-HSA-9707564,0.0448718022802098,TRUE,62,485,11,REAC,Cytoprotection by HMOX1,10835,409,REAC:R-HSA-9711123,FALSE
HP:0001636,0.0449428859756055,TRUE,185,241,23,HP,Tetralogy of Fallot,4962,1188,HP:0001710,FALSE
HPA:0210053,0.0452153940054876,TRUE,1666,418,91,HPA,fallopian tube; glandular cells[High],11006,356,HPA:0210052,FALSE
HPA:0381193,0.0453167429887058,TRUE,295,418,25,HPA,placenta; cytotrophoblasts[High],11006,520,HPA:0381192,FALSE
TF:M10108_1,0.0454638662361104,TRUE,2927,556,118,TF,Factor: WT1; motif: RGGNGGGGGAGGRGGNGGRG; match class: 1,20011,8981,TF:M10108,FALSE
REAC:R-HSA-69656,0.0455680169657485,TRUE,84,485,13,REAC,Cyclin A:Cdk2-associated events at S phase entry,10835,402,REAC:R-HSA-69242,FALSE
HP:0012531,0.0458276024260337,TRUE,811,241,64,HP,Pain,4962,8918,HP:0025142,FALSE
HP:0002577,0.0460322671962639,TRUE,265,241,29,HP,Abnormal stomach morphology,4962,1862,HP:0012718,FALSE
REAC:R-HSA-9705671,0.0462593626567075,TRUE,120,485,16,REAC,SARS-CoV-2 activates/modulates innate and adaptive immune responses,10835,2017,REAC:R-HSA-9705683,FALSE
MIRNA:hsa-miR-26a-5p,0.0463033917512377,TRUE,457,514,33,MIRNA,hsa-miR-26a-5p,14846,482,MIRNA:000000,FALSE
WP:WP4549,0.0463350287060541,TRUE,121,461,17,WP,Fragile X syndrome,8625,131,WP:000000,FALSE
MIRNA:hsa-miR-224-5p,0.0466115882498078,TRUE,133,514,15,MIRNA,hsa-miR-224-5p,14846,455,MIRNA:000000,FALSE
TF:M10112,0.0474667994576393,TRUE,8711,556,291,TF,Factor: Miz-1; motif: NNRGGWGGGGGAGGGGMRR,20011,5200,TF:M00000,FALSE
GO:1902499,0.0477327074873083,TRUE,3,553,3,GO:BP,positive regulation of protein autoubiquitination,21010,23225,GO:0031398|GO:0051865|GO:1902498,FALSE
GO:1904466,0.0477327074873083,TRUE,3,553,3,GO:BP,positive regulation of matrix metallopeptidase secretion,21010,24837,GO:0050714|GO:1904464|GO:1990773,TRUE
GO:1990637,0.0477327074873083,TRUE,3,553,3,GO:BP,response to prolactin,21010,26293,GO:0043434,FALSE
GO:0043970,0.0477327074873083,TRUE,3,553,3,GO:BP,histone H3-K9 acetylation,21010,11409,GO:0043966|GO:0061647,FALSE
GO:0061198,0.0477327074873083,TRUE,3,553,3,GO:BP,fungiform papilla formation,21010,16051,GO:0048646|GO:0061197,FALSE
GO:0099075,0.0477327074873083,TRUE,3,553,3,GO:BP,mitochondrion-derived vesicle mediated transport,21010,19932,GO:0016192,FALSE
GO:0099074,0.0477327074873083,TRUE,3,553,3,GO:BP,mitochondrion to lysosome transport,21010,19931,GO:0006839|GO:0007041|GO:0099075,FALSE
GO:0070933,0.0477327074873083,TRUE,3,553,3,GO:BP,histone H4 deacetylation,21010,17184,GO:0016575,FALSE
GO:0003143,0.0479550182324068,TRUE,72,553,10,GO:BP,embryonic heart tube morphogenesis,21010,1592,GO:0003007|GO:0035050|GO:0048562|GO:0048598|GO:0060562,FALSE
GO:0048844,0.0479550182324068,TRUE,72,553,10,GO:BP,artery morphogenesis,21010,13740,GO:0048514|GO:0060840,FALSE
GO:0002460,0.0482015708389228,TRUE,302,553,22,GO:BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,21010,997,GO:0002250,TRUE
HPA:0461391,0.0482307226441691,TRUE,881,418,55,HPA,skin 1; cells in basal layer[Low],11006,628,HPA:0460000,FALSE
GO:0000803,0.0483040318529515,TRUE,33,548,6,GO:CC,sex chromosome,22090,103,GO:0005694,FALSE
HP:0007700,0.0483630995266424,TRUE,322,241,33,HP,Ocular anterior segment dysgenesis,4962,4918,HP:0004328,FALSE
HP:0009715,0.0483886796455899,TRUE,5,241,4,HP,Papillary cystadenoma of the epididymis,4962,6217,HP:0009714|HP:0030421,FALSE
HP:0030421,0.0483886796455899,TRUE,5,241,4,HP,Epididymal neoplasm,4962,10535,HP:0010785,FALSE
REAC:R-HSA-3315487,0.0484562630120102,TRUE,3,485,3,REAC,SMAD2/3 MH2 Domain Mutants in Cancer,10835,2045,REAC:R-HSA-3304349,FALSE
REAC:R-HSA-3311021,0.0484562630120102,TRUE,3,485,3,REAC,SMAD4 MH2 Domain Mutants in Cancer,10835,2048,REAC:R-HSA-3304347,FALSE
REAC:R-HSA-1368071,0.0484562630120102,TRUE,3,485,3,REAC,NR1D1 (REV-ERBA) represses gene expression,10835,1463,REAC:R-HSA-400253,FALSE
REAC:R-HSA-5602571,0.0484562630120102,TRUE,3,485,3,REAC,TRAF3 deficiency - HSE,10835,2346,REAC:R-HSA-5602358,FALSE
REAC:R-HSA-3304347,0.0484562630120102,TRUE,3,485,3,REAC,Loss of Function of SMAD4 in Cancer,10835,1270,REAC:R-HSA-3304351,FALSE
MIRNA:hsa-miR-200a-3p,0.0485139950321315,TRUE,149,514,16,MIRNA,hsa-miR-200a-3p,14846,384,MIRNA:000000,FALSE
MIRNA:hsa-miR-378a-3p,0.0486934299020053,TRUE,165,514,17,MIRNA,hsa-miR-378a-3p,14846,852,MIRNA:000000,FALSE
MIRNA:hsa-miR-100-5p,0.0489131469062311,TRUE,250,514,22,MIRNA,hsa-miR-100-5p,14846,38,MIRNA:000000,FALSE
GO:0001936,0.0492098288095006,TRUE,139,553,14,GO:BP,regulation of endothelial cell proliferation,21010,561,GO:0001935|GO:0050678,FALSE
HP:0005561,0.0493276970166415,TRUE,212,241,25,HP,Abnormality of bone marrow cell morphology,4962,3756,HP:0001871,FALSE
REAC:R-HSA-6804114,0.0496450797756664,TRUE,18,485,6,REAC,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,10835,2343,REAC:R-HSA-6791312,FALSE
GO:0001093,0.0497362189091772,TRUE,4,555,3,GO:MF,TFIIB-class transcription factor binding,20139,159,GO:0001091,FALSE
GO:0003886,0.0497362189091772,TRUE,4,555,3,GO:MF,DNA (cytosine-5-)-methyltransferase activity,20139,426,GO:0008757|GO:0009008,TRUE
GO:1990513,0.0497588127400909,TRUE,5,548,3,GO:CC,CLOCK-BMAL transcription complex,22090,3929,GO:0090575,FALSE
GO:0032449,0.0497588127400909,TRUE,5,548,3,GO:CC,CBM complex,22090,1306,GO:0140535,TRUE
WP:WP3877,0.0498853985604998,TRUE,18,461,6,WP,MYD88 distinct input-output pathway,8625,43,WP:000000,FALSE
GO:0071695,0.0498968303361685,TRUE,259,553,20,GO:BP,anatomical structure maturation,21010,17677,GO:0021700|GO:0048856,FALSE
CORUM:2745,0.0499539460404357,TRUE,5,292,4,CORUM,"Ubiquitin E3 ligase (TRAF6, TAB2, MALT1, UEV1A, BCL10)",3383,1169,CORUM:0000000,FALSE
CORUM:585,0.0499539460404357,TRUE,5,292,4,CORUM,Mi2/NuRD-BCL6-MTA3 complex,3383,326,CORUM:0000000,FALSE
CORUM:7225,0.0499539460404357,TRUE,5,292,4,CORUM,CDH4-HDAC2-MTA2-RBBP7-TWIST1 complex,3383,2707,CORUM:0000000,FALSE
CORUM:41,0.0499539460404357,TRUE,5,292,4,CORUM,Mi-2/NuRD-MTA3 complex,3383,18,CORUM:0000000,FALSE
